| Psychedelics ↗ | Kelmendi B, Kaye AP, Pittenger C et al. | 2022 | Current biology : CB | 1246 |
| Predicting new molecular targets for known drugs ↗ | Keiser MJ, Setola V, Irwin JJ et al. | 2009 | Nature | 1118 |
| Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial ↗ | Palhano-Fontes F, Barreto D, Onias H et al. | 2019 | Psychological medicine | 829 |
| The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator ↗ | Fontanilla D, Johannessen M, Hajipour AR et al. | 2009 | Science (New York, N.Y.) | 528 |
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report ↗ | Osório Fde L, Sanches RF, Macedo LR et al. | 2015 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 487 |
| Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study ↗ | Sanches RF, de Lima Osório F, Dos Santos RG et al. | 2016 | Journal of clinical psychopharmacology | 468 |
| The pharmacology of psilocybin ↗ | Passie T, Seifert J, Schneider U et al. | 2002 | Addiction biology | 465 |
| The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network ↗ | Palhano-Fontes F, Andrade KC, Tofoli LF et al. | 2015 | PloS one | 461 |
| Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale ↗ | Strassman RJ, Qualls CR, Uhlenhuth EH et al. | 1994 | Archives of general psychiatry | 454 |
| A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system ↗ | Dumuis A, Bouhelal R, Sebben M et al. | 1988 | Molecular pharmacology | 439 |
| Psychedelics and Psychedelic-Assisted Psychotherapy ↗ | Reiff CM, Richman EE, Nemeroff CB et al. | 2020 | The American journal of psychiatry | 401 |
| Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca ↗ | McKenna DJ, Towers GH, Abbott F | 1984 | Journal of ethnopharmacology | 399 |
| Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics ↗ | Riba J, Valle M, Urbano G et al. | 2003 | The Journal of pharmacology and experimental therapeutics | 383 |
| A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors ↗ | Goodwin GM, Green AR | 1985 | British journal of pharmacology | 380 |
| Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens ↗ | Rickli A, Moning OD, Hoener MC et al. | 2016 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 376 |
| Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations ↗ | Bowdle TA, Radant AD, Cowley DS et al. | 1998 | Anesthesiology | 371 |
| Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile ↗ | Kehne JH, Baron BM, Carr AA et al. | 1996 | The Journal of pharmacology and experimental therapeutics | 359 |
| The Columbian Exchange: A History of Disease, Food, and Ideas ↗ | Nathan Nunn, Nancy Qian | 2010 | The Journal of Economic Perspectives | 333 |
| Neural correlates of the DMT experience assessed with multivariate EEG ↗ | Timmermann C, Roseman L, Schartner M et al. | 2019 | Scientific reports | 326 |
| Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study ↗ | Bouso JC, González D, Fondevila S et al. | 2012 | PloS one | 314 |
| Towards an understanding of psychedelic-induced neuroplasticity ↗ | Calder AE, Hasler G | 2023 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 309 |
| Pharmacokinetics of Hoasca alkaloids in healthy humans ↗ | Callaway JC, McKenna DJ, Grob CS et al. | 1999 | Journal of ethnopharmacology | 307 |
| Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers ↗ | Riba J, Rodríguez-Fornells A, Urbano G et al. | 2001 | Psychopharmacology | 302 |
| Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges ↗ | McKenna DJ | 2004 | Pharmacology & therapeutics | 299 |
| The hallucinogenic world of tryptamines: an updated review ↗ | Araújo AM, Carvalho F, Bastos Mde L et al. | 2015 | Archives of toxicology | 291 |
| Clinical toxicology of newer recreational drugs ↗ | Hill SL, Thomas SH | 2011 | Clinical toxicology (Philadelphia, Pa.) | 289 |
| Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects ↗ | Strassman RJ, Qualls CR | 1994 | Archives of general psychiatry | 286 |
| Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics ↗ | de Vos CMH, Mason NL, Kuypers KPC | 2021 | Frontiers in psychiatry | 261 |
| Neuropharmacology of N,N-dimethyltryptamine ↗ | Carbonaro TM, Gatch MB | 2016 | Brain research bulletin | 259 |
| Human psychopharmacology of N,N-dimethyltryptamine ↗ | Strassman RJ | 1996 | Behavioural brain research | 257 |
| Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics ↗ | Aleksandrova LR, Phillips AG | 2021 | Trends in pharmacological sciences | 257 |
| Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT ↗ | Griffiths RR, Hurwitz ES, Davis AK et al. | 2019 | PloS one | 249 |
| Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome ↗ | Smith LM, Peroutka SJ | 1986 | Pharmacology, biochemistry, and behavior | 245 |
| Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant ↗ | Riba J, Romero S, Grasa E et al. | 2006 | Psychopharmacology | 245 |
| Effects of psilocybin on time perception and temporal control of behaviour in humans ↗ | Wittmann M, Carter O, Hasler F et al. | 2007 | Journal of psychopharmacology (Oxford, England) | 245 |
| Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids ↗ | Gable RS | 2007 | Addiction (Abingdon, England) | 240 |
| The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization ↗ | Frecska E, Bokor P, Winkelman M | 2016 | Frontiers in pharmacology | 237 |
| Endogenous Release of Neuronal Serotonin and 5‐Hydroxyindoleacetic Acid in the Caudate‐Putamen of the Rat as Revealed by Intracerebral Dialysis Coupled to High‐Performance Liquid Chromatography with Fluorimetric Detection ↗ | Peter Kalén, Robert E. Strecker, Evald Rosengren et al. | 1988 | Journal of Neurochemistry | 236 |
| Assessment of addiction severity among ritual users of ayahuasca ↗ | Fábregas JM, González D, Fondevila S et al. | 2010 | Drug and alcohol dependence | 228 |
| DMT Models the Near-Death Experience ↗ | Timmermann C, Roseman L, Williams L et al. | 2018 | Frontiers in psychology | 228 |
| Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors ↗ | Gudelsky GA, Koenig JI, Meltzer HY | 1986 | Neuropharmacology | 224 |
| Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans ↗ | Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A et al. | 2015 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 224 |
| Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin ↗ | Kennett GA, Chaouloff F, Marcou M et al. | 1986 | Brain research | 223 |
| Ayahuasca: Pharmacology, neuroscience and therapeutic potential ↗ | Domínguez-Clavé E, Soler J, Elices M et al. | 2016 | Brain research bulletin | 221 |
| Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies ↗ | Breeksema JJ, Niemeijer AR, Krediet E et al. | 2020 | CNS drugs | 220 |
| Human brain effects of DMT assessed via EEG-fMRI ↗ | Timmermann C, Roseman L, Haridas S et al. | 2023 | Proceedings of the National Academy of Sciences of the United States of America | 218 |
| The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain ↗ | Burchett SA, Hicks TP | 2006 | Progress in neurobiology | 217 |
| Recreational use, analysis and toxicity of tryptamines ↗ | Tittarelli R, Mannocchi G, Pantano F et al. | 2015 | Current neuropharmacology | 217 |
| Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine ↗ | Trulson ME, Jacobs BL | 1976 | European journal of pharmacology | 214 |
| Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice ↗ | Halberstadt AL, Koedood L, Powell SB et al. | 2011 | Journal of psychopharmacology (Oxford, England) | 213 |
| Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities ↗ | Soler J, Elices M, Franquesa A et al. | 2016 | Psychopharmacology | 212 |
| Hallucinogens and dissociative agents naturally growing in the United States ↗ | Halpern JH | 2004 | Pharmacology & therapeutics | 210 |
| The globalization of ayahuasca: harm reduction or benefit maximization? ↗ | Tupper KW | 2008 | The International journal on drug policy | 207 |
| A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy ↗ | Luoma JB, Chwyl C, Bathje GJ et al. | 2020 | Journal of psychoactive drugs | 207 |
| Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors ↗ | Glennon RA, Dukat M, Grella B et al. | 2000 | Drug and alcohol dependence | 205 |
| Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities ↗ | Sampedro F, de la Fuente Revenga M, Valle M et al. | 2017 | The international journal of neuropsychopharmacology | 205 |
| Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking ↗ | Kuypers KP, Riba J, de la Fuente Revenga M et al. | 2016 | Psychopharmacology | 204 |
| Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat ↗ | Lucki I, Nobler MS, Frazer A | 1984 | The Journal of pharmacology and experimental therapeutics | 202 |
| The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain ↗ | Nagai F, Nonaka R, Satoh Hisashi Kamimura K | 2007 | European journal of pharmacology | 199 |
| Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers ↗ | Gouzoulis-Mayfrank E, Heekeren K, Neukirch A et al. | 2005 | Pharmacopsychiatry | 198 |
| A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms ↗ | Uthaug MV, Lancelotta R, van Oorsouw K et al. | 2019 | Psychopharmacology | 198 |
| The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat ↗ | Barbeau H, Rossignol S | 1990 | Brain research | 196 |
| Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies ↗ | Andersen KAA, Carhart-Harris R, Nutt DJ et al. | 2021 | Acta psychiatrica Scandinavica | 195 |
| The promises and perils of psychedelic pharmacology for psychiatry ↗ | McClure-Begley TD, Roth BL | 2022 | Nature reviews. Drug discovery | 195 |
| Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats ↗ | Kennett GA, Dickinson SL, Curzon G | 1985 | Brain research | 193 |
| beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) ↗ | Herraiz T, González D, Ancín-Azpilicueta C et al. | 2010 | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association | 191 |
| Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells ↗ | Szabo A, Kovacs A, Frecska E et al. | 2014 | PloS one | 191 |
| Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro ↗ | Saavedra JM, Axelrod J | 1972 | Science (New York, N.Y.) | 187 |
| Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists ↗ | Glennon RA, Young R, Rosecrans JA | 1983 | European journal of pharmacology | 187 |
| Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine ↗ | Trulson ME, Eubanks EE, Jacobs BL | 1976 | The Journal of pharmacology and experimental therapeutics | 186 |
| Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil ↗ | Grob CS, McKenna DJ, Callaway JC et al. | 1996 | The Journal of nervous and mental disease | 185 |
| Enzymatic formation of psychotomimetic metabolites from normally occurring compounds ↗ | AXELROD J | 1961 | Science (New York, N.Y.) | 184 |
| Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents ↗ | Njung'e K, Handley SL | 1991 | British journal of pharmacology | 181 |
| Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada ↗ | Thomas G, Lucas P, Capler NR et al. | 2013 | Current drug abuse reviews | 180 |
| Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor ↗ | Grahame-Smith DG | 1971 | British journal of pharmacology | 179 |
| Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness ↗ | Hamill J, Hallak J, Dursun SM et al. | 2019 | Current neuropharmacology | 179 |
| Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans ↗ | Valle M, Maqueda AE, Rabella M et al. | 2016 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 175 |
| N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function ↗ | Barker SA | 2018 | Frontiers in neuroscience | 175 |
| “Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation ↗ | Laurent Rivier, Jan‐Erik Lindgren | 1972 | Economic Botany | 173 |
| Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone ↗ | Kennett GA, Dickinson SL, Curzon G | 1985 | European journal of pharmacology | 173 |
| The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro ↗ | Morales-García JA, de la Fuente Revenga M, Alonso-Gil S et al. | 2017 | Scientific reports | 173 |
| Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial ↗ | de Almeida RN, Galvão ACM, da Silva FS et al. | 2019 | Frontiers in psychology | 173 |
| Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons ↗ | Kelland MD, Freeman AS, Chiodo LA | 1990 | The Journal of pharmacology and experimental therapeutics | 172 |
| Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin ↗ | Claude de Montigny, George K. Aghajanian | 1977 | Neuropharmacology | 171 |
| Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions ↗ | Shen HW, Jiang XL, Winter JC et al. | 2010 | Current drug metabolism | 171 |
| Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids ↗ | Moloudizargari M, Mikaili P, Aghajanshakeri S et al. | 2013 | Pharmacognosy reviews | 171 |
| Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America ↗ | Miller MJ, Albarracin-Jordan J, Moore C et al. | 2019 | Proceedings of the National Academy of Sciences of the United States of America | 171 |
| Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review ↗ | Breeksema JJ, Kuin BW, Kamphuis J et al. | 2022 | Journal of psychopharmacology (Oxford, England) | 171 |
| Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression ↗ | Cameron LP, Benson CJ, Dunlap LE et al. | 2018 | ACS chemical neuroscience | 169 |
| Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies ↗ | Dos Santos RG, Bouso JC, Hallak JEC | 2017 | Therapeutic advances in psychopharmacology | 167 |
| 5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons ↗ | Cardenas CG, Del Mar LP, Cooper BY et al. | 1997 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 166 |
| Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years ↗ | Dos Santos RG, Osório FL, Crippa JA et al. | 2016 | Therapeutic advances in psychopharmacology | 164 |
| Chronic, Intermittent Microdoses of the Psychedelic <i>N</i>,<i>N</i>-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents ↗ | Cameron LP, Benson CJ, DeFelice BC et al. | 2019 | ACS chemical neuroscience | 164 |
| Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum ↗ | Ennis C, Kemp JD, Cox B | 1981 | Journal of neurochemistry | 163 |
| Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors ↗ | Critchley MA, Handley SL | 1987 | Psychopharmacology | 158 |
| Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca ↗ | Callaway JC, Raymon LP, Hearn WL et al. | 1996 | Journal of analytical toxicology | 158 |
| Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation ↗ | Svenningsson P, Tzavara ET, Qi H et al. | 2007 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 158 |
| Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis ↗ | Heekeren K, Daumann J, Daumann J et al. | 2008 | Psychopharmacology | 158 |
| Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies ↗ | Dos Santos RG, Osório FL, Crippa JA et al. | 2016 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 158 |
| Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder ↗ | D'Souza DC, Syed SA, Flynn LT et al. | 2022 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 156 |
| Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture ↗ | Dumuis A, Sebben M, Bockaert J | 1988 | Molecular pharmacology | 155 |
| Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca ↗ | Viol A, Palhano-Fontes F, Onias H et al. | 2017 | Scientific reports | 154 |
| Default Mode Network Modulation by Psychedelics: A Systematic Review ↗ | Gattuso JJ, Perkins D, Ruffell S et al. | 2023 | The international journal of neuropsychopharmacology | 154 |
| Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs ↗ | Evans JP, Grahame-Smith DG, Green AR et al. | 1976 | British journal of pharmacology | 153 |
| Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities ↗ | Szabo A | 2015 | Frontiers in immunology | 153 |
| The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats ↗ | Deakin JF, Green AR | 1978 | British journal of pharmacology | 152 |
| Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex ↗ | Pierce PA, Peroutka SJ | 1989 | Psychopharmacology | 152 |
| DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences ↗ | Rick J. Strassman | 2000 | UNM’s Digital Repository (University of New Mexico) | 152 |
| Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA ↗ | Mithoefer MC, Grob CS, Brewerton TD | 2016 | The lancet. Psychiatry | 151 |
| Improved Fischer Indole Reaction for the Preparation of N,N-Dimethyltryptamines: Synthesis of L-695,894, a Potent 5-HT1D Receptor Agonist ↗ | Cheng-yi Chen, Chris H. Senanayake, Timothy J. Bill et al. | 1994 | The Journal of Organic Chemistry | 150 |
| 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors ↗ | Glennon RA, Lee M, Rangisetty JB et al. | 2000 | Journal of medicinal chemistry | 149 |
| Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion ↗ | de Araujo DB, Ribeiro S, Cecchi GA et al. | 2012 | Human brain mapping | 146 |
| Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors ↗ | Smith RL, Canton H, Barrett RJ et al. | 1998 | Pharmacology, biochemistry, and behavior | 145 |
| Survey of entity encounter experiences occasioned by inhaled <i>N,N</i>-dimethyltryptamine: Phenomenology, interpretation, and enduring effects ↗ | Davis AK, Clifton JM, Weaver EG et al. | 2020 | Journal of psychopharmacology (Oxford, England) | 145 |
| Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists ↗ | Gudelsky GA, Yamamoto BK, Nash JF | 1994 | European journal of pharmacology | 144 |
| Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats ↗ | Fantegrossi WE, Harrington AW, Kiessel CL et al. | 2006 | Pharmacology, biochemistry, and behavior | 144 |
| Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter ↗ | Cozzi NV, Gopalakrishnan A, Anderson LL et al. | 2009 | Journal of neural transmission (Vienna, Austria : 1996) | 144 |
| A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010 ↗ | Barker SA, McIlhenny EH, Strassman R | 2012 | Drug testing and analysis | 143 |
| Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews ↗ | Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ et al. | 2018 | Expert review of clinical pharmacology | 143 |
| Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants ↗ | Galvão-Coelho NL, Marx W, Gonzalez M et al. | 2021 | Psychopharmacology | 143 |
| A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation ↗ | Sklerov J, Levine B, Moore KA et al. | 2005 | Journal of analytical toxicology | 142 |
| Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat ↗ | Tricklebank MD, Forler C, Middlemiss DN et al. | 1985 | European journal of pharmacology | 141 |
| 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety ↗ | Davis AK, So S, Lancelotta R et al. | 2019 | The American journal of drug and alcohol abuse | 141 |
| N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo ↗ | Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA et al. | 2020 | Translational psychiatry | 140 |
| Pharmacology of ayahuasca administered in two repeated doses ↗ | Dos Santos RG, Grasa E, Valle M et al. | 2012 | Psychopharmacology | 139 |
| The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption ↗ | Davis AK, Barsuglia JP, Lancelotta R et al. | 2018 | Journal of psychopharmacology (Oxford, England) | 138 |
| Classical psychedelics for the treatment of depression and anxiety: A systematic review ↗ | Muttoni S, Ardissino M, John C | 2019 | Journal of affective disorders | 138 |
| Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT ↗ | Dakic V, Minardi Nascimento J, Costa Sartore R et al. | 2017 | Scientific reports | 137 |
| Pharmahuasca: human pharmacology of oral DMT plus harmine ↗ | Ott J | 1999 | Journal of psychoactive drugs | 136 |
| Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine ↗ | Dos Santos RG, Valle M, Bouso JC et al. | 2011 | Journal of clinical psychopharmacology | 136 |
| Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review ↗ | Ko K, Knight G, Rucker JJ et al. | 2022 | Frontiers in psychiatry | 136 |
| 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution ↗ | Duncan MJ, Takahashi JS, Dubocovich ML | 1988 | Endocrinology | 134 |
| Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines ↗ | Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D et al. | 2000 | Journal of medicinal chemistry | 133 |
| Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment ↗ | Brierley DI, Davidson C | 2012 | Progress in neuro-psychopharmacology & biological psychiatry | 133 |
| Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography ↗ | Riba J, Anderer P, Jané F et al. | 2004 | Neuropsychobiology | 131 |
| Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis ↗ | Sadzot B, Baraban JM, Glennon RA et al. | 1989 | Psychopharmacology | 130 |
| Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans ↗ | Strassman RJ, Qualls CR, Berg LM | 1996 | Biological psychiatry | 130 |
| The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory ↗ | Winter JC, Petti DT | 1987 | Pharmacology, biochemistry, and behavior | 128 |
| The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases ↗ | Penke B, Fulop L, Szucs M et al. | 2018 | Current neuropharmacology | 127 |
| Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213 ↗ | Pugh MT, O'Boyle KM, Molloy AG et al. | 1985 | Psychopharmacology | 126 |
| Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers ↗ | Riba J, Anderer P, Morte A et al. | 2002 | British journal of clinical pharmacology | 126 |
| The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging ↗ | Dos Santos RG, Balthazar FM, Bouso JC et al. | 2016 | Journal of psychopharmacology (Oxford, England) | 126 |
| Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis ↗ | Hinkle JT, Graziosi M, Nayak SM et al. | 2024 | JAMA psychiatry | 126 |
| Bufo alvarius: a potent hallucinogen of animal origin ↗ | Weil AT, Davis W | 1994 | Journal of ethnopharmacology | 125 |
| Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action ↗ | Kennett GA, Marcou M, Dourish CT et al. | 1987 | European journal of pharmacology | 124 |
| Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution ↗ | Uthaug MV, van Oorsouw K, Kuypers KPC et al. | 2018 | Psychopharmacology | 124 |
| The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine ↗ | Gillin JC, Kaplan J, Stillman R et al. | 1976 | The American journal of psychiatry | 123 |
| The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells ↗ | Szabo A, Kovacs A, Riba J et al. | 2016 | Frontiers in neuroscience | 123 |
| Serotonin receptor sensitivity after acute and chronic treatment with mianserin ↗ | Blackshear MA, Sanders-Bush E | 1982 | The Journal of pharmacology and experimental therapeutics | 122 |
| Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin ↗ | Carter OL, Pettigrew JD, Hasler F et al. | 2005 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 122 |
| Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons ↗ | Fuxe K, Holmstedt B, Jonsson G | 1972 | European journal of pharmacology | 120 |
| Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis ↗ | Haleem DJ, Kennett G, Curzon G | 1988 | Brain research | 119 |
| Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat ↗ | Schoenfeld RI | 1976 | Science (New York, N.Y.) | 118 |
| Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine ↗ | Jacob MS, Presti DE | 2005 | Medical hypotheses | 118 |
| Serotonergic Hallucinogen-Induced Visual Perceptual Alterations ↗ | Kometer M, Vollenweider FX | 2018 | Current topics in behavioral neurosciences | 118 |
| The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition ↗ | Grahame-Smith DG, Green AR | 1974 | British journal of pharmacology | 117 |
| Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms ↗ | Dos Santos RG, Hallak JEC | 2020 | Neuroscience and biobehavioral reviews | 117 |
| Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment ↗ | Uthaug MV, Lancelotta R, Szabo A et al. | 2020 | Psychopharmacology | 116 |
| A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats ↗ | Uthaug MV, Mason NL, Toennes SW et al. | 2021 | Psychopharmacology | 116 |
| Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses ↗ | Drummond E-Wen McCulloch, Gitte M. Knudsen, Frederick S. Barrett et al. | 2022 | Neuroscience & Biobehavioral Reviews | 116 |
| Acute Biphasic Effects of Ayahuasca ↗ | Schenberg EE, Alexandre JF, Filev R et al. | 2015 | PloS one | 115 |
| Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey ↗ | Bouso JC, Andión Ó, Sarris JJ et al. | 2022 | PLOS global public health | 115 |
| Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT) ↗ | Cameron LP, Olson DE | 2018 | ACS chemical neuroscience | 114 |
| N, N-dimethyltryptamine: an endogenous hallucinogen ↗ | Barker SA, Monti JA, Christian ST | 1981 | International review of neurobiology | 113 |
| The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands ↗ | Mishra AK, Mavlyutov T, Singh DR et al. | 2015 | The Biochemical journal | 113 |
| Health status of ayahuasca users ↗ | Barbosa PC, Mizumoto S, Bogenschutz MP et al. | 2012 | Drug testing and analysis | 112 |
| Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase ↗ | Yu AM, Idle JR, Herraiz T et al. | 2003 | Pharmacogenetics | 111 |
| Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members ↗ | Santos RG, Landeira-Fernandez J, Strassman RJ et al. | 2007 | Journal of ethnopharmacology | 111 |
| Potential applications for sigma receptor ligands in cancer diagnosis and therapy ↗ | van Waarde A, Rybczynska AA, Ramakrishnan NK et al. | 2015 | Biochimica et biophysica acta | 111 |
| Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain ↗ | Dean JG, Liu T, Huff S et al. | 2019 | Scientific reports | 111 |
| Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination ↗ | Jiménez-Garrido DF, Gómez-Sousa M, Ona G et al. | 2020 | Scientific reports | 111 |
| Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids <i>N</i>,<i>N</i>-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact ↗ | Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM et al. | 2020 | Pharmaceuticals (Basel, Switzerland) | 111 |
| ↗ | Ai‐Ming Yu, Jeffrey R. Idle, Tomás Herraiz et al. | 2003 | Pharmacogenetics | 110 |
| When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor ↗ | Su TP, Hayashi T, Vaupel DB | 2009 | Science signaling | 110 |
| Activity of serotonin-containing neurons in the nucleus raphe pallidus of freely moving cats ↗ | Heym J, Steinfels GF, Jacobs BL | 1982 | Brain research | 109 |
| Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5 ↗ | Shapiro DA, Kristiansen K, Kroeze WK et al. | 2000 | Molecular pharmacology | 109 |
| Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors ↗ | Heal DJ, Philpot J, Molyneux SG et al. | 1985 | Neuropharmacology | 108 |
| Selective activation of 5HT1A receptors induces lower lip retraction in the rat ↗ | Berendsen HH, Jenck F, Broekkamp CL | 1989 | Pharmacology, biochemistry, and behavior | 108 |
| The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) ↗ | Reckweg JT, Uthaug MV, Szabo A et al. | 2022 | Journal of neurochemistry | 108 |
| A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity ↗ | Frecska E, Szabo A, Winkelman MJ et al. | 2013 | Journal of neural transmission (Vienna, Austria : 1996) | 107 |
| Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine ↗ | Ott J | 2001 | Journal of psychoactive drugs | 106 |
| The oligomeric states of the purified sigma-1 receptor are stabilized by ligands ↗ | Gromek KA, Suchy FP, Meddaugh HR et al. | 2014 | The Journal of biological chemistry | 106 |
| Serotonergic psychedelics temporarily modify information transfer in humans ↗ | Alonso JF, Romero S, Mañanas MÀ et al. | 2015 | The international journal of neuropsychopharmacology | 105 |
| Psychological and neuropsychological assessment of regular hoasca users ↗ | Barbosa PC, Strassman RJ, da Silveira DX et al. | 2016 | Comprehensive psychiatry | 104 |
| Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program ↗ | Soler J, Elices M, Dominguez-Clavé E et al. | 2018 | Frontiers in pharmacology | 104 |
| Sigma Receptors in Oncology: Therapeutic and Diagnostic Applications of Sigma Ligands ↗ | Aren van Waarde, Anna A. Rybczynska, Nisha K. Ramakrishnan et al. | 2010 | Current Pharmaceutical Design | 103 |
| Investigation of the Structure-Activity Relationships of Psilocybin Analogues ↗ | Klein AK, Chatha M, Laskowski LJ et al. | 2021 | ACS pharmacology & translational science | 103 |
| A Dimethyltryptamine-Forming Enzyme in Human Blood ↗ | Richard Jed Wyatt, Juan M. Saavedra, Julius Axelrod | 1973 | American Journal of Psychiatry | 102 |
| Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample ↗ | Winstock AR, Kaar S, Borschmann R | 2014 | Journal of psychopharmacology (Oxford, England) | 102 |
| Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls ↗ | Galvão ACM, de Almeida RN, Silva EADS et al. | 2018 | Frontiers in psychiatry | 102 |
| Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors ↗ | Backus LI, Sharp T, Grahame-Smith DG | 1990 | British journal of pharmacology | 101 |
| Psilocybin: from ancient magic to modern medicine ↗ | Nichols DE | 2020 | The Journal of antibiotics | 101 |
| Noradrenergic-serotonergic interactions and nociception in the rat ↗ | Archer T, Jonsson G, Minor BG et al. | 1986 | European journal of pharmacology | 99 |
| 5HT-2 mediation of acute behavioral effects of hallucinogens in rats ↗ | Wing LL, Tapson GS, Geyer MA | 1990 | Psychopharmacology | 99 |
| Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys ↗ | Fantegrossi WE, Woods JH, Winger G | 2004 | Behavioural pharmacology | 99 |
| Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat ↗ | Pic-Taylor A, da Motta LG, de Morais JA et al. | 2015 | Behavioural processes | 99 |
| Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei ↗ | Nicolaou NM, Garcia-Munoz M, Arbuthnott GW et al. | 1979 | European journal of pharmacology | 98 |
| Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis ↗ | Ko K, Kopra EI, Cleare AJ et al. | 2023 | Journal of affective disorders | 97 |
| The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats ↗ | Krebs-Thomson K, Ruiz EM, Masten V et al. | 2006 | Psychopharmacology | 96 |
| Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users ↗ | Bouso JC, Fábregas JM, Antonijoan RM et al. | 2013 | Psychopharmacology | 96 |
| Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study ↗ | Riba J, McIlhenny EH, Bouso JC et al. | 2015 | Drug testing and analysis | 96 |
| Three serotonin responses in cultured mouse hippocampal and striatal neurons ↗ | Yakel JL, Trussell LO, Jackson MB | 1988 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 95 |
| Minimum inhibitory concentrations of medicinal plants used in Northern Peru as antibacterial remedies ↗ | Bussmann RW, Malca-García G, Glenn A et al. | 2010 | Journal of ethnopharmacology | 95 |
| Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca ↗ | Barbosa PCR, Tófoli LF, Bogenschutz MP et al. | 2018 | Frontiers in psychiatry | 95 |
| Psychedelic Drug Legislative Reform and Legalization in the US ↗ | Siegel JS, Daily JE, Perry DA et al. | 2023 | JAMA psychiatry | 95 |
| A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors ↗ | Parker EM, Grisel DA, Iben LG et al. | 1993 | Journal of neurochemistry | 92 |
| N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists ↗ | Tsai Y, Dukat M, Slassi A et al. | 2000 | Bioorganic & medicinal chemistry letters | 92 |
| Psychometric assessment of the Hallucinogen Rating Scale ↗ | Riba J, Rodríguez-Fornells A, Strassman RJ et al. | 2001 | Drug and alcohol dependence | 92 |
| Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting ↗ | Palamar JJ, Martins SS, Su MK et al. | 2015 | Drug and alcohol dependence | 92 |
| Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans ↗ | Nunes AA, Dos Santos RG, Osório FL et al. | 2016 | Journal of psychoactive drugs | 92 |
| Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants ↗ | Lucki I, Frazer A | 1982 | Psychopharmacology | 91 |
| Anti-aversive role of serotonin in the dorsal periaqueductal grey matter ↗ | Schütz MT, de Aguiar JC, Graeff FG | 1985 | Psychopharmacology | 91 |
| Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease ↗ | Samoylenko V, Rahman MM, Tekwani BL et al. | 2010 | Journal of ethnopharmacology | 91 |
| Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca ↗ | Riba J, McIlhenny EH, Valle M et al. | 2012 | Drug testing and analysis | 91 |
| Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process ↗ | Inserra A | 2018 | Frontiers in pharmacology | 91 |
| N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats ↗ | Nardai S, László M, Szabó A et al. | 2020 | Experimental neurology | 91 |
| Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice ↗ | Glatfelter GC, Pottie E, Partilla JS et al. | 2022 | ACS pharmacology & translational science | 91 |
| Effects of maternal stress during different gestational periods on the serotonergic system in adult rat offspring ↗ | Peters DA | 1988 | Pharmacology, biochemistry, and behavior | 90 |
| Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications ↗ | Kraehenmann R | 2017 | Current neuropharmacology | 90 |
| Identification of Psychoplastogenic <i>N</i>,<i>N</i>-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies ↗ | Dunlap LE, Azinfar A, Ly C et al. | 2020 | Journal of medicinal chemistry | 90 |
| Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis ↗ | Callaway JC, Brito GS, Neves ES | 2005 | Journal of psychoactive drugs | 89 |
| A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists ↗ | Green AR, Hall JE, Rees AR | 1981 | British journal of pharmacology | 88 |
| Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain ↗ | Peroutka SJ | 1985 | Brain research | 88 |
| Stimulation of spinal serotonergic receptors facilitates seminal emission and suppresses penile erectile reflexes ↗ | Mas M, Zahradnik MA, Martino V et al. | 1985 | Brain research | 88 |
| Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers ↗ | Murphy-Beiner A, Soar K | 2020 | Psychopharmacology | 88 |
| Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine ↗ | Franzen F, Gross H | 1965 | Nature | 87 |
| The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants ↗ | Green AR, Guy AP, Gardner CR | 1984 | Neuropharmacology | 87 |
| Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine ↗ | Thor KB, Hisamitsu T, de Groat WC | 1990 | Brain research. Developmental brain research | 87 |
| A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression ↗ | Reckweg JT, van Leeuwen CJ, Henquet C et al. | 2023 | Frontiers in psychiatry | 87 |
| The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo ↗ | Brazell MP, Marsden CA, Nisbet AP et al. | 1985 | British journal of pharmacology | 86 |
| A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus ↗ | Lima da Cruz RV, Moulin TC, Petiz LL et al. | 2018 | Frontiers in molecular neuroscience | 86 |
| DMT alters cortical travelling waves ↗ | Alamia A, Timmermann C, Nutt DJ et al. | 2020 | eLife | 86 |
| Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants ↗ | Vogt SB, Ley L, Erne L et al. | 2023 | Translational psychiatry | 86 |
| Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca ↗ | Yritia M, Riba J, Ortuño J et al. | 2002 | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 84 |
| Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being ↗ | Kiraga MK, Mason NL, Uthaug MV et al. | 2021 | Frontiers in pharmacology | 84 |
| Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats ↗ | Fornal CA, Litto WJ, Metzler CW et al. | 1994 | The Journal of pharmacology and experimental therapeutics | 83 |
| Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans ↗ | Davis AK, Averill LA, Sepeda ND et al. | 2020 | Chronic stress (Thousand Oaks, Calif.) | 83 |
| A narrative synthesis of research with 5-MeO-DMT ↗ | Ermakova AO, Dunbar F, Rucker J et al. | 2022 | Journal of psychopharmacology (Oxford, England) | 83 |
| 5-methyltetrahydrofolic Acid as a mediator in the formation of pyridoindoles ↗ | Mandel LR, Rosegay A, Walker RW et al. | 1974 | Science (New York, N.Y.) | 82 |
| Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior ↗ | Marek GJ, Li AA, Seiden LS | 1989 | The Journal of pharmacology and experimental therapeutics | 82 |
| Examining changes in personality following shamanic ceremonial use of ayahuasca ↗ | Weiss B, Miller JD, Carter NT et al. | 2021 | Scientific reports | 81 |
| The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors ↗ | Winter JC, Filipink RA, Timineri D et al. | 2000 | Pharmacology, biochemistry, and behavior | 80 |
| Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study ↗ | Barsuglia J, Davis AK, Palmer R et al. | 2018 | Frontiers in psychology | 80 |
| The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial ↗ | Zeifman RJ, Palhano-Fontes F, Hallak J et al. | 2019 | Frontiers in pharmacology | 80 |
| Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis ↗ | Yao Y, Guo D, Lu TS et al. | 2024 | Psychiatry research | 80 |
| Effects of 5-HT receptor agonists and antagonists on a reflex response to radiant heat in normal and spinally transected rats ↗ | Berge OG | 1982 | Pain | 79 |
| Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory ↗ | Egashira N, Mishima K, Katsurabayashi S et al. | 2002 | European journal of pharmacology | 79 |
| A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS ↗ | Vorce SP, Sklerov JH | 2004 | Journal of analytical toxicology | 79 |
| Secondary metabolites from three Florida sponges with antidepressant activity ↗ | Kochanowska AJ, Rao KV, Childress S et al. | 2008 | Journal of natural products | 79 |
| The effects of quipazine on 5-HT metabolism in the rat brain ↗ | Hamon M, Bourgoin S, Enjalbert A et al. | 1976 | Naunyn-Schmiedeberg's archives of pharmacology | 78 |
| Identification of cytokinins produced by the plant parasitic nematodes Heterodera schachtii and Meloidogyne incognita ↗ | Jan De Meutter, Tom Tytgat, Erwin Witters et al. | 2003 | Molecular plant pathology | 78 |
| SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist ↗ | Sard H, Kumaran G, Morency C et al. | 2005 | Bioorganic & medicinal chemistry letters | 78 |
| Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N'-dimethyltryptamine forming enzyme, indole-N-methyl transferase ↗ | Mavlyutov TA, Epstein ML, Liu P et al. | 2012 | Neuroscience | 78 |
| Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions ↗ | Liester MB, Prickett JI | 2012 | Journal of psychoactive drugs | 78 |
| Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey ↗ | Lawn W, Hallak JE, Crippa JA et al. | 2017 | Scientific reports | 78 |
| An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats ↗ | Adell A, Sarna GS, Hutson PH et al. | 1989 | British journal of pharmacology | 77 |
| Novel antidepressant drugs: Beyond monoamine targets ↗ | Gonda X, Dome P, Neill JC et al. | 2023 | CNS spectrums | 77 |
| In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat ↗ | Sitaram BR, Lockett L, Talomsin R et al. | 1987 | Biochemical pharmacology | 76 |
| Synthesis and Serotonergic Activity of N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and Analogs: Potent Agonists for 5-HT1D Receptors ↗ | Leslie J. Street, R. BAKER, William B. Davey et al. | 1995 | Journal of Medicinal Chemistry | 76 |
| Various alkaloid profiles in decoctions of Banisteriopsis caapi ↗ | Callaway JC | 2005 | Journal of psychoactive drugs | 76 |
| Specificity of a rat behavioral model for serotonin receptor activation ↗ | Sloviter RS, Drust EG, Connor JD | 1978 | The Journal of pharmacology and experimental therapeutics | 75 |
| Activity of serotonin-containing neurons in nucleus centralis superior of freely moving cats ↗ | Rasmussen K, Heym J, Jacobs BL | 1984 | Experimental neurology | 75 |
| The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs ↗ | Riga MS, Soria G, Tudela R et al. | 2014 | The international journal of neuropsychopharmacology | 75 |
| Structural pharmacology and therapeutic potential of 5-methoxytryptamines ↗ | Warren AL, Lankri D, Cunningham MJ et al. | 2024 | Nature | 75 |
| Hydroxylation and N-demethylation of N, N-dimethyltryptamine ↗ | SZARA S, AXELROD J | 1959 | Experientia | 74 |
| beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine ↗ | Costain DW, Green AR | 1978 | British journal of pharmacology | 74 |
| Effects of 5-methoxy-N,N-dimethyltryptamine on behavior and raphe unit activity in freely moving cats ↗ | Trulson ME, Jacobs BL | 1979 | European journal of pharmacology | 74 |
| Modulation of the brain aversive system by GABAergic and serotonergic mechanisms ↗ | Graeff FG, Brandão ML, Audi EA et al. | 1986 | Behavioural brain research | 74 |
| Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers ↗ | Barbanoj MJ, Riba J, Clos S et al. | 2008 | Psychopharmacology | 74 |
| Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage ↗ | Pires AP, De Oliveira CD, Moura S et al. | 2009 | Phytochemical analysis : PCA | 74 |
| Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems ↗ | Mollica A, Locatelli M, Stefanucci A et al. | 2012 | Molecules (Basel, Switzerland) | 74 |
| Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca ↗ | Galvão-Coelho NL, de Menezes Galvão AC, de Almeida RN et al. | 2020 | Journal of psychopharmacology (Oxford, England) | 74 |
| Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study ↗ | Simon Ruffell, Nige Netzband, WaiFung Tsang et al. | 2021 | Frontiers in psychiatry | 74 |
| Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings ↗ | Pallavicini C, Cavanna F, Zamberlan F et al. | 2021 | Journal of psychopharmacology (Oxford, England) | 74 |
| Hyponeophagia and arousal in rats: effects of diazepam, 5-methoxy-N,N-dimethyltryptamine, d-amphetamine and food deprivation ↗ | Shephard RA, Broadhurst PL | 1982 | Psychopharmacology | 73 |
| Activity of serotonin-containing neurons in nucleus raphe magnus in freely moving cats ↗ | Fornal C, Auerbach S, Jacobs BL | 1985 | Experimental neurology | 73 |
| Reduced-5-hydroxytryptamine-dependent behavior in rats following chronic corticosterone treatment ↗ | Dickinson SL, Kennett GA, Curzon G | 1985 | Brain research | 73 |
| Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors ↗ | Deliganis AV, Pierce PA, Peroutka SJ | 1991 | Biochemical pharmacology | 73 |
| Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users ↗ | Cakic V, Potkonyak J, Marshall A | 2010 | Drug and alcohol dependence | 73 |
| LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate ↗ | Barker SA, Borjigin J, Lomnicka I et al. | 2013 | Biomedical chromatography : BMC | 73 |
| Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results ↗ | Loizaga-Velder A, Verres R | 2014 | Journal of psychoactive drugs | 73 |
| Therapeutic potential of ayahuasca in grief: a prospective, observational study ↗ | González D, Cantillo J, Pérez I et al. | 2020 | Psychopharmacology | 73 |
| Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey ↗ | Perkins D, Schubert V, Simonová H et al. | 2021 | Frontiers in pharmacology | 73 |
| The Psychedelic Future of Post-Traumatic Stress Disorder Treatment ↗ | Zaretsky TG, Jagodnik KM, Barsic R et al. | 2024 | Current neuropharmacology | 73 |
| Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates ↗ | Barker SA, Monti JA, Christian ST | 1980 | Biochemical pharmacology | 72 |
| Effect of isolation rearing on 5-HT agonist-induced responses in the rat ↗ | Wright IK, Ismail H, Upton N et al. | 1991 | Psychopharmacology | 72 |
| Subacute effects of the psychedelic ayahuasca on the salience and default mode networks ↗ | Pasquini L, Palhano-Fontes F, Araujo DB | 2020 | Journal of psychopharmacology (Oxford, England) | 72 |
| Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers ↗ | Jerome Sarris, Daniel Perkins, Lachlan Cribb et al. | 2021 | Journal of Affective Disorders Reports | 72 |
| Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively ↗ | Riba J, Rodríguez-Fornells A, Barbanoj MJ | 2002 | Psychopharmacology | 71 |
| Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study ↗ | van Oorsouw K, Toennes SW, Ramaekers JG | 2022 | Psychopharmacology | 71 |
| Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects ↗ | Kaplan J, Mandel LR, Stillman R et al. | 1974 | Psychopharmacologia | 70 |
| Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions ↗ | Callaway JC, Grob CS | 1998 | Journal of psychoactive drugs | 70 |
| The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle ↗ | Geyer MA, Petersen LR, Rose GJ et al. | 1978 | The Journal of pharmacology and experimental therapeutics | 69 |
| Brain iron and dopamine receptor function ↗ | Youdim MB, Ben-Shachar D, Ashkenazi R et al. | 1983 | Advances in biochemical psychopharmacology | 69 |
| Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine ↗ | Spencer DG Jr, Glaser T, Traber J | 1987 | Psychopharmacology | 69 |
| Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats ↗ | Fone KC, Robinson AJ, Marsden CA | 1991 | British journal of pharmacology | 69 |
| Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin ↗ | David E. Nichols | 1999 | Synthesis | 68 |
| Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys ↗ | May JA, McLaughlin MA, Sharif NA et al. | 2003 | The Journal of pharmacology and experimental therapeutics | 68 |
| A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract ↗ | Frison G, Favretto D, Zancanaro F et al. | 2008 | Forensic science international | 68 |
| The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice ↗ | Carbonaro TM, Eshleman AJ, Forster MJ et al. | 2015 | Psychopharmacology | 68 |
| N,N-dimethyltryptamine and the pineal gland: Separating fact from myth ↗ | Nichols DE | 2018 | Journal of psychopharmacology (Oxford, England) | 68 |
| Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test ↗ | Kitada Y, Miyauchi T, Kanazawa Y et al. | 1983 | Neuropharmacology | 67 |
| Lack of response of serotonergic neurons in the dorsal raphe nucleus of freely moving cats to stressful stimuli ↗ | Wilkinson LO, Jacobs BL | 1988 | Experimental neurology | 67 |
| A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects ↗ | Barbosa PC, Cazorla IM, Giglio JS et al. | 2009 | Journal of psychoactive drugs | 67 |
| Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice ↗ | Oliveira-Lima AJ, Santos R, Hollais AW et al. | 2015 | Physiology & behavior | 67 |
| The morphological and functional characteristics of the pineal gland ↗ | Bogdan‐Alexandru Gheban, Ioana Andreea Rosca, Maria Crişan | 2019 | Medicine and Pharmacy Reports | 67 |
| N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain ↗ | Szabó Í, Varga VÉ, Dvorácskó S et al. | 2021 | Neuropharmacology | 67 |
| The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism ↗ | Goodwin GM, De Souza RJ, Wood AJ et al. | 1986 | Psychopharmacology | 66 |
| Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclases in rat brain ↗ | A Enjalbert, M. Hamon, Sylvie Bourgoin et al. | 1978 | PubMed | 65 |
| 5-Hydroxytryptamine-mediated behaviour in male and female rats ↗ | Dickinson SL, Curzon G | 1986 | Neuropharmacology | 65 |
| The role of 5-HT(1A) receptors in control of lower urinary tract function in cats ↗ | Thor KB, Katofiasc MA, Danuser H et al. | 2002 | Brain research | 65 |
| Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence ↗ | Sarris J, McIntyre E, Camfield DA | 2013 | CNS drugs | 65 |
| Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging ↗ | Dos Santos RG, Osório FL, Crippa JAS et al. | 2016 | Neuroscience and biobehavioral reviews | 65 |
| In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape ↗ | Luppi AI, Hansen JY, Adapa R et al. | 2023 | Science advances | 65 |
| Behavioral effects of 5-methoxy-N:N-dimethyltryptamine, other tryptamines, and LSD ↗ | Peter K. Gessner, Irvine H. Page | 1962 | American Journal of Physiology-Legacy Content | 64 |
| Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats ↗ | Fone KC, Johnson JV, Bennett GW et al. | 1989 | British journal of pharmacology | 64 |
| Harmine is an inflammatory inhibitor through the suppression of NF-κB signaling ↗ | Liu X, Li M, Tan S et al. | 2017 | Biochemical and biophysical research communications | 64 |
| Serotonergic psychedelics and personality: A systematic review of contemporary research ↗ | Bouso JC, Dos Santos RG, Alcázar-Córcoles MÁ et al. | 2018 | Neuroscience and biobehavioral reviews | 64 |
| Registered clinical studies investigating psychedelic drugs for psychiatric disorders ↗ | Siegel AN, Meshkat S, Benitah K et al. | 2021 | Journal of psychiatric research | 64 |
| Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience ↗ | Lawrence DW, Carhart-Harris R, Griffiths R et al. | 2022 | Scientific reports | 64 |
| 5-HT<sub>2A</sub> receptors: Pharmacology and functional selectivity ↗ | Cummins BR, Billac GB, Nichols DE et al. | 2025 | Pharmacological reviews | 64 |
| The Use of Hallucinogens in the Treatment of Addiction ↗ | John H. Halpern | 1996 | Addiction Research | 63 |
| Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine ↗ | Blair JB, Marona-Lewicka D, Kanthasamy A et al. | 1999 | Journal of medicinal chemistry | 63 |
| Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens ↗ | McKenna DJ, Towers GH, Abbott FS | 1984 | Journal of ethnopharmacology | 62 |
| Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats ↗ | Arnt J | 1989 | Pharmacology & toxicology | 62 |
| Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis ↗ | Daumann J, Wagner D, Heekeren K et al. | 2010 | Journal of psychopharmacology (Oxford, England) | 62 |
| Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine ↗ | Chu UB, Vorperian SK, Satyshur K et al. | 2014 | Biochemistry | 62 |
| Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders ↗ | Lafrance A, Loizaga-Velder A, Fletcher J et al. | 2017 | Journal of psychoactive drugs | 62 |
| Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs ↗ | Hassan Z, Bosch OG, Singh D et al. | 2017 | Frontiers in psychiatry | 62 |
| Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease ↗ | Katchborian-Neto A, Santos WT, Nicácio KJ et al. | 2020 | Journal of ethnopharmacology | 62 |
| Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial ↗ | Zeifman RJ, Singhal N, Dos Santos RG et al. | 2021 | Psychopharmacology | 62 |
| Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2-adrenoceptor mediated function in mice ↗ | Goodwin GM, DeSouza RJ, Wood AJ et al. | 1986 | Psychopharmacology | 61 |
| Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum ↗ | Carter D, Champney M, Hwang B et al. | 1995 | European journal of pharmacology | 61 |
| Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels ↗ | Johannessen M, Fontanilla D, Mavlyutov T et al. | 2011 | American journal of physiology. Cell physiology | 61 |
| Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being ↗ | Corneille JS, Luke D | 2021 | Frontiers in psychology | 61 |
| THE EFFECT OF N,N-DIMETHYLTRYPTAMINE IN HUMAN SUBJECTS TOLERANT TO LYSERGIC ACID DIETHYLAMIDE ↗ | ROSENBERG DE, ISBELL H, MINER EJ et al. | 1964 | Psychopharmacologia | 60 |
| Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptamine-induced head-twitch response in mice ↗ | Matsumoto K, Mizowaki M, Takayama H et al. | 1997 | Pharmacology, biochemistry, and behavior | 60 |
| Pharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine ↗ | Ott J | 2001 | Journal of psychoactive drugs | 60 |
| Report on psychoactive drug use among adolescents using ayahuasca within a religious context ↗ | Doering-Silveira E, Grob CS, de Rios MD et al. | 2005 | Journal of psychoactive drugs | 60 |
| Psilocybin-induced stimulus control in the rat ↗ | Winter JC, Rice KC, Amorosi DJ et al. | 2007 | Pharmacology, biochemistry, and behavior | 60 |
| Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception ↗ | Wallach JV | 2009 | Medical hypotheses | 60 |
| Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying ↗ | Sweeney MM, Nayak S, Hurwitz ES et al. | 2022 | PloS one | 60 |
| Studies on the Mechanism of Action of Monoamine Oxidase: Metabolism of N,N-Dimethyltryptamine and N,N-Dimethyltryptamine-N-Oxide ↗ | Thomas E. Smith, Herbert Weissbach, Sidney Udenfriend | 1962 | Biochemistry | 59 |
| The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent ↗ | Christian ST, Harrison R, Quayle E et al. | 1977 | Biochemical medicine | 59 |
| beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses ↗ | Cowen PJ, Grahame-Smith DG, Green AR et al. | 1982 | British journal of pharmacology | 59 |
| Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine ↗ | Nabeshima T, Fukaya H, Yamaguchi K et al. | 1987 | European journal of pharmacology | 59 |
| Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells ↗ | Tourino MC, de Oliveira EM, Bellé LP et al. | 2013 | Cell biochemistry and function | 59 |
| The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges ↗ | Dos Santos RG, Bouso JC, Rocha JM et al. | 2021 | Risk management and healthcare policy | 59 |
| Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT ↗ | Barker SA | 2022 | Psychopharmacology | 59 |
| A characteristic effect of hallucinogens on investigatory responding in rats ↗ | Geyer MA, Light RK, Rose GJ et al. | 1979 | Psychopharmacology | 58 |
| 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens ↗ | Rabin RA, Regina M, Doat M et al. | 2002 | Pharmacology, biochemistry, and behavior | 58 |
| Ayahuasca in adolescence: a preliminary psychiatric assessment ↗ | Da Silveira DX, Grob CS, de Rios MD et al. | 2005 | Journal of psychoactive drugs | 58 |
| Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament ↗ | Halpern JH, Sherwood AR, Passie T et al. | 2008 | Medical science monitor : international medical journal of experimental and clinical research | 58 |
| Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges ↗ | Labate BC, Feeney K | 2012 | The International journal on drug policy | 58 |
| Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach ↗ | Franquesa A, Sainz-Cort A, Gandy S et al. | 2018 | Psychiatry research | 58 |
| Rapid-acting antidepressants ↗ | Witkin JM, Martin AE, Golani LK et al. | 2019 | Advances in pharmacology (San Diego, Calif.) | 58 |
| A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers ↗ | Reckweg J, Mason NL, van Leeuwen C et al. | 2021 | Frontiers in pharmacology | 58 |
| 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice ↗ | Jefferson SJ, Gregg I, Dibbs M et al. | 2023 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 58 |
| Biogenesis of 5-methoxy-N,N-dimethyltryptamine in human pineal gland ↗ | Guchhait RB | 1976 | Journal of neurochemistry | 57 |
| Methodology for determining major constituents of ayahuasca and their metabolites in blood ↗ | McIlhenny EH, Riba J, Barbanoj MJ et al. | 2012 | Biomedical chromatography : BMC | 57 |
| Ayahuasca: Uses, Phytochemical and Biological Activities ↗ | Estrella-Parra EA, Almanza-Pérez JC, Alarcón-Aguilar FJ | 2019 | Natural products and bioprospecting | 57 |
| Modulatory effects of ayahuasca on personality structure in a traditional framework ↗ | Netzband N, Ruffell S, Linton S et al. | 2020 | Psychopharmacology | 57 |
| United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020 ↗ | Barnett BS, Parker SE, Weleff J | 2022 | The International journal on drug policy | 57 |
| A SYNTHESIS OF THE METHYLTRYPTAMINES AND SOME DERIVATIVES ↗ | Richard H. F. Manske | 1931 | Canadian Journal of Research/Canadian journal of research | 56 |
| Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil ↗ | Barbosa PC, Giglio JS, Dalgalarrondo P | 2005 | Journal of psychoactive drugs | 56 |
| Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function ↗ | Eshleman AJ, Forster MJ, Wolfrum KM et al. | 2014 | Psychopharmacology | 56 |
| Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca ↗ | Winkelman M | 2014 | Current drug abuse reviews | 56 |
| Cardiovascular safety of psychedelic medicine: current status and future directions ↗ | Wsół A | 2023 | Pharmacological reports : PR | 56 |
| Sustained effects of single doses of classical psychedelics in humans ↗ | Knudsen GM | 2023 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 56 |
| Biogenic Monoamine Metabolism and Functional Activity in Iron‐Deficient Rats: Behavioural Correlates ↗ | Moussa B. H. Youdim, A. R. Green | 1977 | Novartis Foundation symposium | 55 |
| High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs ↗ | Whitaker PM, Seeman P | 1978 | Psychopharmacology | 55 |
| The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats ↗ | Goodwin GM, De Souza RJ, Green AR | 1986 | Psychopharmacology | 55 |
| Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor ↗ | Halberstadt AL, Nichols DE, Geyer MA | 2012 | Psychopharmacology | 55 |
| A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses ↗ | Chi T, Gold JA | 2020 | Journal of the neurological sciences | 55 |
| Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial ↗ | Dos Santos RG, Osório FL, Rocha JM et al. | 2021 | Journal of clinical psychopharmacology | 55 |
| A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs ↗ | Solmi M, Chen C, Daure C et al. | 2022 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 55 |
| Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine ↗ | Bradley PB, Briggs I | 1974 | British journal of pharmacology | 54 |
| Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors ↗ | Aghajanian GK, Hailgler HJ | 1975 | Psychopharmacology communications | 54 |
| Altered responses to serotonergic agents in Fawn-Hooded rats ↗ | Gudelsky GA, Koenig JI, Meltzer HY | 1985 | Pharmacology, biochemistry, and behavior | 54 |
| BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism ↗ | Mitchell ES, Hoplight BJ, Lear SP et al. | 2006 | Neuropharmacology | 54 |
| Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports ↗ | Martial C, Cassol H, Charland-Verville V et al. | 2019 | Consciousness and cognition | 54 |
| Chemical Composition of Traditional and Analog Ayahuasca ↗ | Kaasik H, Souza RCZ, Zandonadi FS et al. | 2021 | Journal of psychoactive drugs | 54 |
| Pharmacokinetics of N,N-dimethyltryptamine in Humans ↗ | Good M, Joel Z, Benway T et al. | 2023 | European journal of drug metabolism and pharmacokinetics | 54 |
| Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain ↗ | Hungen KV, Roberts S, Hill DF | 1975 | Brain research | 53 |
| Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens ↗ | Lyon RA, Titeler M, Seggel MR et al. | 1988 | European journal of pharmacology | 53 |
| The role of spinal cord 5-HT1A and 5-HT1B receptors in the modulation of a spinal nociceptive reflex ↗ | Eide PK, Joly NM, Hole K | 1990 | Brain research | 53 |
| 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity ↗ | Millan MJ, Bervoets K, Colpaert FC | 1991 | The Journal of pharmacology and experimental therapeutics | 53 |
| Rabbit Lung Indolethylamine N-Methyltransferase ↗ | Michael A. Thompson, Richard M. Weinshilboum | 1998 | Journal of Biological Chemistry | 53 |
| Harmine stimulates proliferation of human neural progenitors ↗ | Dakic V, Maciel RM, Drummond H et al. | 2016 | PeerJ | 53 |
| Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway ↗ | Vallersnes OM, Persett PS, Øiestad EL et al. | 2017 | Clinical toxicology (Philadelphia, Pa.) | 53 |
| Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders ↗ | Lowe H, Toyang N, Steele B et al. | 2022 | Molecules (Basel, Switzerland) | 53 |
| Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review ↗ | Hovmand OR, Poulsen ED, Arnfred S et al. | 2023 | Journal of psychopharmacology (Oxford, England) | 53 |
| COMPARISON OF A PLACEBO, N-DIMETHYLTRYPTAMINE, AND 6-HYDROXY-N-DIMETHYLTRYPTAMINE IN MAN ↗ | ROSENBERG DE, ISBELL H, MINER EJ | 1963 | Psychopharmacologia | 52 |
| Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs ↗ | Rogawski MA, Aghajanian GK | 1981 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 52 |
| Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour ↗ | Dickinson SL, Curzon G | 1983 | Neuropharmacology | 52 |
| Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors ↗ | Peroutka SJ, Huang S, Allen GS | 1986 | The Journal of pharmacology and experimental therapeutics | 52 |
| Prenatal stress increases the behavioral response to serotonin agonists and alters open field behavior in the rat ↗ | Peters DA | 1986 | Pharmacology, biochemistry, and behavior | 52 |
| Both prenatal and postnatal factors contribute to the effects of maternal stress on offspring behavior and central 5-hydroxytryptamine receptors in the rat ↗ | Peters DA | 1988 | Pharmacology, biochemistry, and behavior | 52 |
| Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies ↗ | Matsumoto K, Morishige R, Murakami Y et al. | 2005 | European journal of pharmacology | 52 |
| Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies ↗ | Davies MA, Setola V, Strachan RT et al. | 2006 | The pharmacogenomics journal | 52 |
| Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage ↗ | Gambelunghe C, Aroni K, Rossi R et al. | 2008 | Biomedical chromatography : BMC | 52 |
| Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis ↗ | Daumann J, Daumann J, Heekeren K et al. | 2008 | Psychopharmacology | 52 |
| Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions ↗ | Blei F, Baldeweg F, Fricke J et al. | 2018 | Chemistry (Weinheim an der Bergstrasse, Germany) | 52 |
| Production Options for Psilocybin: Making of the Magic ↗ | Fricke J, Lenz C, Wick J et al. | 2019 | Chemistry (Weinheim an der Bergstrasse, Germany) | 52 |
| Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action ↗ | Dos Santos RG, Hallak JE, Baker G et al. | 2021 | Journal of psychopharmacology (Oxford, England) | 52 |
| Potato root diffusate-induced secretion of soluble, basic proteins originating from the subventral esophageal glands of potato cyst nematodes ↗ | Smant G, Goverse A, Stokkermans JP et al. | 1997 | Phytopathology | 51 |
| Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture ↗ | Freedland CS, Mansbach RS | 1999 | Drug and alcohol dependence | 51 |
| Chemistry of verongida sponges. 10. Secondary metabolite composition of the caribbean sponge Verongula gigantea ↗ | Ciminiello P, Dell'Aversano C, Fattorusso E et al. | 2000 | Journal of natural products | 51 |
| Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan ↗ | Tsujikawa K, Mohri H, Kuwayama K et al. | 2006 | Forensic science international | 51 |
| Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine ↗ | McIlhenny EH, Riba J, Barbanoj MJ et al. | 2011 | Biomedical chromatography : BMC | 51 |
| Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion ↗ | de Castro-Neto EF, da Cunha RH, da Silveira DX et al. | 2013 | World journal of biological chemistry | 51 |
| Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose? ↗ | Lanaro R, Calemi DB, Togni LR et al. | 2015 | Journal of psychoactive drugs | 51 |
| A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience ↗ | Gallimore AR, Strassman RJ | 2016 | Frontiers in pharmacology | 51 |
| Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada ↗ | Argento E, Capler R, Thomas G et al. | 2019 | Drug and alcohol review | 51 |
| Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca ↗ | Agin-Liebes G, Zeifman R, Luoma JB et al. | 2022 | Journal of psychopharmacology (Oxford, England) | 51 |
| Effect of chronic variable stress on monoamine receptors: influence of imipramine administration ↗ | Molina VA, Volosin M, Cancela L et al. | 1990 | Pharmacology, biochemistry, and behavior | 50 |
| Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues ↗ | Kärkkäinen J, Forsström T, Tornaeus J et al. | 2005 | Scandinavian journal of clinical and laboratory investigation | 50 |
| Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States ↗ | Palamar JJ, Barratt MJ, Ferris JA et al. | 2016 | The American journal on addictions | 50 |
| Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment ↗ | Cata-Preta EG, Serra YA, Moreira-Junior EDC et al. | 2018 | Frontiers in pharmacology | 50 |
| Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies ↗ | Calleja-Conde J, Morales-García JA, Echeverry-Alzate V et al. | 2022 | Addiction biology | 50 |
| Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile ↗ | Holze F, Singh N, Liechti ME et al. | 2024 | Biological psychiatry. Cognitive neuroscience and neuroimaging | 50 |
| Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients ↗ | Wyatt RJ, Mandel LR, Ahn HS et al. | 1973 | Psychopharmacologia | 49 |
| Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations ↗ | Corbett L, Christian ST, Morin RD et al. | 1978 | The British journal of psychiatry : the journal of mental science | 49 |
| Regional differences in the response of serotonergic neurons in rat CNS to drugs ↗ | Long JB, Youngblood WY, Kizer JS | 1983 | European journal of pharmacology | 49 |
| Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics ↗ | Cunningham KA, Callahan PM, Appel JB | 1987 | European journal of pharmacology | 49 |
| 2-[125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina ↗ | Dubocovich ML, Shankar G, Mickel M | 1989 | European journal of pharmacology | 49 |
| Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis ↗ | Heekeren K, Neukirch A, Daumann J et al. | 2007 | Journal of psychopharmacology (Oxford, England) | 49 |
| Serotonin, psychedelics and psychiatry ↗ | Robin Carhart‐Harris | 2018 | World Psychiatry | 49 |
| How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence ↗ | Peter G. Brindley | 2021 | Anesthesia & Analgesia | 49 |
| Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects ↗ | Durante Í, Dos Santos RG, Bouso JC et al. | 2021 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 49 |
| The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics ↗ | Evens R, Schmidt ME, Majić T et al. | 2023 | Therapeutic advances in psychopharmacology | 49 |
| Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones ↗ | Euvrard C, Javoy F, Herbet A et al. | 1977 | European journal of pharmacology | 48 |
| The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs ↗ | Heal DJ, Philpot J, O'Shaughnessy KM et al. | 1986 | Psychopharmacology | 48 |
| Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia ↗ | Löscher W, Witte U, Fredow G et al. | 1990 | Naunyn-Schmiedeberg's archives of pharmacology | 48 |
| Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function ↗ | Darmani NA, Martin BR, Glennon RA | 1992 | Pharmacology, biochemistry, and behavior | 48 |
| Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia ↗ | Winkelman M | 2005 | Journal of psychoactive drugs | 48 |
| In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine ↗ | Vitale AA, Pomilio AB, Cañellas CO et al. | 2011 | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 48 |
| Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens ↗ | Bouso JC, Pedrero-Pérez EJ, Gandy S et al. | 2016 | Human psychopharmacology | 48 |
| Toxicology and Analysis of Psychoactive Tryptamines ↗ | Malaca S, Lo Faro AF, Tamborra A et al. | 2020 | International journal of molecular sciences | 48 |
| The acute effects of classic psychedelics on memory in humans ↗ | Healy CJ | 2021 | Psychopharmacology | 48 |
| Exploring DMT: Endogenous role and therapeutic potential ↗ | Schimmelpfennig J, Jankowiak-Siuda K | 2025 | Neuropharmacology | 48 |
| Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities ↗ | Glennon RA, Young R, Rosecrans JA et al. | 1980 | Psychopharmacology | 47 |
| Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors ↗ | Geyer MA, Tapson GS | 1988 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 47 |
| Stress adaptation and hypersensitivity in 5-HT neuronal systems after repeated foot shock ↗ | Ohi K, Mikuni M, Takahashi K | 1989 | Pharmacology, biochemistry, and behavior | 47 |
| Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs ↗ | Sanders-Bush E, Breeding M | 1991 | Psychopharmacology | 47 |
| Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies ↗ | Frecska E, Móré CE, Vargha A et al. | 2012 | Journal of psychoactive drugs | 47 |
| Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015 ↗ | Heise CW, Brooks DE | 2017 | Journal of medical toxicology : official journal of the American College of Medical Toxicology | 47 |
| Alkaloids and Palatability of Phalaris arundinacea L. Grown in Diverse Environments<sup>1</sup> ↗ | G. C. Marten, R. F. Barnes, A. B. Simons et al. | 1973 | Agronomy Journal | 46 |
| The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat ↗ | Sidney L. Smith, Arlene F. Aucella | 1986 | British journal of pharmacology | 46 |
| Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents ↗ | Simansky KJ, Schechter LE | 1988 | The Journal of pharmacology and experimental therapeutics | 46 |
| Benzofuran bioisosteres of hallucinogenic tryptamines ↗ | Tomaszewski Z, Johnson MP, Huang X et al. | 1992 | Journal of medicinal chemistry | 46 |
| Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs ↗ | Newton RA, Phipps SL, Flanigan TP et al. | 1996 | Journal of neurochemistry | 46 |
| Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors ↗ | Halberstadt AL, Buell MR, Masten VL et al. | 2008 | Psychopharmacology | 46 |
| Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology ↗ | dos Santos RG | 2013 | Journal of psychoactive drugs | 46 |
| Bufotenine is able to block rabies virus infection in BHK-21 cells ↗ | Vigerelli H, Sciani JM, Jared C et al. | 2014 | The journal of venomous animals and toxins including tropical diseases | 46 |
| Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users ↗ | Ona G, Kohek M, Massaguer T et al. | 2019 | Journal of psychoactive drugs | 46 |
| Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits ↗ | Domínguez-Clavé E, Soler J, Pascual JC et al. | 2019 | Psychopharmacology | 46 |
| Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial ↗ | Rocha JM, Rossi GN, de Lima Osório F et al. | 2021 | Journal of clinical psychopharmacology | 46 |
| The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology ↗ | Mastinu A, Anyanwu M, Carone M et al. | 2023 | International journal of molecular sciences | 46 |
| Training dose as a factor in LSD-saline discrimination ↗ | White FJ, Appel JB | 1982 | Psychopharmacology | 45 |
| The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock ↗ | Heal DJ, Smith SL | 1988 | Neuropharmacology | 45 |
| Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks ↗ | Kavenská V, Simonová H | 2015 | Journal of psychoactive drugs | 45 |
| Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report ↗ | Szmulewicz AG, Valerio MP, Smith JM | 2015 | International journal of bipolar disorders | 45 |
| An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders ↗ | Renelli M, Fletcher J, Tupper KW et al. | 2020 | Eating and weight disorders : EWD | 45 |
| Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis ↗ | Goldberg SB, Shechet B, Nicholas CR et al. | 2020 | Psychological medicine | 45 |
| Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans ↗ | Cumming P, Scheidegger M, Dornbierer D et al. | 2021 | Molecules (Basel, Switzerland) | 45 |
| Dimethyltryptamine levels in blood of schizophrenic patients and control subjects ↗ | Angrist B, Gershon S, Sathananthan G et al. | 1976 | Psychopharmacology | 44 |
| Indoleamine-mediated reciprocal modulation of on-centre and off-centre ganglion cell activity in the retina of the cat ↗ | Thier P, Wässle H | 1984 | The Journal of physiology | 44 |
| Antidromic activation of dorsal raphe neurons from neostriatum: physiological characterization and effects of terminal autoreceptor activation ↗ | Sawyer SF, Tepper JM, Young SJ et al. | 1985 | Brain research | 44 |
| The effects of corticosterone on 5-HT receptor function in rodents ↗ | Young AH, MacDonald LM, St John H et al. | 1992 | Neuropharmacology | 44 |
| Platelet serotonin uptake sites increased in drinkers of ayahuasca ↗ | Callaway JC, Airaksinen MM, McKenna DJ et al. | 1994 | Psychopharmacology | 44 |
| Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers ↗ | Pichini S, Marchei E, García-Algar O et al. | 2014 | Journal of pharmaceutical and biomedical analysis | 44 |
| Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature ↗ | Rocha JM, Osório FL, Crippa JAS et al. | 2019 | Therapeutic advances in psychopharmacology | 44 |
| Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder ↗ | Markopoulos A, Inserra A, De Gregorio D et al. | 2021 | Frontiers in pharmacology | 44 |
| Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research ↗ | Bender D, Hellerstein DJ | 2022 | Psychopharmacology | 44 |
| Relationship of Indole Alkaloids to Palatability of Phalaris arundinacea L.<sup>1</sup> ↗ | A. B. Simons, G. C. Marten | 1971 | Agronomy Journal | 43 |
| Failure of N,N-dimethyltryptamine to evoke tolerance in cats ↗ | Gillin JC, Cannon E, Magyar R et al. | 1973 | Biological psychiatry | 43 |
| Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry ↗ | Smythies, Morin Rd, Brown Gb | 1979 | PubMed | 43 |
| Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium ↗ | Medhurst AD, Kaumann AJ | 1993 | British journal of pharmacology | 43 |
| Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor ↗ | Moloney GP, Martin GR, Mathews N et al. | 1999 | Journal of medicinal chemistry | 43 |
| Abuse liability profile of three substituted tryptamines ↗ | Gatch MB, Forster MJ, Janowsky A et al. | 2011 | The Journal of pharmacology and experimental therapeutics | 43 |
| Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy ↗ | Zhao T, Zheng SS, Zhang BF et al. | 2012 | Food chemistry | 43 |
| The pharmacological interaction of compounds in ayahuasca: a systematic review ↗ | Ruffell S, Netzband N, Bird C et al. | 2020 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 43 |
| A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions ↗ | Brennan W, Kelman AR, Belser AB | 2023 | Psychedelic medicine (New Rochelle, N.Y.) | 43 |
| Drug-drug interactions involving classic psychedelics: A systematic review ↗ | Halman A, Kong G, Sarris J et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 43 |
| Distribution and Metabolism of Tryptamine in Rat Brain ↗ | Peng Wu, Alan A. Boulton | 1973 | Canadian Journal of Biochemistry | 42 |
| Drugs and PGO waves in the lateral geniculate body of the curarized cat. II. PGO wave activity and brain 5-hydroxytryptamine ↗ | Ruch-Monachon MA, Jalfre M, Haefely W | 1976 | Archives internationales de pharmacodynamie et de therapie | 42 |
| Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus ↗ | Glennon RA, Rosecrans JA, Young R et al. | 1979 | Life sciences | 42 |
| 5-hydroxytryptamine stimulates [3H]dopamine release from the fish retina ↗ | Kato S, Teranishi T, Kuo CH et al. | 1982 | Journal of neurochemistry | 42 |
| 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests ↗ | Eide PK, Hole K, Berge OG et al. | 1988 | Brain research | 42 |
| Effects of serotonin receptor antagonists and agonists on the tail-flick response in mice involve altered tail-skin temperature ↗ | Eide PK, Tjølsen A | 1988 | Neuropharmacology | 42 |
| Human hallucinogenic drug research in the United States: a present-day case history and review of the process ↗ | Strassman RJ | 1991 | Journal of psychoactive drugs | 42 |
| Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamine ↗ | Sawynok J, Reid A | 1994 | European journal of pharmacology | 42 |
| Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy ↗ | da-Silva VA, Altenburg SP, Malheiros LR et al. | 1999 | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 42 |
| Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons ↗ | Sano K, Mishima K, Koushi E et al. | 2008 | Neuroscience | 42 |
| Analysis of toxic alkaloids in body samples ↗ | Beyer J, Drummer OH, Maurer HH | 2009 | Forensic science international | 42 |
| Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al ↗ | Romano AG, Quinn JL, Li L et al. | 2010 | Psychopharmacology | 42 |
| Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology ↗ | David Luke | 2011 | Greenwich Academic Literature Archive (University of Greenwich) | 42 |
| Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro ↗ | Janowsky A, Eshleman AJ, Johnson RA et al. | 2014 | Psychopharmacology | 42 |
| Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection? ↗ | Attila, Szabó, Ede et al. | 2016 | Neural Regeneration Research | 42 |
| Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies ↗ | Dos Santos RG, Hallak JE | 2017 | Journal of psychoactive drugs | 42 |
| An ontology of psychedelic entity experiences in evolutionary psychology and neurophenomenology ↗ | Michael Winkelman | 2018 | Journal of Psychedelic Studies | 42 |
| Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil ↗ | Souza RCZ, Zandonadi FS, Freitas DP et al. | 2019 | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 42 |
| Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma ↗ | Cohen I, Vogel WH | 1972 | Biochemical pharmacology | 41 |
| Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS ↗ | Forsström T, Tuominen J, Karkkäinen J | 2001 | Scandinavian journal of clinical and laboratory investigation | 41 |
| The Chemistry of Indoles. CIII. Simple Syntheses of Serotonin, N-Methylserotonin, Bufotenine, 5-Methoxy-N-methyltryptamine, Bufobutanoic Acid, N-(Indol-3-yl)methyl-5-methoxy-N-methyltryptamine, and Lespedamine Based on 1-Hydroxyindole Chemistry ↗ | Masanori Somei, Fumio Yamada, Takashi Kurauchi et al. | 2001 | Chemical and Pharmaceutical Bulletin | 41 |
| Psychotria viridis: Chemical constituents from leaves and biological properties ↗ | Soares DBS, Duarte LP, Cavalcanti AD et al. | 2017 | Anais da Academia Brasileira de Ciencias | 41 |
| N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine ↗ | James E, Keppler J, L Robertshaw T et al. | 2022 | Human psychopharmacology | 41 |
| Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice ↗ | Thomas CW, Blanco-Duque C, Bréant BJ et al. | 2022 | Translational psychiatry | 41 |
| N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk ↗ | Cheng D, Lei ZG, Chu K et al. | 2024 | Alzheimer's research & therapy | 41 |
| Psychological and physiological effects of extended DMT ↗ | Luan LX, Eckernäs E, Ashton M et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 41 |
| Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies ↗ | Sabé M, Sulstarova A, Glangetas A et al. | 2025 | Molecular psychiatry | 41 |
| Decreased platelet monoamine oxidase activity in chronic schizophrenia, shown with novel substrates ↗ | Berrettini WH, Prozialeck W, Vogel WH | 1978 | Archives of general psychiatry | 40 |
| Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine ↗ | Räisänen M, Kärkkäinen J | 1979 | Journal of chromatography | 40 |
| Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists ↗ | Grome JJ, Harper AM | 1986 | Journal of neurochemistry | 40 |
| Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus ↗ | Winter JC, Rabin RA | 1988 | Pharmacology, biochemistry, and behavior | 40 |
| Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses ↗ | Nash JF Jr, Meltzer HY, Gudelsky GA | 1989 | Pharmacology, biochemistry, and behavior | 40 |
| Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics ↗ | Shen HW, Wu C, Jiang XL et al. | 2010 | Biochemical pharmacology | 40 |
| Emerging psychoactive substance use among regular ecstasy users in Australia ↗ | Bruno R, Matthews AJ, Dunn M et al. | 2012 | Drug and alcohol dependence | 40 |
| Ayahuasca and the Treatment of Drug Addiction ↗ | José Carlos Bouso, Jordi Riba | 2013 | | 40 |
| Citrus genus plants contain N-methylated tryptamine derivatives and their 5-hydroxylated forms ↗ | Servillo L, Giovane A, Balestrieri ML et al. | 2013 | Journal of agricultural and food chemistry | 40 |
| ALKALOIDS OF<i>MUCUNA PRURIENS</i>CHEMISTRY AND PHARMACOLOGY ↗ | S. Ghosal, Saumitra Sen Singh, S. Bhattacharya | 1971 | Planta Medica | 39 |
| Blood dimethyltryptamine concentrations in psychotic disorders ↗ | Lipinski JF, Mandel LR, Ahn HS et al. | 1974 | Biological psychiatry | 39 |
| 5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle ↗ | Davis M, Astrachan DI, Gendelman PM et al. | 1980 | Psychopharmacology | 39 |
| Monoaminergic involvement in the pharmacological actions of buspirone ↗ | Skolnick P, Weissman BA, Youdim MB | 1985 | British journal of pharmacology | 39 |
| Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action ↗ | Gerard J. Marek, George K. Aghajanian | 1998 | Drug and Alcohol Dependence | 39 |
| Phenomenology of N,N-Dimethyltryptamine use : a thematic analysis ↗ | Christopher Cott, Adam J. Rock | 2008 | DOAJ (DOAJ: Directory of Open Access Journals) | 39 |
| Indolethylamine-<i>N</i>-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous <i>N,N</i>,-dimethyltryptamine ↗ | Dean JG | 2018 | Frontiers in neuroscience | 39 |
| An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study ↗ | Michael P, Luke D, Robinson O | 2021 | Frontiers in psychology | 39 |
| The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study ↗ | Gonzalez D, Cantillo J, Perez I et al. | 2021 | Frontiers in pharmacology | 39 |
| The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility ↗ | Wolff M, Mertens LJ, Walter M et al. | 2022 | Journal of psychopharmacology (Oxford, England) | 39 |
| The risk of chronic psychedelic and MDMA microdosing for valvular heart disease ↗ | Tagen M, Mantuani D, van Heerden L et al. | 2023 | Journal of psychopharmacology (Oxford, England) | 39 |
| Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review ↗ | Yu Z, Burback L, Winkler O et al. | 2024 | Frontiers in psychiatry | 39 |
| Dimethyltryptamine Experiments with Psychotics ↗ | Z Böszörményi, St. Szára | 1958 | Journal of Mental Science | 38 |
| Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects ↗ | Oon MC, Murray RM, Rodnight R et al. | 1977 | Psychopharmacology | 38 |
| Behavioural changes induced by N,N-dimethyl-tryptamine in rodents ↗ | Jenner P, Marsden CD, Thanki CM | 1980 | British journal of pharmacology | 38 |
| Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats ↗ | Kuhn CM, Vogel RA, Mailman RB et al. | 1981 | Psychopharmacology | 38 |
| The healing practices of a Peruvian shaman ↗ | Luna LE | 1984 | Journal of ethnopharmacology | 38 |
| Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP ↗ | Sills MA, Lucki I, Frazer A | 1985 | Life sciences | 38 |
| Analgesia induced by 5-hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-depletion in rats ↗ | Post C, Minor BG, Davies M et al. | 1986 | Brain research | 38 |
| Differential interactions of "prosexual" drugs with 5-hydroxytryptamine1A and alpha 2-adrenergic receptors ↗ | Kwong LL, Smith ER, Davidson JM et al. | 1986 | Behavioral neuroscience | 38 |
| Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs ↗ | Stewart BR, Jenner P, Marsden CD | 1989 | European journal of pharmacology | 38 |
| Effects of 5-hydroxytryptamine on the firing rates of neurons of the lateral vestibular nucleus in the rat ↗ | Licata F, Li Volsi G, Maugeri G et al. | 1990 | Experimental brain research | 38 |
| 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner ↗ | Millan MJ, Colpaert FC | 1991 | The Journal of pharmacology and experimental therapeutics | 38 |
| 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices ↗ | Yamazaki J, Fukuda H, Nagao T et al. | 1992 | European journal of pharmacology | 38 |
| The Meixner test in the detection of alpha-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines ↗ | Beuhler M, Lee DC, Gerkin R | 2004 | Annals of emergency medicine | 38 |
| Applications of Hadamard transform to gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry ↗ | Lin CH, Kaneta T, Chen HM et al. | 2008 | Analytical chemistry | 38 |
| A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine ↗ | Björnstad K, Beck O, Helander A | 2009 | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 38 |
| Experiences of encounters with ayahuasca--"the vine of the soul" ↗ | Kjellgren A, Eriksson A, Norlander T | 2009 | Journal of psychoactive drugs | 38 |
| Hearing loss alters serotonergic modulation of intrinsic excitability in auditory cortex ↗ | Rao D, Basura GJ, Roche J et al. | 2010 | Journal of neurophysiology | 38 |
| Influence of saponins and tannins on intake and nutrient digestion of alkaloid-containing foods ↗ | Owens J, Provenza FD, Wiedmeier RD et al. | 2012 | Journal of the science of food and agriculture | 38 |
| Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish ↗ | Savoldi R, Polari D, Pinheiro-da-Silva J et al. | 2017 | Frontiers in behavioral neuroscience | 38 |
| Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats ↗ | Colaço CS, Alves SS, Nolli LM et al. | 2020 | Metabolic brain disease | 38 |
| Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer ↗ | Zhong S, Jeong JH, Huang C et al. | 2021 | Journal of experimental & clinical cancer research : CR | 38 |
| Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation ↗ | Raut SB, Marathe PA, van Eijk L et al. | 2022 | Pharmacology & therapeutics | 38 |
| The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder ↗ | Rosenblat JD, Husain MI, Lee Y et al. | 2023 | Canadian journal of psychiatry. Revue canadienne de psychiatrie | 38 |
| Effects of DMT on mental health outcomes in healthy volunteers ↗ | Timmermann C, Zeifman RJ, Erritzoe D et al. | 2024 | Scientific reports | 38 |
| Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association ↗ | Murray RM, Oon MC, Rodnight R et al. | 1979 | Archives of general psychiatry | 37 |
| Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion ↗ | Archer T, Minor BG, Post C | 1985 | Brain research | 37 |
| Effects of DOM and DMT in a proposed animal model of hallucinogenic activity ↗ | Adams LM, Geyer MA | 1985 | Progress in neuro-psychopharmacology & biological psychiatry | 37 |
| The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues ↗ | Leff P, Martin GR, Morse JM | 1986 | British journal of pharmacology | 37 |
| Excitatory and inhibitory effects of 5-hydroxytryptamine on the firing rate of medial vestibular nucleus neurons in the rat ↗ | Licata F, Li Volsi G, Maugeri G et al. | 1993 | Neuroscience letters | 37 |
| The excitability and rhythm of medullary respiratory neurons in the cat are altered by the serotonin receptor agonist 5-methoxy-N,N, dimethyltryptamine ↗ | Lalley PM | 1994 | Brain research | 37 |
| Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats ↗ | Gatch MB, Rutledge MA, Carbonaro T et al. | 2009 | Psychopharmacology | 37 |
| Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry ↗ | McIlhenny EH, Pipkin KE, Standish LJ et al. | 2009 | Journal of chromatography. A | 37 |
| Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease ↗ | Wang YH, Samoylenko V, Tekwani BL et al. | 2010 | Journal of ethnopharmacology | 37 |
| Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia ↗ | van den Buuse M, Ruimschotel E, Martin S et al. | 2011 | Neuropharmacology | 37 |
| A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder ↗ | Barsuglia JP, Polanco M, Palmer R et al. | 2018 | Progress in brain research | 37 |
| Long-term effects of ayahuasca in patients with recurrent depression: a 5-year qualitative follow-up ↗ | Rafael G. dos Santos, Rafael Faria Sanches, Flávia de Lima Osório et al. | 2018 | Archives of Clinical Psychiatry (São Paulo) | 37 |
| Characterizing Complex Networks Using Entropy-Degree Diagrams: Unveiling Changes in Functional Brain Connectivity Induced by Ayahuasca ↗ | Viol A, Palhano-Fontes F, Onias H et al. | 2019 | Entropy (Basel, Switzerland) | 37 |
| Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review ↗ | Simão AY, Gonçalves J, Duarte AP et al. | 2019 | Medicines (Basel, Switzerland) | 37 |
| Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders ↗ | Mertens LJ, Preller KH | 2021 | Pharmacopsychiatry | 37 |
| On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review ↗ | Zeifman RJ, Singhal N, Breslow L et al. | 2021 | ACS pharmacology & translational science | 37 |
| Ayahuasca: A review of historical, pharmacological, and therapeutic aspects ↗ | Ruffell SGD, Crosland-Wood M, Palmer R et al. | 2023 | PCN reports : psychiatry and clinical neurosciences | 37 |
| Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception ↗ | Berge OG, Fasmer OB, Hole K | 1983 | Pharmacology, biochemistry, and behavior | 36 |
| Ejaculations induced by p-chloroamphetamine in the rat ↗ | Rènyi L | 1985 | Neuropharmacology | 36 |
| Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact ↗ | Spampinato U, Esposito E, Samanin R | 1985 | Journal of neurochemistry | 36 |
| The Therapeutic Potentials of Ayahuasca in the Treatment of Depression ↗ | Fernanda Palhano-Fontes, João Carlos Alchieri, João Paulo Maia‐de‐Oliveira et al. | 2013 | | 36 |
| Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples ↗ | de Oliveira Silveira G, Guimarães Dos Santos R, Rebello Lourenço F et al. | 2020 | Molecules (Basel, Switzerland) | 36 |
| Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year ↗ | Otto Simonsson, Peter S. Hendricks, Robin Carhart‐Harris et al. | 2021 | Hypertension | 36 |
| THE PREVENTION BY INHIBITORS OF BRAIN PROTEIN SYNTHESIS OF THE HYPERACTIVITY AND HYPERPYREXIA PRODUCED IN RATS BY MONOAMINE OXIDASE INHIBITION AND THE ADMINISTRATION OF L‐TRYPTOPHAN OR 5‐METHOXY‐N,N‐DIMETHYLTRYPTAMINE ↗ | D. G. Grahame‐Smitha | 1972 | Journal of Neurochemistry | 35 |
| Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues ↗ | Glennon RA, Liebowitz SM, Mack EC | 1978 | Journal of medicinal chemistry | 35 |
| Beta-adrenoceptor antagonists may attenuate hyponeophagia in the rat through a serotonergic mechanism ↗ | Shephard RA, Buxton DA, Broadhurst PL | 1982 | Pharmacology, biochemistry, and behavior | 35 |
| Discriminative stimulus properties of the serotonin agonist MK 212 ↗ | Cunningham KA, Callahan PM, Appel JB | 1986 | Psychopharmacology | 35 |
| Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat ↗ | Sitaram BR, Lockett L, Blackman GL et al. | 1987 | Biochemical pharmacology | 35 |
| Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat ↗ | Schreiber R, de Vry J | 1993 | The Journal of pharmacology and experimental therapeutics | 35 |
| Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials ↗ | Björnstad K, Hultén P, Beck O et al. | 2009 | Clinical toxicology (Philadelphia, Pa.) | 35 |
| Changes in spirituality among ayahuasca ceremony novice participants ↗ | Trichter S, Klimo J, Krippner S | 2009 | Journal of psychoactive drugs | 35 |
| Chemical composition of the bark of Tetrapterys mucronata and identification of acetylcholinesterase inhibitory constituents ↗ | Queiroz MM, Queiroz EF, Zeraik ML et al. | 2014 | Journal of natural products | 35 |
| What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse? ↗ | Wagmann L, Meyer MR, Maurer HH | 2016 | Toxicology letters | 35 |
| Trends in DMT and other tryptamine use among young adults in the United States ↗ | Palamar JJ, Le A | 2018 | The American journal on addictions | 35 |
| Purging and the body in the therapeutic use of ayahuasca ↗ | Fotiou E, Gearin AK | 2019 | Social science & medicine (1982) | 35 |
| Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey ↗ | Perkins D, Opaleye ES, Simonova H et al. | 2022 | Drug and alcohol review | 35 |
| Dosing Psychedelics and MDMA ↗ | Liechti ME, Holze F | 2022 | Current topics in behavioral neurosciences | 35 |
| Psychedelics in the treatment of unipolar and bipolar depression ↗ | Bosch OG, Halm S, Seifritz E | 2022 | International journal of bipolar disorders | 35 |
| Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression ↗ | Falchi-Carvalho M, Palhano-Fontes F, Wießner I et al. | 2025 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 35 |
| Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine ↗ | Winter JC | 1972 | Archives internationales de pharmacodynamie et de therapie | 34 |
| The effects of N,N-dimethyltryptamine on operant behavior in squirrel monkeys ↗ | Cole JM, Pieper WA | 1973 | Psychopharmacologia | 34 |
| Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex ↗ | Davis M, Sheard MH | 1974 | Pharmacology, biochemistry, and behavior | 34 |
| Nociception is enhanced after low doses and reduced after high doses of the serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine ↗ | Berge OG, Hole K, Dahle H | 1980 | Neuroscience letters | 34 |
| Effects of chronic antidepressant treatment on serotonin receptor activity in mice ↗ | Friedman E, Cooper TB, Dallob A | 1983 | European journal of pharmacology | 34 |
| Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines ↗ | Glennon RA, Jacyno JM, Young R et al. | 1984 | Journal of medicinal chemistry | 34 |
| Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia ↗ | Pomilio AB, Vitale AA, Ciprian-Ollivier J et al. | 1999 | Journal of ethnopharmacology | 34 |
| Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks ↗ | Alain Gaujac, Sabrina Teixeira Martinez, Arão Araújo Gomes et al. | 2012 | Microchemical Journal | 34 |
| Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate ↗ | Jiménez JH, Bouso JC | 2022 | Journal of psychopharmacology (Oxford, England) | 34 |
| Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects ↗ | Aicher HD, Mueller MJ, Dornbierer DA et al. | 2023 | Frontiers in psychiatry | 34 |
| Psychological Effects and Metabolism of N,N-diethyltryptamine in Man ↗ | Stephen Szára | 1966 | Archives of General Psychiatry | 33 |
| Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma ↗ | Walker RW, Ahn HS, Albers-Schönberg G et al. | 1973 | Biochemical medicine | 33 |
| Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat ↗ | Kovacic B, Domino EF | 1976 | The Journal of pharmacology and experimental therapeutics | 33 |
| Urinary dimethyltryptamine and psychiatric symptomatology and classification ↗ | Rodnight R, Murray RM, Oon MC et al. | 1976 | Psychological medicine | 33 |
| Studies on several 7-substituted N,N-dimethyltryptamines ↗ | Glennon RA, Schubert E, Jacyno JM et al. | 1980 | Journal of medicinal chemistry | 33 |
| Identity of a New World Psychoactive Toad ↗ | Wade Davis, Andrew Weil | 1992 | Ancient Mesoamerica | 33 |
| Effects of Ayahuasca on the human EEG ↗ | Don NS, McDonough BE, Moura G et al. | 1998 | Phytomedicine : international journal of phytotherapy and phytopharmacology | 33 |
| 永岡薫編『イギリス・デモクラシーの擁護者A・D・リンゼイ--その人と思想』 ↗ | Richard A. Glennon, John A. Rosecrans | 1999 | 思想 | 33 |
| A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation ↗ | Callaway JC, Grob CS, McKenna DJ et al. | 2006 | Journal of analytical toxicology | 33 |
| Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices ↗ | Gaujac A, Navickiene S, Collins MI et al. | 2012 | Drug testing and analysis | 33 |
| Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC-MS/MS ↗ | Oliveira CD, Okai GG, da Costa JL et al. | 2012 | Bioanalysis | 33 |
| Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers ↗ | Chu UB, Ramachandran S, Hajipour AR et al. | 2013 | Biochemistry | 33 |
| Desmodeleganine, a new alkaloid from the leaves of Desmodium elegans as a potential monoamine oxidase inhibitor ↗ | Zhi KK, Yang ZD, Shi DF et al. | 2014 | Fitoterapia | 33 |
| Can psychedelic compounds play a part in drug dependence therapy? ↗ | Sessa B, Johnson MW | 2015 | The British journal of psychiatry : the journal of mental science | 33 |
| Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats ↗ | Favaro VM, Yonamine M, Soares JC et al. | 2015 | PloS one | 33 |
| Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine ↗ | Halberstadt AL | 2016 | Pharmacology, biochemistry, and behavior | 33 |
| The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors ↗ | Riga MS, Bortolozzi A, Campa L et al. | 2016 | Neuropharmacology | 33 |
| The Potential Role of Psychedelic Drugs in Mental Health Care of the Future ↗ | Gründer G, Jungaberle H | 2021 | Pharmacopsychiatry | 33 |
| Analysis of recreational psychedelic substance use experiences classified by substance ↗ | Hase A, Erdmann M, Limbach V et al. | 2022 | Psychopharmacology | 33 |
| Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis ↗ | Leger RF, Unterwald EM | 2022 | Journal of psychopharmacology (Oxford, England) | 33 |
| Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice ↗ | Almeida CAF, Pereira-Junior AA, Rangel JG et al. | 2022 | Behavioural brain research | 33 |
| <i>Regio</i>-Selective C3- and N-Alkylation of Indolines in Water under Air Using Alcohols ↗ | Maji M, Borthakur I, Srivastava S et al. | 2022 | The Journal of organic chemistry | 33 |
| Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine benzoate) in healthy participants ↗ | Rucker JJ, Roberts C, Seynaeve M et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 33 |
| Scoping Review: The Role of Psychedelics in the Management of Chronic Pain ↗ | Robinson CL, Fonseca ACG, Diejomaoh EM et al. | 2024 | Journal of pain research | 33 |
| t-Amine Oxide Rearrangements. N,N-Dimethyltryptamine Oxide ↗ | Margery Fish, N. M. Johnson, E. C. Horning | 1956 | Journal of the American Chemical Society | 32 |
| The fragmentation of NN-dimethyltryptamine oxide and related compounds: a possible implication in indole alkaloid biosynthesis ↗ | A. Ahond, Adrien Cavé, Christiane Kan‐Fan et al. | 1970 | Journal of the Chemical Society D Chemical Communications | 32 |
| Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny ↗ | Tissari AH | 1975 | Medical biology | 32 |
| Effects of 5-HT2 receptor antagonist on cycloheximide-induced amnesia in mice ↗ | Nabeshima T, Itoh K, Kawashima K et al. | 1989 | Pharmacology, biochemistry, and behavior | 32 |
| The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats ↗ | Nanry KP, Tilson HA | 1989 | Psychopharmacology | 32 |
| The pathogenesis of the nervous syndrome of Phalaris aquatica toxicity in sheep ↗ | Bourke CA, Carrigan MJ, Dixon RJ | 1990 | Australian veterinary journal | 32 |
| A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation ↗ | Chen BH, Liu JT, Chen WX et al. | 2008 | Talanta | 32 |
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects ↗ | Caudevilla-Gálligo F, Riba J, Ventura M et al. | 2012 | Journal of psychopharmacology (Oxford, England) | 32 |
| Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction' ↗ | Talin P, Sanabria E | 2017 | The International journal on drug policy | 32 |
| Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum ↗ | Chary M, Yi D, Manini AF | 2018 | Frontiers in psychiatry | 32 |
| Acute effects of ayahuasca in a juvenile non-human primate model of depression ↗ | da Silva FS, Silva EAS, Sousa GM Jr et al. | 2019 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 32 |
| Biodiversity of β-Carboline Profile of <i>Banisteriopsis caapi</i> and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential ↗ | Santos BWL, Oliveira RC, Sonsin-Oliveira J et al. | 2020 | Plants (Basel, Switzerland) | 32 |
| Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects ↗ | Lancelotta RL, Davis AK | 2020 | Journal of psychoactive drugs | 32 |
| Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca ↗ | Berlowitz I, Egger K, Cumming P | 2022 | Frontiers in pharmacology | 32 |
| Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine ↗ | Dornbierer DA, Marten L, Mueller J et al. | 2023 | Frontiers in pharmacology | 32 |
| A test of the transmethylation hypothesis in acute schizophrenic patients ↗ | Carpenter WT Jr, Fink EB, Narasimhachari N et al. | 1975 | The American journal of psychiatry | 31 |
| K+-evoked [3H]-5-HT release from rat frontal cortex slices: the effect of 5-HT agonists and antagonists ↗ | Mounsey I, Brady KA, Carroll J et al. | 1982 | Biochemical pharmacology | 31 |
| Reciprocal changes in the firing rate of neostriatal and dorsal raphe neurons following local infusions or systemic injections of D-amphetamine: evidence for neostriatal heterogeneity ↗ | Rebec GV, Curtis SD | 1983 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 31 |
| The administration of baclofen to mice increases 5-HT2-mediated head-twitch behaviour and 5-HT2 receptor number in frontal cortex ↗ | Metz A, Goodwin GM, Green AR | 1985 | Neuropharmacology | 31 |
| Fluctuations in spontaneous discharge of hippocampal theta cells during sleep-waking states and PCPA-induced insomnia ↗ | Mushiake H, Kodama T, Shima K et al. | 1988 | Journal of neurophysiology | 31 |
| Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models ↗ | Sánchez C, Arnt J, Moltzen E | 1996 | European journal of pharmacology | 31 |
| A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus ↗ | Helsley S, Fiorella D, Rabin RA et al. | 1998 | Progress in neuro-psychopharmacology & biological psychiatry | 31 |
| Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs ↗ | Jolly DC, Richards JB, Seiden LS | 1999 | Biological psychiatry | 31 |
| Ayahuasca in adolescence: a neuropsychological assessment ↗ | Doering-Silveira E, Lopez E, Grob CS et al. | 2005 | Journal of psychoactive drugs | 31 |
| Capillary electrophoresis-laser induced fluorescence-electrospray ionization-mass spectrometry: a case study ↗ | Huhn C, Neusüss C, Pelzing M et al. | 2005 | Electrophoresis | 31 |
| Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis ↗ | Gouzoulis-Mayfrank E, Heekeren K, Neukirch A et al. | 2006 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 31 |
| In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes ↗ | Nonaka R, Nagai F, Ogata A et al. | 2007 | Biological & pharmaceutical bulletin | 31 |
| Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ<sub>1-42</sub>-Injected, Wild-Type Mouse Model of AD ↗ | Borbély E, Varga V, Szögi T et al. | 2022 | International journal of molecular sciences | 31 |
| Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics ↗ | Hovmand OR, Poulsen ED, Arnfred S | 2024 | Journal of psychopharmacology (Oxford, England) | 31 |
| Observations on the Psychotogenic Effect of N-N Diethyltryptamine, a New Tryptamine Derivative ↗ | Z Böszörményi, Der P, Tibor Nagy | 1959 | Journal of Mental Science | 30 |
| The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine ↗ | SAI-HALASZ A | 1962 | Experientia | 30 |
| Metabolism of 5-methoxy-N,-N dimethyltryptamine- 14 C in the rat ↗ | Agurell S, Holmstedt B, Lindgren JE | 1969 | Biochemical pharmacology | 30 |
| Use of High Pressure Liquid Chromatography for the Separation of Drugs of Abuse ↗ | M. L. Chan, C. Whetsell, James D. McChesney | 1974 | Journal of Chromatographic Science | 30 |
| Functional aspects of 5-hydroxytryptamine in early embryogenesis of the sea urchinParacentrotus lividus ↗ | Toneby M | 1977 | Wilhelm Roux's archives of developmental biology | 30 |
| A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients ↗ | Checkley SA, Murray RM, Oon MC et al. | 1980 | The British journal of psychiatry : the journal of mental science | 30 |
| Electrophysiological evidence for the existence of separate receptor mechanisms mediating the action of 5-hydroxytryptamine ↗ | Berridge MJ | 1981 | Molecular and cellular endocrinology | 30 |
| Analgesia induced by brief footshock is inhibited by 5-hydroxytryptamine but unaffected by antagonists of 5-hydroxytryptamine or by naloxone ↗ | Tricklebank MD, Hutson PH, Curzon G | 1982 | Neuropharmacology | 30 |
| The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors ↗ | Spencer DG Jr, Traber J | 1987 | Psychopharmacology | 30 |
| 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors ↗ | Thielen RJ, Fangon NB, Frazer A | 1996 | The Journal of pharmacology and experimental therapeutics | 30 |
| Bringing ayahuasca to the clinical research laboratory ↗ | Riba J, Barbanoj MJ | 2005 | Journal of psychoactive drugs | 30 |
| qNMR: An applicable method for the determination of dimethyltryptamine in ayahuasca, a psychoactive plant preparation ↗ | Sidnei Moura, Felipe Garcia Carvalho, Carolina Dizioli Rodrigues de Oliveira et al. | 2010 | Phytochemistry Letters | 30 |
| Determination of N,N-dimethyltryptamine in Mimosa tenuiflora inner barks by matrix solid-phase dispersion procedure and GC-MS ↗ | Gaujac A, Aquino A, Navickiene S et al. | 2012 | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 30 |
| Dimethyltryptamine: Endogenous Role and Therapeutic Potential ↗ | Rodrigues AV, Almeida FJ, Vieira-Coelho MA | 2019 | Journal of psychoactive drugs | 30 |
| Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics ↗ | Sexton JD, Nichols CD, Hendricks PS | 2019 | Frontiers in psychiatry | 30 |
| Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience ↗ | Dos Santos RG, Hallak JEC | 2021 | Epilepsy & behavior : E&B | 30 |
| Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review ↗ | Więckiewicz G, Stokłosa I, Piegza M et al. | 2021 | Pharmaceuticals (Basel, Switzerland) | 30 |
| Chemical Characterization and Molecular Dynamics Simulations of Bufotenine by Surface-Enhanced Raman Scattering (SERS) and Density Functional Theory (DFT) ↗ | Wu X, Cañamares MV, Kakoulli I et al. | 2022 | The journal of physical chemistry letters | 30 |
| Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms ↗ | Calder A, Mock S, Friedli N et al. | 2023 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 30 |
| Remarks on bipolar cubic fuzzy graphs and its chemical applications ↗ | Juanjuan Lu, Linli Zhu, Wei Gao | 2023 | International Journal of Mathematics and Computer in Engineering | 30 |
| Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors ↗ | Egger K, Aicher HD, Cumming P et al. | 2024 | Cellular and molecular life sciences : CMLS | 30 |
| Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio) ↗ | Meldrum BS, Naquet R | 1971 | Electroencephalography and clinical neurophysiology | 29 |
| Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration ↗ | Nisbet AP, Marsden CA | 1984 | European journal of pharmacology | 29 |
| In mice repeated administration of electroconvulsive shock or desmethylimipramine produces rapid alterations in 5-HT2-mediated head-twitch responses and cortical 5-HT2 receptor number ↗ | Metz A, Heal DJ | 1986 | European journal of pharmacology | 29 |
| Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies ↗ | Sitaram BR, McLeod WR | 1990 | Biological psychiatry | 29 |
| Opioid involvement in the adaptive change of 5-HT1 receptors induced by chronic restraint ↗ | Cancela L, Volosin M, Molina VA | 1990 | European journal of pharmacology | 29 |
| Identifying Spiritual Content in Reports From Ayahuasca Sessions ↗ | Stanley Krippner, Joseph Sulla | 2000 | International Journal of Transpersonal Studies | 29 |
| Hallucinogens and redemption ↗ | de Rios MD, Grob CS, Baker JR | 2002 | Journal of psychoactive drugs | 29 |
| Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice ↗ | Shen HW, Jiang XL, Yu AM | 2011 | Drug metabolism and disposition: the biological fate of chemicals | 29 |
| Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry ↗ | Gaujac A, Dempster N, Navickiene S et al. | 2013 | Talanta | 29 |
| Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell ↗ | Brierley DI, Davidson C | 2013 | Journal of psychopharmacology (Oxford, England) | 29 |
| Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status ↗ | Jiang XL, Shen HW, Mager DE et al. | 2013 | Drug metabolism and disposition: the biological fate of chemicals | 29 |
| Teratogenic effects of Mimosa tenuiflora in a rat model and possible role of N-methyl- and N,N-dimethyltryptamine ↗ | Gardner D, Riet-Correa F, Lemos D et al. | 2014 | Journal of agricultural and food chemistry | 29 |
| On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis ↗ | Grammenos D, Barker SA | 2015 | Journal of neural transmission (Vienna, Austria : 1996) | 29 |
| New psychoactive substances: Purchasing and supply patterns in Australia ↗ | Sutherland R, Bruno R, Peacock A et al. | 2017 | Human psychopharmacology | 29 |
| Potential Use of Ayahuasca in Grief Therapy ↗ | González D, Carvalho M, Cantillo J et al. | 2019 | Omega | 29 |
| Cannabis as entheogen: survey and interview data on the spiritual use of cannabis ↗ | Johnstad PG | 2020 | Journal of cannabis research | 29 |
| Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm ↗ | Perkins D, Sarris J, Rossell S et al. | 2021 | The Australian and New Zealand journal of psychiatry | 29 |
| Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant ↗ | Rossi GN, Guerra LTL, Baker GB et al. | 2022 | Biomolecules | 29 |
| Pharmahuasca and DMT Rescue ROS Production and Differentially Expressed Genes Observed after Predator and Psychosocial Stress: Relevance to Human PTSD ↗ | Kelley DP, Venable K, Destouni A et al. | 2022 | ACS chemical neuroscience | 29 |
| Psychedelics for treatment resistant depression: are they game changers? ↗ | Kalfas M, Taylor RH, Tsapekos D et al. | 2023 | Expert opinion on pharmacotherapy | 29 |
| Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways ↗ | Sinha JK, Trisal A, Ghosh S et al. | 2024 | Ageing research reviews | 29 |
| Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines ↗ | Gessner PK, Godse DD, Krull AH et al. | 1968 | Life sciences | 28 |
| Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring ↗ | Narasimhachari N, Himwich HE | 1973 | Biochemical and biophysical research communications | 28 |
| Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse ↗ | Singleton C, Marsden CA | 1981 | Psychopharmacology | 28 |
| Intracellular studies on the effects of systemic administration of serotonin agonists on rat facial motoneurons ↗ | Vandermaelen CP, Aghajanian GK | 1982 | European journal of pharmacology | 28 |
| The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat ↗ | Dickinson SL, Andrews CD, Curzon G | 1984 | Neuropharmacology | 28 |
| Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats ↗ | Jackson HC, Kitchen I | 1989 | Neuropharmacology | 28 |
| Sociopsychotherapeutic functions of ayahuasca healing in Amazonia ↗ | Andritzky W | 1989 | Journal of psychoactive drugs | 28 |
| Neural regulation of the vas deferens in the rat: an electrophysiological analysis ↗ | Kolbeck SC, Steers WD | 1992 | The American journal of physiology | 28 |
| Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists ↗ | Scott PA, Chou JM, Tang H et al. | 1994 | The Journal of pharmacology and experimental therapeutics | 28 |
| Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience ↗ | Netto SM, Guimarães FS | 1996 | Behavioural brain research | 28 |
| A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions ↗ | dos Santos RG | 2013 | Journal of psychoactive drugs | 28 |
| Ayahuasca and cancer treatment ↗ | Schenberg EE | 2013 | SAGE open medicine | 28 |
| Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety ↗ | Giovannetti C, Garcia Arce S, Rush B et al. | 2020 | Journal of psychoactive drugs | 28 |
| Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE) ↗ | Gicquel T, Richeval C, Mesli V et al. | 2021 | Forensic science international | 28 |
| New Insights into the Chemical Composition of Ayahuasca ↗ | Rodríguez L, López A, Moyna G et al. | 2022 | ACS omega | 28 |
| Role of 5-HT<sub>2A</sub> receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice ↗ | Serra YA, Barros-Santos T, Anjos-Santos A et al. | 2022 | Psychopharmacology | 28 |
| Psychedelic-assisted treatment for substance use disorder: A narrative systematic review ↗ | Piper T, Small F, Brown S et al. | 2025 | Addiction (Abingdon, England) | 28 |
| Psychedelics in neuroinflammation: Mechanisms and therapeutic potential ↗ | de Deus JL, Maia JM, Soriano RN et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 28 |
| Effect of N,N-dimethyltryptamine and D-lysergic acid diethylamide on the release of 5-hydroxyindoles in rat forebrain ↗ | Randić M, Padjen A | 1971 | Nature | 27 |
| The use of o-phthalaldehyde as a spray reagent for the thin-layer chromatographic identification and quantitation of bufotenin and 5-methoxy-N:N-dimethyltryptamine ↗ | Narasimhachari N, Plaut J | 1971 | Journal of chromatography | 27 |
| A gas chromatographic procedure for determining N, N-dimethyltryptamine and N-monomethyltryptamine in urine using a nitrogen detector ↗ | Oon MC, Rodnight R | 1977 | Biochemical medicine | 27 |
| Effects of 5-hydroxytryptamine on the lower esophageal sphincter in vivo: evidence for multiple sites of action ↗ | Rattan S, Goyal RK | 1977 | The Journal of clinical investigation | 27 |
| Methylation hypothesis ↗ | Baldessarini RJ, Stramentinoli G, Lipinski JF | 1979 | Archives of general psychiatry | 27 |
| Dual agonist-antagonist effects of 5-hydroxytryptamine (5-HT) in the guinea pig ileum: evidence for a selective receptor desensitization effect ↗ | Huidobro-Toro JP, Foree B | 1980 | European journal of pharmacology | 27 |
| Drug interactions do not support reduction in serotonin turnover as the mechanism of action of benzodiazepines ↗ | Shephard RA, Buxton DA, Broadhurst PL | 1982 | Neuropharmacology | 27 |
| Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat ↗ | Stolz JF, Marsden CA | 1982 | European journal of pharmacology | 27 |
| Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram ↗ | Arnt J, Overø KF, Hyttel J et al. | 1984 | Psychopharmacology | 27 |
| 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions ↗ | Takahashi T, Takahashi K, Ido T et al. | 1985 | The International journal of applied radiation and isotopes | 27 |
| Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse ↗ | Moser PC, Redfern PH | 1985 | Psychopharmacology | 27 |
| A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats ↗ | Carlsson M, Eriksson E | 1986 | Acta pharmacologica et toxicologica | 27 |
| Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats ↗ | Nabeshima T, Ishikawa K, Yamaguchi K et al. | 1987 | Neuroscience letters | 27 |
| Characterization of serotonin transporter in goldfish retina by the binding of [3H]paroxetine and the uptake of [3H]serotonin: modulation by light ↗ | Lima L, Schmeer C | 1994 | Journal of neurochemistry | 27 |
| Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use ↗ | Perkins D, Ruffell SGD, Day K et al. | 2022 | Frontiers in neuroscience | 27 |
| The White Sun of Substance: Spinozism and the Psychedelic amor Dei intellectualis ↗ | Peter Sjöstedt-Hughes | 2022 | Bloomsbury Academic eBooks | 27 |
| The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity ↗ | Gupta S, Bhatnagar RK, Gupta D et al. | 2025 | Psychopharmacology | 27 |
| Actions of some analogues of 5-hydroxytryptamine on the isolated rat uterus and the rat fundus strip preparations ↗ | BARLOW RB, KHAN I | 1959 | British journal of pharmacology and chemotherapy | 26 |
| Biological activities of some 5-substituted N,N-dimethyltryptamines, ?-methyltryptamines, and gramines ↗ | Beng T. Ho, William M. McIsaac, Rong An et al. | 1970 | Psychopharmacology | 26 |
| Biosynthesis and turnover of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in Phalaris tuberosa ↗ | Claire Baxter, M. Slaytor | 1972 | Phytochemistry | 26 |
| Identification of N,N-dimethyltryptamine as the product of an in vitro enzymic methylation ↗ | Walker RW, Ahn HS, Mandel LR et al. | 1972 | Analytical biochemistry | 26 |
| Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats ↗ | Green AR, Tordoff AF, Bloomfield MR | 1976 | Journal of neural transmission | 26 |
| Improved selective ion monitoring mass-spectrometric assay for the determination of N,N-dimethyltryptamine in human blood utilizing capillary column gas chromatography ↗ | Walker RW, Mandel LR, Kleinman JE et al. | 1979 | Journal of chromatography | 26 |
| Hyposensitivity to serotonergic stimulation in protein malnourished rats ↗ | Hall RD, Leahy JP, Robertson WM | 1983 | Physiology & behavior | 26 |
| Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study ↗ | Shen HW, Jiang XL, Yu AM | 2009 | Bioanalysis | 26 |
| A study of ayahuasca use in North America ↗ | Harris R, Gurel L | 2012 | Journal of psychoactive drugs | 26 |
| N,N-Dimethyltryptamine-Induced Psychosis ↗ | Paterson NE, Darby WC, Sandhu PS | 2015 | Clinical neuropharmacology | 26 |
| Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors ↗ | Jiang XL, Shen HW, Yu AM | 2015 | Neuropharmacology | 26 |
| Simultaneous determination of traditional and emerging illicit drugs in sediments, sludges and particulate matter ↗ | Álvarez-Ruiz R, Andrés-Costa MJ, Andreu V et al. | 2015 | Journal of chromatography. A | 26 |
| Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats ↗ | Karolina Noworyta, Katarzyna Kamińska, Grzegorz Kreiner et al. | 2016 | Neurotoxicity Research | 26 |
| <i>Ayahuasca</i>: An ancient sacrament for treatment of contemporary psychiatric illness? ↗ | Malcolm BJ, Lee KC | 2017 | The mental health clinician | 26 |
| Acute Intoxication following Dimethyltryptamine Ingestion ↗ | Bilhimer MH, Schult RF, Higgs KV et al. | 2018 | Case reports in emergency medicine | 26 |
| Biomedical analysis of New Psychoactive Substances (NPS) of natural origin ↗ | Lo Faro AF, Di Trana A, La Maida N et al. | 2020 | Journal of pharmaceutical and biomedical analysis | 26 |
| Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center ↗ | Rush B, Marcus O, García S et al. | 2021 | Frontiers in pharmacology | 26 |
| Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines ↗ | Lenz C, Dörner S, Trottmann F et al. | 2022 | Chembiochem : a European journal of chemical biology | 26 |
| Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence ↗ | Ortiz Bernal AM, Raison CL, Lancelotta RL et al. | 2022 | Frontiers in psychiatry | 26 |
| Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model ↗ | Heinsbroek JA, Giannotti G, Bonilla J et al. | 2023 | Psychedelic medicine (New Rochelle, N.Y.) | 26 |
| CHEMICAL AND PHARMACOLOGICAL EVALUATION OF<i>DESMODIUM PULCHELLUM</i> ↗ | S. Ghosal, Somnath Banerjee, S. Bhattacharya et al. | 1972 | Planta Medica | 25 |
| Letter: Blood and urinary dimethyltryptamine in acute psychotic disorders ↗ | Bidder TG, Mandel LR, Ahn HS et al. | 1974 | Lancet (London, England) | 25 |
| Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses ↗ | Green AR | 1978 | British journal of pharmacology | 25 |
| Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour ↗ | Blackburn TP, Foster GA, Heapy CG et al. | 1980 | European journal of pharmacology | 25 |
| Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action ↗ | Commissaris RL, Davis M | 1982 | Neuroscience and biobehavioral reviews | 25 |
| Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105 ↗ | Young R, Rosecrans JA, Glennon RA | 1983 | Psychopharmacology | 25 |
| Reinstatement of responding maintained by cocaine or thiamylal ↗ | Slikker W Jr, Brocco MJ, Killam KF Jr | 1984 | The Journal of pharmacology and experimental therapeutics | 25 |
| A primate model for the study of hallucinogens ↗ | Schlemmer RF Jr, Davis JM | 1986 | Pharmacology, biochemistry, and behavior | 25 |
| Biotransformation of Tryptamine to Serotonin by Cell Suspension Cultures of Peganum harmala ↗ | Sasse F, Witte L, Berlin J | 1987 | Planta medica | 25 |
| 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil ↗ | Eison AS, Wright RN | 1992 | Pharmacology, biochemistry, and behavior | 25 |
| Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245 ↗ | Pullagurla M, Bondareva T, Young R et al. | 2004 | Pharmacology, biochemistry, and behavior | 25 |
| Maternal and developmental toxicity of ayahuasca in Wistar rats ↗ | Oliveira CD, Moreira CQ, de Sá LR et al. | 2010 | Birth defects research. Part B, Developmental and reproductive toxicology | 25 |
| Neurobehavioral, reflexological and physical development of Wistar rat offspring exposed to ayahuasca during pregnancy and lactation ↗ | Carolina Dizioli Rodrigues de Oliveira, Camila Queiroz Moreira, Helenice de Souza Spinosa et al. | 2011 | Revista Brasileira de Farmacognosia | 25 |
| <i>Banisteriopsis caapi</i>, a Forgotten Potential Therapy for Parkinson's Disease? ↗ | Djamshidian A, Bernschneider-Reif S, Poewe W et al. | 2016 | Movement disorders clinical practice | 25 |
| The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS? ↗ | Mavlyutov TA, Baker EM, Losenegger TM et al. | 2017 | Advances in experimental medicine and biology | 25 |
| Asymmetric Total Synthesis and Biological Evaluation of (+)-Cycloclavine ↗ | Stephanie R. McCabe, Peter Wipf | 2018 | Synthesis | 25 |
| A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting ↗ | Malin V. Uthaug, Rafael Lancelotta, Ana María Ortiz Bernal et al. | 2020 | Journal of Psychedelic Studies | 25 |
| Relational Processes in Ayahuasca Groups of Palestinians and Israelis ↗ | Roseman L, Ron Y, Saca A et al. | 2021 | Frontiers in pharmacology | 25 |
| Ayahuasca for the Treatment of Depression ↗ | Palhano-Fontes F, Soares BL, Galvão-Coelho NL et al. | 2022 | Current topics in behavioral neurosciences | 25 |
| Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands ↗ | Kohek M, Ona G, van Elk M et al. | 2023 | Journal of psychoactive drugs | 25 |
| Efficacy and Safety of Psychedelics in Treating Anxiety Disorders ↗ | Feulner L, Sermchaiwong T, Rodland N et al. | 2023 | Ochsner journal | 25 |
| Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review ↗ | Sharma R, Batchelor R, Sin J | 2023 | Journal of psychoactive drugs | 25 |
| Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-<i>N,N</i>-dimethyltryptamine in Mice ↗ | Glatfelter GC, Naeem M, Pham DNK et al. | 2023 | ACS pharmacology & translational science | 25 |
| Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial ↗ | Falchi-Carvalho M, Wießner I, Silva SRB et al. | 2024 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 25 |
| Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression ↗ | Ramaekers JG, Reckweg JT, Mason NL | 2025 | The American journal of psychiatry | 25 |
| Native use and occurence of N,N-Dimethyltryptamine in the leaves of Banisteriopsis rusbyana ↗ | Marderosian AH, Pinkley HV, Dobbins MF | 1968 | American journal of pharmacy and the sciences supporting public health | 24 |
| CONSTITUENTS OF THE BARK OF<i>VIROLA SEBIFERA</i> ↗ | E. Corothie, T. Nakano | 1969 | Planta Medica | 24 |
| The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia ↗ | Richard Jed Wyatt, Juan M. Saavedra, Robert H. Belmaker et al. | 1973 | American Journal of Psychiatry | 24 |
| Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain ↗ | Waldmeier PC, Maître L | 1977 | Psychopharmacology | 24 |
| Stimulation of rat prolactin secretion by indolealkylamine hallucinogens ↗ | Meltzer HY, Fessler RG, Simonovic M et al. | 1978 | Psychopharmacology | 24 |
| Alkaloid Production in <i>Catharanthus</i><i>roseus</i> Cell Cultures. IV. Characterization of the 953 Cell Line ↗ | Wolfgang Kurz, K. B. Chatson, F. Constabel et al. | 1980 | Helvetica Chimica Acta | 24 |
| Morphological and functional studies on the serotoninergic innervation of the inferior olive ↗ | Wiklund L, Sjölund B, Björklund A | 1981 | Journal de physiologie | 24 |
| Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect ↗ | Barker SA, Beaton JM, Christian ST et al. | 1982 | Biochemical pharmacology | 24 |
| Neurophysiological effects of hallucinogens on serotonergic neuronal systems ↗ | McCall RB | 1982 | Neuroscience and biobehavioral reviews | 24 |
| In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine ↗ | Yanai K, Ido T, Ishiwata K et al. | 1986 | European journal of nuclear medicine | 24 |
| Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors ↗ | Gudelsky GA, Koenig JI, Jackman H et al. | 1986 | Psychopharmacology | 24 |
| Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit ↗ | Pierre Mallorga, Michael F. Sugrue | 1987 | Current Eye Research | 24 |
| Serotonin-evoked modifications of the neuronal firing rate in the superior vestibular nucleus: a microiontophoretic study in the rat ↗ | Licata F, Li Volsi G, Maugeri G et al. | 1993 | Neuroscience | 24 |
| Development of immunoassays for tyramine and tryptamine toxins of Phalaris aquatica L ↗ | Skerritt JH, Guihot SL, McDonald SE et al. | 2000 | Journal of agricultural and food chemistry | 24 |
| N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates ↗ | Pullagurla MR, Dukat M, Setola V et al. | 2003 | Bioorganic & medicinal chemistry letters | 24 |
| Analysis of Phenethylamines and Tryptamines in Designer Drugs Using Gas Chromatographymass Spectrometry ↗ | Misako Takahashi, Machiko Nagashima, Jin Suzuki et al. | 2008 | JOURNAL OF HEALTH SCIENCE | 24 |
| Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice ↗ | Fabregat-Safont D, Barneo-Muñoz M, Martinez-Garcia F et al. | 2017 | Journal of chromatography. A | 24 |
| Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers? ↗ | Jensen O, Rafehi M, Gebauer L et al. | 2020 | Frontiers in pharmacology | 24 |
| Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study ↗ | Perkins D, Pagni BA, Sarris J et al. | 2022 | Frontiers in pharmacology | 24 |
| Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies ↗ | Rodrigues LS, Rossi GN, Rocha JM et al. | 2022 | European archives of psychiatry and clinical neuroscience | 24 |
| Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma ↗ | Luethi D, Kolaczynska KE, Vogt SB et al. | 2022 | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 24 |
| Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry ↗ | Sakurai H, Yonezawa K, Tani H et al. | 2022 | Pharmacopsychiatry | 24 |
| Psychedelic medicines for mood disorders: current evidence and clinical considerations ↗ | Sarris J, Pinzon Rubiano D, Day K et al. | 2022 | Current opinion in psychiatry | 24 |
| Ayahuasca's therapeutic potential: What we know - and what not ↗ | Maia LO, Daldegan-Bueno D, Wießner I et al. | 2023 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 24 |
| 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals ↗ | Gillin JC, Tinklenberg J, Stoff DM et al. | 1976 | Biological psychiatry | 23 |
| N'N-dimethyltryptamine lowers rat brain acetylcholine and dopamine ↗ | Haubrich DR, Wang PF | 1977 | Brain research | 23 |
| Evidence that respiratory depression by serotonin agonists may be exerted in the central nervous system ↗ | Mueller RA, Lundberg D, Breese GR | 1980 | Pharmacology, biochemistry, and behavior | 23 |
| Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD ↗ | Young R, Rosecrans JA, Glennon RA | 1982 | Life sciences | 23 |
| Sensitivity of spinal reflexes to TRH and 5-HT in 5,6-dihydroxytryptamine-treated rats ↗ | Nagano N, Ono H, Ozawa M et al. | 1987 | European journal of pharmacology | 23 |
| Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography ↗ | Sitaram BR, Talomsin R, Blackman GL et al. | 1987 | Biochemical pharmacology | 23 |
| Experimental evidence that tryptamine alkaloids do not cause Phalaris aquatica sudden death syndrome in sheep ↗ | Bourke CA, Carrigan MJ, Dixon RJ | 1988 | Australian veterinary journal | 23 |
| Identification of serotonin 5HT2 receptors in bovine pineal gland ↗ | Govitrapong P, Prapapanich V, Ebadi M | 1991 | Journal of pineal research | 23 |
| Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal mono- and polysynaptic reflex pathways in the rat ↗ | Yamazaki J, Ono H, Nagao T | 1992 | Neuropharmacology | 23 |
| Ritual and medicinal plants of the Ese'ejas of the Amazonian rainforest (Madre de Dios, Perú) ↗ | Desmarchelier C, Gurni A, Ciccia G et al. | 1996 | Journal of ethnopharmacology | 23 |
| Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method ↗ | Barker SA, Littlefield-Chabaud MA, David C | 2001 | Journal of chromatography. B, Biomedical sciences and applications | 23 |
| A versatile linkage strategy for solid-phase synthesis of N,N-dimethyltryptamines and beta-carbolines ↗ | Wu TY, Schultz PG | 2002 | Organic letters | 23 |
| Fast and slow metabolizers of Hoasca ↗ | Callaway JC | 2005 | Journal of psychoactive drugs | 23 |
| Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships ↗ | Klein MT, Dukat M, Glennon RA et al. | 2011 | The Journal of pharmacology and experimental therapeutics | 23 |
| N-methylated tryptamine derivatives in citrus genus plants: identification of N,N,N-trimethyltryptamine in bergamot ↗ | Servillo L, Giovane A, Balestrieri ML et al. | 2012 | Journal of agricultural and food chemistry | 23 |
| Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures ↗ | Lesiak AD, Musah RA | 2016 | Forensic science international | 23 |
| Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish ↗ | Andrade TS, de Oliveira R, da Silva ML et al. | 2018 | Chemico-biological interactions | 23 |
| Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects ↗ | Nathan D. Sepeda, John Clifton, Laura Y. Doyle et al. | 2019 | Journal of Psychedelic Studies | 23 |
| Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders ↗ | Shomrat T, Nesher N | 2019 | Frontiers in endocrinology | 23 |
| Covid-19: Experts question guidance to reuse PPE ↗ | Abi Rimmer | 2020 | BMJ | 23 |
| Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications ↗ | O'Callaghan C, Hubik DJ, Dwyer J et al. | 2020 | Journal of music therapy | 23 |
| Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting ↗ | Tagliazucchi E, Zamberlan F, Cavanna F et al. | 2021 | Frontiers in psychiatry | 23 |
| Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis ↗ | Radakovic C, Radakovic R, Peryer G et al. | 2021 | PsyArXiv | 23 |
| "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli" ↗ | Friedberg LM, Sen AK, Nguyen Q et al. | 2023 | Metabolic engineering | 23 |
| Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties ↗ | Pol Puigseslloses, Núria Nadal‐Gratacós, Gabriel Ketsela et al. | 2024 | Molecular Psychiatry | 23 |
| 5-methoxy-N, N-dimethyltryptamine, a possible endogenous psychotoxin ↗ | Benington F, Morin RD, Clark LC Jr | 1965 | The Alabama journal of medical sciences | 22 |
| Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients ↗ | Tanimukai H, Ginther R, Spaide J et al. | 1967 | Life sciences | 22 |
| The behavioural effects of some derivatives of mescaline and N,N-dimethyltryptamine in the rat ↗ | Smythies JR, Bradley RJ, Johnston VS et al. | 1967 | Life sciences | 22 |
| Gas Liquid Chromatographic and Mass Spectrometric Studies on Trimethylsilyl Derivatives of N-Methyl- and N,N-Dimethyltryptamines ↗ | N. Narasimhachari, J. Spaide, BH Heller | 1971 | Journal of Chromatographic Science | 22 |
| Palatability of Leaves of Tall Fescue and Reed Canarygrass and of Some of Their Alkaloids to Meadow Voles<sup>1</sup> ↗ | W. A. Kendall, R. T. Sherwood | 1975 | Agronomy Journal | 22 |
| Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver ↗ | Wang Lu LJ, Domino E | 1976 | Biochemical pharmacology | 22 |
| Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), improniazid and chlorpromazine ↗ | Shah NS, Hedden MP | 1978 | Pharmacology, biochemistry, and behavior | 22 |
| Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior ↗ | Harris RA, Snell D, Loh HH | 1978 | The Journal of pharmacology and experimental therapeutics | 22 |
| The identification of LSD-like hallucinogens using the chronic spinal dog ↗ | Martin WR, Vaupel DB, Nozaki M et al. | 1978 | Drug and alcohol dependence | 22 |
| Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities ↗ | Glennon RA, Liebowitz SM, Leming-Doot D et al. | 1980 | Journal of medicinal chemistry | 22 |
| Effects of diazepam and of serotonin agonists on hyponeophagia in rats ↗ | Shephard RA, Broadhurst PL | 1982 | Neuropharmacology | 22 |
| Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats ↗ | Beaton JM, Morris PE | 1984 | Mechanisms of ageing and development | 22 |
| The effects of the GABA-mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxytryptamine and noradrenaline ↗ | Gray JA, Metz A, Goodwin GM et al. | 1986 | Neuropharmacology | 22 |
| 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytryptamine lesioning or repeated antidepressant treatments ↗ | Godfrey PP, McClue SJ, Young MM et al. | 1988 | Journal of neurochemistry | 22 |
| Effects of carbamazepine on 5-hydroxytryptamine function in rodents ↗ | Elphick M, Anderson SM, Hallis KF et al. | 1990 | Psychopharmacology | 22 |
| The effects of tianeptine on wet-dog shakes, fore-paw treading and a flexor reflex in rats are consistent with enhancement of 5-hydroxytryptamine uptake ↗ | Koshikawa N, Mocaër E, Stephenson JD | 1991 | European journal of pharmacology | 22 |
| Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems ↗ | Nakamura S, Tani Y, Maezono Y et al. | 1992 | Pharmacology, biochemistry, and behavior | 22 |
| Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection ↗ | Ohue T, Koshimura K, Akiyama Y et al. | 1992 | Brain research | 22 |
| Evidence for 5-HT2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats ↗ | Tanaka E, Baba N, Toshida K et al. | 1993 | Life sciences | 22 |
| Application of transcerebral, weak (1 microT) complex magnetic fields and mystical experiences: are they generated by field-induced dimethyltryptamine release from the pineal organ? ↗ | Hill DR, Persinger MA | 2003 | Perceptual and motor skills | 22 |
| DMT at fifty ↗ | Szára S | 2007 | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 22 |
| NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa ↗ | Buchanan MS, Carroll AR, Pass D et al. | 2007 | Magnetic resonance in chemistry : MRC | 22 |
| Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela ↗ | Rodd R | 2008 | Journal of psychoactive drugs | 22 |
| A randomized placebo-controlled trial on the antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression ↗ | Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias et al. | 2017 | bioRxiv (Cold Spring Harbor Laboratory) | 22 |
| Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space ↗ | Ibrahim MA, El-Alfy AT, Ezel K et al. | 2017 | Marine drugs | 22 |
| A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines ↗ | Palamar JJ, Acosta P | 2020 | Human psychopharmacology | 22 |
| Identification of Quorum Sensing Activators and Inhibitors in The Marine Sponge <i>Sarcotragus spinosulus</i> ↗ | Saurav K, Borbone N, Burgsdorf I et al. | 2020 | Marine drugs | 22 |
| Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca ↗ | Apud Peláez IE | 2020 | Journal of psychoactive drugs | 22 |
| Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use ↗ | Sherwood AM, Claveau R, Lancelotta R et al. | 2020 | ACS omega | 22 |
| The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies ↗ | Castelhano J, Lima G, Teixeira M et al. | 2021 | Frontiers in pharmacology | 22 |
| Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations ↗ | Eckernäs E, Timmermann C, Carhart-Harris R et al. | 2022 | Clinical and translational science | 22 |
| In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials ↗ | Soliman PS, Curley DE, Capone C et al. | 2024 | Psychopharmacology | 22 |
| Indolethylamine‐<i>N</i>‐methyltransferase in developing rabbit lung ↗ | R.-L. Lin, S. Sargeant, N. Narasimhachari | 1974 | Developmental Psychobiology | 21 |
| Increased synthesis of striatal dopamine by N,N-dimethyltryptamine ↗ | Smith TL | 1977 | Life sciences | 21 |
| The role of dopamine and serotonin in the discriminative stimulus effects of lisuride ↗ | White FJ, Appel JB | 1982 | The Journal of pharmacology and experimental therapeutics | 21 |
| Neural control of the sphincter of Oddi. A physiological role of 5-hydroxytryptamine in the regulation of basal sphincter of Oddi motor activity in the cat ↗ | Behar J, Biancani P | 1983 | The Journal of clinical investigation | 21 |
| Serotonin regulation of the canine migrating motor complex ↗ | Ormsbee HS 3rd, Silber DA, Hardy FE Jr | 1984 | The Journal of pharmacology and experimental therapeutics | 21 |
| The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs ↗ | Mokler DJ, Stoudt KW, Rech RH | 1985 | Pharmacology, biochemistry, and behavior | 21 |
| Acute and chronic treatment with selective serotonin uptake inhibitors in mice: effects on nociceptive sensitivity and response to 5-methoxy-N,N-dimethyltryptamine ↗ | Eide PK, Hole K | 1988 | Pain | 21 |
| Functional significance of subtypes of 5-HT receptors in the rat spinal reflex pathway ↗ | Nagano N, Ono H, Fukuda H | 1988 | General pharmacology | 21 |
| Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy ↗ | Wada Y, Hasegawa H, Nakamura M et al. | 1992 | Neuroscience letters | 21 |
| Direct analysis of the secretions of the potato cyst nematode Globodera rostochiensis ↗ | Robertson L, Robertson WM, Jones JT | 1999 | Parasitology | 21 |
| Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation ↗ | Frecska E, White KD, Luna LE | 2004 | Psychopharmacology | 21 |
| Serotonergic and dopaminergic influence of the duration of embryogenesis and intracapsular locomotion of Lymnaea stagnalis L ↗ | Filla A, Hiripi L, Elekes K | 2004 | Acta biologica Hungarica | 21 |
| Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores ↗ | Diers JA, Ivey KD, El-Alfy A et al. | 2008 | Pharmacology, biochemistry, and behavior | 21 |
| Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases ↗ | Gomes MM, Coimbra JB, Clara RO et al. | 2014 | Biochemical pharmacology | 21 |
| A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT) ↗ | Brown T, Shao W, Ayub S et al. | 2017 | Journal of psychoactive drugs | 21 |
| A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents ↗ | Vargas-Perez H, Grieder TE, Ting-A-Kee R et al. | 2017 | The European journal of neuroscience | 21 |
| N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model ↗ | Nemes B, Pető K, Németh N et al. | 2019 | Transplantation proceedings | 21 |
| Ayahuasca Beverages: Phytochemical Analysis and Biological Properties ↗ | Gonçalves J, Luís Â, Gradillas A et al. | 2020 | Antibiotics (Basel, Switzerland) | 21 |
| Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases ↗ | da Silva MG, Daros GC, de Bitencourt RM | 2021 | Behavioural brain research | 21 |
| Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples ↗ | Gonçalves J, Luís Â, Gallardo E et al. | 2021 | Molecules (Basel, Switzerland) | 21 |
| Enlightening the "Spirit Molecule": Photomodulation of the 5-HT<sub>2A</sub> Receptor by a Light-Controllable N,N-Dimethyltryptamine Derivative ↗ | Gerwe H, He F, Pottie E et al. | 2022 | Angewandte Chemie (International ed. in English) | 21 |
| A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers ↗ | Ables JL, Israel L, Wood O et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 21 |
| Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT<sub>2A</sub> and 5-HT<sub>1A</sub> receptors ↗ | Werle I, Nascimento LMM, Dos Santos ALA et al. | 2024 | British journal of pharmacology | 21 |
| Criticality supports cross-frequency cortical-thalamic information transfer during conscious states ↗ | Toker D, Müller E, Miyamoto H et al. | 2024 | eLife | 21 |
| Psilocybin and Other Classic Psychedelics in Depression ↗ | Nutt DJ, Peill JM, Weiss B et al. | 2024 | Current topics in behavioral neurosciences | 21 |
| Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis ↗ | Bahji A, Lunsky I, Gutierrez G et al. | 2025 | Journal of psychoactive drugs | 21 |
| THE EFFECT OF MAO INHIBITION ON THE EXPERIMENTAL PSYCHOSIS INDUCED BY DIMETHYLTRYPTAMINE ↗ | SAI HALASZ A | 1963 | Psychopharmacologia | 20 |
| Characterization of Alkaloids in Palatable and Unpalatable Clones of Phalaris arundinacea L<sup>1</sup> ↗ | Martin Williams, R. F. Barnes, John M. Cassady | 1971 | Crop Science | 20 |
| The crystal and molecular structure of bufotenine, 5-hydroxy-(N,N)-dimethyltryptamine ↗ | Gerald Falkenberg | 1972 | Acta Crystallographica Section B | 20 |
| Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography ↗ | Riceberg LJ, Vunakis HV | 1978 | The Journal of pharmacology and experimental therapeutics | 20 |
| Hallucinogenic plant use and related indigenous belief systems in the Ecuadorian Amazon ↗ | Naranjo P | 1979 | Journal of ethnopharmacology | 20 |
| Inheritance of Three Groups of Indole Alkaloids in Reed Canarygrass<sup>1</sup> ↗ | P. Marum, A. W. Hovin, G. C. Marten | 1979 | Crop Science | 20 |
| Urinary excretion of dimethyltryptamine in liver disease ↗ | Checkley SA, Oon MC, Rodnight R et al. | 1979 | The American journal of psychiatry | 20 |
| Serotonin involvement in aversive conditioning: reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine ↗ | Archer T, Ogren SO, Ross SB | 1982 | Neuroscience letters | 20 |
| Hyponeophagia in the Roman rat strains: effects of 5-methoxy-N,N-dimethyltryptamine, diazepam, methysergide and the stereoisomers of propranolol ↗ | Shephard RA, Broadhurst PL | 1983 | European journal of pharmacology | 20 |
| Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine ↗ | Berge OG, Chacho D, Hole K | 1983 | European journal of pharmacology | 20 |
| Chronic treatment with antidepressant drugs and the analgesia induced by 5-methoxy-N,N-dimethyltryptamine: attenuation by desipramine ↗ | Danysz W, Minor BG, Post C et al. | 1986 | Acta pharmacologica et toxicologica | 20 |
| GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus ↗ | Fowler CJ, Ahlgren PC, Brännström G | 1992 | British journal of pharmacology | 20 |
| Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat ↗ | Liminga U, Johnson AE, Andrén PE et al. | 1993 | Pharmacology, biochemistry, and behavior | 20 |
| EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences ↗ | Stuckey DE, Lawson R, Luna LE | 2005 | Journal of psychoactive drugs | 20 |
| Recreational use of naturally occurring dimethyltryptamine – contributing to psychosis? ↗ | Johanna M. Warren, Pallavi Dham-Nayyar, Jacob Alexander | 2012 | Australian & New Zealand Journal of Psychiatry | 20 |
| An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice ↗ | Correa-Netto NF, Masukawa MY, Nishide F et al. | 2017 | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 20 |
| Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure ↗ | Alana de Fátima Andrade Santos, Ana Luiza Sarkis Vieira, Aline Pic‐Taylor et al. | 2017 | Revista Brasileira de Farmacognosia | 20 |
| Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain ↗ | Müller F, Liechti ME, Lang UE et al. | 2018 | Progress in brain research | 20 |
| Reply to “Ayahuasca turned on my mind’s eye”: A case of acquired versus congenital aphantasia, as evidenced with DMT use? ↗ | David Luke | 2018 | Journal of Psychedelic Studies | 20 |
| Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study ↗ | Révész D, Ona G, Rossi GN et al. | 2021 | Frontiers in psychiatry | 20 |
| Set and Setting in the Santo Daime ↗ | Hartogsohn I | 2021 | Frontiers in pharmacology | 20 |
| Ayahuasca may help to improve self-compassion and self-criticism capacities ↗ | Domínguez-Clavé E, Soler J, Elices M et al. | 2022 | Human psychopharmacology | 20 |
| Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials ↗ | Dos Santos RG, Rocha JM, Rossi GN et al. | 2022 | Human psychopharmacology | 20 |
| Potential role of PANoptosis in neuronal cell death: commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons” ↗ | Yanyan Sun, Changlian Zhu | 2022 | Neural Regeneration Research | 20 |
| Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019 ↗ | Davis AK, Arterberry BJ, Xin Y et al. | 2022 | Frontiers in epidemiology | 20 |
| Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells ↗ | Robinson GI, Li D, Wang B et al. | 2023 | Current issues in molecular biology | 20 |
| Interaction of psychedelic tryptamine derivatives with a lipid bilayer ↗ | Zohairi F, Khandelia H, Hakami Zanjani AA | 2023 | Chemistry and physics of lipids | 20 |
| Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders ↗ | Rhee TG, Davoudian PA, Sanacora G et al. | 2023 | Drug discovery today | 20 |
| The use of classic psychedelics among adults: a Danish online survey study ↗ | Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A | 2023 | Nordic journal of psychiatry | 20 |
| Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness ↗ | Christopher Timmermann, James W. Sanders, David Reydellet et al. | 2025 | Neuroscience of Consciousness | 20 |
| Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients ↗ | Narasimhachari N, Baumann P, Pak HS et al. | 1974 | Biological psychiatry | 19 |
| Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats ↗ | Walters JK, Sheard MH, Davis M | 1978 | Pharmacology, biochemistry, and behavior | 19 |
| Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens' ↗ | Koerner J, Appel JB | 1982 | Psychopharmacology | 19 |
| Activity of serotonin-containing nucleus centralis superior (Raphe medianus) neurons in freely moving cats ↗ | Trulson ME, Crisp T, Trulson VM | 1984 | Experimental brain research | 19 |
| In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain ↗ | Barker SA, Beaton JM, Christian ST et al. | 1984 | Biochemical pharmacology | 19 |
| The inhibition of the cage-leaving response--a model for studies of the serotonergic neurotransmission in the rat ↗ | Rényi L, Archer T, Minor BG et al. | 1986 | Journal of neural transmission | 19 |
| N,N-dimethyltryptamine alkaloid in Mimosa tenuiflora bark (tepescohuite) ↗ | Meckes-Lozoya M, Lozoya X, Marles RJ et al. | 1990 | Archivos de investigacion medica | 19 |
| Os conteúdos das visões da ayahuasca ↗ | Benny Shanon | 2003 | Mana | 19 |
| [Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS] ↗ | Kawamura M, Kikura-Hanajiri R, Goda Y | 2009 | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan | 19 |
| Conformational, spectroscopic and nonlinear optical properties of biologically active N,N-dimethyltryptamine molecule: a theoretical study ↗ | Öner N, Tamer Ö, Avcı D et al. | 2014 | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy | 19 |
| Sigma-1 receptors modulate neonatal Na<sub>v</sub>1.5 ion channels in breast cancer cell lines ↗ | Aydar E, Stratton D, Fraser SP et al. | 2016 | European biophysics journal : EBJ | 19 |
| New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca ↗ | McKenna D, Riba J | 2018 | Current topics in behavioral neurosciences | 19 |
| Plant based assisted therapy for the treatment of substance use disorders - part 1. The case of takiwasi center and other similar experiences ↗ | Matteo Politi, Fabio Friso, Jacques Mabit | 2018 | Cultura y Droga | 19 |
| Evaluation of the Cytotoxicity of Ayahuasca Beverages ↗ | Simão AY, Gonçalves J, Gradillas A et al. | 2020 | Molecules (Basel, Switzerland) | 19 |
| Ayahuasca and the traveller: A scoping review of risks and possible benefits ↗ | Houle SKD, Evans D, Carter CA et al. | 2021 | Travel medicine and infectious disease | 19 |
| Pharmacologic Similarities and Differences Among Hallucinogens ↗ | Waters K | 2021 | Journal of clinical pharmacology | 19 |
| Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties ↗ | Politi M, Tresca G, Menghini L et al. | 2022 | Planta medica | 19 |
| Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness ↗ | Forstmann M, Kettner HS, Sagioglou C et al. | 2023 | Journal of psychopharmacology (Oxford, England) | 19 |
| Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey ↗ | Tessa Cowley‐Court, Richard Chenhall, Jerome Sarris et al. | 2023 | Psychoactives | 19 |
| Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans ↗ | Stacey B. Armstrong, Yitong Xin, Nathan D. Sepeda et al. | 2023 | Military Psychology | 19 |
| Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue ↗ | Robinson GI, Li D, Wang B et al. | 2023 | Life (Basel, Switzerland) | 19 |
| Symmetry Perception and Psychedelic Experience ↗ | Alexis D. J. Makin, Marco Roccato, Elena Karakashevska et al. | 2023 | Symmetry | 19 |
| This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience ↗ | Michael P, Luke D, Robinson O | 2023 | Frontiers in psychology | 19 |
| Psychedelia: The interplay of music and psychedelics ↗ | Jerotic K, Vuust P, Kringelbach ML | 2024 | Annals of the New York Academy of Sciences | 19 |
| Psychedelic therapy in depression and substance use disorders ↗ | Korkmaz ND, Cikrikcili U, Akan M et al. | 2024 | The European journal of neuroscience | 19 |
| Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression ↗ | Farid Aboharb, Pasha A. Davoudian, Ling-Xiao Shao et al. | 2025 | Nature Communications | 19 |
| Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians ↗ | Vina SM | 2025 | Journal of racial and ethnic health disparities | 19 |
| The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies ↗ | Low ZXB, Ng WS, Lim ESY et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 19 |
| A comparative study of hydroxyindole oxidases ↗ | Blaschko H, Levine WG | 1960 | British journal of pharmacology and chemotherapy | 18 |
| Ayahuasca--the healing vine ↗ | Dobkin de Rios M | 1971 | The International journal of social psychiatry | 18 |
| The crystal and molecular structure of (N,N)-dimethyltryptamine ↗ | Gerald Falkenberg | 1972 | Acta Crystallographica Section B | 18 |
| The biosynthesis of 5-methoxy-N,N-dimethyltryptamine in vitro ↗ | Mandel LR, Walker RW | 1974 | Life sciences | 18 |
| Simultaneous detection of a wide variety of commonly abused drugs in a urine screening program using thin-layer identification techniques ↗ | Kaistha KK, Tadrus R, Janda R | 1975 | Journal of chromatography | 18 |
| Accumulation of N,N-dimethyltryptamine in rat brain cortical slices ↗ | Sangiah S, Gomez MV, Domino EF | 1979 | Biological psychiatry | 18 |
| Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding ↗ | Nielsen EB, Ginn SR, Cunningham KA et al. | 1985 | Behavioural brain research | 18 |
| Development of tolerance to repeated administration of 5-methoxy-N,N-dimethyltryptamine in rats ↗ | Trulson ME, Keltch GF | 1985 | European journal of pharmacology | 18 |
| Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats ↗ | Nabeshima T, Yamaguchi K, Ishikawa K et al. | 1987 | The Journal of pharmacology and experimental therapeutics | 18 |
| Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor ↗ | McClue SJ, Brazell C, Stahl SM | 1989 | Biological psychiatry | 18 |
| The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig ↗ | Evenden JL | 1994 | British journal of pharmacology | 18 |
| Simple Syntheses of Lespedamine and 5-Bromo-N,N-dimethyltryptamine Based on 1-Hydroxyindole Chemistry ↗ | Masanori Somei, Kensuke Kobayashi, Keiko Tanii et al. | 1995 | Heterocycles | 18 |
| Alkaloids from Fissistigma latifolium (Dunal) Merr ↗ | Alias A, Hazni H, Jaafar FM et al. | 2010 | Molecules (Basel, Switzerland) | 18 |
| Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives ↗ | Labate BC | 2011 | Journal of psychoactive drugs | 18 |
| Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death ↗ | Wiltshire PE, Hawksworth DL, Edwards KJ | 2015 | Journal of forensic and legal medicine | 18 |
| A rapid and simple method for the determination of psychoactive alkaloids by CE-UV: application to Peganum Harmala seed infusions ↗ | Tascón M, Benavente F, Vizioli NM et al. | 2017 | Drug testing and analysis | 18 |
| Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand ↗ | Al-Imam A | 2017 | Case reports in neurological medicine | 18 |
| Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies ↗ | Santos MC, Navickiene S, Gaujac A | 2017 | Journal of AOAC International | 18 |
| “Ayahuasca turned on my mind’s eye”: Enhanced visual imagery after ayahuasca intake in a man with “blind imagination” (aphantasia) ↗ | Rafael G. dos Santos, Scotty Enyart, José Carlos Bouso et al. | 2018 | Journal of Psychedelic Studies | 18 |
| Human indole(ethyl)amine-N-methyltransferase (hINMT) catalyzed methylation of tryptamine, dimethylsulfide and dimethylselenide is enhanced under reducing conditions - A comparison between 254C and 254F, two common hINMT variants ↗ | Torres B, Tyler JS, Satyshur KA et al. | 2019 | PloS one | 18 |
| Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction ↗ | Nolli LM, de Oliveira DGR, Alves SS et al. | 2020 | Alcohol (Fayetteville, N.Y.) | 18 |
| Natural Psychoplastogens As Antidepressant Agents ↗ | Benko J, Vranková S | 2020 | Molecules (Basel, Switzerland) | 18 |
| Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity ↗ | Fricke J, Sherwood AM, Halberstadt AL et al. | 2021 | Journal of natural products | 18 |
| Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil ↗ | Daldegan-Bueno D, Maia LO, Massarentti CM et al. | 2022 | Psychopharmacology | 18 |
| Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma ↗ | Eckernäs E, Bendrioua A, Cancellerini C et al. | 2022 | Journal of pharmaceutical and biomedical analysis | 18 |
| Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing ↗ | Daniel Perkins, Emérita Sátiro Opaleye, José Carlos Bouso et al. | 2023 | Psychoactives | 18 |
| Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice ↗ | Nogueira M, Ferreira Golbert DC, Menezes R et al. | 2025 | Molecular psychiatry | 18 |
| The crystal and molecular structure of 5-methoxy-(N,N)-dimethyltryptamine hydrochloride ↗ | Gerald Falkenberg, D. Carlström | 1971 | Acta Crystallographica Section B | 17 |
| Evidence of 5-HT participation in vagal inhibitory pathway to opossum LES ↗ | Rattan S, Goyal RK | 1978 | The American journal of physiology | 17 |
| Bufotenine esters ↗ | Glennon RA, Gessner PK, Godse DD et al. | 1979 | Journal of medicinal chemistry | 17 |
| Serotonergic function in mouse head twitches induced by lithium and reserpine ↗ | Yamada K, Furukawa T | 1979 | Psychopharmacology | 17 |
| Severe aggression in rats induced by mescaline but not other hallucinogens ↗ | Sbordone RJ, Wingard JA, Gorelick DA et al. | 1979 | Psychopharmacology | 17 |
| Influence of psychotomimetics and lisuride on synaptosomal dopamine release in the nucleus accumbens of rats ↗ | Hetey L, Schwitzkowsky R, Oelssner W | 1983 | European journal of pharmacology | 17 |
| Serotonin receptor activation in rats previously deprived of REM sleep ↗ | Santos R, Carlini EA | 1983 | Pharmacology, biochemistry, and behavior | 17 |
| The ion-pair extraction, purification, and liquid chromatographic analysis of indolealkylamines in human urine ↗ | Sitaram BR, Blackman GL, McLeod WR et al. | 1983 | Analytical biochemistry | 17 |
| Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats ↗ | Trulson ME, Preussler DW, Trulson VM | 1984 | The Journal of pharmacology and experimental therapeutics | 17 |
| Discriminative stimulus properties of lysergic acid diethylamide in the monkey ↗ | Nielsen EB | 1985 | The Journal of pharmacology and experimental therapeutics | 17 |
| Evidence for multiple serotonergic influences on LH release in ovariectomized rats and for modulation of their relative effectiveness by estrogen ↗ | Lenahan SE, Seibel HR, Johnson JH | 1986 | Neuroendocrinology | 17 |
| Kinetic characterization of 5-hydroxytryptamine receptor desensitization in isolated guinea-pig trachea and rabbit aorta ↗ | Ben-Harari RR, Dalton BA, Osman R et al. | 1991 | The Journal of pharmacology and experimental therapeutics | 17 |
| Veratramine-induced behavior associated with serotonergic hyperfunction in mice ↗ | Nagata R, Izumi K | 1991 | Japanese journal of pharmacology | 17 |
| The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity ↗ | Reimann W, Schneider F | 1993 | General pharmacology | 17 |
| alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice ↗ | Matsumoto K, Mizowaki M, Thongpraditchote S et al. | 1997 | Pharmacology, biochemistry, and behavior | 17 |
| Pharmacology of the serotonergic inhibition of steroid-induced reinitiation of oocyte meiosis in the teleost Fundulus heteroclitus ↗ | Cerdà J, Petrino TR, Greenberg MJ et al. | 1997 | Molecular reproduction and development | 17 |
| Comparative levels of dimethyltryptamine- and tyramine-related alkaloid toxins in Australian cultivars and some wild populations of Phalaris aquatica ↗ | R. A. Culvenor, K. F. M. Reed, Scott McDonald | 2005 | Australian Journal of Agricultural Research | 17 |
| The Analysis of the Chemical Drugs among Structural Isomer ↗ | Kayo Doi, Maki Miyazawa, Hisashi Fujii et al. | 2006 | YAKUGAKU ZASSHI | 17 |
| Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice ↗ | Lucas P | 2009 | The International journal on drug policy | 17 |
| Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics ↗ | Tófoli LF, de Araujo DB | 2016 | International review of neurobiology | 17 |
| Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014 ↗ | Palamar JJ, Mauro PM, Han BH et al. | 2017 | Drug and alcohol dependence | 17 |
| Detection and Quantification of Psychoactive <i>N</i>,<i>N</i>-Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry ↗ | Chambers MI, Appley MG, Longo CM et al. | 2020 | ACS omega | 17 |
| Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms ↗ | Morita I, Oyama H, Kiguchi Y et al. | 2020 | Journal of pharmaceutical and biomedical analysis | 17 |
| Neural and subjective effects of inhaled DMT in natural settings ↗ | Pallavicini C, Cavanna F, Zamberlan F et al. | 2020 | bioRxiv | 17 |
| Neural network models for DMT-induced visual hallucinations ↗ | Schartner MM, Timmermann C | 2020 | Neuroscience of consciousness | 17 |
| The need for publicly funded research on therapeutic use of psychedelic drugs ↗ | Wayne Hall | 2021 | World Psychiatry | 17 |
| Chemical study of <i>Mimosa tenuiflora</i> barks ↗ | Amariz IAE, Pereira ECV, Alencar Filho JMT et al. | 2022 | Natural product research | 17 |
| Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives ↗ | Kaypak AC, Raz A | 2022 | Transcultural psychiatry | 17 |
| Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults ↗ | Yang KH, Han BH, Palamar JJ | 2022 | Addictive behaviors | 17 |
| Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women ↗ | Gómez-Ruiz LM, Marchei E, Rotolo MC et al. | 2022 | Pharmaceuticals (Basel, Switzerland) | 17 |
| The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides ↗ | Mallaroni P, Mason NL, Vinckenbosch FRJ et al. | 2022 | Psychopharmacology | 17 |
| 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study ↗ | Ragnhildstveit A, Khan R, Seli P et al. | 2023 | Frontiers in psychiatry | 17 |
| A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine ↗ | Egger K, Gudmundsen F, Jessen NS et al. | 2023 | Frontiers in pharmacology | 17 |
| Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review ↗ | Halman A, Kong G, Sarris J et al. | 2023 | medRxiv | 17 |
| Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats ↗ | Glynos NG, Carter L, Lee SJ et al. | 2023 | Scientific reports | 17 |
| Role of Psychedelics in Treatment-Resistant Depression ↗ | Kamal S, Jha MK, Radhakrishnan R | 2023 | The Psychiatric clinics of North America | 17 |
| Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience. ↗ | Singleton, S Parker, Timmermann, Christopher, Luppi, Andrea I et al. | 2023 | bioRxiv : the preprint server for biology | 17 |
| Influent wastewater analysis to investigate emerging trends of new psychoactive substances use in Europe ↗ | Salgueiro-Gonzalez N, Béen F, Bijlsma L et al. | 2024 | Water research | 17 |
| Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents ↗ | Werle I, Bertoglio LJ | 2024 | Neuroscience and biobehavioral reviews | 17 |
| Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology ↗ | Shinozuka K, Jerotic K, Mediano P et al. | 2024 | Translational psychiatry | 17 |
| N,N-dimethyltryptamine--a possible relationship to schizophrenia? ↗ | Wyatt RJ, Gillin JC, Kaplan J et al. | 1974 | Advances in biochemical psychopharmacology | 16 |
| Effects of N,N-dimethyltryptamine on behavioural habituation in the rat ↗ | File SE | 1977 | Pharmacology, biochemistry, and behavior | 16 |
| Behavioral properties of psychoactive phenylisopropylamines in rats ↗ | Glennon RA, Rosecrans JA, Young R | 1981 | European journal of pharmacology | 16 |
| Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity ↗ | Ortmann R, Martin S, Waldmeier PC | 1981 | Psychopharmacology | 16 |
| Antagonism of apomorphine-enhanced startle by alpha 1-adrenergic antagonists ↗ | Davis M, Kehne JH, Commissaris RL | 1985 | European journal of pharmacology | 16 |
| 5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats ↗ | Archer T, Danysz W, Jonsson G et al. | 1986 | British journal of pharmacology | 16 |
| Dopamine and noradrenaline content in fish retina: modulation by serotonin ↗ | Jaffé EH, Urbina M, Ayala C et al. | 1987 | Journal of neuroscience research | 16 |
| Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone ↗ | Freedman J, Hökfelt T, Post C et al. | 1989 | Experimental brain research | 16 |
| Synthesis and serotonergic activity of 2-oxadiazolyl-5-substituted-N,N-dimethyltryptamines: novel antagonists for the vascular 5-HT1B-like receptor ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 1999 | Journal of the Chemical Society Perkin Transactions 1 | 16 |
| Variation in the accumulation levels of N,N-dimethyltryptamine in micropropagated trees and in in vitro cultures of Mimosa tenuiflora ↗ | Nicasio Mdel P, Villarreal ML, Gillet F et al. | 2005 | Natural product research | 16 |
| The adverse effects of hallucinogens from intramural perspective ↗ | Frecska E, Luna LE | 2006 | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 16 |
| Tryptamines ↗ | Javed Khan, Thomas J. Kennedy, Donnell R. Christian | 2011 | Humana Press eBooks | 16 |
| An approach to the new psychoactive drugs phenomenon ↗ | Helen Dolengevich-Segal, Fundación Psiformación. Madrid., Beatriz Rodríguez-Salgado et al. | 2017 | Salud Mental | 16 |
| Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model ↗ | Peto K, Nemeth N, Mester A et al. | 2018 | Clinical hemorheology and microcirculation | 16 |
| Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence? ↗ | Cruz JI, Nappo SA | 2018 | Journal of psychoactive drugs | 16 |
| The effect of <scp><i>Banisteriopsis caapi</i></scp> (<scp><i>B. caapi</i></scp>) on the motor deficits in the MPTP‐treated common marmoset model of Parkinson's disease ↗ | Ria Fisher, Louise Lincoln, Michael J. Jackson et al. | 2018 | Phytotherapy Research | 16 |
| Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study ↗ | Kim van Oorsouw, Malin V. Uthaug, Natasha L. Mason et al. | 2021 | Journal of Psychedelic Studies | 16 |
| Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology ↗ | Stephan Schleim | 2022 | Frontiers in Psychiatry | 16 |
| Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders ↗ | Vorobyeva N, Kozlova AA | 2022 | Frontiers in pharmacology | 16 |
| A Systematic Review on the Therapeutic Effects of Ayahuasca ↗ | Gonçalves J, Luís Â, Gallardo E et al. | 2023 | Plants (Basel, Switzerland) | 16 |
| An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study ↗ | Michael P, Luke D, Robinson O | 2023 | Frontiers in psychology | 16 |
| Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training? ↗ | Emmerich N, Humphries B | 2023 | Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees | 16 |
| Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial ↗ | James E, Erritzoe D, Benway T et al. | 2023 | Frontiers in psychiatry | 16 |
| Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being ↗ | Bonnelle V, Feilding A, Rosas FE et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 16 |
| Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study ↗ | Aday JS, Bloesch EK, Davis AK et al. | 2025 | Journal of psychoactive drugs | 16 |
| The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression ↗ | Falchi-Carvalho M, Barros H, Bolcont R et al. | 2025 | Psychedelic medicine (New Rochelle, N.Y.) | 16 |
| 6-hydroxylation: effect on the psychotropic potency of tryptamines ↗ | Taborsky RG, Delvigs P, Page IH | 1966 | Science (New York, N.Y.) | 15 |
| Effects of N-N-dimethyltryptamine on retention of startle response habituation in the rat ↗ | Davis M, Bear HD | 1972 | Psychopharmacologia | 15 |
| Effects of iproniazid, chlorpromazine and methiothepin on DMT-induced changes in body temperature, pupillary dilatation, blood pressure and EEG in the rabbit ↗ | Moore RH, Demetriou SK, Domino EF | 1975 | Archives internationales de pharmacodynamie et de therapie | 15 |
| New and Uncommon Indole- and Imidazole-Alkylamines in Skins of Amphibians from Australia and Papua New Guinea ↗ | M. Roseghini, R. Endean, A. Temperilli | 1976 | Zeitschrift für Naturforschung C | 15 |
| Dorsal raphe neurons: self-inhibition by an amphetamine-induced release of endogenous serotonin ↗ | Rebec GV, Curtis SD, Zimmerman KS | 1982 | Brain research | 15 |
| Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity ↗ | Lima L, Sourkes TL | 1986 | Neuroscience | 15 |
| Phencyclidine-induced head-weaving observed in mice after ritanserin treatment ↗ | Nabeshima T, Ishikawa K, Yamaguchi K et al. | 1987 | European journal of pharmacology | 15 |
| In vivo determination of 5-hydroxytryptamine receptor-stimulated phosphoinositide turnover in rat brain ↗ | Hide I, Kato T, Yamawaki S | 1989 | Journal of neurochemistry | 15 |
| Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors ↗ | Alhaider AA, Hamon M, Wilcox GL | 1993 | European journal of pharmacology | 15 |
| Altered consciousness states and endogenous psychoses: a common molecular pathway? ↗ | Ciprian-Ollivier J, Cetkovich-Bakmas MG | 1997 | Schizophrenia research | 15 |
| Effects of serotoninergic drugs on tremor induced by physostigmine in rats ↗ | Sarkar S, Thomas B, Muralikrishnan D et al. | 2000 | Behavioural brain research | 15 |
| Indolealkylamines in Mucuna species ↗ | N.J. Szabo | 2003 | | 15 |
| Ayahuasca–From Dangerous Drug to National Heritage: An Interview with Antonio A. Arantes ↗ | Beatriz Caiuby Labate, Ilana Seltzer Goldstein, Campinas State Univesity | 2009 | International Journal of Transpersonal Studies | 15 |
| Alcaloides e o chá de ayahuasca: uma correlação dos "estados alterados da consciência" induzido por alucinógenos ↗ | Priscila Alves de Souza | 2011 | Revista Brasileira de Plantas Medicinais | 15 |
| Concise syntheses of 5,6-dibromotryptamine and 5,6-dibromo-N,N-dimethyltryptamine en route to the antibiotic alternatamide D ↗ | Jonathan Sperry | 2011 | Tetrahedron Letters | 15 |
| Ayahuasca, psychedelic studies and health sciences: the politics of knowledge and inquiry into an Amazonian plant brew ↗ | Tupper KW, Labate BC | 2014 | Current drug abuse reviews | 15 |
| QEEG studies of the acute effects of the visionary tryptamine DMT ↗ | Juan Acosta‐Urquidi | 2015 | Open Humanities Press - Cosmos and History: The Journal of Natural and Social Philosophy | 15 |
| Ayahuasca: what mental health professionals need to know ↗ | Rafael G. dos Santos, José Carlos Bouso, Jaime E. C. Hallak | 2017 | Archives of Clinical Psychiatry (São Paulo) | 15 |
| Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala ↗ | Herraiz T, Guillén H, Arán VJ et al. | 2017 | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association | 15 |
| It's Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish ↗ | Lobao-Soares B, Eduardo-da-Silva P, Amarilha H et al. | 2018 | Frontiers in behavioral neuroscience | 15 |
| Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats ↗ | da Motta LG, de Morais JA, Tavares ACAM et al. | 2018 | Reproductive toxicology (Elmsford, N.Y.) | 15 |
| Reaction of <i>N</i>,<i>N</i>-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions ↗ | Dunlap LE, Olson DE | 2018 | ACS omega | 15 |
| Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users ↗ | Mello SM, Soubhia PC, Silveira G et al. | 2019 | Journal of psychoactive drugs | 15 |
| Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines ↗ | Grafinger KE, Wilke A, König S et al. | 2019 | Drug testing and analysis | 15 |
| Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application ↗ | Körmöczi T, Szabó Í, Farkas E et al. | 2020 | Journal of pharmaceutical and biomedical analysis | 15 |
| Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS ↗ | Tavares L, Monedeiro F, Bordin DM et al. | 2020 | Journal of analytical toxicology | 15 |
| Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers ↗ | Mendes Rocha J, Rossi GN, Osório FL et al. | 2021 | Frontiers in psychiatry | 15 |
| [Efficacy of psychedelics in psychiatry, a systematic review of the literature] ↗ | Berkovitch L, Roméo B, Karila L et al. | 2021 | L'Encephale | 15 |
| Essential oil-based dispersive liquid-liquid microextraction for the determination of N,N-dimethyltryptamine and β-carbolines in human plasma: A novel solvent-free alternative ↗ | Silveira GO, Lourenço FR, Fonseca Pego AM et al. | 2021 | Talanta | 15 |
| The Power of Social Attribution: Perspectives on the Healing Efficacy of Ayahuasca ↗ | Brabec de Mori B | 2021 | Frontiers in psychology | 15 |
| Antidepressant and anxiolytic-like effects of ayahuasca in rats subjected to LPS-induced neuroinflammation ↗ | Goulart da Silva M, Daros GC, Santos FP et al. | 2022 | Behavioural brain research | 15 |
| Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation ↗ | Daneluz DM, Sohn JMB, Silveira GO et al. | 2022 | Psychopharmacology | 15 |
| Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief ↗ | González D, Aixalà MB, Neimeyer RA et al. | 2022 | Frontiers in psychology | 15 |
| Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users ↗ | Ramaekers JG, Mallaroni P, Kloft L et al. | 2023 | Journal of cognitive neuroscience | 15 |
| Examining the Therapeutic Effect of Ceremonial Ayahuasca on Narcissistic Personality and Antagonistic Externalizing in Adults ↗ | Weiss B, Sleep C, Miller JD et al. | 2023 | Journal of personality disorders | 15 |
| Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders ↗ | Kargbo RB | 2023 | ACS medicinal chemistry letters | 15 |
| N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis ↗ | Eckernäs E, Timmermann C, Carhart-Harris R et al. | 2023 | CPT: pharmacometrics & systems pharmacology | 15 |
| Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat ↗ | Meling D, Egger K, Aicher HD et al. | 2024 | Journal of psychopharmacology (Oxford, England) | 15 |
| Electrogenerated Chemiluminescence Coupled with Molecularly Imprinted Polymer for Sensitive and Selective Detection of <i>N</i>,<i>N</i>-Dimethyltryptamine ↗ | Motchaalangaram JA, Mahalingam P, Wallace KJ et al. | 2025 | Analytical chemistry | 15 |
| [Dimethyltryptamine: a new psycho-active drug] ↗ | SAI-HALASZ A, BRUNECKER G, SZARA S | 1958 | Psychiatria et neurologia | 14 |
| Identification of N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine and bufotenin by cellulose TLC ↗ | Baumann P, Narasimhachari | 1973 | Journal of chromatography | 14 |
| The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior ↗ | Schlemmer RF Jr, Narasimhachari N, Thompson VD et al. | 1977 | Communications in psychopharmacology | 14 |
| Reversed-phase high-pressure liquid chromatography of some tryptamine derivatives ↗ | Balandrin MF, Kinghorn AD, Smolenski SJ et al. | 1978 | Journal of chromatography | 14 |
| A comparison of the behavioral effects of proteo-and deutero-N, N-dimethyltryptamine ↗ | Beaton JM, Barker SA, Liu WF | 1982 | Pharmacology, biochemistry, and behavior | 14 |
| Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation ↗ | Slater P, Longman DA, Dickinson SL | 1982 | Naunyn-Schmiedeberg's archives of pharmacology | 14 |
| Inhibition of synaptosomal neurotransmitter uptake by hallucinogens ↗ | Whipple MR, Reinecke MG, Gage FH | 1983 | Journal of neurochemistry | 14 |
| A multidisciplinary overview of intoxicating snuff rituals in the western hemisphere ↗ | de Smet PA | 1985 | Journal of ethnopharmacology | 14 |
| A new metabolic pathway for N,N-dimethyltryptamine ↗ | Hryhorczuk LM, Rainey JM Jr, Frohman CE et al. | 1986 | Biological psychiatry | 14 |
| Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam ↗ | Lima L | 1991 | Pharmacology, biochemistry, and behavior | 14 |
| A Simple Synthesis of 5-Amino-3-(2-dimethylaminoethyl) indole [5-Amino-N,N-dimethyltryptamine] ↗ | John E. Macor, Ronald J. Post, Kevin Ryan | 1993 | Synthetic Communications | 14 |
| Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N,N-dimethyltryptamine ↗ | Cancela LM, Volosin M, Molina VA | 1996 | Brain research bulletin | 14 |
| The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens ↗ | Winter JC, Helsley S, Fiorella D et al. | 1999 | Pharmacology, biochemistry, and behavior | 14 |
| Antagonism of a PCP drug discrimination by hallucinogens and related drugs ↗ | West WB, Lou A, Pechersky K et al. | 2000 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 14 |
| Synthetic studies of psilocin analogs having either a formyl group or bromine atom at the 5- or 7-position ↗ | Yamada F, Tamura M, Hasegawa A et al. | 2002 | Chemical & pharmaceutical bulletin | 14 |
| Synthesis of deuterium labeled standards of 5‐methoxy‐<i>N</i>,<i>N</i>‐dimethyltryptamine (5‐Meo‐DMT) ↗ | Ya-Zhu Xu, Chinpiao Chen | 2006 | Journal of Labelled Compounds and Radiopharmaceuticals | 14 |
| The "vine of the soul" vs. the Controlled Substances Act: implications of the hoasca case ↗ | Bullis RK | 2008 | Journal of psychoactive drugs | 14 |
| Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry ↗ | Brandt SD, Moore SA, Freeman S et al. | 2010 | Drug testing and analysis | 14 |
| Hallucinogen Rating Scale (HRS) - Versão brasileira: tradução e adaptação transcultural ↗ | Suely Mizumoto, Dartiu Xavier da Silveira, Paulo César Ribeiro Barbosa et al. | 2011 | Archives of Clinical Psychiatry (São Paulo) | 14 |
| Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser ↗ | Yasuko Fuse‐Nagase, Toru Nishikawa | 2013 | Addiction Science & Clinical Practice | 14 |
| Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry ↗ | Damila Rodrigues de Morais, Rafael Lanaro, Ingrid Lopes Barbosa et al. | 2017 | Forensic Toxicology | 14 |
| Psychedelics and Personality ↗ | Aixalà M, Dos Santos RG, Hallak JEC et al. | 2018 | ACS chemical neuroscience | 14 |
| Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations ↗ | Reis HS, Rodrigues IRS, Anjos-Santos A et al. | 2020 | Psychopharmacology | 14 |
| Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life ↗ | Kaasik H, Kreegipuu K | 2020 | Journal of psychoactive drugs | 14 |
| Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series ↗ | Gómez-Sousa M, Jiménez-Garrido DF, Ona G et al. | 2021 | Journal of clinical psychopharmacology | 14 |
| Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca ↗ | Liu M, Yang H, Hu J et al. | 2021 | Forensic science international | 14 |
| Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report ↗ | Rubin-Kahana DS, Hassan AN, Le Foll B | 2021 | Journal of addiction medicine | 14 |
| A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap ↗ | Ledwos N, Rosenblat JD, Blumberger DM et al. | 2022 | Journal of clinical psychopharmacology | 14 |
| Moderators of ayahuasca's biological antidepressant action ↗ | de Sousa GM, de Oliveira Tavares VD, de Menezes Galvão AC et al. | 2022 | Frontiers in psychiatry | 14 |
| Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines ↗ | Glatfelter GC, Pham DNK, Walther D et al. | 2022 | ACS omega | 14 |
| A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines ↗ | Chen X, Li J, Yu L et al. | 2023 | The Journal of biological chemistry | 14 |
| Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment ↗ | David J, Bouso JC, Kohek M et al. | 2023 | Frontiers in psychiatry | 14 |
| Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters ↗ | Jahanabadi S, Amiri S, Karkeh-Abadi M et al. | 2023 | Fitoterapia | 14 |
| Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico ↗ | Davis AK, Xin Y, Sepeda N et al. | 2023 | The American journal of drug and alcohol abuse | 14 |
| The entropic heart: Tracking the psychedelic state via heart rate dynamics ↗ | Rosas FE, Mediano PA, Timmermann C et al. | 2023 | bioRxiv | 14 |
| Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine Analogs in Mice ↗ | Glatfelter GC, Clark AA, Cavalco NG et al. | 2024 | ACS chemical neuroscience | 14 |
| Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants ↗ | Erne L, Vogt SB, Müller L et al. | 2025 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 14 |
| Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study ↗ | Klemens Egger, Javier Jareño Redondo, J Müller et al. | 2025 | Biomedicine & Pharmacotherapy | 14 |
| The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials ↗ | Hogea L, Tabugan DC, Costea I et al. | 2025 | Medicina (Kaunas, Lithuania) | 14 |
| A bufotenin-like substance in the urine of schizophrenics. ↗ | FISCHER, E, FERNANDEZ LAGRAVERE, T A, VAZQUEZ, A J et al. | 1961 | The Journal of nervous and mental disease | 13 |
| Alkaloids of <i>Acacia</i> . I. NbNb-Dimethyltryptamine in <i>Acacia phlebophylla</i> F. Muell ↗ | B Rovelli, GN Vaughan | 1967 | Australian Journal of Chemistry | 13 |
| Plant admixtures to Ayahuasca, the South American hallucinogenic drink ↗ | Pinkley HV | 1969 | Lloydia | 13 |
| Correlation between brain N,N dimethyltryptamine (DMT) levels and bar pressing behavior in rats: effect of MAO inhibition ↗ | Lee‐Jane W. Lu, Ann Wilson, R. H. Moore et al. | 1974 | | 13 |
| Biochemical studies in early infantile autism ↗ | Narasimhachari N, Himwich HE | 1975 | Biological psychiatry | 13 |
| Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance ↗ | Stoff DM, Moja EA, Gillin JC et al. | 1977 | Biological psychiatry | 13 |
| Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation ↗ | Green AR | 1977 | British journal of pharmacology | 13 |
| Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat ↗ | Ruffing D, Kovacic B, Demetriou S et al. | 1979 | Psychopharmacology | 13 |
| Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model ↗ | Slater P | 1980 | Pharmacology, biochemistry, and behavior | 13 |
| Analgesia induced by brief footshock: blockade by fenfluramine and 5-methoxy-N,N-dimethyltryptamine and prevention of blockade by 5-HT antagonists ↗ | Hutson PH, Tricklebank MD, Curzon G | 1983 | Brain research | 13 |
| Opioid-hallucinogen interactions ↗ | Domino EF | 1986 | Pharmacology, biochemistry, and behavior | 13 |
| Chemical and enzymatic oxidative coupling of 5-hydroxy-N,N-dimethyltryptamine with amines ↗ | Babin F, Huynh-Dinh T | 1987 | Journal of medicinal chemistry | 13 |
| Behavioral effects of 8-OH-DPAT: studies using the Microtaxic ventricular injector ↗ | Wieland S, Goodale D, Lucki I | 1989 | Journal of neuroscience methods | 13 |
| Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat ↗ | Nash JF, Meltzer HY | 1989 | The Journal of pharmacology and experimental therapeutics | 13 |
| Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration ↗ | Heidenreich BA, Rebec GV | 1989 | Neuroscience letters | 13 |
| Agonist action of indole derivatives at 5-HT1-like, 5-HT3, and 5HT4 receptors in vitro ↗ | Eglen RM, Perkins LA, Walsh LK et al. | 1992 | Journal of autonomic pharmacology | 13 |
| Dopamine uptake inhibitory activity of novel tryptamine 5‐HT<sub>1</sub> receptor ligands ↗ | Lorraine A. Lebel, Jolanta Nowakowski, John E. Macor et al. | 1994 | Drug Development Research | 13 |
| Lack of adaptive changes in 5-HT sites in perinatally undernourished rats after chronic stress: opioid influence ↗ | Keller EA, Cancela LM, Molina VA et al. | 1994 | Pharmacology, biochemistry, and behavior | 13 |
| Ayahuasca in adolescence: Qaualitative results ↗ | de Rios MD, Grob CS, Lopez E et al. | 2005 | Journal of psychoactive drugs | 13 |
| Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors ↗ | Nyandege A, Kolanos R, Roth BL et al. | 2007 | Bioorganic & medicinal chemistry letters | 13 |
| Statement on ayahuasca ↗ | Anderson BT, Labate BC, Meyer M et al. | 2012 | The International journal on drug policy | 13 |
| The effects of ayahuasca ritual participation on gay and lesbian identity ↗ | Cavnar C | 2014 | Journal of psychoactive drugs | 13 |
| Ayahuasca Alters Structural Parameters of the Rat Aorta ↗ | Pitol DL, Siéssere S, Dos Santos RG et al. | 2015 | Journal of cardiovascular pharmacology | 13 |
| Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms ↗ | Jiang XL, Shen HW, Yu AM | 2016 | Pharmacological reports : PR | 13 |
| The Breakthrough Experience: DMT Hyperspace and its Liminal Aesthetics ↗ | Graham St John | 2018 | Anthropology of Consciousness | 13 |
| Long-lasting analgesic effect of the psychedelic drug <i>changa</i>: A case report ↗ | Genís Oña, Sebastián Peña-Troncoso | 2019 | Journal of Psychedelic Studies | 13 |
| Ayahuasca's Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness ↗ | Mian MN, Altman BR, Earleywine M | 2020 | Journal of psychoactive drugs | 13 |
| How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy ↗ | Orsolini L, Chiappini S, Papanti D et al. | 2020 | Human psychopharmacology | 13 |
| Discriminative Stimulus Effects of Substituted Tryptamines in Rats ↗ | Gatch MB, Hoch A, Carbonaro TM | 2021 | ACS pharmacology & translational science | 13 |
| The Potential Role of Serotonergic Hallucinogens in Depression Treatment ↗ | Psiuk D, Nowak E, Cholewa K et al. | 2021 | Life (Basel, Switzerland) | 13 |
| The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study ↗ | Maia LO, Daldegan-Bueno D, Tófoli LF | 2021 | Journal of psychoactive drugs | 13 |
| Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments ↗ | Alves CL, Cury RG, Roster K et al. | 2022 | PloS one | 13 |
| Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity ↗ | Gianfratti B, Tabach R, Sakalem ME et al. | 2022 | Journal of ethnopharmacology | 13 |
| Human behavioral pharmacology of psychedelics ↗ | Strickland JC, Johnson MW | 2022 | Advances in pharmacology (San Diego, Calif.) | 13 |
| Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae) ↗ | Schwelm HM, Zimmermann N, Scholl T et al. | 2022 | Journal of analytical toxicology | 13 |
| Cardiovascular effects of bufotenin on human 5-HT<sub>4</sub> serotonin receptors in cardiac preparations of transgenic mice and in human atrial preparations ↗ | Neumann J, Schulz N, Fehse C et al. | 2023 | Naunyn-Schmiedeberg's archives of pharmacology | 13 |
| A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder ↗ | Velit-Salazar MR, Shiroma PR, Cherian E | 2024 | Brain sciences | 13 |
| Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review ↗ | White E, Kennedy T, Ruffell S et al. | 2024 | International journal of toxicology | 13 |
| Ayahuasca: pharmacology, safety, and therapeutic effects ↗ | Dos Santos RG, Hallak JEC | 2024 | CNS spectrums | 13 |
| Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT) ↗ | Soares C, Lima G, Pais ML et al. | 2024 | Frontiers in pharmacology | 13 |
| Psychedelics: From Cave Art to 21st-Century Medicine for Addiction ↗ | Vamvakopoulou IA, Nutt DJ | 2024 | European addiction research | 13 |
| The flattening of spacetime hierarchy of the <i>N,N</i>-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework ↗ | Vohryzek J, Cabral J, Timmermann C et al. | 2024 | National science review | 13 |
| Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy ↗ | Halman A, Conyers R, Moore C et al. | 2025 | Clinical pharmacology and therapeutics | 13 |
| Effects on amine oxidase of substances which antagonize 5-hydroxytryptamine more than tryptamine on the rat fundus strip ↗ | BARLOW RB | 1961 | British journal of pharmacology and chemotherapy | 12 |
| Alkaloids of the Australian Leguminosae. VI. Alkaloids of <i>Petalostylus labicheoides</i> var. <i>casseoides</i> Benth ↗ | SR Johns, JA Lamberton, AA Sioumis | 1966 | Australian Journal of Chemistry | 12 |
| Chromatographic methods for the identification of the new hallucinogen, 4-methyl-2,5-dimethoxy-α-methyl-phenethylamine, and related drugs ↗ | K. Genest, Donald W. Hughes | 1968 | The Analyst | 12 |
| New characteristics of harmaline inhibition of intestinal transport systems ↗ | Sepúlveda FV, Robinson JW | 1975 | Naunyn-Schmiedeberg's archives of pharmacology | 12 |
| [Altered states of consciousness induced by N,N-dimethyltryptamine (DMT)] ↗ | Bickel P, Dittrich A, Schoepf J | 1976 | Pharmakopsychiatrie, Neuro-Psychopharmakologie | 12 |
| Studies on the constiuents of Desmodium caudatum DC ↗ | Akira Ueno, Yukinobu Ikeya, SEIGO FUKUSHIMA et al. | 1978 | Chemical and Pharmaceutical Bulletin | 12 |
| Neurotransmitter basis of the behavioral effects of hallucinogens ↗ | Rech RH, Commissaris RL | 1982 | Neuroscience and biobehavioral reviews | 12 |
| Biphasic effect of 5-methoxy-N,N-dimethyltryptamine on rat prolactin secretion ↗ | Simonovic M, Meltzer HY | 1983 | Brain research | 12 |
| Dissociation of head twitches and tremors during the study of interactions with 5-hydroxytryptophan in mice ↗ | Martin P, Frances H, Simon P | 1985 | Journal of pharmacological methods | 12 |
| Ontogenesis of unit activity in the raphe dorsalis of the behaving kitten: its relationship with the states of vigilance ↗ | Adrien J, Lanfumey L | 1986 | Brain research | 12 |
| 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina ↗ | Lima L, Schmeer C, Urbina M | 1994 | Neurochemical research | 12 |
| Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster ↗ | Richter A, Löscher W | 1995 | Pharmacology, biochemistry, and behavior | 12 |
| Synthesis of 131I derivatives of indolealkylamines for brain mapping ↗ | Jose A. Sintas, Arturo A. Vitale | 1997 | Journal of Labelled Compounds and Radiopharmaceuticals | 12 |
| [(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors ↗ | Harris LC, Awe SO, Opere CA et al. | 2001 | Experimental eye research | 12 |
| Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods ↗ | Wang MJ, Liu JT, Chen HM et al. | 2008 | Journal of chromatography. A | 12 |
| Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule ↗ | Drug Enforcement Administration (DEA), Department of Justice | 2010 | Federal register | 12 |
| Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society ↗ | Blainey MG | 2015 | Journal of religion and health | 12 |
| Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective ↗ | Apud I, Romaní O | 2017 | The International journal on drug policy | 12 |
| Hallucinogens and Their Therapeutic Use: A Literature Review ↗ | Begola MJ, Schillerstrom JE | 2019 | Journal of psychiatric practice | 12 |
| Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine ↗ | Silveira GO, Lourenço FR, Bruno V et al. | 2020 | Frontiers in chemistry | 12 |
| Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N,N-dimethyltryptamine with monoamine oxidase A ↗ | Kubicskó K, Farkas Ö | 2020 | Organic & biomolecular chemistry | 12 |
| Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials ↗ | Cozzi NV, Daley PF | 2020 | Drug testing and analysis | 12 |
| The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified ↗ | Mishraki-Berkowitz T, Kochelski E, Kavanagh P et al. | 2020 | Journal of forensic sciences | 12 |
| β-carboline-independent antidepressant-like effect of the standardized extract of the barks of <i>Mimosa tenuiflora</i> (Willd) Poir. occurs via 5-HT<sub>2A/2C</sub> receptors in mice ↗ | Duarte-Filho LAMS, Amariz IA, Nishimura RHV et al. | 2022 | Journal of psychopharmacology (Oxford, England) | 12 |
| The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users ↗ | Pontual AAD, Tófoli LF, Corradi-Webster CM et al. | 2022 | Frontiers in psychology | 12 |
| Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review ↗ | Zhornitsky S, Oliva HNP, Jayne LA et al. | 2023 | Frontiers in psychiatry | 12 |
| Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial ↗ | Rossi GN, Rocha JM, Osório FL et al. | 2023 | Journal of clinical psychopharmacology | 12 |
| Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans ↗ | Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A et al. | 2023 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 12 |
| Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca ↗ | Weiss B, Wingert A, Erritzoe D et al. | 2023 | Scientific reports | 12 |
| Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review ↗ | Fonseka LN, Woo BK | 2023 | World journal of psychiatry | 12 |
| Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science ↗ | Rush B, Marcus O, García S et al. | 2024 | Journal of studies on alcohol and drugs | 12 |
| Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders ↗ | Wong S, Yu AY, Fabiano N et al. | 2024 | Journal of psychoactive drugs | 12 |
| Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022 ↗ | Simon MW, Olsen HA, Hoyte CO et al. | 2024 | Annals of emergency medicine | 12 |
| Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis ↗ | Hsu TW, Tsai CK, Kao YC et al. | 2024 | BMJ (Clinical research ed.) | 12 |
| Effects of hallucinogenic drugs on the human heart ↗ | Neumann J, Dhein S, Kirchhefer U et al. | 2024 | Frontiers in pharmacology | 12 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview ↗ | Tabaac BJ, Shinozuka K, Arenas A et al. | 2024 | American journal of therapeutics | 12 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca ↗ | Shinozuka K, Tabaac BJ, Arenas A et al. | 2024 | American journal of therapeutics | 12 |
| The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action ↗ | Tap SC | 2024 | Addiction biology | 12 |
| Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis ↗ | Calder AE, Hase A, Hasler G | 2025 | Molecular psychiatry | 12 |
| Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis ↗ | Højlund M, Kafali HY, Kırmızı B et al. | 2025 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 12 |
| Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice ↗ | McGriff SA, Hecker JC, Maitland AD et al. | 2025 | Psychopharmacology | 12 |
| Quality of reporting on psychological interventions in psychedelic treatments: a systematic review ↗ | Seybert C, Schimmers N, Silva L et al. | 2025 | The lancet. Psychiatry | 12 |
| Xylamidine tosylate: differential antagonism of the hypothermic effects of N,N-dimethyltryptamine, bufotenine, and 5-methoxytryptamine ↗ | Winter JC | 1972 | Archives internationales de pharmacodynamie et de therapie | 11 |
| Distribution of Specific Alkaloids in Reed Canarygrass Cultivars<sup>1</sup> ↗ | A. W. Hovin, G. C. Marten | 1975 | Crop Science | 11 |
| Effects of N,N-dimethyltryptamine on electrically evoked responses in the cat visual system and modification by neuroleptic agents ↗ | Moore RH, Hatada K, Domino EF | 1976 | Neuropharmacology | 11 |
| LACK OF ENHANCEMENT OF DIMETHYLTRYPTAMINE FORMATION IN RAT BRAIN AND RABBIT LUNG <i>IN VIVO</i> BY METHIONINE OR <i>S</i>‐ADENOSYLMETHIONINE ↗ | Giorgio Stramentinoli, Ross J. Baldessarini | 1978 | Journal of Neurochemistry | 11 |
| Repeated administration of 5-methoxy-N,N-dimethyltryptamine to male rats potentiates stimulation of prolactin secretion by serotonin agonists ↗ | Simonovic M, Meltzer HY | 1979 | European journal of pharmacology | 11 |
| LDS-25 as a discriminative stimulus for response selection by pigeons ↗ | Järbe TU | 1980 | Pharmacology, biochemistry, and behavior | 11 |
| Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat ↗ | Ruffing DM, Domino EF | 1981 | Psychopharmacology | 11 |
| Evidence for dopamine mediation of submissive gestures in the stumptail macaque monkey ↗ | Schlemmer RF Jr, Davis JM | 1981 | Pharmacology, biochemistry, and behavior | 11 |
| Inhibition of phrenic and sympathetic vasomotor neurons in cats by the serotonin analog 5-methoxy-N,N-dimethyltryptamine ↗ | Lalley PM | 1982 | The Journal of pharmacology and experimental therapeutics | 11 |
| 5-hydroxytryptamine: its facilitative action on [3H]dopamine release from the retina ↗ | Kato S, Negishi K, Teranishi T et al. | 1983 | Vision research | 11 |
| Effects of apomorphine, clonidine or 5-methoxy-NN-dimethyltryptamine on approach and escape components of lateral hypothalamic and mesencephalic central gray stimulation in two inbred strains of mice ↗ | Cazala P, Garrigues AM | 1983 | Pharmacology, biochemistry, and behavior | 11 |
| Effects of chronic administration of antidepressant drugs on central serotonergic receptor mechanisms ↗ | S-O Ögren, Kjell Fuxé, Odd‐Geir Berge et al. | 1983 | Palgrave Macmillan UK eBooks | 11 |
| Intrathecal substance P modulates the depressant effect of 5-methoxy-N,N-dimethyltryptamine on a reflex response to radiant heat in mice ↗ | Eide PK, Hole K | 1988 | Neuroscience letters | 11 |
| The spinal reflex of chronic spinal rats is supersensitive to 5-HTP but not to TRH or 5-HT agonists ↗ | Nagano N, Ono H, Ozawa M et al. | 1988 | European journal of pharmacology | 11 |
| 5-HT3 agonist 2-methylserotonin as a training drug in discrimination studies ↗ | Glennon RA, Young R, Dukat M | 1992 | Pharmacology, biochemistry, and behavior | 11 |
| Modulation of 5HT1A receptors in the hippocampus and the raphe area of rats treated with clonazepam ↗ | Lima L, Salazar M, Trejo E | 1993 | Progress in neuro-psychopharmacology & biological psychiatry | 11 |
| The antiaggressive potency of (-)-penbutolol involves both 5-HT1A and 5-HT1B receptors and beta-adrenoceptors ↗ | Sánchez C, Arnt J, Moltzen EK | 1996 | European journal of pharmacology | 11 |
| 11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation ↗ | Simon M. Ametamey, F.X. Vollenweider, J. T. Patt et al. | 1998 | Journal of Labelled Compounds and Radiopharmaceuticals | 11 |
| Synthesis and serotonergic activity of a series of 2-(N-benzyl)carboxamido-5-substituted-N,N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT1B-like receptors ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 1999 | Journal of the Chemical Society Perkin Transactions 1 | 11 |
| Screening the receptorome for plant-based psychoactive compounds ↗ | O'Connor KA, Roth BL | 2005 | Life sciences | 11 |
| Characterisation of a proposed internet synthesis of N,N-dimethyltryptamine using liquid chromatography/electrospray ionisation tandem mass spectrometry ↗ | Martins CP, Freeman S, Alder JF et al. | 2009 | Journal of chromatography. A | 11 |
| Constituents in Desmodium blandum and their antitumor activity ↗ | Ping He | 2009 | Zhongcaoyao | 11 |
| Optimization of separation and online sample concentration of N,N-dimethyltryptamine and related compounds using MEKC ↗ | Wang MJ, Tsai CH, Hsu WY et al. | 2009 | Journal of separation science | 11 |
| Discriminative stimulus effects of N,N-diisopropyltryptamine ↗ | Carbonaro TM, Forster MJ, Gatch MB | 2013 | Psychopharmacology | 11 |
| VILCA, ENCUENTRO DE MIRADAS: ANTECEDENTES Y HERRAMIENTAS PARA SU PESQUISA EN CONTEXTOS ARQUEOLÓGICOS DEL ÁREA CENTRO SUR ANDINA ↗ | Francisca Gilí, Ximena Albornoz, Javier Echeverría et al. | 2016 | Chungara | 11 |
| Influence of Environmental Factors and Cultural Methods on the Content of N,N‑Dimethyltryptamine in Psychotria viridis (Rubiaceae) ↗ | André D. Cavalcante, Gabriele A. Cardoso, Fernando de Oliveira et al. | 2017 | Journal of the Brazilian Chemical Society | 11 |
| Ayahuasca: A risk for travellers? ↗ | Bauer IL | 2018 | Travel medicine and infectious disease | 11 |
| Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic ↗ | Horák M, Hasíková L, Verter N | 2018 | Journal of psychoactive drugs | 11 |
| Ayahuasca: Between Cognition and Culture ↗ | Ismael Eduardo Apud Peláez | 2020 | Publicacions URV eBooks | 11 |
| Subjective time under altered states of consciousness in ayahuasca users in shamanistic rituals involving music ↗ | Campagnoli APS, Pereira LAS, Bueno JLO | 2020 | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 11 |
| Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis ↗ | Basedow LA, Riemer TG, Reiche S et al. | 2021 | Frontiers in pharmacology | 11 |
| On Revelations and Revolutions: Drinking Ayahuasca Among Palestinians Under Israeli Occupation ↗ | Roseman L, Karkabi N | 2021 | Frontiers in psychology | 11 |
| Rituximab for people with multiple sclerosis ↗ | Filippini G, Kruja J, Del Giovane C | 2021 | The Cochrane database of systematic reviews | 11 |
| Self-care, social norms and anomie during COVID-19: from contestation of the greater good to building future normative resilience in the UK ↗ | Richard A. Powell, Kathleen Kendall, Beniamino Cislaghi et al. | 2021 | Journal of Epidemiology & Community Health | 11 |
| Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology ↗ | Oña G, Bouso JC | 2021 | Current medicinal chemistry | 11 |
| Application of Deuterated <i>N</i>,<i>N</i>-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders ↗ | Robert B. Kargbo | 2022 | ACS Medicinal Chemistry Letters | 11 |
| Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects ↗ | Nižnanský Ľ, Nižnanská Ž, Kuruc R et al. | 2022 | Journal of clinical medicine | 11 |
| Components of <i>Banisteriopsis caapi</i>, a Plant Used in the Preparation of the Psychoactive Ayahuasca, Induce Anti-Inflammatory Effects in Microglial Cells ↗ | Santos BWL, Moreira DC, Borges TKDS et al. | 2022 | Molecules (Basel, Switzerland) | 11 |
| Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience ↗ | Madrid-Gambin F, Gomez-Gomez A, Busquets-Garcia A et al. | 2022 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 11 |
| Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies ↗ | Weleff J, Akiki TJ, Barnett BS | 2023 | Journal of psychoactive drugs | 11 |
| Microextraction by packed sorbent of synthetic tryptamines from urine and ion mobility spectrometry determination ↗ | María Aparici-Lozano, Sergio Armenta, Salvador Garrigues et al. | 2023 | Advances in Sample Preparation | 11 |
| The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials ↗ | Rossi GN, Hallak JEC, Baker G et al. | 2023 | European archives of psychiatry and clinical neuroscience | 11 |
| Shared functional connectome fingerprints following ritualistic ayahuasca intake ↗ | Mallaroni P, Mason NL, Kloft L et al. | 2024 | NeuroImage | 11 |
| Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics ↗ | Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun et al. | 2024 | Frontiers in Psychiatry | 11 |
| Evidence that 5‐HT <sub>2A</sub> receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs ↗ | Aurelija Ippolito, Sridhar R. Vasudevan, Shaun Hurley et al. | 2025 | British Journal of Pharmacology | 11 |
| Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N-Dimethyltryptamine in Rats. ↗ | Glynos, Nicolas G, Huels, Emma R, Nelson, Amanda et al. | 2025 | bioRxiv : the preprint server for biology | 11 |
| Utilizing Psychedelics to Enhance Well-Being: A Systematic Review ↗ | Thomson S, Thomacos N | 2025 | Journal of psychoactive drugs | 11 |
| Subsynaptosomal distribution, inhibition, and characterization of the binding of (14C) 5-OH-indole-3-acetaldehyde to brain preparations ↗ | Ungar F, Alivisatos SG | 1976 | Research communications in chemical pathology and pharmacology | 10 |
| The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance ↗ | Stoff DM, Gorelick DA, Bozewicz T et al. | 1978 | Neuropharmacology | 10 |
| Biochemistry and the schizophrenias ↗ | Smythies JR | 1979 | Southern medical journal | 10 |
| Increased responsiveness to 5-methoxy-N,N-dimethyltryptamine in mice on a high tryptophan diet ↗ | Singleton C, Marsden CA | 1979 | Neuropharmacology | 10 |
| Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine ↗ | Young R, Rosecrans JA, Glennon RA | 1986 | Pharmacology, biochemistry, and behavior | 10 |
| The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat ↗ | Rényi L | 1986 | British journal of pharmacology | 10 |
| Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats ↗ | Hallberg H | 1987 | Acta physiologica Scandinavica | 10 |
| Phencyclidine-induced head-twitch response in rats treated chronically with methysergide ↗ | Nabeshima T, Ishikawa K, Yamaguchi K et al. | 1987 | European journal of pharmacology | 10 |
| The effect of benzodiazepines on the 5-HT agonist-induced head-twitch response in mice ↗ | Moser PC, Redfern PH | 1988 | European journal of pharmacology | 10 |
| Neonatal treatment with 5-HT antiserum alters 5-HT metabolism and function in adult rats ↗ | Mohanakumar KP, Mohanty S, Ganguly DK | 1995 | Neuroreport | 10 |
| Absence of alkaloids in Psychotria carthagenensis Jacq. (Rubiaceae) ↗ | Leal MB, Elisabetsky E | 1996 | Journal of ethnopharmacology | 10 |
| The metabolism of biogenic monoamines during embryogenesis and metamorphosis in two anuran species ↗ | Takeda N | 1997 | General and comparative endocrinology | 10 |
| Synthesis and pharmacological profile of a series of 2,5-substituted-N,N-dimethyltryptamine derivatives as novel antagonists for the vascular 5-HT1B-like receptor ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 1999 | Journal of the Chemical Society Perkin Transactions 1 | 10 |
| Ayahuasca : liane de l'âme, chamanes et soumission chimique ↗ | Gilbert Pépin, Gaëlle Duffort | 2004 | Annales de Toxicologie Analytique | 10 |
| [Mescaline and the San Pedro cactus ritual: archaeological and ethnographic evidence in northern Peru] ↗ | Carod-Artal FJ, Vázquez-Cabrera CB | 2006 | Revista de neurologia | 10 |
| Urinary excretion of dietary contaminants in horses ↗ | Respondek F, Lallemand A, Julliand V et al. | 2006 | Equine veterinary journal. Supplement | 10 |
| Halogenated solvent interactions with N,N-dimethyltryptamine: formation of quaternary ammonium salts and their artificially induced rearrangements during analysis ↗ | Brandt SD, Martins CP, Freeman S et al. | 2008 | Forensic science international | 10 |
| N,N-Dimethyltryptamine and dichloromethane: rearrangement of quaternary ammonium salt product during GC-EI and CI-MS-MS analysis ↗ | Brandt SD, Martins CP, Freeman S et al. | 2008 | Journal of pharmaceutical and biomedical analysis | 10 |
| Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice ↗ | Winter JC, Amorosi DJ, Rice KC et al. | 2011 | Pharmacology, biochemistry, and behavior | 10 |
| The expansion of the field of research on ayahuasca: some reflections about the ayahuasca track at the 2010 MAPS "Psychedelic Science in the 21st Century" conference ↗ | Labate BC, Cavnar C | 2011 | The International journal on drug policy | 10 |
| Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry ↗ | Alain Gaujac, James L. Ford, Nicola M. Dempster et al. | 2013 | Microchemical Journal | 10 |
| LC-MS/MS quantitative determination of Tetrapterys mucronata alkaloids, a plant occasionally used in ayahuasca preparation ↗ | Queiroz MM, Marti G, Queiroz EF et al. | 2015 | Phytochemical analysis : PCA | 10 |
| Methylation of Thiols and Thioethers by Human Indolethylamine‐N Methyl Transferase ↗ | Uyen B. Chu, Timur Mavlyutov, Amanda Schulman et al. | 2015 | The FASEB Journal | 10 |
| Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice ↗ | Correa-Netto NF, Coelho LS, Galfano GS et al. | 2017 | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 10 |
| DMT Gland ↗ | Graham St John | 2017 | International Journal for the Study of New Religions | 10 |
| Psicosis inducida por ayahuasca: reporte de un caso ↗ | Diego Neyra-Ontaneda | 2017 | Revista de Neuro-Psiquiatría | 10 |
| Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol ↗ | Júlia Movilla Pires, Fúlvio Rieli Mendes, Ana Paula Salum Pires et al. | 2018 | Brazilian Journal of Pharmaceutical Sciences | 10 |
| 5-methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity ↗ | Germann CB | 2019 | bioRxiv | 10 |
| Ayahuasca in the Czech Republic: Extended Version ↗ | Miroslav Horák, Nahanga Verter | 2019 | | 10 |
| Internet method for the extraction of <i>N,N</i>-dimethyltryptamine from <i>Mimosa hostilis</i> roots: Does it really extract dimethyltryptamine? ↗ | Giordano Novak Rossi, Eduardo José Crevelin, Gabriela de Oliveira Silveira et al. | 2019 | Journal of Psychedelic Studies | 10 |
| Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning ↗ | Liu CH, Chu WL, Liao SC et al. | 2019 | Clinical toxicology (Philadelphia, Pa.) | 10 |
| The fumarate salts of the <i>N</i>-isopropyl-<i>N</i>-methyl derivatives of DMT and psilocin ↗ | A.R. Chadeayne, Duyen N. K. Pham, James A. Golen et al. | 2019 | Acta Crystallographica Section E Crystallographic Communications | 10 |
| Determination of N,N-dimethyltryptamine and beta-carbolines in plants used to prepare ayahuasca beverages by means of solid-phase extraction and gas-chromatography–mass spectrometry ↗ | Ana Y. Simão, Joana Gonçalves, Débora Caramelo et al. | 2020 | SN Applied Sciences | 10 |
| A methanol extract and N,N-dimethyltryptamine from Psychotria viridis Ruiz & Pav. inhibit Zika virus infection in vitro ↗ | Moraes TFS, Ferraz AC, da Cruz Nizer WS et al. | 2021 | Archives of virology | 10 |
| Human hair tests to document drug environmental contamination: Application in a family law case involving N,N-dimethyltryptamine ↗ | Kintz P, Ameline A, Raul JS | 2021 | Drug testing and analysis | 10 |
| Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context ↗ | Lanaro R, Mello SM, da Cunha KF et al. | 2021 | Drug testing and analysis | 10 |
| Phytochemistry and teratogenic potential of Mimosa tenuiflora (willd.) poir. (Fabaceae) in ruminants: A systematic review ↗ | Lima Bezerra JJ, Vieira Pinheiro AA, Barbosa Lucena R | 2021 | Toxicon : official journal of the International Society on Toxinology | 10 |
| Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa ↗ | Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor et al. | 2021 | OBM Neurobiology | 10 |
| Traditional Use of <i>Banisteriopsis caapi</i> Alone and Its Application in a Context of Drug Addiction Therapy ↗ | Politi M, Friso F, Saucedo G et al. | 2021 | Journal of psychoactive drugs | 10 |
| Gas Chromatography Mass Spectrometry (GCMS) analysis of the antagonistic potential of <i>Trichoderma hamatum</i> against <i>Fusarium oxysporum</i> f. sp. cepae causing basal rot disease of onion ↗ | R. Oviya, S. Thiruvudainambi, V. Ramamoorthy et al. | 2022 | Journal of Biological Control | 10 |
| Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey ↗ | Daldegan-Bueno D, Révész D, Morais PR et al. | 2022 | Substance use & misuse | 10 |
| Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye ↗ | Szilágyi A, Takács B, Szekeres R et al. | 2022 | Biomedicines | 10 |
| Elucidation of Pharmacological Mechanism Underlying the Anti-Alzheimer's Disease Effects of <i>Evodia rutaecarpa</i> and Discovery of Novel Lead Molecules: An In Silico Study ↗ | Zhang L, Xu J, Guo J et al. | 2023 | Molecules (Basel, Switzerland) | 10 |
| <i>In vivo</i> validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin ↗ | Jones NT, Wagner L, Hahn MCP et al. | 2023 | Frontiers in psychiatry | 10 |
| Interpretation of hair and nails findings in an infant death case related to maternal addiction to tramadol ↗ | Alexandr Gish, Camille Richeval, Jean‐François Wiart et al. | 2023 | Drug Testing and Analysis | 10 |
| The possible place for psychedelics in pharmacotherapy of mental disorders ↗ | Wojtas A | 2023 | Pharmacological reports : PR | 10 |
| Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial ↗ | Mueller MJ, Aicher HD, Dornbierer DA et al. | 2024 | The international journal of neuropsychopharmacology | 10 |
| Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials ↗ | Kwaśny A, Wilkowska A, Cubała WJ | 2024 | Frontiers in psychiatry | 10 |
| What should constitute a control condition in psychedelic drug trials? ↗ | Colloca L, Fava M | 2024 | Nature. Mental health | 10 |
| Complex slow waves in the human brain under 5-MeO-DMT ↗ | Blackburne G, McAlpine RG, Fabus M et al. | 2025 | Cell reports | 10 |
| Psychedelics, entactogens and psychoplastogens for depression and related disorders ↗ | Hoyer D | 2026 | British journal of pharmacology | 10 |
| Benzyldimethylbufotenin, a Powerful Antimetabolite of Serotonin ↗ | E. Shaw, D. W. Woolley | 1956 | Experimental Biology and Medicine | 9 |
| A Note on the Oxidative Deamination of Isomers of 5-Hydroxytryptamine and Other Indolealkylamines ↗ | V. Erspamer, R Ferrini, A. Glässer | 1960 | Journal of Pharmacy and Pharmacology | 9 |
| HALLUCINOGENIC AMINES AND SCHIZOPHRENIA (WITH A BRIEF ADDENDUM ON N-DIMETHYLTRYPTAMINE) ↗ | Stephen Szára | 1967 | Elsevier eBooks | 9 |
| Evidence for dimethyltryptamine (DMT) as a naturally-occurring transmitter in mammalian brain ↗ | Christian St, R. J. Harrison, J.F. Pagel | 1976 | PubMed | 9 |
| Observational determination of dose-response curves in hallucinogen-treated monkeys ↗ | Brewster JM, Siegel RK, Johnson CA et al. | 1976 | International pharmacopsychiatry | 9 |
| 2,3-dihydro and carbocyclic analogues of tryptamines: interaction with serotonin receptors ↗ | Glennon RA, Jacyno JM, Salley JJ Jr | 1982 | Journal of medicinal chemistry | 9 |
| Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors ↗ | Trulson ME, Crisp T, Henderson LJ | 1983 | European journal of pharmacology | 9 |
| Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain ↗ | Rényi L | 1986 | Acta pharmacologica et toxicologica | 9 |
| Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites ↗ | Sitaram BR, Lockett L, McLeish M et al. | 1987 | Journal of chromatography | 9 |
| Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists ↗ | Gudelsky GA, Koenig JI, Meltzer HY | 1987 | Neuropharmacology | 9 |
| N,N-Dimethyltryptamine Production in Phalaris aquatica Seedlings: A Mathematical Model for its Synthesis ↗ | Mack JP, Mulvena DP, Slaytor M | 1988 | Plant physiology | 9 |
| Site-selective serotonin agonists as discriminative stimuli ↗ | Glennon RA | 1988 | Psychopharmacology series | 9 |
| [3H]serotonin binding sites in goldfish retinal membranes ↗ | Lima L, Radtke I, Drujan B | 1992 | Neurochemical research | 9 |
| Interview with Guillermo Arrévalo, a Shipibo urban shaman, by Roger Rumrrill. Interview by Roger Rumrrill ↗ | Arrévalo G | 2005 | Journal of psychoactive drugs | 9 |
| Toxicity of chronic ayahuasca administration to the pregnant rat: how relevant it is regarding the human, ritual use of ayahuasca? ↗ | Dos Santos RG | 2010 | Birth defects research. Part B, Developmental and reproductive toxicology | 9 |
| Investigation of the photoionization properties of pharmaceutically relevant substances by resonance-enhanced multiphoton ionization spectroscopy and single-photon ionization spectroscopy using synchrotron radiation ↗ | Kleeblatt J, Ehlert S, Hölzer J et al. | 2013 | Applied spectroscopy | 9 |
| Immunological effects of ayahuasca in humans ↗ | dos Santos RG | 2014 | Journal of psychoactive drugs | 9 |
| Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu ↗ | Veronika Kavenská, Hana Šimonová | 2014 | Anthropologia integra | 9 |
| Harmala Alkaloids Identify Ayahausca Intoxication in a Urine Drug Screen ↗ | Pope JD, Choy KW, Drummer OH et al. | 2019 | Journal of analytical toxicology | 9 |
| Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay ↗ | Kummrow F, Maselli BS, Lanaro R et al. | 2019 | Environmental and molecular mutagenesis | 9 |
| Changes in field concentrations of five phalaris alkaloids and their association with toxicity in pastures of Victoria, Australia ↗ | Elizabeth S. Read, Priyanka Reddy, D. RENDELL et al. | 2020 | Crop and Pasture Science | 9 |
| Optimal immobilization of trypsin from the spleen of albacore tuna (Thunnus alalunga) and its characterization ↗ | Poonsin T, Simpson BK, Visessanguan W et al. | 2020 | International journal of biological macromolecules | 9 |
| Who Turns to Amazonian Medicine for Treatment of Substance Use Disorder? Patient Characteristics at the Takiwasi Addiction Treatment Center ↗ | Berlowitz I, Walt H, Ghasarian C et al. | 2020 | Journal of studies on alcohol and drugs | 9 |
| Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (<i>Phyllomedusa bicolor</i>): Motivations for use, settings and subjective experiences ↗ | Majić T, Sauter M, Bermpohl F et al. | 2021 | Journal of psychopharmacology (Oxford, England) | 9 |
| In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages ↗ | Gonçalves J, Castilho M, Rosado T et al. | 2021 | Molecules (Basel, Switzerland) | 9 |
| Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability ↗ | Rossi GN, Dias ICDS, Baker G et al. | 2022 | Expert opinion on drug safety | 9 |
| Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease ↗ | Katchborian-Neto A, Santos MFC, Vilas-Boas DF et al. | 2022 | Chemistry & biodiversity | 9 |
| Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation ↗ | Schenberg EE, Gerber K | 2022 | Transcultural psychiatry | 9 |
| Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs ↗ | Niebel A, Pragst F, Krumbiegel F et al. | 2022 | Forensic science international | 9 |
| Teacher plants - Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives ↗ | Berlowitz I, O'Shaughnessy DM, Heinrich M et al. | 2022 | Journal of ethnopharmacology | 9 |
| Classic psychedelics do not affect T cell and monocyte immune responses ↗ | Rudin D, Areesanan A, Liechti ME et al. | 2023 | Frontiers in psychiatry | 9 |
| 'Everybody's creating it along the way': ethical tensions among globalized ayahuasca shamanisms and therapeutic integration practices ↗ | Marcus O | 2023 | Interdisciplinary science reviews : ISR | 9 |
| The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness ↗ | Longo MSC, Bienemann B, Multedo M et al. | 2023 | Journal of psychoactive drugs | 9 |
| The current state of ayahuasca research in animal models: A systematic review ↗ | Daldegan-Bueno D, Simionato NM, Favaro VM et al. | 2023 | Progress in neuro-psychopharmacology & biological psychiatry | 9 |
| The Resurgence of Hallucinogen Drugs in Clinical Research ↗ | Rivera-García MT, Cruz SL | 2023 | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion | 9 |
| Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task ↗ | Olami A, Peled-Avron L | 2024 | Scientific reports | 9 |
| Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans ↗ | Barman R, Kumar Bora P, Saikia J et al. | 2024 | Phytochemistry | 9 |
| Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees ↗ | Lowe MX, Kettner H, Jolly DRP et al. | 2024 | Frontiers in psychiatry | 9 |
| Psychedelic-related deaths in England, Wales and Northern Ireland (1997–2022) ↗ | Emma I Kopra, Jenni Penttinen, James Rucker et al. | 2024 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 9 |
| Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects ↗ | Martial C, Carhart-Harris R, Timmermann C | 2024 | Neuroscience of consciousness | 9 |
| Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives ↗ | Czopek A, Jończyk J, Fryc M et al. | 2025 | ACS chemical neuroscience | 9 |
| Co-use of psychedelics with other substances: Findings from the global psychedelic survey ↗ | Lake S, Lucas P | 2025 | Journal of psychopharmacology (Oxford, England) | 9 |
| Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine ↗ | Barnett BS, Koons CJ, Van den Eynde V et al. | 2025 | Journal of psychoactive drugs | 9 |
| <i>N</i>,<i>N</i>-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation ↗ | László MJ, Vigh JP, Kocsis AE et al. | 2025 | Science advances | 9 |
| Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics ↗ | Agrawal R, Gillie D, Mungenast A et al. | 2025 | ACS chemical neuroscience | 9 |
| An international mega-analysis of psychedelic drug effects on brain circuit function ↗ | Girn M, Doss MK, Roseman L et al. | 2026 | Nature medicine | 9 |
| Studies on Useful Components in Natural Sources. XVII ↗ | Minoru Goto, Tomoaki Noguchi, Takeshi Watanabe | 1958 | YAKUGAKU ZASSHI | 8 |
| Dimethyltryptamine, A Do-It-Yourself Hallucinogenic Drug ↗ | D. R. Rubin | 1967 | JAMA | 8 |
| Evaluation of Selected Clones of <i>Phalaris arundinacea</i> II. Indole Alkaloid Derivatives<sup>1</sup> ↗ | R. F. Barnes, A. B. Simons, G. C. Marten | 1971 | Agronomy Journal | 8 |
| Protection against burn, tourniquet and endotoxin shock by histamine, 5-hydroxytryptamine and 5-hydroxytryptamine derivatives ↗ | Markley K, Smallman E, Thornton SW | 1971 | British journal of pharmacology | 8 |
| OCCURRENCE OF PSYCHODELIC SUBSTANCES IN SOME INDIAN MEDICINAL PLANTS ↗ | S. P. Ghosal | 1972 | Planta Medica | 8 |
| Photoinduced oxidation of tryptamine derivatives. Formation of pyrrolo[2,3-b]indole and N b-(4-cyanobutadienyl)tryptamine ↗ | Masako Nakagawa, Takao Kaneko, Hitoshi Yamaguchi | 1972 | Journal of the Chemical Society Chemical Communications | 8 |
| [Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)] ↗ | Dittrich A, Bickel P, Schöpf J et al. | 1976 | Archiv fur Psychiatrie und Nervenkrankheiten | 8 |
| Spectral analysis of mouse EEG after the administration of N,N-dimethyltryptamine ↗ | Morley BJ, Bradley RJ | 1977 | Biological psychiatry | 8 |
| The biosynthesis of dimethyltryptamine in vivo ↗ | Mandel LR, Prasad R, Lopez-Ramos B et al. | 1977 | Research communications in chemical pathology and pharmacology | 8 |
| Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings] ↗ | Jenner P, Marsden CD, Thanki CM | 1978 | British journal of pharmacology | 8 |
| ACTIONS OF HYPERALGESIC SUBSTANCES {(-)NALOXONE, THEOPHYLLINE AND 5-METHOXY-N,N- DIMETHYLTRYPTAMINE} ON NOCICEPTIVE LEARNING ↗ | K. Ramabadran, J.-C. Guillon, J. Jacob | 1980 | Elsevier eBooks | 8 |
| DMT self-administration by monkeys in isolation ↗ | Ronald K. Siegel, Murray E. Jarvik | 1980 | Bulletin of the Psychonomic Society | 8 |
| Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterparts ↗ | Glennon RA, Young R, Benington F et al. | 1982 | Life sciences | 8 |
| [Methylated and unmethylated indolamine in the cisternal fluid in acute endogenous psychoses] ↗ | Uebelhack R, Franke L, Seidel K | 1983 | Biomedica biochimica acta | 8 |
| Antagonism of 5-methoxy-N,N-dimethyltryptamine-induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission ↗ | Archer T, Tandberg B, Rènyi L et al. | 1985 | The Journal of pharmacy and pharmacology | 8 |
| Comparative study of the effects of stimulation or blockade of beta-adrenoceptors on the head-twitches induced in mice by 5-hydroxytryptophan versus 5-methoxy-N, N-dimethyltryptamine ↗ | Martin P, Soubrié P, Simon P | 1986 | Journal de pharmacologie | 8 |
| Involvement of noradrenaline in potentiation of the head-twitch response by GABA-related drugs ↗ | Singh L, Heaton JC, Rea PJ et al. | 1986 | Psychopharmacology | 8 |
| 5-Hydroxytryptamine agonistic action of methysergide and the absence of supersensitivity to 5-HT agonists in spinal flexor reflexes in rats ↗ | Ono H, Miyamoto M, Kobayashi M et al. | 1987 | Neuropharmacology | 8 |
| Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163 ↗ | Donohoe TP, Hutson PH, Curzon G | 1987 | Psychopharmacology | 8 |
| Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists ↗ | Shearman GT, Tolcsvai L | 1987 | Psychopharmacology | 8 |
| Robotics: Growing maintenance option for utilities ↗ | G. Paula | 1989 | Electrical world | 8 |
| Slow fluctuations of single unit activities of hippocampal and thalamic neurons in cats. II. Role of serotonin on the stability of neuronal activities ↗ | Kodama T, Mushiake H, Shima K et al. | 1989 | Brain research | 8 |
| Effects of the Amazonian psychoactive beverage Ayahuasca on binocular rivalry: interhemispheric switching or interhemispheric fusion? ↗ | Frecska E, White KD, Luna LE | 2003 | Journal of psychoactive drugs | 8 |
| Ayahuasca: entre o legal e o cultural ↗ | Rodrigo Grazinoli Garrido, Bruno Duarte Sabino | 2009 | Saúde Ética & Justiça | 8 |
| Alkaloid profiles of <i>Mimosa tenuiflora</i> and associated methods of analysis ↗ | Dale R. Gardner, Franklin Riet-Corrêa, Kip E. Panter | 2011 | CABI eBooks | 8 |
| Ayahuasca, entheogenic education & public policy ↗ | Kenneth W. Tupper | 2011 | cIRcle (University of British Columbia) | 8 |
| Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and Endocannabinoids in a Healthy Human Subject ↗ | Dos Santos RG, Crippa JA, Osório FL et al. | 2018 | Journal of clinical psychopharmacology | 8 |
| [Practices in search of legitimacy: the contemporary use of ayahuasca, between religious and therapeutic vindications] ↗ | Dupuis D | 2018 | Salud colectiva | 8 |
| Sequencing the Vine of the Soul: Full Chloroplast Genome Sequence of <i>Banisteriopsis caapi</i> ↗ | Ramachandran P, Zhang N, McLaughlin WB et al. | 2018 | Genome announcements | 8 |
| Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study ↗ | Dorsen C, Palamar J, Shedlin MG | 2019 | Addiction research & theory | 8 |
| The influence of context on ayahuasca experiences: An analysis of experience reports ↗ | Avery Sapoznikow, Zachary Walsh, Kenneth W. Tupper et al. | 2019 | Journal of Psychedelic Studies | 8 |
| Translational evidence for ayahuasca as an antidepressant: what's next? ↗ | Dos Santos RG, Bouso JC | 2019 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 8 |
| Amazonian Medicine and the Psychedelic Revival: Considering the "Dieta" ↗ | O'Shaughnessy DM, Berlowitz I | 2021 | Frontiers in pharmacology | 8 |
| How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter ↗ | Sachkova A, Doetsch DA, Jensen O et al. | 2021 | Biochemical pharmacology | 8 |
| Natural and Experimental Evidence Drives Marmosets for Research on Psychiatric Disorders Related to Stress ↗ | de Sousa MBC, de Meiroz Grilo MLP, Galvão-Coelho NL | 2021 | Frontiers in behavioral neuroscience | 8 |
| Rethinking enhancement substance use: A critical discourse studies approach ↗ | Askew R, Williams L | 2021 | The International journal on drug policy | 8 |
| Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field ↗ | Daldegan-Bueno D, Favaro VM, Morais PR et al. | 2022 | Behavioural brain research | 8 |
| Human Hepatocyte 4-Acetoxy-<i>N</i>,<i>N</i>-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry ↗ | Malaca S, Huestis MA, Lattanzio L et al. | 2022 | Metabolites | 8 |
| Alkaloids from the entheogenic plant Peganum harmala ↗ | Daniel G. Anstis, Jessica Liyu, Emma K. Davison et al. | 2023 | Australian Journal of Chemistry | 8 |
| Cortical structural differences following repeated ayahuasca use hold molecular signatures ↗ | Mallaroni P, Mason NL, Kloft L et al. | 2023 | Frontiers in neuroscience | 8 |
| Psychedelics for Patients With Cancer: A Comprehensive Literature Review ↗ | White CM, Weisman N, Dalo J | 2023 | The Annals of pharmacotherapy | 8 |
| Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans ↗ | Weiss B, Dinh-Williams LL, Beller N et al. | 2024 | Psychological trauma : theory, research, practice and policy | 8 |
| Complex slow waves radically reorganise human brain dynamics under 5-MeO-DMT ↗ | Blackburne G, McAlpine RG, Fabus M et al. | 2024 | bioRxiv | 8 |
| Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial ↗ | Rodrigues LS, Reis JAS, Rossi GN et al. | 2024 | Journal of clinical psychopharmacology | 8 |
| Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD) ↗ | Olivier B, Olivier JDA | 2024 | Advances in experimental medicine and biology | 8 |
| Neuroprotective effects of psilocybin in a rat model of stroke ↗ | Yu SJ, Wu KJ, Wang YS et al. | 2024 | BMC neuroscience | 8 |
| Psychedelics as a potential treatment for tobacco use disorder: a systematic review ↗ | Spoelstra SK, Schoevers RA, Venema SD et al. | 2024 | Discover mental health | 8 |
| Rapid effects of tryptamine psychedelics on perceptual distortions and early visual cortical population receptive fields ↗ | Pais ML, Teixeira M, Soares C et al. | 2024 | NeuroImage | 8 |
| The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness ↗ | Frankie A. Colosimo, Philip Borsellino, Reese I. Krider et al. | 2024 | Psychoactives | 8 |
| The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics ↗ | Wilkes R, Roberts DM, Liknaitzky P et al. | 2024 | Clinical toxicology (Philadelphia, Pa.) | 8 |
| Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT ↗ | Jakub Vohryzek, Andrea I. Luppi, Selen Atasoy et al. | 2024 | bioRxiv (Cold Spring Harbor Laboratory) | 8 |
| Ayahuasca Pretreatment Prevents Sepsis-Induced Anxiety-Like Behavior, Neuroinflammation, and Oxidative Stress, and Increases Brain-Derived Neurotrophic Factor ↗ | de Camargo RW, Joaquim L, Machado RS et al. | 2025 | Molecular neurobiology | 8 |
| Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis ↗ | van der Heijden KV, Otto ME, Schoones JW et al. | 2025 | Clinical pharmacokinetics | 8 |
| Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action ↗ | Jonathan Repple, Maximilian Bayas, Chiara Möser et al. | 2025 | Biological Psychiatry | 8 |
| Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience ↗ | Singleton SP, Timmermann C, Luppi AI et al. | 2025 | Communications biology | 8 |
| Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ | van der Heijden KV, Zuiker RGJA, Otto ME et al. | 2025 | Clinical and translational science | 8 |
| Effects of LSD-25, n,n-dimethyltryptamine (DMT), and N,N-diethyltryptamine (DET) on the photic evoked responses in the unanesthetized rabbit ↗ | Khazan N, McCash D | 1965 | Archives internationales de pharmacodynamie et de therapie | 7 |
| Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio) ↗ | Meldrum BS, Naquet R | 1970 | British journal of pharmacology | 7 |
| Relative potency of amphetamine derivatives and N,N-dimethyltryptamines ↗ | Edward T. Uyeno | 1971 | Psychopharmacology | 7 |
| Dimethyltryptamine from the leaves of certain Acacia species of northern Sudan ↗ | Wahba Khalil SK, Elkheir YM | 1975 | Lloydia | 7 |
| Oxidative Cyclization of Nb-Dimethyltryptamine, 3-Indolepropanol, and 3-Indolepropnethiol with N-Bromo- or N-Chlorosuccinimide ↗ | Tohru Hino, Hidetoshi Miura, Toru Nakamura et al. | 1975 | Heterocycles | 7 |
| Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia ↗ | Gillin JC, Wyatt RJ | 1976 | Psychopharmacology bulletin | 7 |
| On the conformational varieties of 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine and serotonin in crystalline environment ↗ | J. Caillet, P. Claverie, B. Pullman | 1977 | Acta Crystallographica Section A | 7 |
| 5-Methoxy-<i>NN</i>-dimethyltryptamine: differential modulation of the rewarding and aversive components of lateral hypothalamic self-stimulation ↗ | J.D. Sinden, Dale M. Atrens | 1978 | Journal of Pharmacy and Pharmacology | 7 |
| Behavioural effects produced in mice infected with venezuelan equine encephalomyelitis virus ↗ | Lima L, Ayala C, Walder R et al. | 1988 | Physiology & behavior | 7 |
| Hypotensive spinal serotonergic effect. Are S1 or S2 receptors involved? ↗ | Berger A, Ramirez AJ | 1988 | Hypertension (Dallas, Tex. : 1979) | 7 |
| Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine ↗ | Minor BG, Persson ML, Post C et al. | 1988 | Journal of neural transmission | 7 |
| Effects of metaphit on phencyclidine and serotonin2 receptors ↗ | Nabeshima T, Tohyama K, Noda A et al. | 1989 | Neuroscience letters | 7 |
| Subsensitivity of serotonin and substance P receptors involved in nociception after repeated administration of a serotonin receptor agonist ↗ | Eide PK, Hole K | 1989 | Journal of neural transmission | 7 |
| Plants and mushrooms of abuse ↗ | Spoerke DG, Hall AH | 1990 | Emergency medicine clinics of North America | 7 |
| Ayahuasca versus violence--a case report ↗ | Frecska E | 2008 | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 7 |
| CHARLATANS, SEEKERS, AND SHAMANS: THE AYAHUASCA BOOM IN WESTERN PERUVIAN AMAZONIA ↗ | Joshua Homan | 2011 | KU ScholarWorks (The University of Kansas) | 7 |
| Building Alien Worlds - The Neuropsychological and Evolutionary Implications of the Astonishing Psychoactive Effects of N,N-Dimethyltryptamine (DMT) ↗ | A. P. Gallimore | 2013 | DOAJ (DOAJ: Directory of Open Access Journals) | 7 |
| [Emergent drugs (III): hallucinogenic plants and mushrooms] ↗ | Burillo-Putze G, López Briz E, Climent Díaz B et al. | 2013 | Anales del sistema sanitario de Navarra | 7 |
| Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos ↗ | Christopher Timmermann S | 2014 | Revista chilena de neuro-psiquiatría | 7 |
| A persisting perception disorder after cannabis use ↗ | Zoë Ellison‐Wright, Ben Sessa | 2015 | Progress in Neurology and Psychiatry | 7 |
| Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: A case report ↗ | Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa et al. | 2017 | Journal of Psychedelic Studies | 7 |
| Isolation, spectral characterization, molecular docking, and cytotoxic activity of alkaloids from Erythroxylum pungens O. E. Shulz ↗ | Macedo Pereira G, Moreira LGL, Neto TDSN et al. | 2018 | Phytochemistry | 7 |
| Kambô: A Shamanistic Ritual Arriving in the West - Description, Risks and Perception by the Users ↗ | Hesselink Jan M Keppel | 2018 | International Journal of Psychology and Psychoanalysis | 7 |
| N,N-Dimethyltryptamine: DMT-induced psychosis ↗ | Barbic D, Fernandes J, Eberdt C et al. | 2020 | The American journal of emergency medicine | 7 |
| Sigma-1 receptor: culprit and rescuer in motor neuron diseases ↗ | Jean-Charles Liévens, Tangui Maurice | 2020 | Neural Regeneration Research | 7 |
| 2,5-Dimethylbufotenine and 2,5-dimethylbufotenidine: novel derivatives of natural tryptamines found in <i>Bufo alvarius</i> toads ↗ | Duyen N. K. Pham, A.R. Chadeayne, James A. Golen et al. | 2021 | Acta Crystallographica Section E Crystallographic Communications | 7 |
| Accidental Environmentalism: Nature and Cultivated Affect in European Neoshamanic Ayahuasca Consumption ↗ | Arne Harms | 2021 | Anthropology of Consciousness | 7 |
| Adverse Effects After Ayahuasca Administration in the Clinical Setting ↗ | Rocha JM, Rossi GN, Osório FL et al. | 2022 | Journal of clinical psychopharmacology | 7 |
| Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets ↗ | Sousa TR, Rema J, Machado S et al. | 2022 | Current topics in medicinal chemistry | 7 |
| Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland ↗ | Al-Imam A, Motyka MA, Witulska Z et al. | 2022 | International journal of environmental research and public health | 7 |
| The complete organellar genomes of the entheogenic plant <i>Psychotria viridis</i> (Rubiaceae), a main component of the ayahuasca brew ↗ | Varani AM, Silva SR, Lopes S et al. | 2022 | PeerJ | 7 |
| Harmonic decomposition of spacetime (HADES) framework characterises the spacetime hierarchy of the DMT brain state ↗ | Vohryzek J, Cabral J, Timmermann C et al. | 2023 | bioRxiv | 7 |
| Microbiota-derived psychedelics: Lessons from COVID-19 ↗ | Sfera A, Hazan S, Kozlakidis Z et al. | 2023 | Advances in clinical and experimental medicine : official organ Wroclaw Medical University | 7 |
| 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats ↗ | Souza AC, Souza BC, França A et al. | 2024 | Scientific reports | 7 |
| Ayahuasca ceremonies, relationality, and inner-outer transformations to sustainability. Evidence from Takiwasi Center in Peru ↗ | David Manuel‐Navarrete, Serena DeLuca, Fabio Friso et al. | 2024 | Ecosystems and People | 7 |
| Classic psychedelics and the treatment for alcoholism ↗ | Lodetti G, de Bitencourt RM, Rico EP | 2024 | Progress in neuro-psychopharmacology & biological psychiatry | 7 |
| Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT<sub>2A</sub> Receptor Agonists ↗ | M Ro Rsted E, Jensen AA, Smits G et al. | 2024 | Journal of medicinal chemistry | 7 |
| New frontiers in the biosynthesis of psychoactive specialized metabolites ↗ | Li G, Facchini PJ | 2024 | Current opinion in plant biology | 7 |
| Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT) ↗ | Witowski CG, Hess MR, Jones NT et al. | 2024 | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 7 |
| Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence ↗ | Bassi M, Bilel S, Tirri M et al. | 2024 | Psychopharmacology | 7 |
| Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms ↗ | Schäfer T, Haun F, Rupp B et al. | 2025 | Angewandte Chemie (International ed. in English) | 7 |
| Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption ↗ | Pagni BA, Halman A, Sarris J et al. | 2025 | Journal of psychoactive drugs | 7 |
| Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial ↗ | Wießner I, Falchi-Carvalho M, Laborde S et al. | 2025 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 7 |
| Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons ↗ | Petrušková A, Guhathakurta D, Akdaş EY et al. | 2025 | Journal of neurochemistry | 7 |
| Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo ↗ | GEY KF, PLETSCHER A | 1962 | British journal of pharmacology and chemotherapy | 6 |
| THE SYNTHESIS OF 5-DIMETHYLAMINOINDOLE AND DERIVATIVES ↗ | Joseph I. DeGraw | 1966 | Canadian Journal of Chemistry | 6 |
| Proceedings: Dimethyltryptamine: its biosynthesis and possible role in mental disease ↗ | Mandel LR | 1974 | Psychopharmacology bulletin | 6 |
| N-methylation of 1-methyltryptamines by indolethylamine N-methyltransferase ↗ | Lin R, Narasimhachari N | 1975 | Biochemical pharmacology | 6 |
| Urinary Excretion of N,N-Dimethylated Tryptamines in Chronic Schizophrenia: A Review of the Present Status of the Hypothesis ↗ | Louis Huszka, D.H. Zabek, John W. Lovett Doust | 1976 | Canadian Psychiatric Association Journal | 6 |
| Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat ↗ | Kovacic B, Wang Lu LJ, Ruffing D et al. | 1978 | European journal of pharmacology | 6 |
| The ionization of 5-hydroxytryptamine and related compounds and an appraisal of methods for the estimation of zwitterion constants ↗ | Barlow RB, Burston KN | 1980 | British journal of pharmacology | 6 |
| Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding ↗ | Laubscher A, Pletscher A, Noll H | 1981 | The Journal of pharmacology and experimental therapeutics | 6 |
| Biological markers for the schizophrenic and atypical psychoses ↗ | Smythies JR | 1982 | The Journal of nervous and mental disease | 6 |
| Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raphé nuclei ↗ | Blackburn TP, Cox B, Lee TF | 1982 | Psychopharmacology | 6 |
| Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives ↗ | Kline TB, Benington F, Morin RD et al. | 1982 | Journal of medicinal chemistry | 6 |
| Interaction of synthetic opioid metenkephalin peptide analogs, Lilly 127623 and FK 33-824 with indole hallucinogens: antagonism of N,N-dimethyltryptamine- and LSD-induced disruption of food-rewarded bar pressing behavior in the rat ↗ | Ruffing DM, Domino EF | 1983 | Psychopharmacology | 6 |
| Effects of acute administration of 5-methoxy-N,N-dimethyltryptamine upon the latency and duration of post-decapitation convulsions ↗ | Archer T, Tandberg B | 1984 | Acta pharmacologica et toxicologica | 6 |
| Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine ↗ | Danysz W, Jonsson G, Minor BG et al. | 1986 | Behavioral and neural biology | 6 |
| Spinal noradrenergic neurotransmission and the analgesia induced by brief footshock ↗ | Danysz W, Minor BG, Jonsson G et al. | 1986 | Brain research | 6 |
| 5-Hydroxytryptamine involvement in the intrinsic control of oesophageal EMG activity ↗ | Fileccia R, Mule' F, Postorino A et al. | 1987 | Archives internationales de physiologie et de biochimie | 6 |
| [Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist] ↗ | Kubota M, Ueno K, Yamano M et al. | 1989 | Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology | 6 |
| An investigation of the role of 5-hydroxytryptamine in the attenuation of presynaptic alpha 2-adrenoceptor-mediated responses by antidepressant treatments ↗ | Heal DJ, Hurst EM, Prow MR et al. | 1990 | Psychopharmacology | 6 |
| Pharmacological characterization of medullary serotonin neurons ↗ | Clement ME, McCall RB | 1991 | Brain research | 6 |
| Serotonergic influence on cholinergic-induced analgesia: differences in two inbred strains of mice ↗ | Pavone F, Fagioli S | 1992 | Brain research | 6 |
| Indolealkylamine metabolism: Synthesis of deuterated indolealkylamines as metabolic probes ↗ | Philip E. Morris, Cheng Chiao | 1993 | Journal of Labelled Compounds and Radiopharmaceuticals | 6 |
| A simple and sensitive quantitation of N,N-dimethyltryptamine by gas chromatography with surface ionization detection ↗ | Ishii A, Seno H, Suzuki O et al. | 1997 | Journal of analytical toxicology | 6 |
| Cult-Hoasca: A Model for Schizophrenia ↗ | Alicia B. Pomilio, Arturo A. Vitale, Jorge Ciprian‐Ollivier | 2003 | | 6 |
| Detection and determination of abused hallucinogens in biological material ↗ | Ondra P, Zedníková K, Válka I | 2006 | Neuro endocrinology letters | 6 |
| L’Ayahuasca : clinique, neurobiologie et ambiguïté thérapeutique ↗ | Xavier Laqueille, S. Martins | 2007 | Annales Médico-psychologiques revue psychiatrique | 6 |
| [Studies on constituents of rootsanel leaves from Desmodium blandum and their cytotoxic activity against growth of several tumor cells] ↗ | Gan N, Yang X, Li TH et al. | 2008 | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica | 6 |
| O processo de regulamentação da ayahuasca no Brasil e na esfera internacional: desafios e implicações ↗ | Beatriz Caiuby Labate, Kevin Feeney | 2011 | Periferia | 6 |
| Ayahuasca: el encuentro de dos paradigmas ↗ | Daniel Rojas-Bolívar | 2014 | Revista de Neuro-Psiquiatría | 6 |
| Can Ayahuasca and sleep loss change sexual performance in male rats? ↗ | Alvarenga TA, Polesel DN, Matos G et al. | 2014 | Behavioural processes | 6 |
| Indigenous healing practice: ayahuasca. Opening a discussion ↗ | Prue R, Voss RW | 2014 | The journal of pastoral care & counseling : JPCC | 6 |
| The Botany of Mitragyna speciosa (Korth.) Havil. and Related Species ↗ | Robert B. Raffa | 2014 | | 6 |
| Thin-layer chromatography method for the detection of<i>N</i>,<i>N</i>-dimethyltryptamine in seized street samples ↗ | Boris Duffau, Sonia Rojas, Sebastián Jofré et al. | 2014 | Journal of Planar Chromatography – Modern TLC | 6 |
| IDENTIFICATION CHALLENGES IN EXAMINATION OF COMMERCIAL PLANT MATERIAL OF PSYCHOTRIA VIRIDIS ↗ | Kowalczuk AP, Łozak A, Bachliński R et al. | 2015 | Acta poloniae pharmaceutica | 6 |
| AYAHUASCA V ČESKÉ REPUBLICE ↗ | Miroslav Horák | 2017 | Mendelova univerzita v Brně eBooks | 6 |
| Retrospective Analyses of High-risk NPS: Integrative Analyses of PubMed, Drug Fora, and the Surface Web ↗ | Ahmed Al-Imam | 2017 | Global Journal of Health Science | 6 |
| Comparing the Detection of Endogenous Psychedelics in Individuals With and Without Alleged Mediumistic Experiences ↗ | Vinhosa Bastos MA Jr, Haidamus de Oliveira Bastos PR, Dos Santos ML et al. | 2018 | Explore (New York, N.Y.) | 6 |
| Gnosis Potency: DMT Breakthroughs and Paragnosis ↗ | Graham St John | 2018 | | 6 |
| Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy ↗ | Courtney C. Walton, Paul Liknaitzky | 2020 | Journal of Applied Sport Psychology | 6 |
| DMT analogues: <i>N</i>-ethyl-<i>N</i>-propyl-tryptamine and <i>N</i>-allyl-<i>N</i>-methytryptamine as their hydro-fumarate salts ↗ | Chadeayne AR, Pham DNK, Golen JA et al. | 2020 | Acta crystallographica. Section E, Crystallographic communications | 6 |
| Non-linear Dynamics and Chaotic Trajectories in Brain-Mind Visual Experiences during Dreams, Meditation, and Non-Ordinary Brain Activity States ↗ | Tania Simona Re, Giuseppe Vitiello | 2020 | OBM Neurobiology | 6 |
| Ancient psychoactive plants in a global village: The ritual use of cannabis in a self-managed community in Catalonia ↗ | Kohek M, Sánchez Avilés C, Romaní O et al. | 2021 | The International journal on drug policy | 6 |
| Determination of the Elemental Composition of Ayahuasca and Assessments Concerning Consumer Safety ↗ | Guimarães IC, Tófoli LF, Sussulini A | 2021 | Biological trace element research | 6 |
| New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances ↗ | Matthias Forstmann, Christina Sagioglou | 2021 | European Psychologist | 6 |
| Psychosis induced by abuse of ayahuasca: a case report ↗ | Palma-Álvarez RF, Grau-López L, Ros-Cucurull E et al. | 2021 | Revista Colombiana de psiquiatria | 6 |
| The Setting Questionnaire for the Ayahuasca Experience: Questionnaire Development and Internal Structure ↗ | Pontual AAD, Tófoli LF, Collares CF et al. | 2021 | Frontiers in psychology | 6 |
| A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms ↗ | Pierre Chue, A. Andreiev, E. Bucuci et al. | 2022 | European Psychiatry | 6 |
| Ayahuasca-induced psychosis: A case report ↗ | Cerón Tapia HR, González Guzmán MA, Córdoba Ortiz SA | 2022 | Revista Colombiana de psiquiatria | 6 |
| Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review ↗ | Kuburi S, Di Passa AM, Tassone VK et al. | 2022 | Chronic stress (Thousand Oaks, Calif.) | 6 |
| Preliminary evidence of links between ayahuasca use and the corpus callosum ↗ | Simonsson O, Bouso JC, Kurth F et al. | 2022 | Frontiers in psychiatry | 6 |
| Psychological effects and subjective experiences of ayahuasca rituals in participants of two neoshamanic centers of Uruguay ↗ | Ismael Apud, Juan Scuro, Ignacio Carrera et al. | 2022 | Journal of Psychedelic Studies | 6 |
| Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay ↗ | Apud I, Scuro J, Carrera I et al. | 2023 | Journal of psychoactive drugs | 6 |
| Building an explanatory model for snakebite envenoming care in the Brazilian Amazon from the indigenous caregivers' perspective ↗ | de Farias AS, do Nascimento EF, Gomes Filho MR et al. | 2023 | PLoS neglected tropical diseases | 6 |
| Discovery and <i>In Vitro</i> Characterization of SPL028: Deuterated <i>N</i>,<i>N</i>-Dimethyltryptamine ↗ | Layzell M, Rands P, Good M et al. | 2023 | ACS medicinal chemistry letters | 6 |
| "Getting to the Root": Ayahuasca Ceremony Leaders' Perspectives on Eating Disorders ↗ | Williams M, Kingston Miller A, Loizaga-Velder A et al. | 2023 | Journal of psychoactive drugs | 6 |
| In silico characterization of the psilocybin biosynthesis pathway ↗ | Irvine W, Tyler M, Delgoda R | 2023 | Computational biology and chemistry | 6 |
| Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the "God Molecule" ↗ | Al-Imam A, Motyka MA, Hoffmann B et al. | 2023 | Pharmaceuticals (Basel, Switzerland) | 6 |
| <i>Incilius alvarius</i> Cell-Based Synthesis of 5-Methoxy-N,N-Dimethyltryptamine ↗ | Lerer L, Reynolds E, Varia J et al. | 2023 | Psychedelic medicine (New Rochelle, N.Y.) | 6 |
| Mystical and Ego-Dissolution Experiences in Ayahuasca and Jurema Holistic Rituals: An Exploratory Study ↗ | Robson Savoldi, Antônio Roazzi, Rita Clara de Oliveira Sales | 2023 | International Journal for the Psychology of Religion | 6 |
| <i>N, N</i>-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an <i>in vitro</i> investigation ↗ | Eckernäs E, Macan-Schönleben A, Andresen-Bergström M et al. | 2023 | Xenobiotica; the fate of foreign compounds in biological systems | 6 |
| Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies ↗ | Guilherme Henrique de Morais Santos, Lucas Silva Rodrigues, Juliana Mendes Rocha et al. | 2023 | Psychoactives | 6 |
| Understanding ayahuasca effects in major depressive disorder treatment through in vitro metabolomics and bioinformatics ↗ | Zandonadi FS, Silva AAR, Melo AAS et al. | 2023 | Analytical and bioanalytical chemistry | 6 |
| Ayahuasca for the treatment of alcohol use disorder ↗ | Marinho EAV, Serra YA, Oliveira-Lima AJ et al. | 2024 | International review of neurobiology | 6 |
| Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists ↗ | Jayakodiarachchi N, Maurer MA, Schultz DC et al. | 2024 | ACS medicinal chemistry letters | 6 |
| Philosophical Perspectives on Psychedelic Psychiatry ↗ | Chris Letheby, Philip Gerrans | 2024 | | 6 |
| A Scoping Review of Research in Naturalistic Studies with Psychedelics ↗ | Carvalho LC, Encantado J, Kettner H et al. | 2025 | Journal of psychoactive drugs | 6 |
| Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges ↗ | Ghaznavi S, Richter SG | 2025 | Drugs | 6 |
| OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study ↗ | Rodrigues RS, Wießner I, Daldegan-Bueno D et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 6 |
| Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress ↗ | Viña SM | 2025 | Psychedelic medicine (New Rochelle, N.Y.) | 6 |
| The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample ↗ | Calder AE, Qualls C, Hasler G et al. | 2025 | Biological psychiatry global open science | 6 |
| Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT) ↗ | Piccinini JI, Sanz Perl Y, Pallavicini C et al. | 2025 | Communications biology | 6 |
| Ayahuasca, caapi, yage. Psychotropic properties of the harmala alkaloids ↗ | Naranjo C | 1967 | Psychopharmacology bulletin | 5 |
| Participation of retinal mechanisms in DMT hallucinations ↗ | Heiss WD, Hoyer J, Poustka F | 1973 | Experientia | 5 |
| Possible source of error in studies of enzymatic formation of dimethyltryptamine ↗ | Rosengarten H, Meller E, Freidhoff AJ | 1976 | Journal of psychiatric research | 5 |
| Effects of various neuroleptics on rabbit hyperthermia induced by N, N-Dimethyltryptamine (DMT) and d-amphetamine ↗ | Domino EF, Gahagan S, Adinoff B et al. | 1977 | Archives internationales de pharmacodynamie et de therapie | 5 |
| Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia ↗ | Stoff DM, Moja EA, Gillin JC et al. | 1978 | Journal of psychiatric research | 5 |
| Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings] ↗ | Harrison-Read PE | 1979 | British journal of pharmacology | 5 |
| Inhibition of prolactin release by stimulation of presynaptic serotonin autoreceptors ↗ | Clemens JA, Roush ME | 1982 | Life sciences | 5 |
| Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat ↗ | Seeman G, Brown GM | 1985 | Neuropharmacology | 5 |
| Stimulation of adenylate cyclase in the heart of Aplysia californica by biogenic amines ↗ | Drummond GI, Wernham S, Lukowiak K | 1985 | Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology | 5 |
| Thyrotrophin releasing hormone--5-hydroxytryptamine interactions in the brain studied using chronic immunization and chemical lesioning techniques ↗ | Bennett GW, Edwards RM, Lighton C et al. | 1987 | Journal of receptor research | 5 |
| Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization? ↗ | Leff P, Martin GR | 1988 | British journal of pharmacology | 5 |
| Cerebral serotonin in viral encephalitis ↗ | Lima L, Drujan B, Walder R | 1990 | Journal of neural transmission. Supplementum | 5 |
| Acute and chronic effects of intrathecal galanin on behavioural and biochemical markers of spinal motor function in adult rats ↗ | Fone KC, Dixon DM | 1991 | Brain research | 5 |
| Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon ↗ | Walker EA, Yamamoto T, Hollingsworth PJ et al. | 1991 | The Journal of pharmacology and experimental therapeutics | 5 |
| Effects of idazoxan on 5-hydroxytryptamine-mediated behaviour in the mouse and rat ↗ | Dickinson SL, Tulloch IF, Gadie B | 1991 | Journal of psychopharmacology (Oxford, England) | 5 |
| Receptors mediating the actions of 5-hydroxytryptamine on the isolated retractor muscle of the penis preparations from Archachatina marginata (Swainson) ↗ | Innocent O, Olufemi A | 1992 | Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology | 5 |
| Indole alkaloids from Antirhea lucida ↗ | Weniger B, Rafik W, Bastida J et al. | 1995 | Planta medica | 5 |
| Myo-inositol attenuates the enhancement of the serotonin syndrome by lithium ↗ | Kofman O, Levin U | 1995 | Psychopharmacology | 5 |
| Two 5-HT<sub>1A</sub> Receptor-Interactive Tryptamine Derivatives from the Unripe Fruit of <i>Evodia </i><i>rutaecarpa</i> ↗ | Lili Yu, Li-Kang Ho, Jyh‐Fei Liao et al. | 1997 | Journal of Natural Products | 5 |
| Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin ↗ | Mitsune Yamaguchi, Toshiaki Saito, Yoshie Horiguchi et al. | 2004 | JOURNAL OF HEALTH SCIENCE | 5 |
| A Methodology for Studying Various Interpretations of the N,N-dimethyltryptamine-Induced Alternate Reality ↗ | Marko A. Rodriguez | 2006 | | 5 |
| Chemical Constituents of Evodia fargesii Dode ↗ | Quan Liu | 2006 | Chinese Journal of Natural Medicines | 5 |
| Hallucinogenic Drugs ↗ | John Smythies, CM Ireland | 2012 | Encyclopedia of Life Sciences | 5 |
| Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp ↗ | Moreira LA, Murta MM, Gatto CC et al. | 2015 | Natural product communications | 5 |
| Genotoxic evaluations in Wistar rats of the hallucinogenic plant extract ayahuasca ↗ | Aline Pic‐Taylor, Willian Melo, José Souza-Filho et al. | 2016 | International Journal of Phytomedicine | 5 |
| Por uma abordagem ecológica dos efeitos anti-depressivos da ayahuasca ↗ | Danielli Katherine Pascoal da Silva | 2017 | Ponto Urbe | 5 |
| William Burroughs: Sailor of the Soul ↗ | Lees AJ | 2017 | Journal of psychoactive drugs | 5 |
| A Single Dose Of Ayahuasca Modulates Salivary Cortisol In Treatment-Resistant Depression ↗ | de Menezes Galvão AC, de Almeida RN, dos Santos Silva EA et al. | 2018 | bioRxiv | 5 |
| Ayahuasca: From the Amazon to a city near you ↗ | Stiffler JD | 2018 | The American journal on addictions | 5 |
| Use of novel haptens in the production of antibodies for the detection of tryptamines ↗ | Maryška M, Fojtíková L, Jurok R et al. | 2018 | RSC advances | 5 |
| [Severe hyponatremia secondary to Phyllomedusa bicolor (Kambó frog) poisoning. Report of one case] ↗ | Campodónico J, Aedo P, Montané MI et al. | 2019 | Revista medica de Chile | 5 |
| A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS ↗ | Eller S, Borges GR, Ossanes DS et al. | 2020 | Forensic science international | 5 |
| Editorial: Sigma Receptors ↗ | Ebru Aydar, Enrique J. Cobos, Tangui Maurice et al. | 2020 | Frontiers in Pharmacology | 5 |
| ELECTROCHEMICAL DETERMINATION OF N,N-DIMETHYLTRYPTAMINE IN WATER BASED ON TETRARUTHENATED PORPHYRINS AND IONIC LIQUID MODIFIED ELECTRODES ↗ | G. Plaza, Benjamı́n Piña, Heidy Herrera et al. | 2020 | Journal of the Chilean Chemical Society | 5 |
| Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing? ↗ | Ona GS, Dos Santos RG, Hallak JEC et al. | 2020 | ACS chemical neuroscience | 5 |
| DMT entity encounters: dialogues on the spirit molecule ↗ | David Luke, Rory Spowers | 2021 | | 5 |
| <sup>1</sup>H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids? ↗ | Vilca-Melendez S, Uthaug MV, Griffin JL | 2021 | Frontiers in psychiatry | 5 |
| Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders ↗ | Chao YS, Horton J | 2021 | Canadian Agency for Drugs and Technologies in Health, Ottawa (ON) | 5 |
| The Failed Globalization of Psychedelic Drugs in the Early Modern World ↗ | Benjamin Breen | 2021 | The Historical Journal | 5 |
| El ritual de la Ayahuasca: patrimonio cultural nacional de Perú ↗ | Rosa A. Giove | 2022 | Cultura y Droga | 5 |
| Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca ↗ | Gonçalves J, Luís Â, Gallardo E et al. | 2022 | Molecules (Basel, Switzerland) | 5 |
| Heart rate (HR) and heart rate variability (HRV) response to inhaled N, N-dimethyltryptamine (N, N-DMT): A case report ↗ | David W. Lawrence | 2022 | Journal of Psychedelic Studies | 5 |
| In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction ↗ | Neyder Contreras‐Puentes, Antistio Alvíz‐Amador, Isabella Manzur-Villalobos | 2022 | Journal of Herbmed Pharmacology | 5 |
| Ketamine Pharmacodynamics Entangled: Comment ↗ | Andrew Bowdle, Nathan Sackett, Rick J. Strassman et al. | 2022 | Anesthesiology | 5 |
| Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape ↗ | Luppi AI, Hansen JY, Adapa R et al. | 2022 | bioRxiv | 5 |
| Sleep-like state during wakefulness induced by psychedelic 5-MeO-DMT in mice ↗ | Bréant BJB, Mengual JP, Hoerder-Suabedissen A et al. | 2022 | bioRxiv | 5 |
| Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS ↗ | Zhai W, Li L, Zhao J et al. | 2022 | Drug testing and analysis | 5 |
| The content of complex psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine ↗ | Stephen Kagan | 2022 | Journal of Psychedelic Studies | 5 |
| Introduction to the chemistry and pharmacology of psychedelic drugs ↗ | Scott R. Walker, Glenn A. Pullella, Matthew Piggott et al. | 2023 | Australian Journal of Chemistry | 5 |
| Toad in the road: Biocultural history and conservation challenges of the Sonoran Desert Toad ↗ | R Villa | 2023 | Journal of Psychedelic Studies | 5 |
| Trajectories of sentiment in 11,816 psychoactive narratives ↗ | Sam Friedman, Galen Ballentine | 2023 | Human Psychopharmacology Clinical and Experimental | 5 |
| A fatal case of aspiration due to consumption of the hallucinogenic tryptamine derivative dipropyltryptamine (DPT) ↗ | Neukamm MA, Pollak S, Thoma V et al. | 2024 | Journal of pharmaceutical and biomedical analysis | 5 |
| Archaeology of psychotropic substances: The problem of analytical detection of ayahuasca ↗ | Enrico Greco, Laurent Rivier, Giorgio Samorini et al. | 2024 | Archaeometry | 5 |
| Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing ↗ | Bonnelle V, Feilding A, Rosas FE et al. | 2024 | bioRxiv | 5 |
| Ayahuasca and its major component harmine promote antinociceptive effects in mouse models of acute and chronic pain ↗ | Lauria PSS, Gomes JM, Abreu LS et al. | 2024 | Journal of ethnopharmacology | 5 |
| Electronic cigarettes are a tool to vape illicit drugs ↗ | Mariaelvina Sala | 2024 | Discover Public Health | 5 |
| Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain ↗ | Frautschi PC, Singh AP, Stowe NA et al. | 2024 | AJNR. American journal of neuroradiology | 5 |
| Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design ↗ | Miranda P, Castro A, Díaz P et al. | 2024 | Polymers | 5 |
| On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments ↗ | Caroline L. Alves, Manuel Ciba, Thaise G. L. de O. Toutain et al. | 2024 | Journal of Physics Complexity | 5 |
| The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression ↗ | Falchi-Carvalho M, Barros H, Bolcont R et al. | 2024 | medRxiv | 5 |
| What is needed for the roll-out of psychedelic treatments? ↗ | Xenakis SN, Shannon SM | 2024 | Current opinion in psychiatry | 5 |
| Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study ↗ | Doss MK, Kloft L, Mason NL et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 5 |
| Ayahuasca reverses ischemic stroke-induced neuroinflammation and oxidative stress ↗ | da Silva Joaquim L, da Rosa LR, Strickert Y et al. | 2025 | Behavioural brain research | 5 |
| Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression ↗ | do Nascimento Sousa D, do Nascimento Sousa D, de Azevedo M et al. | 2025 | Metabolic brain disease | 5 |
| Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users ↗ | Fonseca AM, Dos Santos RG, de Medeiros LS et al. | 2025 | European archives of psychiatry and clinical neuroscience | 5 |
| Preliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico ↗ | Cecile Giovannetti, Anja Loizaga-Velder, Ricardo Campoy Gomez et al. | 2025 | Journal of Psychedelic Studies | 5 |
| Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy ↗ | Belitzky E, Ravani Carvalho LV, Taylor M et al. | 2025 | Cancer medicine | 5 |
| Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: A systematic review of early-phase clinical trials ↗ | Swieczkowski D, Kwaśny A, Cubała WJ | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 5 |
| A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial ↗ | Erritzoe D, Barba T, Benway T et al. | 2026 | Nature medicine | 5 |
| Micro-phenomenology of immersion and perceived presences under DMT ↗ | Sanders JW, Millière R, Demšar E et al. | 2026 | Neuroscience of consciousness | 5 |
| The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research ↗ | Stocker K, Hartmann M, Schmid Y et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 5 |
| [Psychopathological effects of dimethyltryptamine; a further contribution on pharmacopsychiatry; preliminary report] ↗ | ARNOLD OH, HOFMANN G | 1957 | Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete | 4 |
| The Objectivity of Spiritual Experiences: Spontaneous Mental Imagery and the Spiritual Space ↗ | Marcelo S. Mercante | 1969 | Revista Eletrônica Informação e Cognição (Cessada) | 4 |
| [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses] ↗ | Rosengarten H, Szemis A, Piotrowski A et al. | 1970 | Psychiatria polska | 4 |
| A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites ↗ | Narasimhachari N, Lin RL | 1974 | Research communications in chemical pathology and pharmacology | 4 |
| Search for new treatment approaches in schizophrenia: in vitro studies of potential N-methyltransferase inhibitors ↗ | Domino EF | 1976 | Archives internationales de pharmacodynamie et de therapie | 4 |
| Structure-activity relationships among desmethyl derivatives of neuroleptics and antidepressants for substrate specificty to indolethylamine N-methyltransferase from rabbit lung ↗ | Narasimhachari N, Lin RL | 1976 | Psychopharmacology communications | 4 |
| The effects of hallucinogens on blind monkeys ↗ | Siegel RK, Brewster JM, Johnson CA et al. | 1976 | International pharmacopsychiatry | 4 |
| Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver ↗ | Wang Lu LJ, Demetriou SK, Domino EF | 1978 | Archives internationales de pharmacodynamie et de therapie | 4 |
| Inhibition of dimethyltryptamine biosynthesis by N,N'-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II) ↗ | Mandel Lr, Joshua Rokach, Rooney Cs et al. | 1978 | PubMed | 4 |
| Nociception is enhanced by the intrathecal injection of 5-methoxy-N,N-dimethyltryptamine in the rat ↗ | Larson AA | 1982 | Neuroscience letters | 4 |
| Possible mechanism of 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in DRN lesioned rats ↗ | Blackburn TP, Cox B, Heapy CG et al. | 1982 | Pharmacology, biochemistry, and behavior | 4 |
| Neuronal mechanisms involved in drug-induced jumping behavior in mice ↗ | Ushijima I, Mizuki Y, Yamada M et al. | 1985 | European journal of pharmacology | 4 |
| Serotonergic involvement in pharmacological action of the anxiolytic-sedatives thalidomide and supidimide ↗ | Youdim MB, Ashkenazi R | 1985 | European journal of pharmacology | 4 |
| The effect of drugs on the acquisition of stimulus control in a conditioned suppression procedure ↗ | Nielsen EB, Appel JB | 1985 | Psychopharmacology | 4 |
| 3-Acetylpyridine lesions and four serotonergic behavioral syndromes in the rat ↗ | Pranzatelli MR, Gantner C, Snodgrass SR | 1987 | Brain research bulletin | 4 |
| Postmortem- and cryostability of the potassium-evoked release of [3H]5-hydroxytryptamine from rat cerebral cortical miniprisms ↗ | Fowler CJ, Thorell G, Fagervall I | 1989 | Journal of neural transmission | 4 |
| Enamines from formamides. Synthesis of 1,2,3,4-tetrahydro-1-substituted β-carbolines ↗ | Rahul Vohra, David B. MacLean | 1994 | Canadian Journal of Chemistry | 4 |
| Modification of 2,2',2''-tripyridine-induced tremor in mice by serotonergic agonists and antagonists and benzodiazepines ↗ | Lin-Shiau SY, Hsu KS | 1994 | Pharmacology, biochemistry, and behavior | 4 |
| Isolation and Identification of Putative Hallucinogenic Constituents from the Roots of Mimosa ophthalmocentra ↗ | Leônia Maria Batista, Reinaldo Nóbrega de Almeida, E.V.L da-Cunha et al. | 1999 | Pharmaceutical Biology | 4 |
| Flavonoid Aglycones and Indole Alkaloids from the Roots of <i>Acacia Confusa</i> ↗ | Tzong‐Huei Lee, Chang‐Hung Chou | 2000 | Journal of the Chinese Chemical Society | 4 |
| [Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs] ↗ | Carod Artal FJ | 2003 | Revista de neurologia | 4 |
| Ayahuasca use in cross-cultural perspective ↗ | de Rios MD, Grob CS | 2005 | Journal of psychoactive drugs | 4 |
| Interview with Jeffrey Bronfman, representative mestre for the União do Vegetal Church in the United States. Interview by Marlene Dobkin de Rios and Charles S Grob ↗ | Bronfman J | 2005 | Journal of psychoactive drugs | 4 |
| Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells? ↗ | Mereghetti I, Cagnotto A, Mennini T | 2007 | Journal of neuroscience methods | 4 |
| [Inhibition of return in schizophrenia: a review] ↗ | Kebir O, Ben Azouz O, Amado I et al. | 2008 | L'Encephale | 4 |
| Hydrophillic Interaction Chromatography-tandem Mass Spectrometry Method for Identification and Quantitation of 5-MeO-DIPT and its Metabolites in Rat Urine ↗ | Yoon Kim, Un-Yong Kim, Moon-Kyo In et al. | 2011 | Bulletin of the Korean Chemical Society | 4 |
| Motive für den Konsum psychoaktiver Substanzen am Beispiel des Ayahuasca-Gebrauchs in der Santo-Daime-Gemeinschaft ↗ | Lisa Fiedler, Henrik Jungaberle, Rolf Verres | 2011 | Zeitschrift für Medizinische Psychologie | 4 |
| Ayahuasca’s attractions and distractions: examining sexual seduction in shaman-participant interactions ↗ | Daniela M. Peluso | 2014 | Kent Academic Repository (University of Kent) | 4 |
| Traditional Indigenous Medicine of the Peruvian Amazon and its Potential for Psychological Treatment and Personal Growth ↗ | Veronika Kavenská | 2014 | Folia Universitatis Agriculturae et Silviculturae Mendelianae Brunensis | 4 |
| Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice ↗ | Jiang XL, Shen HW, Mager DE et al. | 2016 | Acta pharmaceutica Sinica. B | 4 |
| Transcultual Perspective on Consciousness: Traditional Use of Ayahuasca in Psychiatry in the 21st Century in the Western World ↗ | Tania Simona Re, J R Di Palma, Jorge Emanuel Martins et al. | 2016 | Open Humanities Press - Cosmos and History: The Journal of Natural and Social Philosophy | 4 |
| Hyperespace dans le cyberespace : DMT et méta-ritualisation ↗ | Graham St John | 2017 | Drogues santé et société | 4 |
| In vivo Pharmacodynamics Studies of Acacia tortilis Found in Kingdom of Saudi Arabia on Cardiovascular System of Rats ↗ | Abdulhalim S. Serafi, Aisha Azmat, Muhammad Ahmed et al. | 2018 | International Journal of Pharmacology | 4 |
| N,N-dimethyltryptamine facts and myths ↗ | Barker SA | 2018 | Journal of psychopharmacology (Oxford, England) | 4 |
| Corrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus ↗ | Lima da Cruz RV, Moulin TC, Petiz LL et al. | 2019 | Frontiers in molecular neuroscience | 4 |
| Neural correlates of the DMT experience as assessed via multivariate EEG ↗ | Timmermann C, Roseman L, Schartner M et al. | 2019 | bioRxiv | 4 |
| Ayahuasca - potential therapeutic properties in psychiatry. Research review ↗ | Barabasz-Gembczyk A, Kucia K | 2020 | Psychiatria polska | 4 |
| The Novelty of Ayahuasca Scale and the prediction of intentions to use ↗ | Brianna R. Altman, Maha N. Mian, Mitch Earleywine | 2020 | Journal of Psychedelic Studies | 4 |
| Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice ↗ | Thomas CW, Blanco-Duque C, Bréant B et al. | 2021 | bioRxiv | 4 |
| Psychedelic Medicines in Major Depression: Progress and Future Challenges ↗ | Bouso JC, Ona G, Dos Santos RG et al. | 2021 | Advances in experimental medicine and biology | 4 |
| Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing ↗ | Jessica Sophie Corneille, David Luke | 2021 | | 4 |
| Hordenine: Pharmacological, phytochemical, pharmacokinetic and analytical review of the literature ↗ | Lavanya Athilli, Arumugam Balasubramaniam | 2022 | Annals of Phytomedicine An International Journal | 4 |
| PHARMACOKINETICS OF N,N-DIMETHYLTRYPTAMINE FUMARATE IN HUMANS ↗ | Good M, Benway T, Joel Z et al. | 2022 | Authorea Preprints | 4 |
| Ritualistic use of ayahuasca enhances a shared functional connectome identity with others ↗ | Mallaroni P, Mason NL, Kloft L et al. | 2022 | bioRxiv | 4 |
| A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression ↗ | Cruz L, Bienemann B, Palhano-Fontes F et al. | 2023 | Scientific reports | 4 |
| Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders ↗ | Kargbo RB | 2023 | ACS medicinal chemistry letters | 4 |
| Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts ↗ | Anna Beatriz Vicentini, Lucas Silva Rodrigues, Giordano Novak Rossi et al. | 2023 | Psychoactives | 4 |
| Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico ↗ | Loizaga-Velder A, Giovannetti C, Campoy Gomez R et al. | 2023 | Journal of psychoactive drugs | 4 |
| A dual-receptor model of serotonergic psychedelics ↗ | Arthur Juliani, Veronica Chelu, Laura Graesser et al. | 2024 | bioRxiv (Cold Spring Harbor Laboratory) | 4 |
| Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol ↗ | Sabucedo P, Andión O, Neimeyer RA et al. | 2024 | Frontiers in psychiatry | 4 |
| Defining 5-MeO-DMT in Historical and Cultural Contexts ↗ | Azul Delgrasso | 2024 | World Futures | 4 |
| Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self. ↗ | Pasquini, Lorenzo, Simon, Alexander J, Gallen, Courtney L et al. | 2024 | bioRxiv : the preprint server for biology | 4 |
| Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study ↗ | Arruda Sanchez T, Ramos LR, Araujo F et al. | 2024 | Journal of ethnopharmacology | 4 |
| Potential therapeutic use of ayahuasca: A literature review ↗ | Salvana Priscylla Manso Costa, Keith Cardoso CARVALHO, Isabella Nunes GOMES et al. | 2024 | Acta Amazonica | 4 |
| Psychedelic research, assisted therapy and the role of the anaesthetist: A review and insights for experimental and clinical practices ↗ | Lima G, Soares C, Teixeira M et al. | 2024 | British journal of clinical pharmacology | 4 |
| Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review ↗ | Arenson A, Campbell CI, Remler I | 2024 | Journal of addictive diseases | 4 |
| The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review ↗ | Sheth R, Parikh E, Olayeye K et al. | 2024 | Cureus | 4 |
| Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders ↗ | Valdez T, Patel V, Senesombath N et al. | 2024 | Pharmaceuticals (Basel, Switzerland) | 4 |
| Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders ↗ | Loizaga-Velder A, Loizaga Pazzi A | 2024 | Journal of studies on alcohol and drugs | 4 |
| Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens ↗ | Rahman SM, Salem Y, Hussain A | 2024 | Dermatitis : contact, atopic, occupational, drug | 4 |
| Unlocking the biosynthesis of psychedelic-inspired indolethylamines ↗ | Sen AK, Jones JA | 2024 | Trends in biochemical sciences | 4 |
| Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses ↗ | Fandiño OE, Hutton ARJ, Zhang C et al. | 2025 | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 4 |
| Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces ↗ | Suay D, Aicher HD, Kometer M et al. | 2025 | NeuroImage | 4 |
| Ayahuasca partially preserves striatal integrity in juvenile non-human primates exposed to chronic stress: evidence from stereological evaluation ↗ | Lira-Bandeira WG, Mendonça Batista LAC, Medeiros-Bandeira AS et al. | 2025 | Frontiers in neuroanatomy | 4 |
| Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury ↗ | Plummer Z, Allen J, Brand J et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 4 |
| Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings ↗ | Calnan M, Blest-Hopley G, Busch C et al. | 2025 | Brain and behavior | 4 |
| Landscape analysis of pre-registered clinical trials involving classical psychedelics ↗ | Abdo Uyar, Linda Forbrich, Ulrike Lueken et al. | 2025 | Journal of Psychopharmacology | 4 |
| Psychedelics and Suicide-Related Outcomes: A Systematic Review ↗ | Meshkat S, Malik T, Zeifman R et al. | 2025 | Journal of clinical medicine | 4 |
| What fMRI studies say about the nature of the psychedelic effect: a scoping review ↗ | Beneš M, Páleníček T, Horáček J | 2025 | Frontiers in neuroscience | 4 |
| Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review ↗ | Orsini DK, Wong S, Di Luch S et al. | 2026 | JAMA psychiatry | 4 |
| Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies ↗ | Barstowe A, Kajonius PJ | 2026 | Journal of psychoactive drugs | 4 |
| Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs ↗ | Heal DJ, Gosden J, Smith SL | 2026 | Journal of psychopharmacology (Oxford, England) | 4 |
| Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT) ↗ | Lewis-Healey E, Pallavicini C, Cavanna F et al. | 2026 | Journal of cognitive neuroscience | 4 |
| [Dimethyltryptamine as a new psychotic agent] ↗ | SZARA I, SAI-HALASZ A, BOSZORMENYI Z | 1957 | Acta physiologica Academiae Scientiarum Hungaricae | 3 |
| Occurrence of 5-methoxy-N,N-dimethyltryptamine oxide and other tryptamines in Desmodium pulchellum Benth ex Baker ↗ | Ghosal S, Mukherjee B | 1965 | Chemistry & industry | 3 |
| Behavioral effects of N,N-dimethyltryptamine in rats and mice ↗ | Moussatché H, Carlini EA, dos Santos M | 1970 | Revista brasileira de biologia | 3 |
| THE NORMAL OCCURRENCE OF TRYPTAMINE IN BRAIN AND ITS CONVERSION TO N-METHYL AND N-DIMETHYLTRYPTAMINE IN VITRO AND IN VIVO ↗ | Juan M. Saavedra, J Axelrod | 1973 | Elsevier eBooks | 3 |
| Letter: Urinary dimethyltryptamine in psychiatric patients ↗ | Oon MC, Murray RH, Brockington IF et al. | 1975 | Lancet (London, England) | 3 |
| Drug antagonism and reversibility of the binding of indoleamines in brain ↗ | Ungar F, Hitri A, Alivisatos SG | 1976 | European journal of pharmacology | 3 |
| [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)] ↗ | Bickel P, Dittrich A, Schöpf J | 1977 | Pharmakopsychiatrie, Neuro-Psychopharmakologie | 3 |
| The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs ↗ | Glennon RA, Gessner PK | 1977 | Research communications in chemical pathology and pharmacology | 3 |
| The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity ↗ | Abramson HA, Gettner HH, Carone PA et al. | 1979 | The Journal of asthma research | 3 |
| Serotonin receptor site in human platelets from control and chlorpromazine treated subjects ↗ | Oppenheim B, Hefez A, Youdim MB | 1980 | Progress in biochemical pharmacology | 3 |
| Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline ↗ | Stolz JF, Marsden CA | 1981 | Journal de physiologie | 3 |
| Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice ↗ | Morinan A, Collier JG | 1981 | Psychopharmacology | 3 |
| Tolerance to behavioral effects of N, N-dimethyltryptamine in mice ↗ | Cooper SG, Schiff SR, Bridger WH | 1981 | Biological psychiatry | 3 |
| Effects of various serotoninergic agonists and an antagonist on a nociceptive reaction in mice ↗ | Ramabadran K, Jacob JJ | 1982 | Japanese journal of pharmacology | 3 |
| A novel serotonin antagonist 2,2′‐bis[3‐(2‐<i>N,N</i>‐dimethylaminoethyl)indolyl]sulfide (BDIS) ↗ | Chit‐Kay Chu, Joseph D. Wander, Randall L. Tackett et al. | 1984 | Journal of Heterocyclic Chemistry | 3 |
| Functional change in the rat spinal cord by chronic spinal transection and possible roles of monoamine neurons ↗ | Ito T, Furukawa K, Karasawa T et al. | 1985 | Japanese journal of pharmacology | 3 |
| Trace Indoleamines in the Central Nervous System ↗ | Dennis L. Murphy, Lawrence Tamarkin, Nancy A. Garrick et al. | 1985 | Humana Press eBooks | 3 |
| 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats ↗ | Minor BG, Archer T, Post C et al. | 1986 | Journal of neural transmission | 3 |
| Differential effects of nialamide and clomipramine on serotonin efflux and autoreceptors ↗ | Offord SJ, Warwick RO Jr | 1987 | Pharmacology, biochemistry, and behavior | 3 |
| The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats ↗ | Saito R, Fujiwara M, Kamiya H et al. | 1987 | Pharmacology, biochemistry, and behavior | 3 |
| Pharmacological effects of oxaprotiline enantiomers on the central serotonin system ↗ | Maj J, Dereń A, Moryl E | 1989 | Polish journal of pharmacology and pharmacy | 3 |
| Chronic stress reduced GH response to the serotonin agonist 5‐methoxy‐n, n‐dimethyltriptamine but did not alter pituitary–adrenal, prolactin or TSH responses in the rat ↗ | Antonio Armario, Li. Campmany, Asunción López‐Calderón et al. | 1990 | Stress Medicine | 3 |
| A Method for the Determination of Alkaloids in Reed Canarygrass (<i>Phalaris arundinaceae</i>L.) using HPLC and Solid Phase Extraction ↗ | Gunnar Kalén, Robert Samuelsson, Eva Törmä | 1992 | Acta Agriculturae Scandinavica Section B - Soil & Plant Science | 3 |
| FUNCTIONAL INTERACTION BETWEEN 5-HT1B AND 5-HT1A OR 5-HT2 RECEPTORS IN MICE ↗ | E Chojnacka-Wójcik | 1992 | Clinical Neuropharmacology | 3 |
| Response to commentaries on "The ketamine model of the near-death experience ..." ↗ | Karl Jansen | 1997 | The Journal of near-death studies | 3 |
| Ayahuasca and human destiny ↗ | McKenna DJ | 2005 | Journal of psychoactive drugs | 3 |
| Constitutional Law -- The Supreme Court Can't Have it Both Ways Under RFRA: The Tale of Two Compelling Interest Tests. Gonzales v. O Centro Espirita Beneficente Uniao Do Vegetal, 126 S. Ct. 1211 (2006) ↗ | Aaron D. Bieber | 2007 | Wyoming Law Review | 3 |
| Estudio clínico de marcadores de hipermetilación indólica en las alteraciones de la percepción ↗ | Arturo A. Vitale, Jorge Ciprian‐Ollivier, Martín G. Vitale et al. | 2010 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 3 |
| Monoamine oxidase inhibitors in Amazonian hallucinogenic plants : ethnobotanical, phytochemical, and pharmacological investigations ↗ | Dennis J. McKenna | 2010 | cIRcle (University of British Columbia) | 3 |
| Ayahuasca, Harmala Alkaloids, and Dimethyltryptamines ↗ | Donald G. Barceloux | 2012 | | 3 |
| Does N,N-dimethyltryptamine (DMT) adequately explain near-death experiences? ↗ | Michael Potts | 2012 | The Journal of near-death studies | 3 |
| P4‐246: ACTIVATION OF THE SIGMA‐1 RECEPTOR BY SPECIFIC LIGANDS INHIBITS HUMAN INFLAMMATORY DENDRITIC CELL FUNCTIONS AND EFFECTOR T‐LYMPHOCYTE RESPONSES ↗ | Attila Szabó, Attila Kovács, Ede Frecska et al. | 2014 | Alzheimer s & Dementia | 3 |
| [Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca] ↗ | Szabó A, Kazai A, Frecska E et al. | 2015 | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 3 |
| FOREST SHAMANISM IN THE CITY: THE KAXINAWÁ EXAMPLE ↗ | Tiago Coutinho | 2016 | Sociologia & Antropologia | 3 |
| Pharmacology and Structure-Activity Relationship of Natural Products With Psychoactive Effects From Salvia divinorum, Mitragyna speciosa, and Ayahuasca ↗ | Simon Phipps, Oliver Grundmann | 2017 | Studies in natural products chemistry | 3 |
| Parapsychology, N,N-Dimethyltryptamine and the Pineal Gland ↗ | Nicola Luigi Bragazzi, Hicham Khabbache, Marco Perduca et al. | 2018 | Cosmos and history | 3 |
| The role of ceremonial ayahuasca use and the healing of eating disorders: a qualitative study ↗ | Marika Renelli | 2018 | Lu Zone Ul (Laurentian University) | 3 |
| A RARE CASE: AYAHUASCA TEA INTOXICATION ↗ | Selman Yeniocak, Asım Kalkan, Tuğba AGUŞ et al. | 2019 | Journal of Emergency Medicine Case Reports | 3 |
| One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip ↗ | Ahmed Al-Imam, Faris Lami | 2019 | Modern Applied Science | 3 |
| Yagé: Crisis de occidente y trabajo espiritual ↗ | Javier Ávila, Mariana Pedroza, Oscar Angulo | 2019 | Universidad y Salud | 3 |
| Aspectos Farmacológicos e Toxicológicos do Alcaloide N, N – Dimetiltriptamina (DMT) ↗ | Lilian Carvalho Machado, Renan Honorato Da Cruz, Soraia Sayuri Higa et al. | 2020 | Brazilian Journal of Natural Sciences | 3 |
| Molecular docking and binding interaction between psychedelic drugs and human serum albumin ↗ | Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan et al. | 2020 | Biotechnologia | 3 |
| N,N-Dimethyltryptamine (DMT) ↗ | Virgil Zeigler-Hill, Todd K. Shackelford | 2020 | | 3 |
| Baseline power of theta oscillations predicts mystical-type experiences induced by DMT ↗ | Tagliazucchi E, Zamberlan F, Cavanna F et al. | 2021 | bioRxiv | 3 |
| Influence of Supplemental Legumes that Contain Tannins and Saponins on Intake and Diet Digestibility in Sheep Fed Grasses that Contain Alkaloids ↗ | Jacob Owens | 2021 | Digital Commons - USU (Utah State University) | 3 |
| Potential Risks of Plant Constituents in Dietary Supplements: Qualitative and Quantitative Analysis of <i>Peganum harmala</i> Seeds ↗ | Calderoni M, Altare M, Mastracci L et al. | 2021 | Molecules (Basel, Switzerland) | 3 |
| Symptom specificity of ayahuasca's effect on depressive symptoms ↗ | Cody Gilbert, Mitch Earleywine, Maha N. Mian et al. | 2021 | Journal of Psychedelic Studies | 3 |
| The protective role of dimethyltryptamine and its analogues against ischemiareperfusion injury: Commentary ↗ | | 2021 | The Neuroscience Chronicles | 3 |
| Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates ↗ | Bonnet U, Specka M, Kanti AK et al. | 2022 | Frontiers in psychiatry | 3 |
| Episodios psicóticos inducidos por ayahuasca: revisión sistemática a partir de un caso ↗ | Laura Alcantarilla, Enrique García-Alcarria, Celia Almonacid | 2022 | Revista de Neuro-Psiquiatría | 3 |
| Harmine impairs memory performance of treated rats and nontreated cagemates ↗ | Libânio TC, Eufrásio RA, Niigaki SS et al. | 2022 | Experimental and clinical psychopharmacology | 3 |
| On epistemic injustices, biomedical research with Indigenous people, and the legal regulation of ayahuasca in Brazil: The production of new injustices? ↗ | Labate BC, Antunes H, de Assis GL et al. | 2022 | Transcultural psychiatry | 3 |
| Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior ↗ | de Meiroz Grilo MLP, de Sousa GM, de Mendonça LAC et al. | 2022 | Frontiers in behavioral neuroscience | 3 |
| Psychedelic use in India, its pattern and personal significance – findings from an online survey ↗ | Gokul Raj | 2022 | Indian Journal of Psychiatry | 3 |
| Statistics-Based Optimization of the Extraction Process of N,N-dimethyltryptamine from Mimosa tenuiflora Stem Bark ↗ | Isabela Araújo e Amariz, Jacyara Pereira da Silva, Nathália Andrezza Carvalho de Souza et al. | 2022 | Revista Brasileira de Farmacognosia | 3 |
| Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report ↗ | Bayat Mokhtari M, Bayat Mokhtari M, Rodriguez BZ et al. | 2022 | Cureus | 3 |
| The woman who chose the <i>terreiro</i>. Lay care and medical landscapes in mental health care in Rio de Janeiro ↗ | Müller MR, Ortega F, Martínez-Hernáez A | 2022 | Anthropology & medicine | 3 |
| Use of snuff and its main constituents for religious purposes in an alternative community with shamanic practices in the south of Brazil ↗ | Thais Guimarães Bourscheid, Leonardo Corrêa Cardoso, Marcelo Henrique Nascimento Santana et al. | 2022 | Journal of Psychedelic Studies | 3 |
| A mechanistic insight for the biosynthesis of N,N-dimethyltryptamine: An ONIOM theoretical approach ↗ | Coutinho LP, Silva SRB, de Lima-Neto P et al. | 2023 | Biochemical and biophysical research communications | 3 |
| Design and Application of a New Visible Light-Curing 3D Printing Platform ↗ | Yu Fu, Shuhong Ba, Yulong Yang et al. | 2023 | Applied Sciences | 3 |
| Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings ↗ | Juliana Mendes Rocha, José Augusto Silva Reis, Giordano Novak Rossi et al. | 2023 | Psychoactives | 3 |
| Increases in aesthetic experience following ayahuasca use: An open-label, naturalistic study ↗ | Aday J, Bloesch E, Davis AK et al. | 2023 | PsyArXiv | 3 |
| Psychoplastogens: A Novel Therapeutic Approach for Neurological Diseases and Disorders ↗ | Kargbo RB | 2023 | ACS medicinal chemistry letters | 3 |
| Synthetic studies toward the marine alkaloid convolutindole A, a structurally remarkable derivative of the hallucinogen N,N-Dimethyltryptamine (DMT) ↗ | Karen Ichikawa, Jessica C. Neville, Yihan Yu et al. | 2023 | Tetrahedron Letters | 3 |
| A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences ↗ | Noah S, Shen M, Erowid E et al. | 2024 | Frontiers in psychology | 3 |
| Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders ↗ | Williams M, Kingston Miller A, Lafrance A | 2024 | Eating disorders | 3 |
| Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors. ↗ | Jiwani, Zishan, Goldberg, Simon B, Stroud, Jack et al. | 2024 | medRxiv : the preprint server for health sciences | 3 |
| Continuous flow synthesis of <i>N</i>,<i>N</i>-dimethyltryptamine (DMT) analogues with therapeutic potential ↗ | Simoens A, Dejaegere A, Vandevelde M et al. | 2024 | RSC medicinal chemistry | 3 |
| DMT micro-phenomenology ↗ | James W. Sanders, Raphaël Millière, Zachary G. Daily et al. | 2024 | | 3 |
| Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors ↗ | Lorena Terene Lopes Guerra, Rafael G. dos Santos, Jaime E. C. Hallak | 2024 | Psychedelics. | 3 |
| Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities ↗ | Kanis FC, Broude CN, Hellwarth EB et al. | 2024 | Biotechnology progress | 3 |
| How psychedelics legalization debates could differ from cannabis ↗ | Beau Kilmer | 2024 | Addiction | 3 |
| Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment ↗ | Kargbo RB | 2024 | ACS medicinal chemistry letters | 3 |
| N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q) ↗ | Lawrence DW, DiBattista AP, Timmermann C | 2024 | Journal of psychoactive drugs | 3 |
| Self-Rated Effectiveness of Ayahuasca and Breathwork on Well-Being, Psychological Resilience, Self-Compassion, and Personality: An Observational Comparison Study ↗ | Rishma S. I. Khubsing, Martin van Leerdam, Eline Haijen et al. | 2024 | Psychoactives | 3 |
| Smokable "Vine of the Dead": Two Case Studies of Experiencers of Both Changa and Near-Death Experiences ↗ | Pascal Michael, David Luke, Oliver Robinson | 2024 | International Journal of Transpersonal Studies | 3 |
| Synthesis and Biological Analysis of Iso-dimethyltryptamines in a Model of Light-Induced Retinal Degeneration ↗ | Pazur EJ, Kalatanova A, Tasker NR et al. | 2024 | ACS medicinal chemistry letters | 3 |
| A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life ↗ | Sznitman SR, Behar YA, Dicker-Oren SD et al. | 2025 | Psychopharmacology | 3 |
| A review of psychedelics trials completed in depression, informed by European regulatory perspectives ↗ | Silva F, Butlen-Ducuing F, Guizzaro L et al. | 2025 | Neuroscience applied | 3 |
| Analysis of N,N-dimethyltryptamine (DMT) and its metabolites using LC-MS/MS for forensic purposes ↗ | Gomonit MM, Swortwood MJ, Truver MT et al. | 2025 | Journal of forensic sciences | 3 |
| Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial ↗ | Soto-Angona O, Andión O, Sabucedo P et al. | 2025 | Scientific reports | 3 |
| Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry ↗ | Pego AMF, Schoffner M, Sammeta VR et al. | 2025 | Journal of analytical toxicology | 3 |
| Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults ↗ | Ermakova AO, Dunbar F, Seynaeve M et al. | 2025 | Scientific reports | 3 |
| N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data ↗ | Barker SA | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 3 |
| Pathway engineering for the biosynthesis of psychedelics ↗ | Abrahms ZN, Sen AK, Jones JA | 2025 | Current opinion in biotechnology | 3 |
| Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential ↗ | Echeverry C, Pazos M, Torres-Pérez M et al. | 2025 | Neuroscience | 3 |
| Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects ↗ | Äbelö A, Smallridge JW, von Rotz R et al. | 2025 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 3 |
| Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes ↗ | d'Andrea G, Chiappini S, Ciavoni L et al. | 2025 | Translational psychiatry | 3 |
| Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon ↗ | Correia MS, Gonzaga MJ, Temple C et al. | 2025 | Clinical toxicology (Philadelphia, Pa.) | 3 |
| Resilience and Brain Changes in Long-Term Ayahuasca Users: Insights From Psychometric and fMRI Pattern Recognition ↗ | Ramos LR, Fernandes O Jr, Sanchez TA | 2025 | Journal of magnetic resonance imaging : JMRI | 3 |
| The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field ↗ | Syed OA, Petranker R, Tsang B | 2025 | Neuroscience and biobehavioral reviews | 3 |
| The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications ↗ | Zhai H, Wang H, Li H et al. | 2025 | ACS pharmacology & translational science | 3 |
| GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial ↗ | Cubala WJ, Bajbouj M, Bauer M et al. | 2026 | JAMA psychiatry | 3 |
| Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain ↗ | Vollebregt R, Storm AEM, Lucassen PJ et al. | 2026 | Neuroscience and biobehavioral reviews | 3 |
| [On the determination of homologous amines in biologic substrates. 2. Determination of N,N-dimethyltryptamine in blood and urine] ↗ | Gross H, Franzen F | 1965 | Zeitschrift fur klinische Chemie und klinische Biochemie | 2 |
| ↗ | David R. Rubin | 1967 | JAMA | 2 |
| 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency ↗ | Uyeno Et | 1969 | PubMed | 2 |
| Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens ↗ | K. Genest, Lorna J. Lowry | 1970 | Journal of Pharmacy and Pharmacology | 2 |
| Blocking of 5-methoxy-n-dimethyltryptamine-induced EEG alerting in the rabbit by previous administration of antiserum to this compound ↗ | Strahilevitz M, Narasimhachari N, Fujimori M et al. | 1971 | Biological psychiatry | 2 |
| Effects of bufotenine and p-chlorophenylalanine on reactivity to footshock ↗ | Gordon Winocur, S.P. Bagchi | 1974 | Physiological Psychology | 2 |
| [Biogenic amines and schizophrenia] ↗ | Schöpf J | 1975 | Schweizerische medizinische Wochenschrift | 2 |
| Tetrahydrofolic acid: an inhibitor of the methyltetrahydrofolic acid-mediated methylation of indolethylamines ↗ | Lin RL, Narasimhachari N | 1975 | Biochimica et biophysica acta | 2 |
| The excretion of dimethyltryptamine in psychiatric patients ↗ | Murray RM, Oon MC | 1976 | Proceedings of the Royal Society of Medicine | 2 |
| Transcallosally evoked potentials and the EEG in the decerebrate dog: actions of tryptaminergic, dopaminergic and adrenergic agonists ↗ | Pickworth WB, Sharpe LG, Martin WR | 1977 | Electroencephalography and clinical neurophysiology | 2 |
| Antagonism of ethanol-induced decrease in LH by para-chlorophenylalanine: lack of correlation with altered serotonergic mechanisms ↗ | Chapin RE, Breese GR, Mueller RA | 1981 | Pharmacology, biochemistry, and behavior | 2 |
| [Effects of peripheral electric stimulation on the central 5-hydroxytryptamine in mice: relation to the peripheral stimulation-produced analgesia (author's transl)] ↗ | Shimizu T | 1981 | Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2 |
| Calcium-dependency of the pressor responses to selective 5-hydroxytryptamine receptor agonists in pithed rats ↗ | Kalkman HO, Boddeke HW, Timmermans PB et al. | 1983 | Journal of autonomic pharmacology | 2 |
| Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat ↗ | Larson AA | 1984 | Life sciences | 2 |
| 5-Hydroxytryptamine antagonists and the 5-methoxy-N,N-dimethyltryptamine-induced changes of postdecapitation convulsions ↗ | Archer T | 1987 | Pharmacology & toxicology | 2 |
| Behavioural evidence for an interdependence between GABAA receptors and beta 2-adrenoceptors ↗ | Singh L, Handley SL | 1987 | European journal of pharmacology | 2 |
| Mechanisms by which the putative serotonin receptor antagonist metitepin alters nociception in mice ↗ | Eide PK, Hole K, Berge OG | 1988 | Journal of neural transmission | 2 |
| Cerebral and peripheral demethylation of psychotomimetics measured by expired 14CO2 ↗ | Sargent T 3rd, Braun U, Braun G et al. | 1989 | International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology | 2 |
| Effects of two 5-hydroxytryptamine agonists on head-weaving behaviour in streptozotocin-diabetic mice ↗ | Fujii E, Nomoto T, Muraki T | 1991 | Diabetologia | 2 |
| [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats] ↗ | Bogdanov MB, Gaĭnetdinov RR, Kudrin VS et al. | 1991 | Biulleten' eksperimental'noi biologii i meditsiny | 2 |
| [Neuroleptics and serotonin] ↗ | Hery F, Hamon M | 1993 | L'Encephale | 2 |
| [Brain monoamines and behavior in hyperammonemic sparse-fur mice] ↗ | Minakami K | 1994 | Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2 |
| The union of the vegetable: the ritualised use of hoasca tea ↗ | Eliseu Labigalini, John E. Dunn | 1995 | Psychiatric Bulletin | 2 |
| [Biological addictive drugs--is there a change in drug taking behavior of young drug addicts?] ↗ | Löhrer F, Albers M | 1999 | Psychiatrische Praxis | 2 |
| Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis ↗ | Euphrosyne Gouzoulis‐Mayfrank, Anna Neukirch, Karsten Heekeren | 2005 | Pharmacopsychiatry | 2 |
| Zoonotic potential of emerging animal diseases ↗ | Samson S. Y. Wong, Kwok‐Yung Yuen | 2005 | BMJ | 2 |
| <i>N</i>-Arylsulfonyl-2-vinyltryptamines as new 5-HT<sub>6</sub>serotonin receptor Ligands ↗ | Marion Raoul, Dominique Patigny, Frédréic Fabis et al. | 2006 | Journal of Enzyme Inhibition and Medicinal Chemistry | 2 |
| Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumption, and Accompanied With Psychotic Features Immediately After N,N-Dimethyltryptamine (Dmt) Use: A Case Report ↗ | Gökhan Umut, İlker Küçükparlak, Güliz Özgen et al. | 2011 | Dusunen Adam The Journal of Psychiatry and Neurological Sciences | 2 |
| Quantitative analysis of substituted N,N-dimethyl-tryptamines in the presence of natural type XII alkaloids ↗ | Ivanova B, Spiteller M | 2012 | Natural product communications | 2 |
| [Chemical constituents of Desmodium caudatum] ↗ | Lu WJ, Lu GS, Tan X et al. | 2013 | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials | 2 |
| Quantificação neuronal no córtex cerebral de camundongos sob o uso do chá de Ayahuasca ↗ | Janille Santos Corrêa, Vanessa Almeida Amorin, Denismar Alves Nogueira et al. | 2014 | Revista Neurociências | 2 |
| Ritual Performance of the Santo Daime Church in Miami: Co-constructive Selves in the Midst of Impediments to Local Acculturation ↗ | Alfonso Matas | 2014 | | 2 |
| Allelopathic effects of Psychotria viridis Ruiz & Pavon on the germination and initial growth of Lactuca sativa L ↗ | Amanda Oliveira Andrade, Maria A. P. Da Silva, Alison Honório de Oliveira et al. | 2016 | Journal of Agricultural Science | 2 |
| Between ecstasy and reason: a symbolic interpretation of UDV trance ↗ | ROSA VIRGÍNIA MELO | 2016 | | 2 |
| Identification of volatile compounds in hydro-alcoholic extracts of Calendula officinalis L. flowers and Mimosae tenuiflorae bark using GC/MS ↗ | Isabel O. Caamal-Herrera, David Muñoz‐Rodriguez, Tomás J. Madera‐Santana et al. | 2016 | | 2 |
| Ayahuasca intoxication ↗ | Dos Santos RG, Bouso JC, Hallak JEC | 2017 | Medicina clinica | 2 |
| Do Fishes Hallucinate Human Folks? ↗ | R. Dinesh, Sherry Abraham, Kathiresan K et al. | 2017 | Archive of Food and Nutritional Science | 2 |
| Longitudinal Examination of Learning and Memory in Rats Following Adolescent Exposure to 3,4-Methylenedioxymethamphetamine or 5-Methoxy-N,N-Diisopropyltryptamine ↗ | David M. Compton, Kerri L. Dietrich, Peniel Esquivel et al. | 2017 | Journal of Behavioral and Brain Science | 2 |
| Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine ↗ | Dakic V, Nascimento JM, Sartore RC et al. | 2017 | bioRxiv | 2 |
| Author Correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey ↗ | Lawn W, Hallak JE, Crippa JA et al. | 2018 | Scientific reports | 2 |
| Detection of Diagnostic Plant-Derived Psychoactive Biomarkers in Fingerprints by MALDI-SpiralTOF-Mass Spectrometry Imaging ↗ | Longo CM, Musah RA | 2018 | Methods in molecular biology (Clifton, N.J.) | 2 |
| Use of Coconut Charcoal and Menthone-Thiosemicarbazone Polymer as Solid Phase Materials for the Determination of N,N-Dimethyltryptamine, Harmine, Harmaline, Harmalol, and Tetrahydroharmine in Ayahuasca Beverage by Liquid Chromatography-Tandem Mass Spectrometry ↗ | Sandro Navickiene, Luı́s M. N. B. F. Santos, Mônica C. Santos et al. | 2018 | Journal of the Brazilian Chemical Society | 2 |
| Co-existence of Quorum Sensing and Quorum Sensing Inhibitory Compounds in Marine Sponge <em>Sarcotragus spinosulus</em> ↗ | Saurav K, Borbone N, Burgsdorf I et al. | 2019 | Preprints.org | 2 |
| The Protective Role of Dimethyltryptamine against Ischemia-Reperfusion Injury ↗ | Ede Frecska, A. Kovács, Attila J. Szabó | 2019 | | 2 |
| Cada jurema é uma jurema: Continuidade, rupturas e inovações em religiosidades no Brasil ↗ | Robson Savoldi, Rodrigo de Azeredo Grünewald | 2020 | Revista del CESLA International Latin American Studies Review | 2 |
| The 'enigma' of Richard Schultes, Amazonian hallucinogenic plants, and the limits of ethnobotany ↗ | Sheldrake M | 2020 | Social studies of science | 2 |
| 5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological Disorders ↗ | Kargbo RB | 2021 | ACS medicinal chemistry letters | 2 |
| Ayahuasca: What Healthcare Providers Need to Know ↗ | Goldin D, Salani D | 2021 | Journal of addictions nursing | 2 |
| Psychedelics: A new era of treatment? ↗ | S. Torres | 2021 | European Psychiatry | 2 |
| Rapid quantification of Psilocybin with reversed-phase HPLC and single-wavelength detection ↗ | Alexzander Samuelsson, Eric Janusson, Sajni Shah et al. | 2021 | ChemRxiv | 2 |
| A long trip into the universe: Psychedelics and space travel ↗ | Leonard Lerer, Jeet Varia | 2022 | Frontiers in Space Technologies | 2 |
| Behavioral characterization of ayahuasca treatment on Wistar rats in the open field test ↗ | Cid Pinheiro Farias, Paula Pólvora Victoria, Janaína Xavier et al. | 2022 | Brazilian Journal of Pharmaceutical Sciences | 2 |
| First DNA barcode efficiency assessment for an important ingredient in the Amazonian ayahuasca tea: mariri/jagube, Banisteriopsis (Malpighiaceae) ↗ | Luz TZ, Cunha-Machado AS, Batista JSdS | 2022 | Research Square | 2 |
| Sipping the virtual elixir: An autoethnographic close reading of Ayahuasca Kosmik Journey, a self-transcendent virtual experience ↗ | Noah Miller, John Desnoyers-Stewart, Ekaterina R. Stepanova et al. | 2022 | Virtual Creativity | 2 |
| Use of psychedelics in the Czech Republic: results of recent population surveys ↗ | Chomynová P, Kočárová R, Kňažek F et al. | 2022 | Central European journal of public health | 2 |
| All-natural 5-MeO-DMT sigma receptor 1 agonist and its therapeutic impact in mental and neurodegener-ative diseases through mitochondrial activation ↗ | Milena Batalla | 2023 | Science Reviews Biology | 2 |
| Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies ↗ | Kulikowska J, Czarnowska A, Gudowska-Sawczuk M et al. | 2023 | Neurologia i neurochirurgia polska | 2 |
| Breaking bad buttons: mescaline biosynthesis in peyote ↗ | Gwendolyn K. Kirschner | 2023 | The Plant Journal | 2 |
| Diet and chemical defenses of the Sonoran Desert toads ↗ | Marina D. Luccioni, Jules T. Wyman, Edgard O. Espinoza et al. | 2023 | bioRxiv (Cold Spring Harbor Laboratory) | 2 |
| Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis ↗ | Breu M, Lechner C, Schneider L et al. | 2023 | Pediatric neurology | 2 |
| Intersecting Cultures ↗ | Emma Garrod, Katrina Blommaert | 2023 | | 2 |
| Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants ↗ | Kalirajan R, Rishabh K, Srikanth J et al. | 2023 | Archives of Razi Institute | 2 |
| Neuromodulatory mechanisms of N,N-dimethyltryptamine ↗ | Javier Hidalgo Jiménez | 2023 | Brain Network and Modulation | 2 |
| Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework ↗ | Eckernäs E, Koomen J, Timmermann C et al. | 2023 | CPT: pharmacometrics & systems pharmacology | 2 |
| Position of the Ceremony with the Psychedelic Drink Ayahuasca in the Society of the Amero-Indians of the Amazon ↗ | Matea Stiperski Matoc, Zoran Stiperski, Tomica Hruška | 2023 | IntechOpen eBooks | 2 |
| Psychedelics and cognitive function: A systematic review ↗ | Caíque Gois Cardoso, Milena de Barros Viana | 2023 | Research Society and Development | 2 |
| The potential of keratinized matrices for the retrospective exploration of repeated ayahuasca use by patients ↗ | Gish A, Hakim F, Richeval C et al. | 2023 | Clinical toxicology (Philadelphia, Pa.) | 2 |
| Uso ritual de alucinógenos y medicina psicodélica: Articulaciones alrededor del uso clínico de la ayahuasca en Brasil ↗ | Genís Oña | 2023 | Quaderns de l'Institut Català d'Antropologia | 2 |
| Ayahuasca drinking using a two-bottle choice procedure in male mice ↗ | Kisaki ND, Serra YA, Rodrigues IRS et al. | 2024 | Scientific reports | 2 |
| Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity ↗ | Vohryzek J, Garcia Guzman E, Kringelbach ML et al. | 2024 | bioRxiv | 2 |
| Comparative study of sample preparation procedures to determine the main compounds in ayahuasca beverages by QuEChERS and high-performance liquid chromatography analysis ↗ | Gonçalves J, Rosado T, Barroso M et al. | 2024 | Phytochemical analysis : PCA | 2 |
| Dimethyltryptamine (DMT) and ibogaine elicit membrane effects in HEK cells transiently transfected with the human 5-HT2A receptor ↗ | Jannik Nicklas Eliasen, Uffe Kristiansen, Kristi A. Kohlmeier | 2024 | Brain Research | 2 |
| Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users ↗ | david J, Berkovich-Ohana A, Dor-Ziderman Y | 2024 | PsyArXiv | 2 |
| Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models ↗ | Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey et al. | 2024 | arXiv (Cornell University) | 2 |
| Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine—A Systematic Review and Meta-Analysis ↗ | Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar | 2024 | Psychoactives | 2 |
| Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory ↗ | Vargas-Perez H, Minauro-Sanmiguel F, Ting-A-Kee R et al. | 2024 | Neuroscience letters | 2 |
| Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models ↗ | Almeida E Silva G, Galvão Wakui V, Kato L et al. | 2024 | Biochimica et biophysica acta. Biomembranes | 2 |
| Spectroscopic Identification of Isolated Bioactive Compounds from Methanolic Extract of Psychotria dalzellii leaves ↗ | Preeti N. Tallur, M Abhishek, Vinayak M Nayik et al. | 2024 | Oriental Journal Of Chemistry | 2 |
| Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies ↗ | Kullasate Sakpichaisakul, Kamornwan Katanyuwong, Utcharee Intusoma et al. | 2024 | BMJ Paediatrics Open | 2 |
| Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine ↗ | Holt AK, Rudy AK, Sawyer AN et al. | 2024 | Journal of psychoactive drugs | 2 |
| Suspension of Short‐lasting, Unilateral, Neuralgiform headache attacks with Conjunctival injection and Tearing <scp>(SUNCT)</scp> symptoms with ayahuasca and serotonergic psychedelics ↗ | Jonathan A. Leighton, Cyril Petignat, Brian E. McGeeney | 2024 | Headache The Journal of Head and Face Pain | 2 |
| The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits ↗ | Videira NB, Nair V, Paquet V et al. | 2024 | Journal of applied toxicology : JAT | 2 |
| The mitogenomic landscape of Banisteriopsis caapi (Malpighiaceae), the sacred liana used for ayahuasca preparation ↗ | Chavarro-Mesa E, Almeida JVDA, Silva SR et al. | 2024 | Genetics and molecular biology | 2 |
| The Potential Use of Dimethyltryptamine against Ischemia-reperfusion Injury of the Brain ↗ | Kovacs Attila, Anna Mathe, Ede Frecska | 2024 | Journal of Neuroscience and Neurological Disorders | 2 |
| 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial ↗ | Marsden J, Kelleher M, Dunbar F et al. | 2025 | Addiction (Abingdon, England) | 2 |
| A landscape analysis of psychedelic retreat organizations advertising online ↗ | Neitzke-Spruill L, Beit CS, Robinson JO et al. | 2025 | PloS one | 2 |
| A simple method for the determination of stimulant substances in postmortem blood: development, validation, and application in nearly 1000 forensic cases ↗ | Birk L, Dos Santos BP, Ossanes DS et al. | 2025 | Forensic toxicology | 2 |
| A systematic review of psychedelic use and its relationship with meaning and purpose in life ↗ | Przemysław Rupiński, Weronika Drabek, Paweł Holas | 2025 | Journal of Psychedelic Studies | 2 |
| Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes ↗ | Hooper JF, Gyongyosi EL, Hutchison KE et al. | 2025 | Frontiers in psychology | 2 |
| Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review ↗ | Wong S, Jones BDM, Thiyagarajah MT et al. | 2025 | Therapeutic advances in psychopharmacology | 2 |
| Blunted psychedelic drug effects in older adults ↗ | Aday JS, Carhart-Harris R, Boehnke KF | 2025 | PsyArXiv | 2 |
| Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials ↗ | Dominiak M, Gędek A, Modrzejewski S et al. | 2025 | Journal of clinical medicine | 2 |
| Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users ↗ | David J, Berkovich-Ohana A, Dor-Ziderman Y | 2025 | Psychopharmacology | 2 |
| Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects ↗ | Aicher HD, Wicki IA, Meling D et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 2 |
| Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine ↗ | Camila Moreno Lopes de Andrade, Beatriz Aparecida Passos Bismara Paranhos, Fabiana Pereira Santos et al. | 2025 | Plant Cell Tissue and Organ Culture (PCTOC) | 2 |
| Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT ↗ | Reckweg JT, Mason NL, Theunissen EL et al. | 2025 | Frontiers in psychology | 2 |
| Expressive resource in a clinical psychedelic study: Art as an integration tool ↗ | Barros H, Falchi-Carvalho M, Maia LO et al. | 2025 | Progress in brain research | 2 |
| Intoxication Associated with Ayahuasca Consumption, Characterization, and Comparative Analysis of the Beverage's Components: A Case Report ↗ | Estrella-Parra EA, Avila-Acevedo JG, García-Bores AM et al. | 2025 | Revista Colombiana de psiquiatria | 2 |
| Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy ↗ | Jarne-Ferrer J, Pallàs M, Griñán-Ferré C et al. | 2025 | Cells | 2 |
| Is there a place for psychedelics in sports practice? ↗ | Portes MAM, Werle I, Bertoglio LJ | 2025 | Acta neuropsychiatrica | 2 |
| N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences ↗ | Vohryzek J, Luppi AI, Atasoy S et al. | 2025 | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2 |
| Natural language analysis of the structure of altered states of consciousness ↗ | Daria Dikovskaya, Bhargav Srinivasa Desikan, Joel Frohlich et al. | 2025 | Journal of Psychedelic Studies | 2 |
| Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey ↗ | Rodan SC, Meez N, Lloyd-Hurwitz S et al. | 2025 | Journal of eating disorders | 2 |
| Psychedelics and substance use disorder treatment ↗ | DuPont CM, Johnson MW | 2025 | International review of neurobiology | 2 |
| Psychedelics and the Serotonin Hypothesis of Eating Disorders ↗ | Bilenker D, Avena NM | 2025 | Brain sciences | 2 |
| Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action ↗ | Miller EA, Capone C, Eaton E et al. | 2025 | CNS drugs | 2 |
| Seasonal Effect on the Chemical Composition of Mimosa tenuiflora (Willd.) Poir Stem Bark from the Semi-Arid Region of Pernambuco, Brazil ↗ | de Souza NAC, Sá PGS, Araújo TCL et al. | 2025 | Chemistry & biodiversity | 2 |
| Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis ↗ | Reiche S, Hirschfeld T, Gröticke AL et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 2 |
| The protective effect of DMT against neurodegeneration ↗ | Frecska E, Kovács A, Szabo A | 2025 | International review of neurobiology | 2 |
| The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health ↗ | Du X, Liu J, Wang X et al. | 2025 | Molecular psychiatry | 2 |
| WITHDRAWN ↗ | Elias M. Hart | 2025 | | 2 |
| A novel psychedelic 5-HT<sub>2A</sub> receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer ↗ | Marek GJ, Makai-Bölöni S, Umbricht D et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 2 |
| Classifying Psychedelic-Related Complications ↗ | Majić T, Gouzoulis-Mayfrank E, Evens R | 2026 | Current topics in behavioral neurosciences | 2 |
| Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants ↗ | Berman P, Höfer J, Mehlman H et al. | 2026 | Science advances | 2 |
| Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature ↗ | Kase M, Kaup KK, Aru J | 2026 | Journal of psychopharmacology (Oxford, England) | 2 |
| Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model ↗ | Lima da Cruz RV, Costa RBGM, de Queiroz GM et al. | 2026 | Translational psychiatry | 2 |
| Variation in Indolealkylamine Content of Individual <i>Phalaris aquatica</i> L. Plants<sup>1</sup> ↗ | V. V. Rendig, R. M. Welch, E. A. McComb | 1970 | Crop Science | 1 |
| Relationship of Indole Alkaloids to Palatability of Phalaris arundinacea L ↗ | Simons AB, Marten GC | 1971 | Agronomy Journal. | 1 |
| Effects of N,N-dimethyltryptamine on intracranial self-stimulation in the rat ↗ | Rosen AJ, Kubos KL | 1973 | Life sciences. Pt. 1: Physiology and pharmacology | 1 |
| N,N-dimethyltryptamine like substance in rat brain ↗ | Heller B, Fischer E, Spats H | 1973 | Life sciences | 1 |
| Oxygenation of Tryptamine and Tryptophan Derivatives ↗ | Masako Nakagawa, Takao Kaneko, Kensei Yoshikawa et al. | 1974 | Heterocycles | 1 |
| [N,N-dimethyltryptamine: first comparative results. Preliminary communication] ↗ | Arnold OH | 1975 | Arzneimittel-Forschung | 1 |
| Palatability of Leaves of Tall Fescue and Reed Canarygrass and of Some of Their Alkaloids to Meadow Voles ↗ | Kendall WA, Sherwood RT | 1975 | Agronomy Journal. | 1 |
| ChemInform Abstract: OXIDATIVE CYCLIZATION OF NB‐DIMETHYLTRYPTAMINE, 3‐INDOLEPROPANOL, AND 3‐INDOLEPROPANETHIOL WTH N‐BROMO‐ OR N‐CHLOROSUCCINIMIDE ↗ | Tohru Hino, Hidetoshi Miura, Tõru Nakamura et al. | 1976 | Chemischer Informationsdienst | 1 |
| Primitive group treatment ↗ | Lemlij M | 1978 | Psychiatria clinica | 1 |
| [Gas chromatography-mass spectrometry in the study of illegal mescaline/dimethyltryptamine--laboratory findings] ↗ | Gielsdorf W, Schubert K, Allin K | 1980 | Archiv fur Kriminologie | 1 |
| ↗ | Takao Shimizu | 1981 | Folia Pharmacologica Japonica | 1 |
| EFFECTS OF VARIOUS SEROTONERGIC AGONISTS AND AN ANTAGONIST ON A NOCICEPTIVE REACTION IN MICE ↗ | K. Ramabadran, Joseph Jacob | 1982 | The Japanese Journal of Pharmacology | 1 |
| Separation and Characterization of Amine Drugs and Their Enantiomers by Capillary Column Gas Chromatography-Mass Spectrometry ↗ | Ray H. Liu, Warren W. Ku, Mary P. FitzGerald | 1983 | Journal of AOAC INTERNATIONAL | 1 |
| The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads ↗ | Heinze WJ, Schlemmer RF Jr, Tyler CB et al. | 1983 | Biological psychiatry | 1 |
| In vivo increase in hypothalamic cyclic AMP following 5-hydroxytryptophan administration in rats ↗ | Bundman MC, Browning RA | 1984 | Naunyn-Schmiedeberg's archives of pharmacology | 1 |
| Ascorbic acid antagonizes the behavioural effects of LSD in cats ↗ | Trulson ME, Crisp T, Henderson LJ | 1985 | The Journal of pharmacy and pharmacology | 1 |
| Chronic phenytoin and the stereotyped motor response induced by 5-methoxy-N,N-dimethyltryptamine in rats ↗ | Lalonde R, Botez MI | 1985 | Brain research | 1 |
| Evidence for 5-HT1A binding sites in chick embryo brain and discrimination by 5-methoxytryptamine ↗ | Soblosky JS, Dills C, DuMontier G et al. | 1987 | Biochemistry international | 1 |
| m-trifluoromethylphenylpiperazine and m-chlorophenylpiperazine-induced hypothermia in mice is reversed by tricyclic antidepressants and other drugs ↗ | Volterra G, Cutrufo C, Lecci A | 1991 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 1 |
| [Elimination of N,N-dimethyltryptamine by urine] ↗ | Spatz N, Spatz H, Mesones Arroyo HL et al. | 1993 | Acta psiquiatrica y psicologica de America latina | 1 |
| Potentiation of 5‐methoxy‐n,n‐dimethyltryptamine‐induced head‐twitches by diazepam: Evidence for involvement of adenosine uptake inhibition ↗ | Paul Moser | 1993 | Drug Development Research | 1 |
| ChemInform Abstract: Improved Fischer Indole Reaction for the Preparation of N,N‐ Dimethyltryptamines: Synthesis of L‐695,894, a Potent 5‐HT1D Receptor Agonist ↗ | C. CHEN, Chris H. Senanayake, Timothy J. Bill et al. | 1994 | ChemInform | 1 |
| Synthesis and pharmacological evaluation of fluorinated hallucinogenic tryptamine analogs and thienopyrrole bioisosteres of {\it N,N/}-dimethyltryptamine ↗ | Joseph B. Blair | 1997 | | 1 |
| Cyst nematode-induced changes in plant development ↗ | Aska Goverse | 1999 | | 1 |
| Subject Index Vol. 50, 2004 ↗ | Nikolas Coupland, Tai-Jui Chen, Terence O'Donnell et al. | 2004 | Neuropsychobiology | 1 |
| Hallucinogens ↗ | David L. Eldridge, Karin Hillenbrand | 2006 | Pediatrics in Review | 1 |
| Dietilamida do ácido lisérgico (LSD) e N,N-dimetiltriptamina (DMT) como substratos de peroxidases: uma possível rota de metabolização ↗ | Melissa Medrano Gomes | 2008 | | 1 |
| ChemInform Abstract: Tungstate‐Catalyzed Oxidation of Triptans with Hydrogen Peroxide: A Novel Method for the Synthesis of N,N‐Dimethyltryptamine N‐Oxides ↗ | Purna Chandra Ray, Vasantha Mittapelli, Yogendra Kumar Chauhan et al. | 2009 | ChemInform | 1 |
| Dimethyltryptamine (DMT) a Psychedelic ↗ | Enno Freye | 2009 | | 1 |
| Tungstate-catalyzed oxidation of triptans with hydrogen peroxide: A novel method for the synthesis of N,N- dimethyltryptamine N-oxides ↗ | Purna Chandra Ray, Vasantha Mittapelli, Yogendra Kumar Chauhan et al. | 2009 | | 1 |
| Clandestine Operations: Synthetic Methods, Hazards, and Safety ↗ | Javed Khan, Thomas J. Kennedy, Donnell R. Christian | 2011 | Humana Press eBooks | 1 |
| Enteógenos e Inteligência Existencial: Plantas Mestres como Instrumentos Cognitivos ↗ | Kenneth W. Tupper | 2011 | Periferia | 1 |
| The yagé aesthetic of William Burroughs: the publication and development of his work 1953-1965 ↗ | Joanna Harrop | 2011 | OpenGrey (Institut de l'Information Scientifique et Technique) | 1 |
| Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N-dimethyltryptamines ↗ | Ethan H. McIlhenny | 2012 | | 1 |
| Richard Burnard Rodnight, 1921–2012 ↗ | Peter R. Dunkley | 2012 | Journal of Neurochemistry | 1 |
| I Like The Old Stuff Better Than The New Stuff? Subjective Experiences Of Emerging Psychoactive Substances ↗ | Allison Matthews, Raimondo Bruno, Lucy Burns | 2013 | eCite Digital Repository (University of Tasmania) | 1 |
| Secondary Metabolites from Brazilian Biodiversity, Source of Structural Beauty and Complexity Tracing New Models for Medicinal Chemistry ↗ | VS Bolzani | 2013 | Planta Medica | 1 |
| Effect of peptides corresponding to extracellular domains of serotonin 1B/1D receptors and melanocortin 3 and 4 receptors on hormonal regulation of adenylate cyclase in rat brain ↗ | Shpakova EA, Derkach KV, Shpakov AO | 2014 | Bulletin of experimental biology and medicine | 1 |
| Psychedelics, Glutamate, and Neuroimaging Studies ↗ | Rafael G. dos Santos | 2014 | Anesthesiology | 1 |
| Ayahuasca: farmacología, efectos agudos, potencial terapéutico y rituales ↗ | Marta Aliño, Marién Gadea, Joana Pérez San Miguel et al. | 2015 | Repository of Digital Objects for Teaching Research and Culture (University of Valencia) | 1 |
| Cation-π interaction of N,N-Dimethyltryptamine in hydrochloric acid solution characteristic to gastric acid ↗ | Andrej Vidak, Iva Movre Šapić, Vladimir Dananić | 2015 | Integrative Molecular Medicine | 1 |
| MUSIC, TRANCE, AND TRANSMISSION IN THE SANTO DAIME, A BRAZILIAN AYAHUASCA RELIGION ↗ | Benjamin Nye Blocksom | 2015 | University Libraries (University of Maryland) | 1 |
| Ayahuasca in the English courts: legal entanglements with the jungle vine ↗ | CHARLOTTE WALSH | 2016 | | 1 |
| Basics of the medical use of ayahuasca: physiology of dimethyltryptamine ↗ | Ede F, Attila, Attila S et al. | 2016 | Lege artis medicinae : uj magyar orvosi hirmondo | 1 |
| Desenvolvimento de método para determinação de alcaloides indólicos em amostras de ayahuasca ↗ | Mônica C. Santos | 2016 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 1 |
| Sintomatologia psicótica e ayahuasca: relato de caso ↗ | Thaísa Silva Gios, Maria Carolina Pedalino Pinheiro, Elie Leal de Barros Calfat | 2016 | Debates em Psiquiatria | 1 |
| Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User ↗ | Ahmed Al-Imam | 2017 | Global Journal of Health Science | 1 |
| Jeremy Shaw's <i>DMT</i> ↗ | Jennifer Fisher | 2017 | Performance Research | 1 |
| Tempo subjetivo de participantes com estados alterados da consciência em função de uso da bebida Ayahuasca em rituais xamânicos envolvendo música ↗ | Ana Paula Silva Campagnoli | 2018 | | 1 |
| Terapia asistida por plantas para el tratamiento de los trastornos por uso de sustancias - parte 1. El caso del centro takiwasi y otras experiencias similares ↗ | Matteo Politi, Fabio Friso, Jacques Mabit | 2018 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 1 |
| 06 - CASE-REPORT OF A ‘TEA CEREMONY’ WITH AYAHUASCA: AN EMOTIONAL ROLLERCOASTER ↗ | Matheus Arts, Linda de Jonge, S. Petrykiv | 2019 | | 1 |
| Amphibious anti-depressants and other wonders ↗ | Elias Dakwar | 2019 | The American Journal of Drug and Alcohol Abuse | 1 |
| [Ayahuasca-induced psychosis in a patient with bipolar disorder] ↗ | Zellner N, Zellner T, Warninghoff J | 2019 | Der Nervenarzt | 1 |
| Ayahuasca no tratamento da farmacodependência à cocaína: possíveis intervenções terapêuticas? ↗ | Vítor Bruno | 2019 | | 1 |
| Ayahuasca: perigos inerentes ao seu consumo ↗ | Raquel Cônsul Lourenço | 2019 | Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) | 1 |
| Psi and the 'spirit molecule' DMT ↗ | David Luke | 2019 | Greenwich Academic Literature Archive (University of Greenwich) | 1 |
| A Systematic Literature Review of the Potential Therapeutic Effects of Ayahuasca Tea Prepared From the Use of Banisteriopsis Caapi and Psychotria Viridis ↗ | Adriane Cordeiro Trevisani, João Pedro Cordeiro Trevisani, Moacir Haverroth et al. | 2020 | Journal of Agricultural Studies | 1 |
| [Ayahuasca - religion, life-style or drug?] ↗ | Neu P | 2020 | Fortschritte der Neurologie-Psychiatrie | 1 |
| Ayahuasca’s Religious Diaspora in the Wake of the Doctrine of Discovery ↗ | Roger K. Green | 2020 | Digital Commons - DU (University of Denver) | 1 |
| Intrinsic Motivations and Perceived Benefits of U.S. Males for Taking Dimethyltryptamine ↗ | Timothy Raymond Kazmarek | 2020 | ScholarWorks (Walden University) | 1 |
| Novel harmala-ocudelic tuning (HOT) for ocular disorders ↗ | Lansky ES | 2020 | Medical hypotheses | 1 |
| O USO RITUALISTÍCO E FARMACOLÓGICO DA AYAHUASCA: UMA REVISÃO DE LITERATURA ↗ | Cicero Jerfesson Ferreira Silva, Pedro Walisson Gomes Feitosa, Alyne Oliveira Correia | 2020 | Revista Interfaces Saúde Humanas e Tecnologia | 1 |
| Religion, Place, and Identity at the Intersection of Cultural Bricolage: The Miami Santo Daime Church Revisited ↗ | Alfonso Matas | 2020 | | 1 |
| An Encounter with the Other: A Thematic Analysis of Accounts of DMT Experiences from a Naturalistic Field Study ↗ | Michael P, Luke D, Robinson O | 2021 | PsyArXiv | 1 |
| Assessment of environmental condition and drying process of the plants on the concentration of alkaloids and cytotoxicity of traditional Ayahuasca Tea ↗ | Miranda Ordilena Ferreira de, Almeida Marcílio de, Sousa Ilza Maria de Oliveira et al. | 2021 | World Journal of Advanced Research and Reviews | 1 |
| Ayahuasca experiences for sale on the internet-systematic analysis of health information provided to travellers in commercial websites ↗ | Fu CA, Morales ML, Cabada MM | 2021 | Journal of travel medicine | 1 |
| [Chemical submission by "ayahuasca"] ↗ | Fernández Alonso C, Megía Morales C, Santiago Sáez AE | 2021 | Medicina clinica | 1 |
| Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats ↗ | Colaço CS, Alves SS, Nolli LM et al. | 2021 | Metabolic brain disease | 1 |
| [Identification of New Psychoactive Tryptamines 4-OH-MET and 4-AcO-DMT Using High Resolution Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy] ↗ | Ding KR, Ni CF, He SY et al. | 2021 | Fa yi xue za zhi | 1 |
| Measurement of Hemodynamic Parameters and Antidepressant Activityin Hypertensive Rats Following Two Weeks Consumption of <i>Acacia Tortilis</i>Leaves Extract ↗ | Abdulhalim S. Serafi, Aisha Azmat, Muhammad Ahmed et al. | 2021 | The Natural Products Journal | 1 |
| Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT) ↗ | Diab H, Malcolm B | 2021 | Journal of psychoactive drugs | 1 |
| Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA Sequencing ↗ | Kelley DP, Venable K, Billac G et al. | 2021 | Research Square | 1 |
| Proteomic changes induced by harmine in human brain organoids reveal signaling pathways related to neuroprotection ↗ | Karmirian K, Goto-Silva L, Nascimento JM et al. | 2021 | bioRxiv | 1 |
| Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020) ↗ | Dos Santos RG, Araujo DB, Sanches RF et al. | 2021 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 1 |
| 5-MeO-DMT has not been found in traditional ayahuasca preparations and the combination of 5-MeO-DMT with MAOIs is dangerous ↗ | Lancelotta R | 2022 | Human psychopharmacology | 1 |
| A phase 1/2 trial of a vaporized 5-Methoxy-N,N-Dimethyltryptamine formulation, in patients with treatment-resistant depression ↗ | Johannes T. Reckweg, Cees van Leeuwen, Cécile Henquet et al. | 2022 | Neuroscience Applied | 1 |
| Ayahuasca Lyophilization (Freeze-drying) Protocol with Pre- and Post-procedure Alkaloids Quantification ↗ | Daldegan-Bueno D, Favaro VM, Tófoli LF et al. | 2022 | Journal of psychoactive drugs | 1 |
| Chemical composition of Ayahuasca seized in Poland ↗ | Bogumiła Byrska, Karolina Masier, Roman Stanaszek | 2022 | Annales de Toxicologie Analytique | 1 |
| Correction to: Administration of N,N‑dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT ↗ | Barker SA | 2022 | Psychopharmacology | 1 |
| Frontispiece: Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT<sub>2A</sub> Receptor by a Light‐Controllable <i>N</i>,<i>N</i>‐Dimethyltryptamine Derivative ↗ | Hubert Gerwe, Feng He, Eline Pottie et al. | 2022 | Angewandte Chemie International Edition | 1 |
| Herbal Resources in the medication of depression during pandemic COVID-19 ↗ | Izabela Bolesławska, Natasza Bolesławska-Król, Klaudia Kowalska et al. | 2022 | Acta Poloniae Pharmaceutica - Drug Research | 1 |
| Neuropsychological effect on long-term Ayahuasca use ↗ | Tiffany D Tucker | 2022 | Digital Archive @ GSU | 1 |
| Participation in an indigenous Amazonian led ayahuasca retreat associated with increases in nature relatedness – a pilot study ↗ | Ruffell S, Gandy S, Tsang W et al. | 2022 | PsyArXiv | 1 |
| Psychotherapeutic and neurobiological processes associated with ayahuasca’s mental health and wellbeing outcomes: a proposed model and implications for therapeutic use ↗ | Daniel Perkins, Simon Ruffell, Kimberley Day et al. | 2022 | | 1 |
| Receptor binding profiles and behavioral effects of psilocybin analogs ↗ | Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne et al. | 2022 | The FASEB Journal | 1 |
| Rumors of Psychedelics, Psychotropics and Related Derivatives in <i>Vachellia</i> and <i>Senegalia</i> in Contrast with Verified Records in Australian <i>Acacia</i> ↗ | Sadgrove NJ | 2022 | Plants (Basel, Switzerland) | 1 |
| The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review ↗ | Abdul Wahab Alahmari | 2022 | Brain and Neurological Disorders | 1 |
| Virtual Daime: When Psychedelic Ritual Migrates Online ↗ | Hartogsohn I | 2022 | Frontiers in psychology | 1 |
| 105. Intranasal 5-MeO-DMT: Safety, PK and Effect on Altered States of Consciousness in Healthy Volunteers ↗ | James Rucker, Mathieu Seynaeve, Allan H. Young et al. | 2023 | Biological Psychiatry | 1 |
| Analyse de flacons d’ayahuasca séculaires : détermination de la composition des substances actives après cent ans de conservation ↗ | Nadia Arbouche, Aymon De Lestrange, Romain Hacquet et al. | 2023 | Annales de Toxicologie Analytique | 1 |
| Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study ↗ | Jin H, Geiger C, Jessop N et al. | 2023 | Multiple sclerosis and related disorders | 1 |
| Ayahuasca and Freedom of Religion in Australia ↗ | Amar Dhall, Torsten Wiedemann, Manav Satija | 2023 | | 1 |
| Ayahuasca in the treatment of bipolar disorder with psychotic features–A retrospective case study ↗ | Turkia M | 2023 | PsyArXiv | 1 |
| Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay ↗ | Apud I, Scuro J, Rodríguez L et al. | 2023 | Journal of psychoactive drugs | 1 |
| Case report of a fatal 3-hydroxyphencyclidine intoxication, including blood and hair results ↗ | Ameline A, Baudry M, Garnier D et al. | 2023 | Journal of analytical toxicology | 1 |
| Characterization of the Binding Poses of Classical and Photoswitchable Psychedelics Interacting with 5-HT2AR ↗ | Vito F. Palmisano, Claudio Agnorelli, David Erritzøe et al. | 2023 | ChemRxiv | 1 |
| CHEMISTRY OF AYAHUASCA: A DIDACTIC APPROACH TO TEACH FUNCTIONAL GROUPS ↗ | Mateus Miranda, Lucas Soares de Jesus | 2023 | Editora Científica Digital eBooks | 1 |
| Direct C3-functionalization of indoles with alpha-heteroaryl-substituted methyl alcohols via a metal-free hydrogen autotransfer-type reaction ↗ | Ethan J. Pazur, Nikhil R. Tasker, Peter Wipf | 2023 | ChemRxiv | 1 |
| Editorial: Old and new psychoactive substances: Pharmacology and potential applications ↗ | Felix P. Mayer, Dino Luethi, Lorena B. Areal et al. | 2023 | Frontiers in Psychiatry | 1 |
| Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study ↗ | Aday J, Bloesch E, Davis AK et al. | 2023 | PsyArXiv | 1 |
| Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine ↗ | Sushmit JAHAN | 2023 | International Advanced Researches and Engineering Journal | 1 |
| Moving beyond a figurative psychedelic literacy: Metaphors of psychiatric symptoms in ayahuasca narratives ↗ | Gearin AK | 2023 | Social science & medicine (1982) | 1 |
| Os benefícios do uso da ayahuasca como ferramenta alternativa ao tratamento convencional da depressão: uma revisão de literatura ↗ | Bruna Letícia Martins, Emanuele Da Silva Leite, Raquel Ellen Vicente Salomé et al. | 2023 | Revista Científica do UBM | 1 |
| Safety, pharmacokinetics and pharmacodynamics of n,n-dimethyltryptamine administered as intravenous infusion in healthy smokers ↗ | K. Van Der Heijden, S. Makai Boloni, Rob Zuiker et al. | 2023 | Neuroscience Applied | 1 |
| THE AYAHUASCA’S PSYCHEDELIC COMPONENT DMT POTENTIATES NEURITOGENESIS IN PC12 CELLS ↗ | Mariana Pazos, Ignacio Carrera, Giselle Prunell | 2023 | IBRO Neuroscience Reports | 1 |
| The DEA report on ayahuasca risks: “Science” in service of prohibition? ↗ | Beatriz Caiuby Labate, Anna O. Ermakova, Jordan Sloshower et al. | 2023 | Journal of Psychedelic Studies | 1 |
| Unique biological and physiological properties of endogenous N, N-dimethyltryptamine from the perspective of functioning of the nervous system ↗ | J. Schimmelpfennig, Kamila Jankowiak-Siuda | 2023 | Neuropsychiatria i Neuropsychologia | 1 |
| Vizionáriusok vs. szakértők ↗ | Orsolya Bajusz | 2023 | Kultúra és Közösség | 1 |
| A Fully Validated LC-MS Quantitation Method for Psychoactive Compounds Found in Native South American Plant Species ↗ | Jonathan Tran, Aaron Elkins, Simone Vassiliadis et al. | 2024 | Psychoactives | 1 |
| Comparative analysis of retrosynthesis applications for predicting of pathways for plant Secondary metabolite production ↗ | Nilay Yönet, Selcen Arı Yuka, Musa Türker et al. | 2024 | Biotechnology & Biotechnological Equipment | 1 |
| Detection of Psychoactive N,N-Dimethyltryptamine Alkaloid Based on Surface‑Enhanced Raman Scattering Using Gold Nanostars in Flexible Inkjet‑Printing Paper Substrates ↗ | Edison Huertas-Montoya, Anerise de Barros, Lucas Oliveira et al. | 2024 | Journal of the Brazilian Chemical Society | 1 |
| Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services ↗ | Baker MR, O'Shea CI | 2024 | BMJ case reports | 1 |
| Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease‐Related Dementia ↗ | Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh et al. | 2024 | Alzheimer s & Dementia | 1 |
| Hair analysis to document ayahuasca consumption by LC-MS/MS ↗ | Nadia Arbouche, Jean‐Sébastien Raul, Pascal Kintz | 2024 | Microchemical Journal | 1 |
| Large-scale prediction of biological activities with Active-IT system ↗ | Almeida VL, Dos Santos ODH, Lopes JCD | 2024 | Biomeditsinskaia khimiia | 1 |
| Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral Sclerosis. ↗ | Yu, Mucen, Xu, Jielin, Dutta, Ranjan et al. | 2024 | bioRxiv : the preprint server for biology | 1 |
| Psychedelic-assisted grief therapy: a mixed-method case study ↗ | Pablo Sabucedo, Chris Evans, Donald W. Nicholson et al. | 2024 | Mortality | 1 |
| Psychedelic drugs and the law: What’s next? ↗ | Ben Seal | 2024 | Knowable Magazine | 1 |
| Purging to Cleanse: A Qualitative Study of Ayahuasca Healing at a Drug Treatment Center in Peru ↗ | Lustig Vijay S, Harris M, Friso F et al. | 2024 | Journal of studies on alcohol and drugs | 1 |
| Rapid antidepressant effect of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in treatment-resistant patients: a phase 2a open label study ↗ | Claire Roberts, Mathieu Seynaeve, Anna O. Ermakova et al. | 2024 | Neuroscience Applied | 1 |
| Síndrome serotoninérgico inducido por ayahuasca: a propósito de un caso ↗ | Laura Ortega M., Laura Herrera D., Patricia Caro U. et al. | 2024 | Revista chilena de neuro-psiquiatría | 1 |
| Solvent-free parallel artificial liquid membrane extraction for drugs of abuse in plasma samples using LC-MS/MS ↗ | Fabris AL, Pedersen-Bjergaard S, Øiestad EL et al. | 2024 | Analytica chimica acta | 1 |
| Synthesis of Iso-Dimethyltryptamines and Biological Analysis in a Model of Light-Induced Retinal Degeneration ↗ | Ethan J. Pazur, Anna Kalatanova, Nikhil R. Tasker et al. | 2024 | ChemRxiv | 1 |
| The identification of psychedelic compounds within Australian <i>Acacia</i> species ↗ | Luke O’Grady, X. A. Conlan, Lawrence Webb | 2024 | Australian Journal of Forensic Sciences | 1 |
| Time-resolved neural and experience dynamics of medium- and high-dose DMT ↗ | Lewis-Healey E, Pallavicini C, Cavanna F et al. | 2024 | bioRxiv | 1 |
| Treatment-Related Fluctuation in Guillain-Barre Syndrome With the Acute Motor-Sensory Axonal Neuropathy (AMSAN) Variant: A Case Report ↗ | Hernandez E, Dominguez D, Medina-Rioja R et al. | 2024 | Cureus | 1 |
| 181. Rapid, Sustained and Meaningful Antidepressant Effect of Intranasal BPL-003 (5-Methoxy-N,N-Dimethyltryptamine) in Treatment-Resistant Patients ↗ | Fiona Dunbar, Mathieu Seynaeve, Anna O. Ermakova et al. | 2025 | Biological Psychiatry | 1 |
| A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life ↗ | Kratina S, Strike C, Schwartz R et al. | 2025 | PloS one | 1 |
| A survey of tryptamines in southern African Senegalia and Vachellia reveals N,N-dimethyltryptamine in Senegalia ataxacantha ↗ | Nicholas J. Sadgrove, B.-E. Van Wyk | 2025 | Biochemical Systematics and Ecology | 1 |
| A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction ↗ | Glenn DL, Choi SH, Zimmerman RS | 2025 | Journal of psychopharmacology (Oxford, England) | 1 |
| Banisteriopsis caapi extract: Implications for neuroinflammatory pathways in Locus coeruleus lesion rodent model ↗ | Graça SC, Bustelli IB, Santos ÉVD et al. | 2025 | Journal of ethnopharmacology | 1 |
| Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community ↗ | Kruger DJ, Mersereau G, Sullivan A et al. | 2025 | Harm reduction journal | 1 |
| Clinical pharmacology ↗ | Vogt SB, Liechti ME | 2025 | International review of neurobiology | 1 |
| DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers ↗ | Bonomo YA, Norman AF, Collins L et al. | 2025 | Frontiers in psychiatry | 1 |
| Doped C<sub>20</sub> fullerenes as a new generation of efficient nanosorbents and nanosensors for rapid detection of dimethyltryptamine in drug detection ↗ | Alharby TN, Alanazi M, Alanazi J | 2025 | Scientific reports | 1 |
| Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium ↗ | Vella Y, Syrová K, Petrušková A et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 1 |
| Elevated Endogenous Psychedelic Bufotenine in the Urine of Patients Diagnosed With a Mental Illness: A Systematic Review ↗ | Clarke AJ | 2025 | Cureus | 1 |
| Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey ↗ | Romeo B, Kervadec E, Fauvel B et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 1 |
| Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study ↗ | Biba B, O'Shea BA | 2025 | Journal of psychoactive drugs | 1 |
| Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey ↗ | Sophie van der Helder, Krista J. Siefried, Liam Acheson et al. | 2025 | Journal of Psychedelic Studies | 1 |
| Extraction and Characterization of <i>N</i>,<i>N</i>‑Dimethyltryptamine from <i>Mimosa tenuiflora</i>: A Multivariate Approach ↗ | de Oliveira LC, Pereira Galdino T, Pedro MDS et al. | 2025 | ACS omega | 1 |
| Fatalities following DMT use: two case reports and a review of the literature ↗ | Pullen J, Moore R, Wood R et al. | 2025 | Journal of analytical toxicology | 1 |
| Fluorescent Spectrofluorimetric Method for the Quantification of Harmine in Human Plasma Using Tinopal CBS‐X ↗ | Hanan Khojah, Nasser M. Aldekhail, Randa M. Almudhyan et al. | 2025 | Luminescence | 1 |
| Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use ↗ | Jason K. Day, Michael Th. Grooff | 2025 | Contemporary Drug Problems | 1 |
| Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study ↗ | Egger K, Bozsak R, Aicher H et al. | 2025 | Research Square | 1 |
| Implications of Indolethylamine N-Methyltransferase (INMT) in Health and Disease: Biological Functions, Disease Associations, Inhibitors, and Analytical Approaches ↗ | Abouheif S, Awad A, McCurdy CR | 2025 | Brain sciences | 1 |
| Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats. ↗ | Kolbman, Nicholas, Huels, Emma R, Nelson, Amanda et al. | 2025 | bioRxiv : the preprint server for biology | 1 |
| Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat ↗ | Egger K, Meling D, Polat F et al. | 2025 | Imaging neuroscience (Cambridge, Mass.) | 1 |
| N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex ↗ | Niedernhuber M, Suay D, Mueller M et al. | 2025 | bioRxiv | 1 |
| On the Biosynthesis of Bioactive Tryptamines in Black Cohosh (<i>Actaea racemosa</i> L.) ↗ | Spiering MJ, Parsons JF, Eisenstein E | 2025 | Plants (Basel, Switzerland) | 1 |
| Optimized Parenteral and Intranasal Formulations of Tryptamine Psychedelics for Rapid-Acting Antidepressant Therapy ↗ | Kargbo RB | 2025 | ACS medicinal chemistry letters | 1 |
| Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders ↗ | Mehtani NJ, Mian MN, Agin-Liebes G et al. | 2025 | Journal of psychoactive drugs | 1 |
| Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity ↗ | Yang A, Lv X, Wang H et al. | 2025 | ACS chemical neuroscience | 1 |
| Rapid, open-source, and automated quantification of the head twitch response in C57BL/6J mice using DeepLabCut and Simple Behavioral Analysis ↗ | Alexander D. Maitland, Nicholas R. Gonzalez, Donna Walther et al. | 2025 | bioRxiv (Cold Spring Harbor Laboratory) | 1 |
| Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report ↗ | Kermanshah A, Stapleton M, Mauriello CM et al. | 2025 | Cureus | 1 |
| Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position ↗ | Brown R, Hamilton NM, Mallon C et al. | 2025 | Journal of labelled compounds & radiopharmaceuticals | 1 |
| The Analysis of Hallucinogenic Drugs from Plants and Fungi ↗ | Michael D. Cole, Lata Gautam, Agatha Grela | 2025 | | 1 |
| The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis ↗ | Li JR, Chiang KT, Kao YC et al. | 2025 | Journal of affective disorders | 1 |
| The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry ↗ | Mile Jevtić | 2025 | Engrami | 1 |
| The void and the brain ↗ | Koch C | 2025 | Cell reports | 1 |
| Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics ↗ | Dario Jalilzadeh Masah, Derin Marbin, Tomislav Majić | 2025 | SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice | 1 |
| Updates in the treatment of eating disorders in 2024: a year in review in <i>Eating Disorders: The Journal of Treatment & Prevention</i> ↗ | Tabuenca K, Crowe DE, Gillis AJ et al. | 2025 | Eating disorders | 1 |
| Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows ↗ | Vinarcsik L, Smoller C, Grossberg G | 2025 | Drugs & aging | 1 |
| 5-HT<sub>2A</sub> receptors in the prelimbic cortex VIP-expressing interneurons: A mechanism for psychedelic-induced innate fear attenuation ↗ | Wang Y, Yao Y, Su R et al. | 2026 | British journal of pharmacology | 1 |
| Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset ↗ | Perkins D, Sarris J, Cowley-Court T et al. | 2026 | Journal of psychoactive drugs | 1 |
| Ayahuasca enhances functional connectivity in the third visual pathway and mirror neuron networks: a crossover, multiple-dose functional MRI study ↗ | Soares C, Lima G, Teixeira M et al. | 2026 | Social cognitive and affective neuroscience | 1 |
| Beyond the toad's kiss: Mapping acute 5-MeO-DMT effects on brain connectivity across sex and dose using awake rat neuroimaging ↗ | Noah Cavallaro, Priya Rai, David Akins et al. | 2026 | Neuropharmacology | 1 |
| Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians ↗ | Boehnke KF, Pouyan N, Aday JS | 2026 | Drugs | 1 |
| Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases ↗ | Abrahms ZN, Majdi M, Madsen SM et al. | 2026 | Metabolic engineering | 1 |
| Hallucinogen use in the United States, 2021-2023: Diverging trends and subgroup patterns ↗ | Chen JJ, Berg CJ, Yang YT | 2026 | Drug and alcohol dependence reports | 1 |
| N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine ↗ | de Sousa-Silva AN, Moura CA, de Oliveira Torres CI et al. | 2026 | Neuropharmacology | 1 |
| Neurochemical and Neurophysiological Effects of Intravenous Administration of <i>N,N</i>-Dimethyltryptamine in Rats ↗ | Glynos NG, Huels ER, Groenhout T et al. | 2026 | The Journal of neuroscience : the official journal of the Society for Neuroscience | 1 |
| Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential ↗ | Puigseslloses P, Nadal-Gratacós N, Fumàs B et al. | 2026 | Molecular psychiatry | 1 |
| Pharmacodynamic effects and plasma pharmacokinetics of N, N-dimethyltryptamine after intranasal versus subcutaneous administration in male rats ↗ | Baumann MH, Glatfelter GC, Walton SE et al. | 2026 | Psychopharmacology | 1 |
| Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics ↗ | Higgins GA, MacMillan C, de Lannoy I et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 1 |
| Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling ↗ | Ribeiro GSG, Paranhos BAPB, Dörr F et al. | 2026 | Frontiers in molecular biosciences | 1 |
| Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey ↗ | Syed OA, Petranker R, Fewster EC et al. | 2026 | Journal of psychoactive drugs | 1 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians-5-Methoxy-N,N-Dimethyltryptamine ↗ | Tabaac BJ, Shinozuka K, Weisman A et al. | 2026 | American journal of therapeutics | 1 |
| Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data ↗ | Rached G, Campana A, Fiani D et al. | 2026 | CNS drugs | 1 |
| Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs ↗ | Jesse J. Norris | 2026 | Journal of Psychopharmacology | 1 |
| The efficacy of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) on anhedonia in patients with treatment resistant depression: a phase 2a open label study ↗ | C. Hindocha, S. McGuigan, M. Seynaeve et al. | 2026 | Neuroscience Applied | 1 |
| The impact of drug control on wider research: Psychedelic mushroom exploration ↗ | Sam Lasham, Rhys Ponton | 2026 | Drug Science Policy and Law | 1 |
| Vigilance state dissociation induced by 5-MeO-DMT in mice ↗ | Bréant BJB, Prius Mengual J, Andrews A et al. | 2026 | Communications biology | 1 |
| When I use a word . . . The psychedelic mind’s eye ↗ | J K Aronson | 2026 | BMJ | 1 |
| Some effects of lysergic acid diethylamide and bufotenine on electrical activity in the cat's visual system. ↗ | EVARTS, E V, LANDAU, W, FREYGANG, W et al. | 1955 | The American journal of physiology | |
| Intravenous bufotenine injection in the human being. ↗ | FABING, H D, HAWKINS, J R | 1956 | Science (New York, N.Y.) | |
| Some effects of bufotenine and lysergic acid diethylamide on the monkey. ↗ | EVARTS, E V | 1956 | A.M.A. archives of neurology and psychiatry | |
| Effects of LSD 25, BOL 148, bufotenine, mescaline and ibogaine on the potentiation of hexobarbital hypnosis produced by serotonin and reserpine. ↗ | SALMOIRAGHI, G C, PAGE, I H | 1957 | The Journal of pharmacology and experimental therapeutics | |
| [Effect of dimethyltryptamine (DMT) on the electroencephalogram of normal individuals] ↗ | KAJTOR F | 1958 | Ideggyogyaszati szemle | 0 |
| The effects of two antiserotonin substances (BAS and BAB) and of bufotenin on the spontaneous electric activity of the brain. ↗ | RINALDI, F | 1958 | The Journal of nervous and mental disease | |
| Effect of lysergic acid diethylamide and bufotenine on performance of trained rats. ↗ | MAHLER, D J, HUMOLLER, F L | 1959 | Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) | |
| Electroencephalographic changes induced by dimethyltryptamine in normal adults ↗ | KAJTOR F, SZARA S | 1959 | Confinia neurologica | 0 |
| The antiserotonin effect of the benzyl analog of bufotenin (BAB) and the benzyl analog of serotonin (BAS) in the isolated guinea pig lung. ↗ | STORMORKEN, H | 1959 | Archives internationales de pharmacodynamie et de therapie | |
| [Determination of bufotenin]. ↗ | WACHSMUTH, H, VAN KOECKHOVEN, L | 1960 | Journal de pharmacie de Belgique | |
| [Determination of bufotenin appearing in the urine of schizophrenics. (Preliminary note)]. ↗ | FISCHER, E, FERNANDEZ, T A, LISKOWSKI, L et al. | 1960 | Prensa medica argentina | |
| [Effect of serotonin (5-HT) and N-dimethylserotonin (bufotenin) on hypertensive reflexes produced by compressing both common carotid arteries in cats]. ↗ | MARCZYNSKI, T, VETULANI, J | 1960 | Acta physiologica Polonica | |
| The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin. ↗ | GESSNER, P K, KHAIRALLAH, P A, McISAAC, W M et al. | 1960 | The Journal of pharmacology and experimental therapeutics | |
| A comparative investigation of actions of reserpine, 5-hydroxytryptamine and cinobufotenine. ↗ | PECZENIK, O, ZEI, M | 1961 | Confinia neurologica | |
| [Isolation of enteramine, bufotenin and bufotenedine from toad toxin with coupling of the electrophoretic and chromatographic methods]. ↗ | SPANDRIO, L | 1961 | Archivio di scienze biologiche | |
| [Preliminary aspects of the pharmaco-psychiatric study of the ayahuasca and its active principle] ↗ | RIOS O | 1962 | Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina | 0 |
| [Schizophrenia and bufotenin]. ↗ | BONHOUR, A | 1962 | El Dia medico | |
| [SEROTONIN AND LOCAL EFFECT OF X-RAYS. 6. EXPERIENCES CONCERNING BUFOTENIN AND ISOSEROTONIN]. ↗ | MAGGIORA, A | 1963 | Dermatologica | |
| SOME PHARMACOLOGICAL STUDIES ON BUFOTENINE AND BUFOTENIDINE. ↗ | PEREIRA, N A, MARINS, I C, MOUSSATCHE, H | 1963 | Revista brasileira de biologia | |
| URINARY EXCRETION OF BUFOTENIN-LIKE SUBSTANCE IN PSYCHOTIC PATIENTS. ↗ | BRUNE, G G, HOHL, H H, HIMWICH, H E | 1963 | Journal of neuropsychiatry | |
| AN ELECTROGRAPHIC STUDY OF BUFOTENIN AND 5-HYDROXYTRYPTOPHAN. ↗ | SCHWEIGERDT, A K, HIMWICH, H E | 1964 | The Journal of pharmacology and experimental therapeutics | |
| [ON THE DETERMINATION OF HOMOLOGOUS AMINES IN BIOLOGICAL SUBSTRATES. I. CONTRIBUTIONS TO THE DETERMINATION OF BUFOTENIN IN HUMAN BLOOD AND URINE]. ↗ | GROSS, H, FRANZEN, F | 1964 | Biochemische Zeitschrift | |
| [REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS] ↗ | RAJOTTE P | 1964 | Canadian Medical Association journal | 0 |
| [THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON THE ELIMINATION OF BUFOTENIN AND ON THE SYMPTOMS OF CHRONIC NON-PRODUCTIVE SCHIZOPHRENIA]. ↗ | FISCHER, E, HELLER, B | 1965 | Annales medico-psychologiques | |
| Do It Yourself Hallucinogens ↗ | David R. Rubin | 1967 | JAMA | 0 |
| Hallucinogenic Substances ↗ | John C. Kramer | 1967 | JAMA | 0 |
| MEDICAL NEWS ↗ | | 1967 | JAMA | 0 |
| Notes and News ↗ | | 1968 | Acta Crystallographica Section B | 0 |
| Efeitos Cardiovasculares, Renais e Hepáticos Produzidos pela Administração Crônica de Ayahuasca em Ratos Hipertensos/Cardiovascular, Renal and Hepatic Effects Produced by Chronic Administration of Ayahuasca in Hypertensive Rats ↗ | Aline Cunha Santos, Barbra Rafaela de Melo Santos Azevedo, Nara Kobbaz Pereira et al. | 1970 | REVISTA CIÊNCIAS EM SAÚDE | 0 |
| Bufotenin like substances in form of glucuronide in schizophrenic and normal urines. ↗ | Fischer, E, Spatz, H, Fledel, T | 1971 | Psychosomatics | |
| Evaluation of Selected Clones of Phalaris arundinacea II. Indole Alkaloid Derivatives ↗ | Barnes RF, Simons AB, Marten GC | 1971 | Agronomy Journal. | 0 |
| Interaction of amino acids and related compounds with neutral polyadenylic acid: a proton magnetic resonance study ↗ | Matthew Raszka | 1971 | ScholarSpace (University of Hawaii at Manoa) | 0 |
| [Analysis of the interaction of peripheral serotonin antagonists with tryptamine and N,N-dimethyltryptamine on rabbit electrocorticograms] ↗ | Fediaeva-Basova LP | 1972 | Farmakologiia i toksikologiia | 0 |
| The effect of inhibitors of protein synthesis to inhibit brain protein synthesis and prevent the hyperactivity and hyperpyrexia in rats produced by inhibition of monoamine oxidase and the administration of L-tryptophan or 5-methoxy-<i>NN</i>-dimethyltryptamine ↗ | A. David Smith | 1972 | Biochemical Journal | 0 |
| Alkaloids and Palatability of Phalaris arundinacea L. Grown in Diverse Environments ↗ | Marten GC, Barnes RF, Simons AB et al. | 1973 | Agronomy Journal. | 0 |
| [Studies on hallucinogens. II. Synthesis of N,N-dimethyltryptamine (DMT) and its related compounds (author's transl)] ↗ | Ono M, Shimamine M, Takahashi K | 1973 | Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences | 0 |
| A quantum chemical investigation of the pi-electronic structure of the hallucinogenic N,N-dimethyltryptamines ↗ | Glennon RA | 1974 | Research communications in chemical pathology and pharmacology | 0 |
| DIMETHYLTRYPTAMINE AND PSYCHOSIS ↗ | | 1974 | The Lancet | 0 |
| Editorial: Dimethyltryptamine and psychosis ↗ | | 1974 | Lancet (London, England) | 0 |
| Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine. ↗ | Gerschenfeld, H M, Paupardin-Tritsch, D | 1974 | The Journal of physiology | |
| On the transmitter function of 5-hydroxytryptamine at excitatory and inhibitory monosynaptic junctions. ↗ | Gerschenfeld, H M, Paupardin-Tritsch, D | 1974 | The Journal of physiology | |
| [Charge-transfer complexes of indolalkylamine and ergoline derivatives] ↗ | Gasco MR | 1975 | Il Farmaco; edizione scientifica | 0 |
| Determination of serotonin and bufotenin as their dansyl derivatives. ↗ | Seiler, N, Bruder, K | 1975 | Journal of chromatography | |
| Opposite effects of intraventricular serotonin and bufotenin on rat startle responses. ↗ | Geyer, M A, Warbritton, J D, Menkes, D B et al. | 1975 | Pharmacology, biochemistry, and behavior | |
| Amine N-methylation of tryptamine by the brain : a re-examination of the possibility of the formation of dimethyltryptamine in cerebral tissues ↗ | Boarder MR | 1976 | King's College London (University of London) | 0 |
| Effects of LSD on a visual discrimination between real and illusory stimuli by macaca mulatta ↗ | Paulene Bunker Popek | 1976 | CSUN ScholarWorks (California State University, Northridge) | 0 |
| Metabolism of bufotenine-2'-14C in human volunteers. ↗ | Sanders-Bush, E, Oates, J A, Bush, M T | 1976 | Life sciences | |
| The influence of bufotenin on the feeding behavior and cerebral serotonin content in rats. ↗ | Uluitu, M, Lazăr, M, Catrinescu, G | 1976 | Physiologie (Bucarest) | |
| ACCUMULATION OF 3H-DOPAMINE FORMED FROM 14H-DOPA: II. EFFECT OF N'N-DIMETHYLTRYPTAMINE ↗ | P. C. Waldmeier, L. Maître | 1977 | Abstracts | 0 |
| Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit ↗ | James Edward Guest | 1977 | UA Campus Repository (The University of Arizona) | 0 |
| Mass spectra of some specifically deuterated tryptamines. ↗ | Shaw, G J, Wright, G J, Milne, G W | 1977 | Biomedical mass spectrometry | |
| [Psychomimetic compounds in the urine of schizophrenics. Part II. N,N-dimethylserotonin (bufotenine)]. ↗ | Bidziński, A, Willmann, P K, Puzyński, S | 1977 | Psychiatria polska | |
| [Action of LSD and 5-methoxy-N,N-dimethyltryptamine on the high affinity uptake of [3H]-serotonin by isolated rat brain synaptosomes] ↗ | Uebelhack R, Franke L, Seidel K | 1978 | Acta biologica et medica Germanica | 0 |
| Carbon 11 labeling of the psychoactive drug o-methyl-bufotenine and its distribution in the animal organism. ↗ | Berger, G, Mazière, M, Marazano, C et al. | 1978 | European journal of nuclear medicine | |
| ChemInform Abstract: SEROTONIN RECEPTOR BINDING AFFINITIES OF SEVERAL HALLUCINOGENIC PHENYLALKYLAMINE AND N,N‐DIMETHYLTRYPTAMINE ANALOGS ↗ | Richard A. Glennon, Stephen M. Liebowitz, Elizabeth C. Mack | 1978 | Chemischer Informationsdienst | 0 |
| Dual mechanism of the stimulant action of N,N-dimethyl-5-hydroxy-tryptamine (bufotenine) on cardiac sympathetic nerves. ↗ | Fozard, J R, Mobarok Ali, A T | 1978 | European journal of pharmacology | |
| [Effects of serotonin, 5-hydroxy-N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine on the synaptosomal Mg(Na,K)-ATPase from rat brain] ↗ | Uebelhack R, Franke L, Seidel K et al. | 1978 | Acta biologica et medica Germanica | 0 |
| Oxytryptamines1 ↗ | Ernest Wenkert, ALLEN CHARLES KRYGER | 1978 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders] ↗ | Matsumoto H, Pietruszewska I | 1978 | Psychiatria polska | 0 |
| Copper(II) complexes and basic properties of N,N-dimethyltryptamine ↗ | Harold C. Nelson, George W. Watt | 1979 | Journal of Inorganic and Nuclear Chemistry | 0 |
| [Influence of LSD and 5-methyoxy-N,N,-dimethyltryptamine on the RNA synthesis in the cell nuclei of rat's brain] ↗ | Uebelhack R, Belkner J, Seidel K | 1979 | Psychiatrie, Neurologie, und medizinische Psychologie | 0 |
| Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents ↗ | Quock Rm, Lum Mh, Small Sf | 1979 | PubMed | 0 |
| Interactions between Psychotropic Drugs and Membranes ↗ | Samuel T. Christian | 1979 | Defense Technical Information Center (DTIC) | 0 |
| Psilocin, bufotenine and serotonin: historical and biosynthetic observations. ↗ | Chilton, W S, Bigwood, J, Jensen, R E | 1979 | Journal of psychedelic drugs | |
| [The meaning of the use of ayahuasca among the Chama(Ese'ejja) natives of Eastern Bolivia: a transcultural study] ↗ | Pages Larraya F | 1979 | Acta psiquiatrica y psicologica de America latina | 0 |
| A comparison of cinobufotenine (the quaternary derivative of 5-HT) and some related compounds with coryneine (the quaternary derivative of dopamine) on the frog rectus, guinea-pig ileum and rat fundus strip preparations. ↗ | Barlow, R B, Burston, K N | 1980 | British journal of pharmacology | |
| An evaluation of the mechanism by which serotonergic activation depresses respiration. ↗ | Lundberg, D B, Mueller, R A, Breese, G R | 1980 | The Journal of pharmacology and experimental therapeutics | |
| Extraction of pineal and uterine tissue at different pH values: a preliminary report on the occurrence of a few groups of compounds in both tissues. ↗ | van der Horst, C J, Ebels, I | 1980 | Cytobios | |
| [Extraction of serotonin, bufotenin, 5-methoxytryptamine and 5-methoxy-N,N-dimethyltryptamine and their fluorometric determination with o-phthaldialdehyde] ↗ | Kitzrow W, Franke L, Uebelhack R et al. | 1980 | Acta biologica et medica Germanica | 0 |
| Rat Brain Steady State Levels of Cyclic Nucleotides as an Endpoint of Lsd-Like Hallucinogen Effects ↗ | Michael Steven Rappaport | 1980 | Deep Blue (University of Michigan) | 0 |
| Alteration of aminophylline-induced respiratory stimulation by perturbation of biogenic amine systems. ↗ | Mueller, R A, Lundberg, D B, Breese, G R | 1981 | The Journal of pharmacology and experimental therapeutics | |
| ChemInform Abstract: STUDIES ON SEVERAL 7‐SUBSTITUTED N,N‐DIMETHYLTRYPTAMINES ↗ | R. A. GLENNON, Ernest M. Schubert, John M. Jacyno et al. | 1981 | Chemischer Informationsdienst | 0 |
| Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy. ↗ | Migliaccio, G P, Shieh, T L, Byrn, S R et al. | 1981 | Journal of medicinal chemistry | |
| Effect of neuroleptics on indoleamine-N-methyltransferase activity and brain metabolism of bufotenin. ↗ | Gomes, U C, McCarthy, B W, Shanley, B C | 1981 | Biochemical pharmacology | |
| 11C-Labeled Dimethyltryptamine: A New Radiopharmaceutical for the Brain Imaging ↗ | Kazuhiko Yanai, T. Ido, Kiichi Ishiwata et al. | 1983 | Institutional Repositories DataBase (IRDB) | 0 |
| Roles of Monoamine Neurotransmitters in the Regulation of Hypothalamic-Pituitary-Adrenal Axis (HPA) (II) - Role of 5-H'ydroxytryptamine(Serotonin) in Controlling the Circadian Rhythmicity of Corticosterone in Rat ↗ | Yoo Hun Suh, Chan Woong Park | 1983 | Seoul National University Open Repository (Seoul National University) | 0 |
| Serotonergic-catecholaminergic interactions and foot shock-induced jumping behavior in rats. ↗ | Nishikawa, T, Tanaka, M, Tsuda, A et al. | 1983 | European journal of pharmacology | |
| Serotonin and the central nervous system : an autoradiographic study ↗ | John J. Grome | 1983 | Enlighten: Theses (The University of Glasgow) | 0 |
| Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. ↗ | de Montigny, C | 1984 | The Journal of pharmacology and experimental therapeutics | |
| Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. ↗ | Glennon, R A, Titeler, M, McKenney, J D | 1984 | Life sciences | |
| [Identification of N,N-dimethyl-O-(beta-D-glucopyranuronosyl)-5- hydroxytryptamine as a bufotenine metabolite in the rabbit]. ↗ | Vigdorchik, M M, Turchin, K F, Gus'kova, T A et al. | 1984 | Bioorganicheskaia khimiia | |
| Increased urinary excretion of bufotenin by violent offenders with paranoid symptoms and family violence. ↗ | Räisänen, M J, Virkkunen, M, Huttunen, M O et al. | 1984 | Lancet (London, England) | |
| Justicia pectoralis: a study of the basis for its use as a hallucinogenic snuff ingredient. ↗ | MacRae, W D, Towers, G H | 1984 | Journal of ethnopharmacology | |
| Pre- and post-synaptic effects of 5-hydroxytryptamine and 5-methoxy-N, N-dimethyltryptamine in the guinea-pig vas deferens ↗ | Soichi Yoshida, Tetsurō Kuga | 1984 | The Japanese Journal of Pharmacology | 0 |
| The presence of free and conjugated bufotenin in normal human urine. ↗ | Räisänen, M J | 1984 | Life sciences | |
| [Ayahuasca--liana of the spirits] ↗ | Eigner D, Scholz D | 1985 | Pharmazie in unserer Zeit | 0 |
| Bufotenine reconsidered. ↗ | McLeod, W R, Sitaram, B R | 1985 | Acta psychiatrica Scandinavica | |
| Indoleamine-sensitive adenylate cyclase in rabbit retina: characterization and distribution. ↗ | Blazynski, C, Ferrendelli, J A, Cohen, A I | 1985 | Journal of neurochemistry | |
| Influence of Circadian Rhythms on Head-twitch Response to 5HT-Receptor Stimulation in Mice ↗ | P H Redfern, Paul Moser | 1985 | Palgrave Macmillan UK eBooks | 0 |
| Potentiation of motoneurone excitability by combined administration of 5-HT agonist and TRH analogue. ↗ | Clarke, K A, Parker, A J, Stirk, G C | 1985 | Neuropeptides | |
| Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. ↗ | Artigas, F, Sarrias, M J, Martínez, E et al. | 1985 | Life sciences | |
| Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat ↗ | Larson AA, Anderson EG | 1986 | Pharmacology, biochemistry, and behavior | 0 |
| Effect of TRH, 5-HTP and 5-methoxy-N,N-dimethyltryptamine on spinal reflexes in 5,6-dihydroxytryptamine-treated rats ↗ | Nobuo Nagano, Hideki Ono, Hideomi Fukuda | 1986 | The Japanese Journal of Pharmacology | 0 |
| Presynaptic effect of 5-methoxy-N,N-dimethyltryptamine on the isolated guinea-pig vas deferens ↗ | Soichi Yoshida, Tetsurō Kuga | 1986 | The Japanese Journal of Pharmacology | 0 |
| (+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion. ↗ | Archer, T, Arweström, E, Minor, B G et al. | 1987 | Physiology & behavior | |
| ChemInform Abstract: Chemical and Enzymatic Oxidative Coupling of 5‐Hydroxy‐N,N‐dimethyltryptamine with Amines ↗ | F. BABIN, HUYNH‐DINH TAM HUYNH‐DINH TAM | 1987 | ChemInform | 0 |
| Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. ↗ | Murphy, R M, Zemlan, F P | 1987 | Psychopharmacology | |
| Effects of 5-HT receptor antagonists and starvation on 5-methoxy-N,N-dimethyltryptamine-induced behaviour in mice ↗ | Yumi Sugimoto, Jun Yamada, Kazuyoshi Horisaka | 1987 | The Japanese Journal of Pharmacology | 0 |
| Effects of an atypical barbiturate (valofan) on spontaneous and stimulated locomotor activity and on brain serotonin metabolism in mice ↗ | Traversa U, Puppini P, Florio C et al. | 1987 | Il Farmaco; edizione scientifica | 0 |
| Inhibition of mouse killing behavior by serotonin-mimetic drugs: effects of partial alterations of serotonin neurotransmission. ↗ | Molina, V, Ciesielski, L, Gobaille, S et al. | 1987 | Pharmacology, biochemistry, and behavior | |
| Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. ↗ | Shenker, A, Maayani, S, Weinstein, H et al. | 1987 | Molecular pharmacology | |
| The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration. ↗ | Feuerstein, T J, Lupp, A, Hertting, G | 1987 | Neuropharmacology | |
| Two kinds of modification by 5-methoxy-N,N-dimethyltryptamine of contractile responses to electrical stimulation of isolated guinea-pig vas deferens ↗ | Yoshida S, Kuga T | 1987 | Japanese journal of pharmacology | 0 |
| Two kinds of modification by 5-methoxy-N,N-dimethyltryptamine of contractile responses to electrical stimulation of the isolated guinea-pig vas deferens ↗ | Soichi Yoshida, Tetsurō Kuga | 1987 | The Japanese Journal of Pharmacology | 0 |
| N,N-Dimethyltryptamine Production inPhalaris aquatica Seedlings MATHEMATICAL MODEL FOR ITSSYNTHESIS ↗ | Josephp . G. Mack, Dawn P. Mulvena | 1988 | | 0 |
| Serotonin-mediated behavior in rats chronically treated with (-) deprenyl. ↗ | Gyarmati, S, Timar, J, Knoll, B et al. | 1988 | Polish journal of pharmacology and pharmacy | |
| The relaxation induced by indole and nonindole 5-HT agonists in the molluscan smooth muscle ↗ | Murakami H, Sano M, Tsukimura T et al. | 1988 | Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology | 0 |
| Urinary excretion of free bufotenin by psychiatric patients. ↗ | Kärkkäinen, J, Räisänen, M, Naukkarinen, H et al. | 1988 | Biological psychiatry | |
| セロトニン性神経活動に対するFenfluramineの作用および加齢効果 ↗ | 光一郎 添田, 逸子 牛島, 良二 工藤 et al. | 1989 | Institutional Repositories DataBase (IRDB) | 0 |
| Serotonergic modulation of the acoustic startle response in rats during preweaning development. ↗ | Sheets, L P, Cook, L L, Reiter, L W | 1989 | Pharmacology, biochemistry, and behavior | |
| Serotonin involvement during in vitro conditioning of Hermissenda. ↗ | Grover, L M, Farley, J, Auerbach, S B | 1989 | Brain research bulletin | |
| 1B2-6 外側膝状体キンドリングネコの光過敏性に対する5-Methoxy-N, N-dimethyltryptamineの抑制効果 ↗ | 充彦 中村, 英裕 長谷川, 有司 和田 et al. | 1990 | 日本てんかん学会プログラム・抄録集 | 0 |
| Do functional relationships exist between 5-HT1A and 5-HT2 receptors? ↗ | Darmani, N A, Martin, B R, Pandey, U et al. | 1990 | Pharmacology, biochemistry, and behavior | |
| Modulation of certain 5-HT-related behaviours by serotonergic and noradrenergic systems ↗ | J.C.Patrick Heaton | 1990 | Aston Publications Explorer (Aston University) | 0 |
| Stimulus properties of tiflucarbine: a novel antidepressant agent. ↗ | Glennon, R A, De Vry, J, Spencer, D G et al. | 1990 | Pharmacology, biochemistry, and behavior | |
| The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice. ↗ | Green, A R, DeSouza, R J, Davies, E M et al. | 1990 | British journal of pharmacology | |
| A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sites. ↗ | Boulenguez, P, Chauveau, J, Segu, L et al. | 1991 | European journal of pharmacology | |
| Aplicación de la difracción de rayos X en el análisis de muestras ilícitas de heroína ↗ | Aurelio Luna Maldonado, Aintzane Sánchez, Maximiliano Gómez Zapata | 1991 | Revista de toxicología | 0 |
| Opposite effects of 5-methoxy-N,N-di-methyl-tryptamine and 5-hydroxytryptophan on male rat sexual behavior. ↗ | Ahlenius, S, Larsson, K | 1991 | Pharmacology, biochemistry, and behavior | |
| Sexual receptivity of adult female rats prenatally intoxicated with alcohol on gestational day 8. ↗ | Minetti, S A, Fulginiti, S | 1991 | Neurotoxicology and teratology | |
| The frog prince: tale and toxicology. ↗ | Siegel, D M, McDaniel, S H | 1991 | The American journal of orthopsychiatry | |
| 5-HT3 receptors are not involved in the modulation of the K(+)-evoked release of [3H]5-HT from spinal cord synaptosomes of rat. ↗ | Williams, G M, Smith, D L, Smith, D J | 1992 | Neuropharmacology | |
| 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. ↗ | Rigdon, G C, Weatherspoon, J K | 1992 | The Journal of pharmacology and experimental therapeutics | |
| Acute ethanol intoxication during pregnancy: postnatal effects on the behavioral response to serotonin agents. ↗ | Fulginiti, S, Vigliecca, N S, Minetti, S A | 1992 | Alcohol (Fayetteville, N.Y.) | |
| Effects of indoleamines and short photoperiods on the encystment of Gonyaulax polyedra. ↗ | Balzer, I, Hardeland, R | 1992 | Chronobiology international | |
| Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation ↗ | Chojnacka-Wójcik E | 1992 | Polish journal of pharmacology and pharmacy | 0 |
| Neuronal modulation of foot and body-wall contractions in Aplysia californica. ↗ | McPherson, D R, Blankenship, J E | 1992 | Journal of neurophysiology | |
| Nialamide, an MAO inhibitor, increases urinary excretion of endogenously produced bufotenin in man. ↗ | Kärkkäinen, J, Räisänen, M | 1992 | Biological psychiatry | |
| Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention. ↗ | Paterson, W G, Anderson, M A, Anand, N | 1992 | Canadian journal of physiology and pharmacology | |
| Suppression of 5-methoxy-N,N-dimethyltryptamine(5-MeODHT)-induced head twitches in hyperammonemic state of mice ↗ | Takao Shimizu, Tatsuro Iwashita, Korebumi Minakami et al. | 1992 | The Japanese Journal of Pharmacology | 0 |
| ChemInform Abstract: A Simple Synthesis of 5‐Amino‐3‐(2‐dimethylaminoethyl)indole (5‐Amino‐ N,N‐dimethyltryptamine) ↗ | John E. Macor, Ronald J. Post, Kevin Ryan | 1993 | ChemInform | 0 |
| [Differences in the action of serotonin 1A-receptor agonists on rotating behavior or rats with unilaterally raphe-lesioned rats] ↗ | Bondarenko NA, Bondarenko NA, Voronina TA | 1993 | Biulleten' eksperimental'noi biologii i meditsiny | 0 |
| Bufi u~v~r~u~~ a potent hallucinogen of animal origin ↗ | Andrew Weil, Wade Davisb | 1994 | | 0 |
| Curing agents ↗ | | 1994 | Additives for Polymers | 0 |
| Fire retardants ↗ | | 1994 | Additives for Polymers | 0 |
| Serotonin-degradative pathways in the toad (Bufo bufo japonicus) brain: clues to the pharmacological analysis of human psychiatric disorders. ↗ | Takeda, N | 1994 | Comparative biochemistry and physiology. Pharmacology, toxicology and endocrinology | |
| Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders. ↗ | Takeda, N, Ikeda, R, Ohba, K et al. | 1995 | Neuroreport | |
| ChemInform Abstract: The Chemistry of Indoles. Part 71. Simple Syntheses of Lespedamine and 5‐Bromo‐N,N‐dimethyltryptamine Based on 1‐Hydroxyindole Chemistry ↗ | Masanori Somei, Kazuo Kobayashi, Keiko Tanii et al. | 1995 | ChemInform | 0 |
| Tissue distribution, metabolism and effects of bufotenine administered to rats. ↗ | Fuller, R W, Snoddy, H D, Perry, K W | 1995 | Neuropharmacology | |
| Urinary excretion of bufotenin (N,N-dimethyl-5-hydroxytryptamine) is increased in suspicious violent offenders: a confirmatory study. ↗ | Kärkkäinen, J, Räisänen, M, Huttunen, M O et al. | 1995 | Psychiatry research | |
| Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. ↗ | Lyttle, T, Goldstein, D, Gartz, J | 1996 | Journal of psychoactive drugs | |
| Changes in head twitch response induced by a 5-hydroxytryptamine agonist in mice fed a low-protein diet ↗ | Minakami K, Shimizu T, Toriire Y et al. | 1996 | Journal of psychopharmacology (Oxford, England) | 0 |
| GC/MS comparison of the West Indian aphrodisiac "Love Stone" to the Chinese medication "chan su": bufotenine and related bufadienolides. ↗ | Barry, T L, Petzinger, G, Zito, S W | 1996 | Journal of forensic sciences | |
| Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. ↗ | Almaula, N, Ebersole, B J, Zhang, D et al. | 1996 | The Journal of biological chemistry | |
| Suppressive effect of mitragynine on 5-methoxy-N,N-dimethyltryptamine-induced head twitch responses in mice ↗ | Kinzo Matsumoto, Maho Mizowaki, Hiromitsu Takayama et al. | 1996 | The Japanese Journal of Pharmacology | 0 |
| High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. ↗ | Roth, B L, Choudhary, M S, Khan, N et al. | 1997 | The Journal of pharmacology and experimental therapeutics | |
| Immunological assay methods ↗ | STRAHILEVITZ MEIR | 1997 | | 0 |
| Immunological assay reagent package ↗ | STRAHILEVITZ MEIR | 1997 | | 0 |
| Agglutination inhibition assay methods and reagents for psychoactive substances ↗ | STRAHILEVITZ MEIR | 1998 | | 0 |
| Clozapine이 백서의 억제된 자발적 교대 행동에 미치는 영향 ↗ | 천강훈, 이기철, 최영민 et al. | 1998 | 신경정신의학 | 0 |
| Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists. ↗ | Nielsen, C K | 1998 | European journal of pharmacology | |
| Bufotenine: toward an understanding of possible psychoactive mechanisms. ↗ | McBride, M C | 2000 | Journal of psychoactive drugs | |
| ChemInform Abstract: Synthesis and Pharmacological Profile of a Series of 2,5‐Substituted‐N,N‐dimethyltryptamine Derivatives (I) as Novel Antagonists for the Vascular 5‐HT<sub>1B</sub>‐Like Receptor ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 2000 | ChemInform | 0 |
| ChemInform Abstract: Synthesis and Serotonergic Activity of 2‐Oxadiazolyl‐5‐substituted‐N,N‐dimethyltryptamines (I): Novel Antagonists for the Vascular 5‐HT<sub>1B</sub>‐Like Receptor ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 2000 | ChemInform | 0 |
| ChemInform Abstract: Synthesis and Serotonergic Activity of a Series of 2‐(N‐Benzyl)‐carboxamido‐5‐substituted‐N,N‐dimethyltryptamine Derivatives (I): Novel Antagonists for the Vascular 5‐HT<sub>1B</sub>‐Like Receptors ↗ | Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al. | 2000 | ChemInform | 0 |
| Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry. ↗ | Vishwanathan, K, Bartlett, M G, Stewart, J T | 2000 | Rapid communications in mass spectrometry : RCM | |
| Lndolealkylamines ↗ | Albert C Ludolph | 2000 | | 0 |
| Phalaris Spp ↗ | Alexander Storch Albert C Ludolph | 2000 | | 0 |
| farmacología humana del dmt oral más harmina ↗ | Jonathan Ott, Mariela Nárvaez Marin | 2001 | Repositorio Universidad de Caldas | 0 |
| RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. ↗ | Berg, K A, Cropper, J D, Niswender, C M et al. | 2001 | British journal of pharmacology | |
| Aromatization of 1,6,7,7a-tetrahydro-2H-indol-2-ones by a novel process. Preparation of key-intermediate methyl 1-benzyl-5-methoxy-1H-indole-3-acetate and the syntheses of serotonin, melatonin, and bufotenin. ↗ | Revial, Gilbert, Jabin, Ivan, Lim, Sethy et al. | 2002 | The Journal of organic chemistry | |
| Behavioral and pharmacological characterization of 3,4-methylenedioxymethamphetamine, its enantiomers, and related compounds ↗ | William E. Fantegrossi | 2002 | Deep Blue (University of Michigan) | 0 |
| OBITUARY ↗ | T. Malmfors | 2002 | Pharmacology & Toxicology | 0 |
| Synthesis of N,N-Dimethyltryptamine Derivative ↗ | Liu De-chen | 2002 | Fain kemikaru | 0 |
| The relationship between personality and post traumatic stress disorder ↗ | Farāmarz Sohrābi | 2002 | European Psychiatry | 0 |
| At the edge of eternity's shadows: Scaling the fractal continuum from lower into higher space ↗ | Greene, F. Gordon | 2003 | The Journal of near-death studies | 0 |
| [Book Reviews] [Review of the book DMT: The spirit molecule. A doctor's revolutionary research into the biology of near-death and mystical experiences, by R. Strassman] ↗ | James Fadiman, Jordan Gruber | 2003 | The Journal of near-death studies | 0 |
| Designer Hallucinogens ↗ | Leon Gussow | 2003 | Emergency Medicine News | 0 |
| Methods and devices for removing species ↗ | STRAHILEVITZ MEIR | 2003 | | 0 |
| Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. ↗ | Hirose, Tsuyoshi, Uwahodo, Yasufumi, Yamada, Sakiko et al. | 2004 | Journal of psychopharmacology (Oxford, England) | |
| Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. ↗ | Brush, D Eric, Bird, Steven B, Boyer, Edward W | 2004 | Journal of toxicology. Clinical toxicology | |
| 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. ↗ | Ikeda, Akifumi, Sekiguchi, Kanako, Fujita, Kenichi et al. | 2005 | The American journal of psychiatry | |
| Author's reply ↗ | B. Sessa | 2005 | The British Journal of Psychiatry | 0 |
| B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND 4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION ↗ | Tomáš Páleníček, V. Bubeníková, Martin Votava | 2005 | Behavioural Pharmacology | 0 |
| Occurrence of bufotenin in the Osteocephalus genus (Anura: Hylidae). ↗ | Costa, T O G, Morales, R A V, Brito, J P et al. | 2005 | Toxicon : official journal of the International Society on Toxinology | |
| Yagé: ¿un adaptógeno biológico específico? ↗ | José Carlos Bouso Saiz | 2005 | Repositorio Universidad de Caldas | 0 |
| 基質輔助雷射脫附/游離-飛行時間質譜法對濫用藥物的快速偵測 ↗ | Po-Hung Chen | 2006 | 臺灣師範大學化學系學位論文 | 0 |
| A Demand for Clarity Regarding a Case Report on the Ingestion of 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT) in an Ayahuasca Preparation: Reply ↗ | J. H. Sklerov, Barry Levine, Karla A. Moore et al. | 2006 | Journal of Analytical Toxicology | 0 |
| Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimumacutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau. ↗ | Moretti, Christian, Gaillard, Yvan, Grenand, Pierre et al. | 2006 | Journal of ethnopharmacology | |
| 氣相層析/液相層析/毛細管電泳法對九種色胺類化合物的分離與分析 ↗ | 王曼憬 | 2007 | 臺灣師範大學化學系學位論文 | 0 |
| Dimethyltryptamine ↗ | Stephen Erhorn | 2007 | xPharm: The Comprehensive Pharmacology Reference | 0 |
| Put That in Your Thurible and Smoke It: Religious Gerrymandering of Sacramental Intoxication ↗ | Mark LeVine | 2007 | | 0 |
| Yage, cognition and executive functions ↗ | Ofelia Gallego Beltrán | 2007 | Repositorio Universidad de Caldas | 0 |
| Antidepressant Secondary Metabolites from Three Florida Sponges ↗ | Anna J. Kochanowska, Scott J. Childress, AT El-Alfy et al. | 2008 | Planta Medica | 0 |
| BREBAJE PALO: A CASE STUDY AMONG THE INDIGENOUS HEALERS OF IQUITOS (PERU) ↗ | Claudio Mazzatenta | 2008 | Revista de Biologia Neotropical / Journal of Neotropical Biology | 0 |
| Der Einfluss von S-Ketamin und N,N-dimethyltrytamine (DMT) auf die Präpulsinhibition und die attentive Modulation des Startlereflexes : eine humanexperimentelle Untersuchung zum Modellpsychoseparadigma ↗ | Martina Crysandt, Euphrosyne Gouzoulis‐Mayfrank | 2008 | RWTH Publications (RWTH Aachen) | 0 |
| Lysergic acid diethylamide (LSD) and N,N-dimethyltryptamine (DMT) as peroxidases substrates: a possible metabolization pathway ↗ | Melissa Medrano Gomes | 2008 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| <i>N,N</i> ‐dialkyltryptamines inhibit plasma membrane and vesicular serotonin transport ↗ | Nicholas V. Cozzi, Anupama Gopalakrishnan, Lyndsey L. Anderson et al. | 2008 | The FASEB Journal | 0 |
| Preliminary Research on Pathogenic Secretions Generated by Ditylenchus destructor Thorne ↗ | Xingzhe Wang | 2008 | Acta Agriculturae Boreali-Sinica | 0 |
| Thematic analysis of N.N-Dimethyltryptamine-induced experiences ↗ | Christopher Cott, Adam J. Rock | 2008 | PsycEXTRA Dataset | 0 |
| トリプタミン系ドラッグ5-methoxy-N,N-dimethyltryptamine投与によるマウス雄性生殖器系障害 ↗ | 田山 邦昭, 藤谷 知子, 坂本 義光 et al. | 2009 | | 0 |
| Pharmacological evaluation of the possible effect of anti-alcohol ayahuasca in mice ↗ | Bruno [UNIFESP] Gianfratti | 2009 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Phytochemical studies on alkaloids from Fissistigma latifolium (Dunal) merr. / Asmah Alias ↗ | Asmah Alias | 2009 | UiTM Institutional Repositories (Universiti Teknologi MARA) | 0 |
| Sudden death associated with intravenous injection of toad extract. ↗ | Kostakis, Chris, Byard, Roger W | 2009 | Forensic science international | |
| Telepathine (ayahuasca) and psychic ability: field research in South America ↗ | David Luke | 2009 | Greenwich Academic Literature Archive (University of Greenwich) | 0 |
| Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia. ↗ | Emanuele, Enzo, Colombo, Roberto, Martinelli, Valentina et al. | 2010 | Neuro endocrinology letters | |
| Ethnobiological and chemical investigations of selected Amazonian plants ↗ | W.Donald MacRae | 2010 | cIRcle (University of British Columbia) | 0 |
| The effects of ayahuasca on psi: a preliminary study in South America ↗ | David Luke | 2010 | Greenwich Academic Literature Archive (University of Greenwich) | 0 |
| A HPTLC report on Desmodium gangeticum ↗ | Srivastava Anamika, T. Rajkumar | 2011 | International Journal of Research in Pharmaceutical Sciences | 0 |
| A mood disorder episode with an onset under chronic cannabis consumption and accompanied with psychotic features immediately after N, N-Dimethyltryptamine (DMT) use: a case report ↗ | Guliz Ozgen, ilker kucukparlak, Gökhan Umut et al. | 2011 | DOAJ (DOAJ: Directory of Open Access Journals) | 0 |
| Estudos de farmacocinética dos alcalóides da ayahuasca ↗ | Ana Paula Salum Pires | 2011 | | 0 |
| HPLC method for the detection of N,N-dimethyltryptamine (DMT) metabolites and cytotoxicity on glioma and neuron cell lines ↗ | Janine Baptista Coimbra, Renan Orsati Clara, Ana Čampa | 2011 | Brazilian Journal of Pharmaceutical Sciences | 0 |
| Pharmacognosy of Ayahuasca ↗ | LJ Standish, Dean B. Reardon, Simon Phipps et al. | 2011 | Planta Medica | 0 |
| The Holy Dose: Spiritual adventures with Southern Oregon's psychedelic crusaders ↗ | Alex L Weber | 2011 | eScholarship (California Digital Library) | 0 |
| 2‐Methyl‐5‐Methoxy‐N‐Dimethyltryptamine 67292‐68‐6 ↗ | | 2012 | Sax's Dangerous Properties of Industrial Materials | 0 |
| 4‐Hydroxy‐N,N‐Dimethyltryptamine 520‐53‐6 ↗ | | 2012 | Sax's Dangerous Properties of Industrial Materials | 0 |
| Avaliação dos efeitos neurotóxicos do chá ayahuasca ↗ | Alex Roberto Melgar Figueroa | 2012 | | 0 |
| Effects of ayahuasca on emotional memory in rats ↗ | Daiana Aparecida Kruchelski da Silva | 2012 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Estudo da ação inibitória da enzima indolamina 2,3-dioxigenase pelos compostos triptamina (TRY) e N,N-dimetiltriptamina (DMT) ↗ | Melissa Cavalheiro Tourino | 2012 | | 0 |
| Evaluation of the neurotoxic effects of ayahuasca tea ↗ | Alex Roberto Melgar Figueroa | 2012 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| O‐Phosphoryl‐4‐Hydroxy‐N,N‐Dimethyltryptamine 520‐52‐5 ↗ | | 2012 | Sax's Dangerous Properties of Industrial Materials | 0 |
| Pharmacokinetic and pharmacodynamic interactions of indolealkylamine drugs of abuse ↗ | Ai‐Ming Yu | 2012 | The FASEB Journal | 0 |
| [Physiological functions of sigma-1 receptors and its relation to psychic dependence] ↗ | Mori T, Yoshizawa K, Shibasaki M et al. | 2012 | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence | 0 |
| Study of the indoleamine 2,3-dioxygenase inhibitory action by tryptamine (TRY) and N,N-dimethyltryptamine (DMT) ↗ | Melissa Cavalheiro Tourino | 2012 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Tryptamine and dimethyltryptamine on melanomas: biosynthesis, metabolism and antitumor activity ↗ | Janine Baptista Coimbra | 2012 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS. ↗ | Martin, Rafaela, Schürenkamp, Jennifer, Gasse, Angela et al. | 2013 | International journal of legal medicine | |
| Effect of chronic administration of ayahuasca in preclinical models of memory and anxiety ↗ | Vanessa Manchim Favaro | 2013 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| P.2.017 The hallucinogen 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) disrupts cortical function: reversal by antipsychotic drugs ↗ | Maurizio S. Riga, Francesc Artigas, Pau Celada | 2013 | European Neuropsychopharmacology | 0 |
| Chapter 51. Hallucinogen-Related Disorders ↗ | Robert N. Pechnick, Kathryn A. Cunningham, Itai Danovitch | 2014 | American Psychiatric Publishing eBooks | 0 |
| DMT, Ecocide, and the Western Psyche ↗ | Sebastian Job | 2014 | Clio s Psyche | 0 |
| Efeito do chá de ayahuasca sobre o comportamento de ratos Wistar no campo aberto e labirinto em cruz elevado e sobre a expressão de EAAC1 no hipocampo e córtex pré-frontal ↗ | Luana Gonçalves Zamarrenho | 2014 | | 0 |
| Investigação de alcaloides ß-carbolinas, Triptaminas presentes na Ayahuasca (Santo Daime) em amostras de suor ↗ | Lidiane Silva Tavares | 2014 | | 0 |
| N, N-Dimethyltryptamine and Biological Reductive Accounts for Religious and Spiritual Experiences ↗ | Shaun Smith | 2014 | Digital Commons (Liberty University) | 0 |
| The role of serotonin 2A and 2C receptors in tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine ↗ | Theresa M. Carbonaro, Michael J. Forster, Michael B. Gatch | 2014 | Drug and Alcohol Dependence | 0 |
| Analysis by chromatography and mass spectrometry of harmala alkaloids from banisteriopsis caapi extracts and urine samples ↗ | Cristian Andrés Oliveros | 2015 | Universidad Industrial de Santander | 0 |
| Analysis of psilocin, bufotenine and LSD in hair. ↗ | Martin, Rafaela, Schürenkamp, Jennifer, Gasse, Angela et al. | 2015 | Journal of analytical toxicology | |
| Avaliação farmacológica do possível efeito anti-álcool da ayahuasca em camundongos ↗ | Bruno Gianfratti | 2015 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Ayahuasca: Propagating a Plant Teacher to Heal the World (A Guideline for Future Greenhouse Production of Psychotria viridis) ↗ | Jack Kuderko | 2015 | University of Minnesota Digital Conservancy (University of Minnesota) | 0 |
| Efeito da administração crônica de ayahuasca em modelos pré-clínicos de memória e ansiedade ↗ | Vanessa Manchim Favaro | 2015 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| From C-H Activation to Biomimetic Synthesis: The Construction and Reconstruction of Yuremamine ↗ | Matthew B. Calvert | 2015 | ResearchSpace (University of Auckland) | 0 |
| Preparação de derivados triptamínicos e dímeros inibidores de acetilcolinesterase a partir da bufotenina isolada de Anadenanthera (Fabaceae: Mimosideae) ↗ | Leandro A. Moreira | 2015 | | 0 |
| Pszichedelikumok és kvázi-pszichedelikumok a modern kutatások tükrében: orvosi kannabisz, MDMA, szalvinorin A, ibogain és ayahuasca ↗ | Attila Szabó, Anita Kazai, Ede Frecska et al. | 2015 | University of Debrecen Electronic Archive (University of Debrecen) | 0 |
| Sequestered and Synthesized Chemical Defenses in the Poison Frog Melanophryniscus moreirae. ↗ | Jeckel, Adriana M, Grant, Taran, Saporito, Ralph A | 2015 | Journal of chemical ecology | |
| The Root of All Things ↗ | Nathan Thornburgh | 2015 | River teeth | 0 |
| THE SPIRIT MOLECULE: DMT, BRAINS, AND A THEONEUROLOGICAL MODEL TO EXPLAIN SPIRITUAL EXPERIENCES ↗ | Shaun M. Smith | 2015 | Digital Commons (Liberty University) | 0 |
| À la rencontre des esprits brésiliens : la construction des relations avec l’au-delà chez les adeptes du Santo Daime au Québec ↗ | Jennifer Lopes | 2016 | Open MIND | 0 |
| Aplicações psicológicas e psiquiátricas da Ayahuasca ↗ | José Miguel Graça Pereira Palma | 2016 | Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) | 0 |
| Ayahuasca: Friend or Foe? ↗ | Gerard I. Fernando | 2016 | American Journal of Psychiatry Residents Journal | 0 |
| [Chemical Constituents of the Endophytic Fungus Rhinocladiella sp. lgt-3 from Tripterygium wilfordii] ↗ | Peng C, Yang ZD | 2016 | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials | 0 |
| Eesti ayahuasca tarvitajate psüühika ↗ | Helle Kaasik | 2016 | DSpace repository (University of Tartu) | 0 |
| Harmine stimulates neurogenesis of human neural cells <i>in vitro</i> ↗ | Dakic V, de Moraes Maciel R, Drummond H et al. | 2016 | PeerJ Preprints | 0 |
| Metabolism and physiological effects of dimethyltryptamine ↗ | Petr Matouš | 2016 | Digital Repository (National Repository of Grey Literature) | 0 |
| Peer Review #2 of "Harmine stimulates proliferation of human neural progenitors (v0.1)" ↗ | | 2016 | | 0 |
| [The potential use of ayahuasca in psychiatry] ↗ | Frecska E, Bokor P, Andrassy G et al. | 2016 | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology | 0 |
| A SYSTEMATIC REVIEW OF RESEARCH ON N,N-DIMETHYLTRYPTAMINE ↗ | Denitsa M. Hristova, M. Zhelyazkova-Savova | 2017 | Scripta Scientifica Vox Studentium | 0 |
| ALSUntangled 40: Ayahuasca ↗ | ALSUntangled Group | 2017 | Amyotrophic lateral sclerosis & frontotemporal degeneration | 0 |
| CHÁ DA AYAHUASCA: UMA REVISÃO DOS ASPECTOS TOXICOLÓGICOS ↗ | Rosane Andrade Cezaro, Heber Amilcar Martins | 2017 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Formulation Design, Development and Invitro Evaluation of Mouth Dissolving Tablets of Sumatriptan Succinate ↗ | M. Senthilkumar | 2017 | | 0 |
| L'Ayahuasca : usages traditionnels, pratiques modernes et perspectives thérapeutiques d’une boisson hallucinogène ↗ | Aude Le Floch | 2017 | | 0 |
| Psychoactive and Organic Effects of Banisteriopsis caapi and Diplopteris cabrerana (Cuatrec.) B. Gates in Rats ↗ | Juan Rojas-Arma, Américo Castro, Norma Ramos et al. | 2017 | Research Journal of Medicinal Plant | 0 |
| „Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku ↗ | Joanna Stefaniuk | 2017 | CeON Repository (Centre for Evaluation in Education and Science) | 0 |
| Toxicology Rounds ↗ | Leon Gussow | 2017 | Emergency Medicine News | 0 |
| Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression ↗ | Santos da Silva F, Silva EAdS, de Sousa Junior GM et al. | 2018 | bioRxiv | 0 |
| Anti-malarial Drug Discovery from Australian Flora ↗ | Luke P. Robertson | 2018 | | 0 |
| Ayahuasca : potencial terapêutico na dependência ao álcool e atividade neural da proteína cFOS em modelo experimental ↗ | Luciana Marangni Nolli | 2018 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Biological Effects and Biodistribution of Bufotenine on Mice. ↗ | Vigerelli, Hugo, Sciani, Juliana Mozer, Eula, Maria Andrea Camarano et al. | 2018 | BioMed research international | |
| Caracterização inorgânica da Ayahuasca e avaliação do seu potencial psicoterapêutico ↗ | Ivanilce Cristina Guimarães | 2018 | | 0 |
| Everything old is new again: are psychedelic medicines poised to take mental health by storm? ↗ | Charles L. Raison | 2018 | Acta Psychiatrica Scandinavica | 0 |
| Exploration of Ayahuasca’s Mechanisms in the Treatment of Stimulant Use Disorder ↗ | Aaron M. Eisen, Nicholas A. Smith, W. S Griesar | 2018 | PDXScholar (Portland State University) | 0 |
| Impact of psychoactive drugs on the central nervous system ↗ | Tereza Hrubešová | 2018 | Digital Repository (National Repository of Grey Literature) | 0 |
| Influence of Environmental Factors and Cultural Methods on the Content of N,N-Dimethyltryptamine in Psychotriaviridis (Rubiaceae) ↗ | André D. Cavalcante, Gabriele A. Cardoso, Fernando L. P.De Oliveira et al. | 2018 | Figshare | 0 |
| Psychedelics forge neuron connections ↗ | Cici Zhang | 2018 | C&EN Global Enterprise | 0 |
| The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. ↗ | Riga, Maurizio S, Lladó-Pelfort, Laia, Artigas, Francesc et al. | 2018 | Neuropharmacology | |
| Vliv omamných látek na centrální nervovou soustavu ↗ | Tereza Hrubešová | 2018 | Digital Repository (National Repository of Grey Literature) | 0 |
| Aplicação das técnicas de microextração μMSPD e BAμE para determinação de alcaloides em matrizes in natura e processadas de tabaco (Nicotiana tabacum L.) por cromatografia líquida acoplada a espectrometria de massas ↗ | Luis Fabricio Santana Santos | 2019 | Institutional Repository of the Federal University of Sergipe (Universidade Federal de Sergipe) | 0 |
| Application of the microextraction techniques μMSPD and BAμE for determination of alkaloids in natural and processed tobacco matrix (Nicotiana tabacum l.) by liquid chromatrography-mass spectrometry ↗ | Luis Fabrício Santana Santos | 2019 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Assessing novel expectancies about ayahuasca : a preliminary report ↗ | Brianna R. Altman | 2019 | | 0 |
| Critical Review Report: DOC (4-Chloro-2,5-dimethoxyamfetamine) ↗ | SD Brandt | 2019 | Liverpool John Moores University | 0 |
| Dimethyltryptamine (DMT) - Molecule of the Month September 2019 [Archived version] ↗ | Paul May | 2019 | Bristol Research (University of Bristol) | 0 |
| Intérêt de la psilocybine, de l'acide lysergique diéthylamide (LSD) et de la diméthyltryptamine (DMT) dans la dépression : une revue de la littérature ↗ | Sami Sergent | 2019 | | 0 |
| Psychedelic-assisted therapy: A new way forward in mental health ↗ | Kimberly Wibur | 2019 | National University System Repository (National University System) | 0 |
| Smuggling of the Dimethyltryptamine Drug in the Ayahuasca Drink ↗ | Marat R. Potashov | 2019 | Drug control | 0 |
| Study molecular of interaction between N,N-dimethyltryptamine analogs (DMT) with 5-HT1A and 5-HT1B receptors, associated in neuronal alterations ↗ | Hilder Mercado-la Peira, José Dussan-Ordoñez, Antistio Alvíz‐Amador et al. | 2019 | Faculty of 1000 Research Ltd | 0 |
| Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine ↗ | Jan M. Keppel Hesselink, Jan M. Keppel Hesselink | 2019 | International Journal of Psychotherapy Practice and Research | 0 |
| Working with the Root: The Facilitation of Healing and Activism In the Peruvian Amazon ↗ | Nicholas Ringstad | 2019 | Duo Research Archive (University of Oslo) | 0 |
| A Case Report of an Individual's Experience Participating in a Traditional Costa Rican Ayahuasca Ceremony ↗ | Naratadam GT, Narikkattu J, Shah S | 2020 | The journal of psychedelic psychiatry | 0 |
| Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT. ↗ | Winne, Jessica, Boerner, Barbara C, Malfatti, Thawann et al. | 2020 | Experimental neurology | |
| Avaliação da variação morfológica, anatômica e fitoquímica de >i<Banisteriopsis caapi>/i< (Spruce ex Griseb.) C.v. Morton e >i<Psychotria viridis>/i< Ruiz & Pav em diferentes ambientes, teor de alcaloides e citotoxicidade do chá Ayahuasca ↗ | Ordilena Ferreira de Miranda | 2020 | | 0 |
| [Ayahuasca in the Netherlands: what the doctor should know about its side effects] ↗ | van den Berg A, van Eeghen EE, Kooter AJ et al. | 2020 | Nederlands tijdschrift voor geneeskunde | 0 |
| Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making ↗ | Mitina O, Mirsaidov M, Molchanova N et al. | 2020 | PsyArXiv | 0 |
| Corrigendum: Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study with a Standard 8-Week Mindfulness Training Program ↗ | Soler J, Elices M, Dominguez-Clavé E et al. | 2020 | Frontiers in pharmacology | 0 |
| Desenvolvimento de métodos analíticos para determinação dos alcaloides da >i<ayahuasca>/i< em diferentes matrizes aplicando estratégias de química analítica verde ↗ | Gabriela de Oliveira Silveira | 2020 | | 0 |
| Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities ↗ | Ammar Jawad | 2020 | VCU Scholars Compass (Virginia Commonwealth University) | 0 |
| Erratum: Internet method for the extraction of N,N-dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine? ↗ | Giordano Novak Rossi, Eduardo José Crevelin, Gabriela de Oliveira Silveira et al. | 2020 | Journal of Psychedelic Studies | 0 |
| Faculty Opinions recommendation of Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents ↗ | Eric Hollander, Genoveva Uzunova | 2020 | Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | 0 |
| Is Kambô psychoactive? Acute and subacute effects of the secretion of the Giant Maki Frog (Phyllomedusa bicolor) on human consciousness ↗ | Schmidt TT, Reiche S, Hage CLC et al. | 2020 | bioRxiv | 0 |
| N,N-Dimethyltryptamine ↗ | Kamile YÜCEL | 2020 | KTO Karatay University Institutional Archive | 0 |
| RÉSISTANCES CONTRE LE DISCOURS DOMINANT SUR LES DROGUES : USAGES THÉRAPEUTIQUES ET RELIGIEUX DE L’AYAHUASCA DANS LE MONDE GLOBALISÉ ↗ | Hughes Brisson | 2020 | Revue québécoise de droit international | 0 |
| The aryl hydrocarbon receptor (AhR) in melanomas: association with BRAF mutations, with disease progression and ligand identification ↗ | Maria Carmen Oliveira Pinho de Sales | 2020 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| The pharmacological suppression of spreading depolarization in ischemic neuroprotection ↗ | Írisz Szabó | 2020 | | 0 |
| The Role of Myofascial Tensions, Nitric Oxide (NO) and Dimethyltriptamine (DMT) in Mental Illness Etiology ↗ | Nicola Petrogalli | 2020 | Journal of Traumatic Stress Disorders & Treatment | 0 |
| [Three forms of Dionysus: recreational, medical and religious use of ayahuasca] ↗ | van der Braak A | 2020 | Tijdschrift voor psychiatrie | 0 |
| A Ação Judicial da União do Vegetal vs. Governo dos Estados Unidos ↗ | André Fagundes Pase | 2021 | Dignitas Revista Internacional do Instituto Brasileiro de Direito e Religião | 0 |
| [Analysis of Dimethyltryptamine in Captured Suspicious Substances：Three Case Reports] ↗ | Xu JL, He SY, Qiao D et al. | 2021 | Fa yi xue za zhi | 0 |
| Anti-inflammatory and analgesic actions of bufotenine through inhibiting lipid metabolism pathway. ↗ | Wang, Jiaojiao, Xu, Dihui, Shen, Lili et al. | 2021 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | |
| Avaliação do manejo de população clonal de Psychotria viridis Ruiz & Pav (Rubiaceae) segundo as condições ambientais e sazonalidade ↗ | Camila Dias Lourenço dos Santos | 2021 | | 0 |
| Ayahuasca potential benefits ↗ | Pinilla R, Rodriguez C, Batet-Sanchez D et al. | 2021 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| Bufotenine and its derivatives: synthesis, analgesic effects identification and computational target prediction. ↗ | Zhao, Chao, Chen, Min, Sun, Shan-Liang et al. | 2021 | Chinese journal of natural medicines | |
| (CASO CLÍNICO) UN MAL VIAJE CON AYAHUASCA: A PROPÓSITO DE UN CASO ↗ | | 2021 | LIBRO COMUNICACIONES | 0 |
| Correction: Simão, A.Y., et al. Evaluation of the Cytotoxicity of Ayahuasca Beverages. <i>Molecules</i> 2020, <i>25</i>, 5594 ↗ | Simão AY, Gonçalves J, Gradillas A et al. | 2021 | Molecules (Basel, Switzerland) | 0 |
| Data_Sheet_1_An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study.DOCX ↗ | Pascal Michael (11843246), David Luke (11301588), Oliver Robinson (1364325) | 2021 | Figshare | 0 |
| DataSheet1_A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.docx ↗ | Johannes Reckweg (11755736), Natasha L. Mason (11755739), Cees van Leeuwen (255734) et al. | 2021 | Figshare | 0 |
| Dimethyltryptamine, methyltryptamine, hallucinations and metals ↗ | Elena L. Paley | 2021 | Elsevier eBooks | 0 |
| Elaboração de escala avaliativa do setting no uso de ayahuasca ↗ | Alexandre Augusto de Deus Pontual | 2021 | | 0 |
| Evidence of Ayahuasca's fast antidepressive effect in an animal model of greater depression ↗ | Francisco Cid Coelho Pinto | 2021 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Evidências do efeito antidepressivo rápido da Ayahuasca em um modelo animal de depressão maior ↗ | Francisco Cid Coelho Pinto | 2021 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| In Case You Haven't Heard… ↗ | | 2021 | Mental Health Weekly | 0 |
| In vitro effects of bufotenine against RNA and DNA viruses. ↗ | Barboza, Camila Mosca, Pimenta, Daniel Carvalho, Vigerelli, Hugo et al. | 2021 | Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] | |
| New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review ↗ | Matthias Forstmann, Christina Sagioglou | 2021 | | 0 |
| On the markers for schizophrenia ↗ | Александр Николаевич Еричев, I. I. Bode, V. О. Polyakova et al. | 2021 | V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY | 0 |
| Placebo response in treatment resistant depression: a systematic review and meta-analysis of multiple treatment modalities ↗ | Jones B, Weissman C, Karbi J et al. | 2021 | BJPsych open | 0 |
| Psychedelic Clinical Studies - Bibliometric Dataset ↗ | Jeremy Weleff, Teddy J. Akiki, Brian S. Barnett | 2021 | Figshare | 0 |
| Psychoactive effects and toxicity of tryptamine, N-methyltryptamine (NMT), and N, N-dimethyltryptamine (DMT): quantification methods ↗ | Elena L. Paley | 2021 | Elsevier eBooks | 0 |
| Psychotomimetic to Mind-Manifesting ↗ | Szczech, Klaudia | 2021 | Open Collections | 0 |
| Quo Vadis? Plants of the Gods and Their Recently Discovered Therapeutic Applications ↗ | Sarshar Shabnam Beydokhti | 2021 | Planta Medica | 0 |
| Senses of Self, Society, and Cosmos ↗ | Alex K. Gearin, Óscar Calavia Sáez, Jean-Pierre Chaumeil et al. | 2021 | Kent Academic Repository (University of Kent) | 0 |
| Sensitive and Selective Detection of N,N-Dimethyltryptamine with Molecularly Imprinted Polymer Coupled with Electrogenerated Chemiluminescence ↗ | Wujian Miao, Jesy Alka Motchaalangaram, Arati Biswakarma et al. | 2021 | ECS Meeting Abstracts | 0 |
| The setting questionnaire for the Ayahuasca experience ↗ | Alexandre Augusto de Deus Pontual | 2021 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| The therapeutical role of psychedelic drugs in treatment of mental disorders ↗ | Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță et al. | 2021 | Bulletin of Integrative Psychiatry | 0 |
| TRUST, LEARNING AND ANOMALOUS EXPERIENCE OF JAPAN AND SLOVAK UNIVERSITY STUDENTS ↗ | Martina Blašková, Hideyuki Kokubo, Dominika Tumová et al. | 2021 | | 0 |
| Uso da ayahuasca no tratamento da depressão ↗ | Robenilson Diniz Alves, Epifanio Fernandes da Silva, Maria Loyse da Silva Fernandes et al. | 2021 | RCMOS - Revista Científica Multidisciplinar O Saber | 0 |
| Vegetative anatomy, morphology and histochemistry of three species of Malpighiaceae used in analogues of the Amazonian psychoactive beverage Ayahuasca ↗ | Nagamine-Pinheiro N, Fagg CW, Gomes SM et al. | 2021 | Flora. | 0 |
| Visions from other worlds: Western Esotericism, UFO beliefs and conspiracy theories in New Age ayahuasca groups ↗ | Ricardo Assarice dos Santos, Leornardo Breno Martins | 2021 | | 0 |
| When formulation procedures strongly matter: a case study of ayahuasca use in Centro Luz Divina, Piedade, São Paulo, Brazil ↗ | Arilton Martins Fonseca, Eliana Rodrigues | 2021 | Revista de Ciências Farmacêutica Básica e Aplicadas - RCFBA | 0 |
| A phase 1, dose-ranging trial to assess the safety and psychoactive effects of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation in healthy volunteers ↗ | Johannes T. Reckweg, Natasha L. Mason, Cees van Leeuwen et al. | 2022 | Neuroscience Applied | 0 |
| Advanced Software, applied with the Polygraph technique, is useful to interpret electrochemical signals, emitted from Superior Plants (Gymnosperms), during the Depatterning procedure, with the aim to alter the biophysical state, of the same vegetal, and interpret elaborations through a procedure of reverse engineering ↗ | S. Turini, M. Dunjic, T. Saljic et al. | 2022 | Asian Journal of Basic Science & Research | 0 |
| Application of machine learning and complex network measures to an EEG dataset from DMT experiments ↗ | Alves CL, Toutain TGLdO, Porto JAM et al. | 2022 | medRxiv | 0 |
| Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19 ↗ | Escobar-Cornejo GS, Escobar-Cornejo DM, Ramos-Vargas LF | 2022 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 0 |
| Ayahuasca Self Consciousness and Mysticism ↗ | Savoldi R, Roazzi A | 2022 | PsyArXiv | 0 |
| Beoordeling van Shambala en een soortgelijk kruidenpreparaat ↗ | Rijksinstituut voor Volksgezondheid en Milieu, Wageningen Food Safety Research (WFSR) | 2022 | Socio-Environmental Systems Modeling | 0 |
| Bufotenine use in drug facilitated sexual assult. ↗ | Navarro Escayola, Esperanza, Vega Vega, Clara, Hernando Torrecilla, Cristina | 2022 | Medicina clinica | |
| Bufotenines-loaded liposome exerts anti-inflammatory, analgesic effects and reduce gastrointestinal toxicity through altering lipid and bufotenines metabolism. ↗ | Shen, Lili, Lv, Xiang, Yang, Xin et al. | 2022 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | |
| Chá de ayahuasca ; uma revisão bibliográfica sobre o uso da bebida alucinógena na neuropsiquiatria e na neurociência ↗ | Carolina Martins Cabrera, Yonamine, Maurício | 2022 | | 0 |
| Epistemic losses, cultural exclusions, and the risk of biopiracy in the globalization of ayahuasca: A reply to Labate et al ↗ | Schenberg EE, Gerber K | 2022 | Transcultural psychiatry | 0 |
| Erratum ↗ | | 2022 | Brazilian Journal of Pharmaceutical Sciences | 0 |
| Generic Control in Other Jurisdictions ↗ | | 2022 | Royal Society of Chemistry eBooks | 0 |
| <i>Incilius alvarius</i> cell-based synthesis of 5-MeO-DMT ↗ | Lerer L, Reynolds E, Varia J et al. | 2022 | bioRxiv | 0 |
| Lusaris launches with $60 million ↗ | Gina Vitale | 2022 | C&EN Global Enterprise | 0 |
| Natural Products ↗ | | 2022 | Royal Society of Chemistry eBooks | 0 |
| Neurobiologie der Nahtoderfahrung ↗ | W. Kuhn | 2022 | Universitätsverlag Kiel | Kiel University Publishing eBooks | 0 |
| P03-20 Ayahuasca and N,N-dimethyltryptamine (DMT): Toxicokinetics, toxicodynamics, and biological effects ↗ | Áurea Madureira-Carvalho, Andreia Machado Brito-da-Costa, D. Dias-da-Silva et al. | 2022 | Toxicology Letters | 0 |
| Plausible Mechanism in Prevention/Reversal of Oral Psychosomatic Disorders vis-à-vis Endogenous Secretion of N, N-Dimethyltryptamine ↗ | Khalil Ibrahim Assiri, Jagadish Hosmani, Abdullah A. Alqarni | 2022 | World Journal of Dentistry | 0 |
| Possible Therapeutics Effects of Ayahuasca, a Psychedelic Compound ↗ | L. Silva, L. Bravo | 2022 | European Psychiatry | 0 |
| Psychedelic Psychiatry ↗ | Nutt D | 2022 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| Psychedelics’ binding depends on receptor mutations ↗ | special to C EN Attabey Rodríguez Benítez | 2022 | C&EN Global Enterprise | 0 |
| Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions ↗ | Girala N | 2022 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| Quantum chemical study of the hydrolysis of oxidized endogenous psychedelic N,N-dimethyltryptamine ↗ | Károly Kubicskó, Richárd D. Kovács, Ödön Farkas | 2022 | Computational and Theoretical Chemistry | 0 |
| Reply to: 5-MeO-DMT has not been found in traditional ayahuasca preparations and the combination of 5-MeO-DMT with MAOIs is dangerous ↗ | James E, Keppler J, Robertshaw TL et al. | 2022 | Human psychopharmacology | 0 |
| SP56 Psychedelic drugs and pain ↗ | M Rekatsina, E Moka, A Vadalouca et al. | 2022 | | 0 |
| Substâncias psicotrópicas de origem natural: o que os usuários encontram na internet? ↗ | Juliana Pereira Lopes, Julino Assunção Rodrigues Soares Neto, Fúlvio Rieli Mendes | 2022 | Vigilância Sanitária em Debate | 0 |
| The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions ↗ | Vanessa Eveline VLAIC, Andreea ONA | 2022 | Hop and Medicinal Plants | 0 |
| Therapeutic use of ayahuasca: a review of the evidence of its use in approaching depressive disorders ↗ | Simões G, Jesus S, Silva R | 2022 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| ↗ | | 2023 | Science Reviews Biology | 0 |
| Alkaloids of Papaver rhoeas L. (Papaveraceae) and their biological activity related to Alzheimerʼs disease VI ↗ | Matěj Ludvík | 2023 | Digital Repository (National Repository of Grey Literature) | 0 |
| Anadenanthera colubrina (Vell) Brenan: Ethnobotanical, phytochemical, pharmacological and toxicological aspects. ↗ | Delices, Merline, Muller, Jessica de Araujo Isaias, Arunachalam, Karuppusamy et al. | 2023 | Journal of ethnopharmacology | |
| Aplicações de aprendizagem de máquina e redes complexas à neurociência ↗ | Caroline L. Alves | 2023 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| AYAHUASCA POSSUI EFEITO ANTIDEPRESSIVO? ↗ | Jocimar Rodrigues de Oliveira Júnior | 2023 | | 0 |
| Beyond Phytochemistry ↗ | Felix Krengel, Ricardo Reyes‐Chilpa, Karla Paola García-Cruz et al. | 2023 | | 0 |
| Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery ↗ | Chen X, Li J, Yu L et al. | 2023 | Research Square | 0 |
| Causal analyses of relaxed beliefs under psychedelics (REBUS) in the default mode network ↗ | Mario Stepanik, Robin Carhart-Harris, Christopher Timmermann et al. | 2023 | Open MIND | 0 |
| Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training ↗ | Lawrence Canale, Dhvanit Raval, Preet Chatha et al. | 2023 | American Journal of Psychiatry Residents Journal | 0 |
| Corrigendum: Ceremonial ayahuasca in amazonian retreats-mental health and epigenetic outcomes from a six-month naturalistic study ↗ | Ruffell SGD, Netzband N, Tsang W et al. | 2023 | Frontiers in psychiatry | 0 |
| Currents of Knowledge: the Santo Daime bailado as decolonial dance ↗ | Ana Flecha | 2023 | Revista Brasileira de Estudos da Presença | 0 |
| Defining Neo-Shamanic Practices Involving Dimethyltryptamine (DMT) from Shamans’ Perceptions on Transcendence and Transformation ↗ | Moreno, Ivan Dario | 2023 | Digital Access to Scholarship at Harvard (DASH) (Harvard University) | 0 |
| Desarrollo de sensores electroquímicos para la determinación de drogas sintéticas en fluidos biológicos y muestras de incautación ↗ | Jerson González Hernández | 2023 | Investigative News in Education (Universidad de Costa Rica) | 0 |
| Desenvolvimento de método baseado em Toxicologia Analítica Verde para determinação dos componentes ativos da ayahuasca em cabelo ↗ | Fabiana Pereira Santos | 2023 | | 0 |
| [Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry]. ↗ | Liu, Lei-Qi, Chen, Jing-Ze, Fu, Wu-Sheng et al. | 2023 | Se pu = Chinese journal of chromatography | |
| Development of a method based on green analytical chemistry for foreign ayahuasca active components in hair ↗ | Fabiana Maria da Conceição dos Santos | 2023 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Editor's evaluation: Criticality supports cross-frequency cortical-thalamic information transfer during conscious states ↗ | Tatyana O. Sharpee | 2023 | | 0 |
| Efeitos da ayahuasca sobre a extinção de memórias aversivas contextuais em ratos ↗ | Isabel Schlegel Werle | 2023 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Effects of N, N-Dimethyltryptamine on the phenotype and diathesis of a mice model of depression ↗ | Cruz, Rafael Vitor Lima da | 2023 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine ↗ | Nicolas Glynos | 2023 | Deep Blue (University of Michigan) | 0 |
| EVALUATION OF THE THERAPEUTIC NEUROTOXIC EFFECTS OF THE USE OF AYAHUASCA BY DEPRESSIVE PATIENTS ↗ | Catarina Rodrigues Damasceno Murucci, Rita de Cássia Ramos Queiroz de Freitas, Grazielly Ribeiro Viana et al. | 2023 | Revista Contemporânea | 0 |
| Experts Offer Tips on Talking With Patients About Psychedelics ↗ | Terri D’Arrigo | 2023 | Psychiatric News | 0 |
| Increased clonal growth in heavily harvested ecosystems failed to rescue ayahuasca lianas from decline in the Peruvian Amazon rainforest ↗ | Coe MA, Gaoue OG | 2023 | Journal of Applied Ecology. | 0 |
| Intranasal 5-methoxy-N,N-dimethyltryptamine safety, pharmacokinetics and psychedelic effects in healthy volunteers ↗ | Claire T. Roberts, Mathieu Seynaeve, James Rucker et al. | 2023 | Neuroscience Applied | 0 |
| Kültürel Miras ile Uyuşturucu Madde Tartışmaları Arasında Ayahuasca ↗ | Nadide Şahin | 2023 | Kocatepe İslami İlimler Dergisi | 0 |
| Medicalisation of Ayahuasca as a Depression Treatment ↗ | Elena Gomel Cordeiro | 2023 | The Maastricht Journal of Liberal Arts | 0 |
| Neurodynamics of empathy and prosociality following serotonergic stimulation with an ayahuasca analogue containing N,N-dimethyltryptamine and harmine in a randomised controlled trial ↗ | Helena Aicher, D. Suay, Alexandra Hempe et al. | 2023 | Neuroscience Applied | 0 |
| New psychoactive substances: kratom, DMT, serotonergic hallucinogens, dissociative drugs. The mechanism of action, psychoactive effects ↗ | Andrey Viktorovich Antsyborov | 2023 | Neurology Bulletin | 0 |
| New study investigates the impact of Amazonian ayahuasca retreats on veterans, assessing its effect on brainwaves, the genome, gut microbiome and mental health ↗ | Ruffell S | 2023 | PsyArXiv | 0 |
| On the application of Machine Learning and Complex Networks to Neuroscience ↗ | Caroline L. Alves | 2023 | | 0 |
| OS EFEITOS DA AYAHUASCA NO TRATAMENTO TERAPÊUTICO DA ANSIEDADE E DEPRESSÃO ↗ | Roberto Carlos Gonçalves de Carvalho, Fabiano Lacerda Carvalho | 2023 | Revista Ibero-Americana de Humanidades, Ciências e Educação | 0 |
| Pharmacodynamics of SPL026 (N,N-Dimethyltryptamine fumarate) with supportive therapy in patients with major depressive disorder ↗ | Ellen James, Carol Routledge, Mary-Jo Good et al. | 2023 | Neuroscience Applied | 0 |
| Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain ↗ | Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. | 2023 | | 0 |
| Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health ↗ | Jennings Hernandez | 2023 | Advances in Research | 0 |
| Possible psychotic episode after repeated ayahuasca intake: a case report ↗ | Prades Marin E, Martínez Torres A, Sánchez Díez P | 2023 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| Preface ↗ | | 2023 | | 0 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians – Part I. Historical Perspective and Overview ↗ | Tabaac BJ, Shinozuka K, Arenas A et al. | 2023 | PsyArXiv | 0 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and Ayahuasca ↗ | Shinozuka K, Tabaac BJ, Arenas A et al. | 2023 | PsyArXiv | 0 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians – Part V. Ibogaine ↗ | Cherian K, Shinozuka K, Tabaac BJ et al. | 2023 | PsyArXiv | 0 |
| Psychedelics for depression: from neurobiology to treatment ↗ | Kuypers K | 2023 | European psychiatry : the journal of the Association of European Psychiatrists | 0 |
| Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness? ↗ | Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett et al. | 2023 | Clinical Chemistry | 0 |
| Recurrent cerebral intraparenchymal hemorrhage after ayahuasca consumption: a case report ↗ | Caroline Darold Vieira, Mateus Gustavo Favaro, Renan Barros Lopes et al. | 2023 | | 0 |
| Reports by explorers and travelers and the first scientific studies on ayahuasca (dating from 1850 to 1950) within the current debate on the "psychedelic renaissance" ↗ | Lima VM, Marinho MGSMDC | 2023 | Historia, ciencias, saude--Manguinhos | 0 |
| Review: <i>Liquid Light: Ayahuasca Spirituality and the Santo Daime Tradition</i>, by G. William Barnard ↗ | Tarryl Janik | 2023 | Nova Religio The Journal of Alternative and Emergent Religions | 0 |
| Safety, blood levels and effects of N,N-dimethyltryptamine [DMT (SPL026)] in healthy participants and participants with major depressive disorder ↗ | David Erritzøe | 2023 | http://isrctn.com/ | 0 |
| Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study ↗ | Mika Turkia | 2023 | | 0 |
| THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE ↗ | Chirag Ambaliya, Dimple Gupta, Ashok Vala et al. | 2023 | PARIPEX-INDIAN JOURNAL OF RESEARCH | 0 |
| Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders ↗ | J. Schimmelpfennig, Kamila Jankowiak-Siuda | 2023 | Pharmacotherapy in Psychiatry and Neurology | 0 |
| Touch and play—'spiritual attacks' in ayahuasca ceremonies ↗ | Turkia M | 2023 | PsyArXiv | 0 |
| Translational research investigating psilocybin ↗ | Manon M.J. van den Berg | 2023 | | 0 |
| Unresponsive but Not Necessarily Unconscious: An Introduction to the Special Focus ↗ | Charlotte Martial, Olivia Gosseries | 2023 | Journal of Cognitive Neuroscience | 0 |
| Using an Electrochemical Deblocking Step in ASO Synthesis to Produce Quicker and Higher Yields of Oligonucleotides ↗ | Austin Rockaitis, Daniel S. Kissel | 2023 | ECS Meeting Abstracts | 0 |
| WINE OF SOULS: HOW THE USE OF AYAHUASCA CAN IMPACT ON THE QUALITY OF LIFE IN THE LIGHT OF NEUROPSYCHOLOGY ↗ | Vinícius Eduardo Damacena, Natalie de Castro Almeida | 2023 | International Journal of Human Sciences Research | 0 |
| 5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood—a retrospective case study ↗ | Turkia M | 2024 | PsyArXiv | 0 |
| A contemporary analysis of the effects of neuroplasticity on well-being ↗ | | 2024 | Armenian Journal of Health & Medical Sciences | 0 |
| A phenomenological exploration of experiences with short-acting psychedelics for low mood and depression ↗ | Ryan Little | 2024 | University of Birmingham Institutional Research Archive (University of Birmingham) | 0 |
| Actividad eléctrica del Cerebro Psicodélico; Revisión Sistemática sobre Estudios Clínicos Con EEG en estado de reposo ↗ | Juan Pedro Castro‐Nin, Frank Lozano Jara, Ismael Apud | 2024 | Scientific Electronic Library Online (Scientific Electronic Library Online) | 0 |
| Avaliação da atividade citotóxica e antidepressiva da Jurema-preta (Mimosa tenuiflora (Wild.) poir.) em modelos in vitro e in vivo ↗ | Ana Alves | 2024 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Ayahuasca and Religious Freedom ↗ | Andrew C. Michaels | 2024 | SSRN Electronic Journal | 0 |
| Ayahuasca, etnofarmacologia e usos no tratamento do transtorno de ansiedade: uma revisão sistemática ↗ | Francy Gizella Marroquin Rincon, Rhaiana De Fatima Vidal Gondim, Josana de Castro Peixoto | 2024 | Brazilian Journal of Health Review | 0 |
| Blinding in psychedelic studies: comparison of placebo and sub-perceptual dose of intranasal 5-Methoxy-N,N-dimethyltryptamine in healthy volunteers ↗ | Chandni Hindocha, Mathieu Seynaeve, Anna O. Ermakova et al. | 2024 | Neuroscience Applied | 0 |
| Characterizing alkaloid diversity in Psychotria viridis leaf extracts from central Amazonian terra firme forest understory populations ↗ | Eduardo Tavares | 2024 | International Journal of Pharmacognosy and Life Science | 0 |
| Chronic pain education: past, present, and future of psychedelics for the management of chronic pain ↗ | Christopher L. Robinson, Pawan Solanki, S Snyder et al. | 2024 | Pain Medicine | 0 |
| Clinical pharmacokinetics of N,N-dimethyltryptamine: a systematic review and post-hoc analysis to guide future clinical studies for neuropsychiatric indications ↗ | K. Van Der Heijden, Michael Otto, J.W. Schoones et al. | 2024 | Neuroscience Applied | 0 |
| Correction to "Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans" by Weiss et al. (2023) ↗ | | 2024 | Psychological trauma : theory, research, practice and policy | 0 |
| Could Ayahuasca Communities Play a Role in the Compassionate Communities Movement?: A Commentary ↗ | Débora González, Jordi Cantillo, José Carlos Bouso | 2024 | Archives of Pharmacology and Therapeutics | 0 |
| Dismantling the Myth of “Mother Ayahuasca”: Gender Dynamics and Cosmology within Mestizo Ayahuasca Shamanism, Iquitos, Peru ↗ | EMILY JANE SINCLAIR | 2024 | Durham e-Theses (Durham University) | 0 |
| Diverse avenues of research support the transmethylation theory of psychosis: implications for neuroprotection ↗ | Christine L. Miller | 2024 | Exploration of Neuroprotective Therapy | 0 |
| DMT – psychodelik otwierający duszę ↗ | Izabela Szpręgiel | 2024 | Kosmos | 0 |
| Drugie życie psychodelików ↗ | Krystyna Gołembiowska, Katarzyna Kamińska | 2024 | Kosmos | 0 |
| Efeitos do uso da Ayahuasca utilizada em Cerimônias religiosas sobre aspectos emocionais dos participantes ↗ | Felipe Teixeira | 2024 | Revista Ouricuri | 0 |
| Effect of Intravenous Delivery of N,N Dimethyltryptamine on Sleep-Wake States in Rat ↗ | Rachel Summerfield, Trent Groenhout, T. Liu et al. | 2024 | Physiology | 0 |
| Effects of antidepressant discontinuation on response to psilocybin therapy in treatment resistant depression ↗ | Jess Kerr-Gaffney, James Rucker, Petrina Chu et al. | 2024 | Open MIND | 0 |
| Effects of Ayahuasca on Ethanol-Conditioned Place Preference and ΔFosB Expression in the Nucleus Accumbens in Mice ↗ | Distefano Wiltenburg V, Morales-Lima G, Sousa Santos AV et al. | 2024 | bioRxiv | 0 |
| Effects of N, N-dimethyltryptamine (DMT) in a model of corticosterone-induced resistant depression: investigation of the influence of sex ↗ | Dino César da Silva Clemente | 2024 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Expanding Mindscapes: A Global History of Psychedelics. By ErikaDyck, ChrisElcock (Eds.), Cambridge, MA: The MIT Press. 2023. ISBN: 9780262546935 ↗ | Peder Clark | 2024 | Addiction | 0 |
| Exploring Endogenous Tryptamines: Overlooked Agents Against Fibrosis in Chronic Disease? A Narrative Review ↗ | Hunter Korsmo | 2024 | Livers | 0 |
| From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine ↗ | Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud et al. | 2024 | European Journal of Arts Humanities and Social Sciences | 0 |
| Genotoxic and mutagenic evaluation of Ayahuasca in peripheral blood and bone marrow of Mus musculus ↗ | Feitosa P, Viana M, Figueredo-Silva J et al. | 2024 | Authorea Preprints | 0 |
| Hallucinogens, dissociative drugs, and empathogens ↗ | | 2024 | | 0 |
| Healing with Ayahuasca the Plant Teacher: Psychedelic Metaphoricity and Polyontologies ↗ | Gearin AK | 2024 | Medical anthropology | 0 |
| Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspective ↗ | Mika Turkia | 2024 | | 0 |
| MOLECULES OF CONSCIOUSNESS: THE ROLE OF NEUROTRANSMITTERS IN PSYCHIATRY AND SPIRITUAL EXPERIENCES ↗ | Maruke Yeghiyan, D.A. Palyan | 2024 | ARMENIAN JOURNAL OF MENTAL HEALTH | 0 |
| Neurogenic Potential of <i>Acacia oerfota</i>: Evaluating the Effects of DMT-Rich Extract on PC12 Cells ↗ | Narges Ghasemi Lakeh, Mona Farhadi, Fatemeh Siadat | 2024 | Thrita journal of neuron. | 0 |
| Nixi pae and its transcendental connection: An ethnographic essay on ayahuasca rituals in a Huni Kuin community in Brazil ↗ | Ana Verônica De Sá Resende, Txanawa Inu Bake, Fabrício Borges Carrijo | 2024 | Etnografia Praktyki Teorie Doświadczenia | 0 |
| O relatório da DEA sobre os riscos da ayahuasca: a “ciência” a serviço do proibicionismo? ↗ | Beatriz Caiuby Labate, Anna O. Ermakova, Jordan Sloshower et al. | 2024 | Ponto Urbe | 0 |
| On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders ↗ | Hoyer D | 2024 | Authorea Preprints | 0 |
| One- and Two-Photon Excitable Photoswitchable Orthoand Allosteric Ligands of Class A GPCRs ↗ | Hubert Georg Lambert Gerwe | 2024 | Online Publication Service of Würzburg University (Würzburg University) | 0 |
| Perception, Cognition and Ayahuasca A Multidimensional Analysis of Alter States of Consciousness ↗ | Dila Suay | 2024 | Open MIND | 0 |
| Plant dehydration, alkaloid concentration, and cytotoxicity on ayahuasca traditional tea ↗ | Ordilena Ferreira de Miranda, Marcílio de Almeida, Ilza Maria de Oliveira Sousa et al. | 2024 | Amazon Expedition Magazine. | 0 |
| Plant Medicine, Psychedelics and the Inner-Sciences of Mental Wellness: Implications for Healthy Longevity and Rejuvenation ↗ | Jeffrey L. McNairy | 2024 | International Journal of Translational Science | 0 |
| Primjena psihodelika u psihijatriji ↗ | Marija Kudumija Slijepčević, Gabrijela Japranin, Tamara Salaj et al. | 2024 | Paviljon | 0 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca: Erratum ↗ | | 2024 | American Journal of Therapeutics | 0 |
| Psychedelics: The New Kid on the Block ↗ | Prosenjit Ghosh, Avinash Desousa | 2024 | Annals of Indian Psychiatry | 0 |
| Psychedelics Use and the Risk of Reduced Formal Mental Health Care ↗ | Viña S | 2024 | Research Square | 0 |
| Psychotic Symptoms Following Ayahuasca Use in a Ceremonial Setting ↗ | Torres AM, Marín EP, Díez PS et al. | 2024 | The primary care companion for CNS disorders | 0 |
| Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials ↗ | Fluyau D, Kailasam VK, Revadigar N | 2024 | medRxiv | 0 |
| Reivindicación del derecho a la salud frente al desconocimiento del yagé como posibilidad terapéutica ↗ | Valerie Michelle Vallejo Vilaró, César Alveiro Montoya Agudelo | 2024 | Revista Latinoamericana de Derecho Social | 0 |
| Review of trials finds psychedelics generally well‐tolerated ↗ | | 2024 | The Brown University Psychopharmacology Update | 0 |
| Safety, blood levels and effects of N,N-dimethyltryptamine [DMT (SPL026)] in healthy participants that have taken psychedelic substances before (Part A) and in healthy participants with little to no psychedelic experience (Part B) ↗ | Adeep Puri | 2024 | http://isrctn.com/ | 0 |
| Safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of intravenous dosing of SPL026 drug product (N, N-dimethyltryptamine fumarate; DMT Fumarate [A Serotonergic Psychedelic]) alone or in combination with selective serotonin reuptake inhibitors in patients with major depressive disorder ↗ | Neel Bhatt | 2024 | http://isrctn.com/ | 0 |
| Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-<i>N</i>,<i>N</i>-dimethyltryptamine) ↗ | Matthias Zeller, Stephan D. Parent, N. Schultheiss | 2024 | Acta Crystallographica Section E Crystallographic Communications | 0 |
| Survey finds new users of psychedelics report unusual visual experiences ↗ | | 2024 | The Brown University Psychopharmacology Update | 0 |
| Terapia psicodélica : revisión bibliográfica de los aspectos psicoterapéuticos de cuatro sustancias psicotrópicas ↗ | Garcés Aguirre, Juan David | 2024 | Univalle Digital Repository (University of Valle) | 0 |
| The light at the end of the tunnel ↗ | Johannes Tobias Reckweg | 2024 | | 0 |
| The Putative Role of the Medial Prefrontal Cortex in Emergence from General Anesthesia ↗ | Emma R. Huels | 2024 | Deep Blue (University of Michigan) | 0 |
| The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress ↗ | Gonçalves J, Feijó M, Socorro S et al. | 2024 | Pharmaceuticals (Basel, Switzerland) | 0 |
| Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review ↗ | Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B et al. | 2024 | Journal For International Medical Graduates | 0 |
| Transient destabilization of whole brain dynamics induced by DMT ↗ | Piccinini JI, Perl YS, Pallavicini C et al. | 2024 | bioRxiv | 0 |
| Tryptamine psychedelics shape population receptive fields in early visual cortex in the presence of perceptual distortions ↗ | Marta Lapo Pais, Carla Soares, Marta Teixeira et al. | 2024 | Acta Ophthalmologica | 0 |
| Understanding Neuroplasticity Induced by TrYptamines (UNITy): the effects of dimethyltryptamine (DMT) on drinking ↗ | Ravi Das, Jeremy I Skipper, Gregory M. Cooper | 2024 | http://isrctn.com/ | 0 |
| Unlocking the Therapeutic Potential of DMT’s: Molecular Modelling Insights into Nueropharmacological Mechanisms and Clinical Prospects ↗ | | 2024 | Letters in Applied NanoBioScience | 0 |
| Unraveling the organellar genomic landscape of the therapeutic and entheogenic plant Mimosa tenuiflora: insights into genetic, structural, and evolutionary dynamics ↗ | Trinca V, Silva SR, Almeida JVA et al. | 2024 | Functional & integrative genomics | 0 |
| Utilisation de micro-prélèvements volumétriques dans une situation d’autopsie : à propos d’un cas d’intoxication à la 5-methoxy-dimethyltryptamine ↗ | Laurène Dufayet, Laurence Labat, Romain Magny et al. | 2024 | Annales de Toxicologie Analytique | 0 |
| "Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination ↗ | Banan Ramarushton | 2024 | | 0 |
| 169. THERAPEUTIC MEMORY RECONSOLIDATION AS A TREATMENT FOR SUBSTANCE USE DISORDERS AND HOW PSYCHEDELICS ARE FACILITATING THIS INTERVENTION: THE UNITY STUDY ↗ | Sandra Ofori, Rajenki Das | 2025 | The International Journal of Neuropsychopharmacology | 0 |
| 5-MeO-DMT ↗ | Angelica Ukaigwe, Anjna Chauhan, S. Vinod Kumar | 2025 | | 0 |
| A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens ↗ | William Roseby, Catriona Osborn Moar | 2025 | Psychoactives | 0 |
| A Mesoscale Framework for Psychedelic Drug Action in the Human Brain ↗ | Dai R, Cofre R, Timmermann C et al. | 2025 | bioRxiv | 0 |
| A new insight into ayahuasca's adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS) ↗ | Andión Ó, Bouso JC, Sarris JJ et al. | 2025 | PLOS mental health | 0 |
| A percepção temporal no uso ritual da ayahuasca e rapé ↗ | Ana Paula Silva Campagnoli | 2025 | | 0 |
| A pilot study investigating naturally occurring dimethyltryptamine (DMT) and related psychoactive substances in Western Australian <i>Acacia</i> (Fabaceae: Mimosoideae) ↗ | Richard Donovan, Hannah Crisp, Kelly Anne Shepherd | 2025 | Australian Journal of Forensic Sciences | 0 |
| A stranger in a strange land: negotiating supernatural 'fact' and 'fiction' within visions and hallucinations in non-traditional ayahuasca churches ↗ | Andrew Dean, Anna Waldstein, Rajindra K. Puri | 2025 | Kent Academic Repository (University of Kent) | 0 |
| A streamlined synthesis of 5-methoxy-N,N-dimethyltryptamine, bufotenin, and bufotenin prodrugs from melatonin ↗ | Anton A. Homon, P. V. Vara Prasad, Elham Pourian et al. | 2025 | ChemRxiv | 0 |
| A systematic study of changes in monoamine neurotransmitters in the rat brain following acute administration of alpha-methyltryptamine (AMT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT). ↗ | Li, Kaixi, Li, Nan, Chen, Yuanyuan et al. | 2025 | Neuroscience research | |
| A Toad Less Traveled: Should 5-MeO-DMT Have a Role in Treating Depression? ↗ | Caroline Hayes | 2025 | Psychedelic Medicine | 0 |
| Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study ↗ | Perkins D, Halman A, Urokohara A et al. | 2025 | Scientific reports | 0 |
| Additional NMR data for: A streamlined synthesis of 5-methoxy-N,N-dimethyltryptamine, bufotenin, and bufotenin prodrugs from melatonin ↗ | Homon, Anton, Trant, John F., Prasad, Pavithra et al. | 2025 | Borealis | 0 |
| An encounter with death: a comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience ↗ | Michael P, Luke D, Robinson O | 2025 | Frontiers in psychology | 0 |
| Anti-inflammatory effects of <i>Banisteriopsis caapi</i> and beta-carbolines in neuronal cells: potential implications for neuro-COVID ↗ | Bianco LS, Nicoliche T, Corrêa-Neto NF et al. | 2025 | Frontiers in pharmacology | 0 |
| Author response for "COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS" ↗ | Paola Andrea Caro Aponte, Edison Huertas Montoya, Italo O. Mazali et al. | 2025 | | 0 |
| Ayahuasca ↗ | Anjna Chauhan, Angelica Ukaigwe, S. Vinod Kumar | 2025 | Revista de psicoanalisis | 0 |
| Ayahuasca and debut of psychosis, description of a clinical case ↗ | E. E. Morales Castellano, P. Rivero Rodríguez, Marina Martínez Grimal et al. | 2025 | European Psychiatry | 0 |
| Ayahuasca and the Unified Integrative Model of Medicine: A Path to Healing and Spiritual Transformation ↗ | Nader Butto | 2025 | International Journal of Psychiatry Research | 0 |
| Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community ↗ | Turkia M | 2025 | PsyArXiv | 0 |
| Ayahuasca-Induced Serotonin Syndrome: Risks, Mechanisms, and Clinical Considerations ↗ | Melissa Ortega | 2025 | Pharmaceutical science. | 0 |
| Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation ↗ | Suay D, Aicher HD, Singer B et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 0 |
| Ayahuasca Mitigates Morphological Cortical Alterations in Juvenile Non-human Primates Following Chronic Stress Exposure ↗ | Júnior EdN, Pereira L, Lira-Bandeira W et al. | 2025 | Research Square | 0 |
| Ayahuasca, Pain, and Inflammation: A Systematic Review of Preclinical Studies ↗ | Bianca Villanova, Giordano Novak Rossi, Lorena Terene Lopes Guerra et al. | 2025 | Psychoactives | 0 |
| Ayahuasca: Pharmacological Composition and Potential Benefits ↗ | Raj Nashikkar, Shrikrishna Baokar, Rajendra Patil | 2025 | Research Journal of Pharmacy and Technology | 0 |
| Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice ↗ | Bruno V, Spelta LEW, Pereira ML et al. | 2025 | Psychopharmacology | 0 |
| Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being ↗ | Maclean B, Wilson A, Allen A et al. | 2025 | Journal of psychoactive drugs | 0 |
| Ayahuasca revisited. Case studies & observations ↗ | Turkia M | 2025 | PsyArXiv | 0 |
| Ayahuasca Shifts Brain Dynamics Toward Higher Entropy: Persistent Elevation of Ising Temperature Correlates with Acute Subjective Effects ↗ | Cabral-Carvalho RM, Palhano-Fontes F, Araujo DB et al. | 2025 | bioRxiv | 0 |
| Born Twice DMT and the Echo of Our First Conscious Experience ↗ | Tony R. Montgomery | 2025 | | 0 |
| BPL-003 ↗ | Vjekoslav Peitl, D. Vlahovic | 2025 | Archives of Psychiatry Research | 0 |
| Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine ↗ | Neumann J, Dietrich T, Azatsian K et al. | 2025 | Scientific reports | 0 |
| Clinical pharmacology of ayahuasca: potential applications and future considerations ↗ | Lopes Guerra LT, da Silva Dias IC, Hallak JEC et al. | 2025 | Expert review of clinical pharmacology | 0 |
| Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration ↗ | Muniz, John Marco D.F. | 2025 | Journal of International Crisis and Risk Communication Research | 0 |
| Complexity as a Potential Neurophysiological Correlate of Awe ↗ | Joseph C. C. Chen, Gabriella Mace, Avery Ostrand et al. | 2025 | bioRxiv (Cold Spring Harbor Laboratory) | 0 |
| Computational design of an improved photoswitchable psychedelic based on light absorption, membrane permeation and protein binding ↗ | Palmisano VF, Agnorelli C, Faraji S et al. | 2025 | Physical chemistry chemical physics : PCCP | 0 |
| Consciousness as a Non-Local Field: Completing Federico Faggin's Architecture with the DMT Receiver and the AO Interaction Law ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Corrigendum: Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol ↗ | Pablo Sabucedo, Óscar Andión, Robert A. Neimeyer et al. | 2025 | Frontiers in Psychiatry | 0 |
| Corrigendum: Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment ↗ | David J, Bouso JC, Kohek M et al. | 2025 | Frontiers in psychiatry | 0 |
| Dated Phylogeny of <i>Banisteriopsis</i> (Malpighiaceae) Suggests an Ancient Colonization of the Cerrado and No Evidence of Human Manipulation in the Origin of <i>B. caapi</i> ↗ | Santos TAC, Amorim BS, Maciel JR et al. | 2025 | Plants (Basel, Switzerland) | 0 |
| Decision letter for "COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS" ↗ | | 2025 | | 0 |
| Decoding subjective experience clusters from neural features in breathwork and N,N-Dimethyltryptamine ↗ | Evan Lewis-Healey, Tristan Bekinschtein, Enzo Tagliazucchi | 2025 | OSF Preprints (OSF Preprints) | 0 |
| Detailing a Pilot Study: The "Code of Reality" Protocol, A Phenomenon of N,N-DMT Induced States of Consciousness ↗ | Danny Goler | 2025 | IPI Letters | 0 |
| Determination of 5-OH-DMT (bufotenine) in the Asian toad Duttyphrynus melanostictus, Hoplobatrachus tigerinus and Haemopis sanguisiga in Madagascar by UHPLC-MS/MS ↗ | Ververi C, Nahavitatsara ER, Bezandry BA et al. | 2025 | Environmental toxicology and pharmacology | 0 |
| Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans ↗ | Wittayakarn N, Tan YM, Choomalaiwong P et al. | 2025 | Toxicological sciences : an official journal of the Society of Toxicology | 0 |
| Did the vilca/tobacco snuff combination at Chavín aim for an "ayahuasca effect"? ↗ | Whitridge P | 2025 | Proceedings of the National Academy of Sciences of the United States of America | 0 |
| Diet and chemical defenses of the Sonoran Desert toad ↗ | Luccioni MD, Wyman JT, Espinoza EO et al. | 2025 | PloS one | 0 |
| Differentiation of Ayahuasca Samples According to Preparation Mode and Botanical Varieties Using Metabolomics ↗ | Matos TS, da Silva Zandonadi F, Rosini Silva AA et al. | 2025 | Journal of psychoactive drugs | 0 |
| Disintegration of Default Mode: Functional MRI Insights Into N,N-Dimethyltryptamine (DMT), Consciousness, and Subcortical Connectivity ↗ | Avakian A | 2025 | Cureus | 0 |
| DMT as the Prototype of a New Class of Crisis-Linked Endogenous Consciousness Modulators (cECMs) ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| DMT-Induced Shifts in Criticality Correlate with Self-Dissolution ↗ | Mona Irrmischer, Marco Aqil, Lisa Luan et al. | 2025 | Journal of Neuroscience | 0 |
| DMT, Microtubule Coherence, and the Scalar Clock: A Unified Framework for Time-Consciousness ↗ | EUGENE CATRAMBONE | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Domestication of Phalaris aquatica as a Pasture Grass ↗ | Oram, R N, Schroeder, H E, Culvenor, R A | 2025 | UKnowledge (University of Kentucky) | 0 |
| Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics ↗ | M.L. Williams, Deborah Rudin, Yasmin Schmid et al. | 2025 | Frontiers in Psychiatry | 0 |
| Editorial for "Resilience and Brain Changes in Long-Term Ayahuasca Users: Insights From Psychometric and fMRI Pattern Recognition" ↗ | Bergsland N | 2025 | Journal of magnetic resonance imaging : JMRI | 0 |
| Efeitos de dose única de ayahuasca em universitários com uso abusivo de álcool: um estudo simples-cego ↗ | Lucas Silva Rodrigues | 2025 | | 0 |
| Effects of ayahuasca in preclinical studies with animals: a systematic review ↗ | Walsh-Monteiro A, Morato S, Uribe FAR et al. | 2025 | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 0 |
| Effects of psychedelics on human oscillatory brain activity ↗ | Godfrey K, Luan LX, Timmermann C | 2025 | International review of neurobiology | 0 |
| Electrodynamics of the Psychedelic Experience ↗ | Tamlyn Hunt | 2025 | Preprints.org | 0 |
| Elucidating the Toxicity and Energetic Signatures of DMT and its Analogs at Serotonin Receptors: A Quantum Biochemistry-Guided Approach for Therapeutic Innovation and Human Potential ↗ | Jonas Ivan Nobre Oliveira | 2025 | | 0 |
| Encoded Equilibrium, Crisis Molecules, and the Directive Chain: A Unified Swygert Theory of Everything AO Framework for Consciousness Across Human and Non-Human Intelligence ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Encoded Equilibrium, Crisis Molecules, and the Directive Chain: A Unified Swygert Theory of Everything AO Framework for Consciousness Across Human and Non-Human Intelligence – Part 2 ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Endogenous N,N-Dimethyltryptamine and Sigma-1 Receptor Modulation as Enhancers of Neural-Substrate Coherence in the Swygert Theory of Everything AO (TSTOEAO) ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Entity and environment relationships in psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine ↗ | Stephen Kagan | 2025 | Journal of Psychedelic Studies | 0 |
| Epená (Virola theiodora (Spruce ex Benth.) Warb. Myristicaceae) ↗ | Muhammad Younas, Ayesha Siddiqa, Rahmatullah Qureshi et al. | 2025 | | 0 |
| [Establishment and application of a high-throughput screening method for drugs targeting the 5-hydroxytryptamine 2A receptor based on cellular calcium flux signals] ↗ | Zhang B, Shi J, Zhang Y et al. | 2025 | Sheng wu gong cheng xue bao = Chinese journal of biotechnology | 0 |
| Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review ↗ | Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri et al. | 2025 | Brazilian Journal of Science | 0 |
| Extraction of N, N-dimethyltryptamine (DMT) from <i>Mimosa tenuiflora, syn. Mimosa hostilis</i> (Tepescohuite) using supercritical CO<sub>2</sub> and study of its surface activity ↗ | Arenas-Quevedo MG, Olvera-Santillan E, Gracia-Fadrique J | 2025 | Natural product research | 0 |
| Extraction of N, N-dimethyltryptamine (DMT) from <i>Mimosa tenuiflora, syn. Mimosa hostilis</i> (Tepescohuite) using supercritical CO<sub>2</sub> and study of its surface activity ↗ | Arenas-Quevedo, Miguel Gonzalo, Olvera-Santillan, Eduardo, Gracia-Fadrique, Jesús | 2025 | Open MIND | 0 |
| Fear as medicine: A mixed-methods analysis of 5-MeO-DMT, mental health, and intergenerational healing ↗ | Jeffrey Overall | 2025 | Applied Psychology Research | 0 |
| FRACTAL STRUCTURE OF REALITY: A UNIFIED FRAMEWORK FROM QUANTUM GEOMETRY TO CONSCIOUSNESS ↗ | Nicolai Becker | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| From fundamental phosphorus chemistry all the way to flow : a psychedelic journey ↗ | Andreas Simoens | 2025 | Ghent University Academic Bibliography (Ghent University) | 0 |
| From Prohibition to Prescription: Exploring Injustice, Bias, and Science-Based Solutions ↗ | Alexander Campos | 2025 | | 0 |
| From Spirit Guides to Machine Elves: A Cultural and Phenomenological History of Psychedelic Entity Encounters ↗ | Slade, Trent | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses ↗ | Ardini M, Angelucci F, Rea F et al. | 2025 | Biology direct | 0 |
| Future Ayahuasca Care Spaces: An Experimental Speculative Exercise ↗ | Pietro Benedito, Isabel Santana de Rose, Emilia Sanabria et al. | 2025 | Vibrant Virtual Brazilian Anthropology | 0 |
| Gut-Mind Interactions in Psychedelic Healing: A Case Study Assessing the Effects of Huachuma and Ayahuasca on the Mind and Microbiome ↗ | Follestad P, Filbin P, Thompson B et al. | 2025 | Journal of restorative medicine | 0 |
| Hemp Proteins Conjugated with Green Tea Polyphenol Extract Form <i>De Novo</i> Plant‐Sourced Emulsifiers Suitable for Nanodelivery Systems Bearing Lipophilic Psychopharmaceuticals ↗ | William Charles Hosie, Abhinandan Banerjee, Mary A. Egbuta et al. | 2025 | Advanced Therapeutics | 0 |
| Indolethylamine <i>N</i>-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine Production ↗ | Hatzipantelis CJ, Cameron LP, Liu M et al. | 2025 | ACS chemical neuroscience | 0 |
| Influence of administration setting on the pharmacological effects of the psychedelics dimethyltryptamine (DMT) and 5-methoxy-dimethyltryptamine (5-MeO-DMT) ↗ | Romain Hacquet | 2025 | theses.fr (ABES) | 0 |
| Influence of environmental conditions and seasonality on the metabolome and lipidome of Psychotria viridis leaves ↗ | Matos TS, Santos CDLD, Tófoli LF et al. | 2025 | The Plant journal : for cell and molecular biology | 0 |
| Informe final del proyecto: Psicodélicos, plasticidad y protección neuronal: estudio de mecanismos moleculares novedosos ↗ | Mariana Pazos Vidal Pazos, Ignacio Carrera Garese, Giselle Fabiana Prunell Dos Santos et al. | 2025 | LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) | 0 |
| Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency ↗ | Parnes JE, Earleywine M | 2025 | Journal of psychoactive drugs | 0 |
| Inhaled N, N-dimethyltryptamine diminishes connectivity between the ventral tegmental area and the nucleus accumbens: relevance to pathologies of mesolimbic and mesocortical pathways ↗ | Lima G, Soares C, Teixeira M et al. | 2025 | Scientific reports | 0 |
| Intact neurophysiological markers of death denial in long-term ayahuasca users ↗ | Dor-Ziderman Y, David J, Berkovich-Ohana A | 2025 | Psychopharmacology | 0 |
| Is the mere absence of dimethyltryptamine in hair evidence of ayahuasca non-exposure? Development of an LC-MS/MS method for the comprehensive quantification of β-carbolines and tryptamines in hair ↗ | Nadia Arbouche, Alice Ameline, Laurie Gheddar et al. | 2025 | Annales de Toxicologie Analytique | 0 |
| <b>USO DA AYAHUASCA NO BRASIL: UMA ANÁLISE DE UMA DÉCADA</b> ↗ | Marcos Lorran Paranhos Leão, Estácio Amaro da Silva Júnior | 2025 | Revista Multidisciplinar do Nordeste Mineiro | 0 |
| <i>Diplopterys pubipetala</i> (Malpighiaceae): Insights into Antioxidant, Antibacterial, and Antifungal Activities with Chemical Composition Analysis via UHPLC-MS/MS and GC/MS ↗ | de Melo Sacramento V, de Andrade Royo V, Fonseca Veloso PH et al. | 2025 | Molecules (Basel, Switzerland) | 0 |
| Measuring and Enhancing Psychedelic Preparedness ↗ | McAlpine, Rosalind G | 2025 | UCL Discovery (University College London) | 0 |
| Mechanisms of neuroplasticity induced by permeable serotonergics ↗ | A. N. Fedorov | 2025 | | 0 |
| Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat ↗ | Egger K, Meling D, Polat F et al. | 2025 | medRxiv | 0 |
| Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat ↗ | Egger, Klemens, Meling, Daniel, Polat, Firuze et al. | 2025 | Repository for Publications and Research Data (ETH Zurich) | 0 |
| Modern Pharmacological Paradigms in the Treatment of Depression ↗ | Shraddha Wasnik*, Dr. Shantilal Singune | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Monetizing the Psychoactive Properties in the Invasive Acacia confusa ↗ | Kuniyoshi, Kelsie | 2025 | ScholarSpace (University of Hawaii at Manoa) | 0 |
| Monetizing the Psychoactive Properties in the Invasive Formosan Koa (Acacia confusa) ↗ | Kelsie Kuniyoshi | 2025 | ScholarSpace (University of Hawaii at Manoa) | 0 |
| N , N -dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation ↗ | J Laszlo, Judit Piroska Vigh, Anna E. Kocsis et al. | 2025 | Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) | 0 |
| Natural Hallucinogens in Clinical Studies: A Review of Therapeutic Efficacy and Methodological Limitations ↗ | Ewa Niedzielska-Andres, Angelika Ziaja, Stanisław Zielinski et al. | 2025 | Farmacja Polska | 0 |
| Natural hallucinogens of fungal and animal origin: action and potential applications — a narrative review ↗ | Krzysztof Ciszowski, Angelika Ziaja, Ewa Niedzielska et al. | 2025 | Folia Medica Cracoviensia | 0 |
| Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic Study ↗ | Paracha N | 2025 | Journal of integrative and complementary medicine | 0 |
| Network Rerouting Under Ayahuasca: Temporally and Hemisphere-Resolved EEG Connectomics ↗ | Alves CL, Palhano-Fontes F, Toutain TGLdO et al. | 2025 | bioRxiv | 0 |
| Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner ↗ | Christopher Timmermann, Tommaso Barba, James P Sanders et al. | 2025 | | 0 |
| Neurociência dos psicodélicos: fundamentos bioquímicos, segurança e indicações emergentes em psiquiatria ↗ | Rodrigo Vitorino Gonçalves, Monica Montemor Bertazo, José Claudio Pereira da Silva et al. | 2025 | Contribuciones a las Ciencias Sociales | 0 |
| Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model ↗ | Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho et al. | 2025 | RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia | 0 |
| New psychoactive substances (NPS) identified in Canada: Results of the online NPS survey (2020–2023) ↗ | Sophie Rymill, Lexy Candler, P. Veeraraghavan Ramachandran et al. | 2025 | Emerging Trends in Drugs Addictions and Health | 0 |
| NILR: A Quantum-Resonant Information Layer for Synthetic Phenomenology ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Of shrub, cactus, vine and toad: psychedelic species of conservation concern ↗ | Anna O. Ermakova, Sam Gandy | 2025 | Frontiers in Conservation Science | 0 |
| POTENCIAL TERAPÊUTICO DA AYAHUASCA COMO INTERVENÇÃO NOS TRANSTORNOS PSIQUIÁTRICOS: UMA REVISÃO SISTEMÁTICA ↗ | Jurdi Jasserand Y, Vieira de Oliveira AB, De Queiroz A et al. | 2025 | SciELO Preprints | 0 |
| Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations ↗ | Silva-Costa N, Pessoa JA, Andrade KC et al. | 2025 | Journal of psychopharmacology (Oxford, England) | 0 |
| Psicodélicos S. A.: reflexiones sobre la capitalización y el corporativismo de las plantas de poder ↗ | Genlizzie Elizabeth Garibay Munguía | 2025 | INTERdisciplina | 0 |
| Psychedelic Herbal Medicines: Exploring the Renaissance of a Therapeutic Frontier ↗ | Gaurav Mude, Shantilal Singune, Raghvendra Dubey | 2025 | International Journal of Ayurvedic Medicine | 0 |
| Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review ↗ | de Oliveira AL, de Oliveira DP, Dos Santos RG et al. | 2025 | Progress in neuro-psychopharmacology & biological psychiatry | 0 |
| Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration ↗ | Tony R. Montgomery, DeMond M. Grant | 2025 | | 0 |
| Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) ↗ | Tabaac BJ, Shinozuka K, Weisman A et al. | 2025 | PsyArXiv | 0 |
| Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy ↗ | Pu Jiang, Cong Lin, Xiaohui Wang | 2025 | Psychedelics. | 0 |
| Psychedelics are Bringing a new wind to the Pharmacopoeia ↗ | Michel Bourin | 2025 | Neuroscience and Neurological Surgery | 0 |
| Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges ↗ | Taslim Uddin, Suma Akter, Kanak Yadab Ghosh | 2025 | Advanced Neurology | 0 |
| Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review ↗ | Marco Otto Toscano, Serena Chiara Civardi, Federico Durbano | 2025 | Pharmaceutical science. | 0 |
| Psychedelics induced modulation of motor recovery after stroke ↗ | Koschützke, Leif | 2025 | Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET | 0 |
| Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring ↗ | Kargbo RB | 2025 | ACS medicinal chemistry letters | 0 |
| Psychosis in a Military Veteran in the Context of Hallucinogen Use: A Case Report ↗ | Parhami P, Moriarty SE, Parikh J et al. | 2025 | Cureus | 0 |
| Quantitative evaluation of multiple treatment regimens for treatment-resistant depression ↗ | Feng Y, Lv Y, Yang J et al. | 2025 | The international journal of neuropsychopharmacology | 0 |
| Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence ↗ | Ortiz Bernal AM, Raison CL, Lancelotta RL et al. | 2025 | Journal of psychoactive drugs | 0 |
| Red Ucuuba (Virola sebifera Aubl. Myristicaceae) ↗ | Noureddine Chaachouay, Allal Douira, Lahcen Zidane | 2025 | | 0 |
| Rede social de conhecimentos etnobotânicos da planta sagrada, cipó Mariri Banisteriopsis caapi (Spruce ex Grisebach), da floresta amazônica, componente do chá Ayahuasca ↗ | Arielen Barreto de Carvalho, Anderson Ortiz Alves, Diana Lizeth Vicente Flores et al. | 2025 | OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA | 0 |
| Reducing Cardiovascular Side Effects of DMT Using Beta-Blockers ↗ | Kargbo RB | 2025 | ACS medicinal chemistry letters | 0 |
| Request for Proposals - Exploring expanded consciousness and endogenous DMT ↗ | Tyler Diorio | 2025 | | 0 |
| Review for "COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS" ↗ | Antal Nógrádi | 2025 | | 0 |
| Review for "N,N-Dimethyltryptamine (DMT) acutely exposed to mouse ventral tegmental area Ih-negative neurons alters the firing rate and conductance in a sex-dependent manner" ↗ | Carlos Rozas | 2025 | | 0 |
| Revisiting Ayahuasca: Vine of the Soul of the Amazon ↗ | Kaur J, Modesto-Lowe V | 2025 | The primary care companion for CNS disorders | 0 |
| Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat ↗ | Ehmann S, Mosahvili N, White A et al. | 2025 | PsyArXiv | 0 |
| Serotonergic psychedelics for depression: A comprehensive overview ↗ | Wingert AM, Agnorelli C, Peill J et al. | 2025 | International review of neurobiology | 0 |
| Severe Rhabdomyolysis and Acute Kidney Injury Following Ayahuasca‐Related Trauma: A Case Report ↗ | American Medical Association 2025, Bedi, Ashmeet | 2025 | Underline Science Inc. | 0 |
| Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample ↗ | Petrovitch D, Hosford S, Littlefield AK et al. | 2025 | PsyArXiv | 0 |
| Speech markers of psychedelic-induced psychological change ↗ | Kuc J, McAlpine RG, Sellers A et al. | 2025 | bioRxiv | 0 |
| Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT<sub>1A</sub> Receptor for Therapeutic Potential in Depression and Anxiety ↗ | Li SJ, Yuan QN, Wu WY et al. | 2025 | Research (Washington, D.C.) | 0 |
| Substance use disorders (SUDs) in Latin America and the Caribbean: a narrative review of native medicinal plants as alternative therapies ↗ | Danladi Chiroma Husaini, Joel H. Chiroma, Innocent Ejiofor Nwachukwu et al. | 2025 | Beni-Suef University Journal of Basic and Applied Sciences | 0 |
| Symbios of Substrates: Bridging Biological and Machine Intelligence ↗ | Samuel John Church | 2025 | OSF Preprints (OSF Preprints) | 0 |
| Table 1_DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.docx ↗ | Yvonne A. Bonomo (22061303), Amanda F. Norman (22061306), Lisa Collins (12184515) et al. | 2025 | Figshare | 0 |
| Table 2_DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.docx ↗ | Yvonne A. Bonomo (22061303), Amanda F. Norman (22061306), Lisa Collins (12184515) et al. | 2025 | Figshare | 0 |
| Table 3_DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.docx ↗ | Yvonne A. Bonomo (22061303), Amanda F. Norman (22061306), Lisa Collins (12184515) et al. | 2025 | Figshare | 0 |
| The Consciousness Trinity ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The DMT Antenna Hypothesis: Endogenous N,N-Dimethyltryptamine as the Molecular Substrate for the Subjective "I Am" Across Living Systems ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| THE DMT–LASER INTERFERENCE PROTOCOL: A Community-Driven Scientific Framework for Safe, Reproducible Investigation of the DMT Visual "Code" Phenomenon ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| THE DMT–LASER INTERFERENCE PROTOCOL (Version 2): A Standardized, Open-Source Framework for Safe, Reproducible Investigation of Structured Visual Phenomena in Diffused Coherent Light Under N,N-Dimethyltryptamine ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The forensic identification of N,N-Dimethyltryptamine in plant species commonly used in the preparation of ayahuasca ↗ | Megan Rebecca Dunkle | 2025 | OpenBU (Boston University) | 0 |
| The Ghosts of Ayahuasca: Conceptual Limits and Spectral Residues ↗ | Jacob W. Glazier, Sean O’Donnell | 2025 | Anthropology of Consciousness | 0 |
| The Physics of "I Am": Encoded Equilibrium as the Universal Interaction Law ↗ | Swygert, John | 2025 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The relation between naturalistic use of psychedelics and perception of emotional stimuli: An fMRI study ↗ | Paweł Orlowski, Michał Bola, Aleksandra Domagalik-Pittner | 2025 | OSF Preprints (OSF Preprints) | 0 |
| The role of ayahuasca in cell viability and oxidative stress in gastric adenocarcinoma cell line ↗ | Gonçalves J, Cascalheira JF, Valentão P et al. | 2025 | Natural product research | 0 |
| The Use, Role, and Function of Music During Psychedelic-Assisted Therapy (PAT) with Ayahuasca: A Scoping Review Protocol ↗ | Guillermo Saúl Escobar Cornejo, Fernando P. Cárdenas, Diego José Lira Torres et al. | 2025 | Psychoactives | 0 |
| Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges ↗ | Guilllermo Castaño-Perez, Sara Isabel Castaño-Ocampo | 2025 | Pharmaceutical science. | 0 |
| Title: the use of ayahuasca in the investigation of serious criminal offenses (felonies): a scientific and legal analysis ↗ | K. Shyshkarov | 2025 | Наше право | 0 |
| Translational reinterpretation of ancestral healing rituals: Structured physiological modulation through adaptive biological responses ↗ | Gaspary JFP, Edgar AL, Gaspary FP et al. | 2025 | Explore (New York, N.Y.) | 0 |
| Understanding Neuroplasticity Induced by Tryptamines (UNITy): Understanding Neuroplasticity Induced by Tryptamines: Rewiring Maladaptive Memories in Hazardous Drinking with Memory Reactivation and Dimethyltryptamine (DMT) ↗ | Natalia Fernandez-Vinson, Roger Atkins, Marcus Glennon et al. | 2025 | Open Science Framework | 0 |
| Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report ↗ | Amin Reihani, Fatemeh Shaki | 2025 | DOAJ (DOAJ: Directory of Open Access Journals) | 0 |
| We licked the frogs so you don’t have to: A comprehensive history and analysis of the chemical syntheses of the classical psychedelics Bufotenin(e) and 5-methoxy-N,N-dimethyltryptamine ↗ | Anton A. Homon, Jaxon Laramie, John J. Hayward et al. | 2025 | ChemRxiv | 0 |
| Zalsupindoleis a Nondissociative, NonhallucinogenicNeuroplastogen with Therapeutic Effects Comparable to Ketamine andPsychedelics ↗ | Rajiv Agrawal (22419626), Daniel Gillie (22419629), Alison Mungenast (22419632) et al. | 2025 | Figshare | 0 |
| 0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study ↗ | Denise Vidot, Bria-Necole Diggs, Amrit Baral et al. | 2026 | SLEEP | 0 |
| 5-HT<sub>1A</sub> receptor blockade potentiates the subjective effects of DMT ↗ | Zahid Z, Strassman RJ, Qualls CR et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| 5-Methoxy-N,N-Dimethyltryptamine: Functional Safety Pharmacology and Video-EEG Assessment of a Short-Acting Serotonergic Psychedelic in Beagle Canines ↗ | Lotfi A, Sparapani S, Pouliot M et al. | 2026 | International journal of toxicology | 0 |
| 717. Safety and Tolerability of Intravenous Bolus and Constant Infusion of DMT in Individuals With Major Depressive Disorder and Healthy Controls ↗ | Prakash Gupta, Guillermo Ornelas, Lynda Wang et al. | 2026 | Biological Psychiatry | 0 |
| A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous Functions ↗ | Ramiro Solis | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine Maintains Neuroplasticity ↗ | Ramiro Solis | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| A dispersive liquid-liquid microextraction method for the determination of ayahuasca alkaloids (N,N-dimethyltryptamine and β-carbolines) in human hair ↗ | Santos FP, Bismara Paranhos BAP, Sandini TM et al. | 2026 | Talanta | 0 |
| A Dyadic DMTx Stimulation Protocol for Testing Anomalous Interparticipant Information Transfer ↗ | Jean‐Patrick Pommier | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| A nondirective physical and psychological support protocol for inhaled N,N-Dimethyltryptamine (DMT): A qualitative evaluation of safety, comfort, and integration in a clinical setting ↗ | Handersson Barros, Marcelo Falchi-Carvalho, Lucas Maia et al. | 2026 | Psychology of Consciousness Theory Research and Practice | 0 |
| A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression ↗ | Roberts C, Seynaeve M, Ermakova AO et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects ↗ | Hampsey E, Martin K, Kalfas M et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| A theoretical investigation of DMT metabolism and the formation of apotential biomarker ↗ | Maria Luiza Luiz Marçal, Luiz Antonio Sodre Costa | 2026 | SSRN Electronic Journal | 0 |
| ABSTRACT NUMBER: ESOC2026YS125 DIMETHYLTRYPTAMINE INHIBITS SPREADING DEPOLARISATION IN BRAIN SLICES OF SIGMA-1 RECEPTORKNOCKOUT MICE ↗ | Anna Zsigmond, Rita Frank, Botond Eröss et al. | 2026 | European Stroke Journal | 0 |
| Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report ↗ | Reis JAS, Rossi GN, Zacharias ABV et al. | 2026 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 0 |
| Advancing Next-Generation Psychedelic Therapeutics through Selective 5-HT2A Activation, Precision Aerosol Delivery, and Optimized 5-MeO-DMT Treatment Paradigms ↗ | Anna C. Renner, Robert B. Kargbo | 2026 | ACS Medicinal Chemistry Letters | 0 |
| Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks — Including Life Between Lives and Transpersonal Hypnotherapy ↗ | Gallardo LM | 2026 | Preprints.org | 0 |
| Anchoring Stealth Amine Biomarkers via Coupled Chemical Activation for Surface Immobilization ↗ | Choi J, Park S, Lee J et al. | 2026 | Langmuir : the ACS journal of surfaces and colloids | 0 |
| Assessing the educational quality of grey literature: a case study ↗ | Louise M. O’Grady, Lawrence Webb, Xavier A. Conlan | 2026 | Australian Journal of Forensic Sciences | 0 |
| AVALIAÇÃO IN SÍLICO DAS POSSÍVEIS ATIVIDADES FARMACOLÓGICAS E TOXICOLÓGICAS DOS COMPOSTOS SECUNDÁRIOS QUE COMPÕEM A BEBIDA AYAHUASCA: BANISTERIOPSIS CAAPI E PSYCHOTRIA VIRIDIS ↗ | Maysa Cruz Lima Feitosa, Bernardo Melo Neto, Joubert Aires de Sousa | 2026 | Revista Ibero-Americana de Humanidades, Ciências e Educação | 0 |
| Ayahuasca and Fibromyalgia: Promising Mechanisms, Missing Evidence: A Mini-review ↗ | Jozelio Freire de Carvalho | 2026 | Journal for Transdisciplinary Approach in Complementary and Alternative Medicine | 0 |
| Ayahuasca and Its Main Component <i>N,N</i>-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind ↗ | Melani A, Papini G, Bonaso M et al. | 2026 | Biomedicines | 0 |
| Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind ↗ | Alice Melani, Giorgia Papini, Marco Bonaso et al. | 2026 | Universität des Saarlandes | 0 |
| Ayahuasca and Public Health III: Health Status of a Sample of Ayahuasca Ceremony Attenders in Portugal ↗ | Teixeira PJ, Encantado J, Amaro HD et al. | 2026 | Journal of psychoactive drugs | 0 |
| Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies ↗ | Dráulio B. Araújo, Lucas O. Maia, Tiago Arruda-Sanchez et al. | 2026 | Current Addiction Reports | 0 |
| Ayahuasca modulation of traumatic-like fear memories requires infralimbic cortex BDNF-dependent mechanisms in rats ↗ | Werle I, Guimarães FS, Dos Santos RG et al. | 2026 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 0 |
| Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression - A Systematic Review ↗ | Mano-Sousa BJ, Fontes MCG, Gonçalves ACA et al. | 2026 | Journal of psychoactive drugs | 0 |
| B48-13 Severe Serotonin Syndrome With Acute Respiratory Failure Following Ayahuasca and Dextromethorphan Use: A Case Report ↗ | S Pack, T Ellett, J Pham et al. | 2026 | American Journal of Respiratory and Critical Care Medicine | 0 |
| Beliefs in and experiences of sorcery, black magic and brujería among psychedelic users: a quantitative and qualitative survey ↗ | Evans J, Jurlando C, Luke D et al. | 2026 | PsyArXiv | 0 |
| Beyond a Psychotropic Plant: Exploring the Ethnomedicinal Value of Anadenanthera colubrina var. cebil ↗ | González RB, Ojeda GA, Miragliotta AMG et al. | 2026 | Mini reviews in medicinal chemistry | 0 |
| Beyond Enthusiasm: Ayahuasca and the Future of Depression Research ↗ | Sá Filho AS, Fajemiroye JO, Nardi AE et al. | 2026 | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) | 0 |
| Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression ↗ | Bolcont R, Palhano-Fontes F, Barros H et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Bidirectional alpha collapse, not forward wave increase, under N,N-DMT: A reanalysis of cortical travelling waves ↗ | David M. Remmer | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Brain-body integromics of the ayahuasca experience ↗ | Madrid-Gambin F, Mallaroni P, Haro N et al. | 2026 | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 0 |
| Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models ↗ | Ben-Zion Z, Simon G, Lazebnik T | 2026 | Research Square | 0 |
| Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease ↗ | Xu T, Wong S, Le GH et al. | 2026 | Pharmacopsychiatry | 0 |
| CH DMT Abort Tracker ↗ | Eric [LAST NAME] | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds ↗ | Lewis BR, Reid MJ, Novick AM et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT ↗ | Tarailis P, Griskova-Bulanova I | 2026 | bioRxiv | 0 |
| Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats ↗ | Ladislavová L, Kútná V, Mazochová K et al. | 2026 | Pharmacology, biochemistry, and behavior | 0 |
| Classic psychedelics and personality: An updated systematic review ↗ | Vicentini AB, de Paula CC, Silva Reis JA et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers ↗ | Aicher HD, Dornbierer J, Caflisch L et al. | 2026 | Psychopharmacology | 0 |
| Combined Neuroprotective Effects of N,N-Dimethyltryptamine and Ventral Root Reimplantation Following Spinal Root Avulsion in Rats ↗ | Aponte PAC, Montoya EH, Mazali IO et al. | 2026 | Journal of neurochemistry | 0 |
| Computational evaluation of aluminum and zinc doped C<sub>20</sub> fullerenes as advanced sensors for the detection of the narcotic dimethyltryptamine ↗ | Alshahrani SM | 2026 | Scientific reports | 0 |
| Computational spirits: a neuroscientific account of psychedelic entity encounters ↗ | Mago J, Deane G, Sandved-Smith L et al. | 2026 | Neuroscience of consciousness | 0 |
| CONTRIBUIÇÕES DOS PSICODÉLICOS PARA A PSICOTERAPIA DA ANSIEDADE: PERSPECTIVAS ATUAIS ↗ | Maria Eduarda Marquezi Machioni, Giulia Argueles de Oliveira, Ana Luísa Da Silva Rueda et al. | 2026 | ULAKES JOURNAL OF MEDICINE | 0 |
| Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment ↗ | Uthaug MV, Lancelotta R, Szabo A et al. | 2026 | Psychopharmacology | 0 |
| Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27] ↗ | Wießner I, Falchi-Carvalho M, Laborde S et al. | 2026 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 0 |
| Cross-cultural Attitudes Towards Using Ayahuasca as an Alternative Treatment for PTSD: A Comparative Study of Attitudes in the MENA Region and Western Countries ↗ | Abeer Manneh | 2026 | Digital Access to Scholarship at Harvard (DASH) (Harvard University) | 0 |
| Datasets sued for Honours thesis : <b>Fishy trip or trippy fish? Larval zebrafish as a model for ayahuasca pharmacotherapy</b> ↗ | Alexia Walker | 2026 | Figshare | 0 |
| Datasets used for Honours thesis : <b>Fishy trip or trippy fish? Larval zebrafish as a model for ayahuasca pharmacotherapy</b> ↗ | Alexia Walker | 2026 | Figshare | 0 |
| Decision letter for "N,N-Dimethyltryptamine (DMT) acutely exposed to mouse ventral tegmental area Ih-negative neurons alters the firing rate and conductance in a sex-dependent manner" ↗ | | 2026 | | 0 |
| Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells ↗ | Salles G, Almeida CAF, de Carvalho Alves I et al. | 2026 | Archives of toxicology | 0 |
| Distinguishing 4- vs 5-Hydroxy-<i>N</i>,<i>N</i>-Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-Exchange ↗ | Christopher MW, Prentice BM, Garrett TJ | 2026 | Journal of the American Society for Mass Spectrometry | 0 |
| DMT and Microtubule Coherence Selection: A Testable Model of Informational Throttling in Time Perception ↗ | EUGENE CATRAMBONE | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| DMT, Madness, and Healing: Psychosis Model, Therapy Model, and Their Relations to Mystical Experiences and Positive Emotionality ↗ | Wießner I, Falchi-Carvalho M, Laborde S et al. | 2026 | Research Square | 0 |
| DMT microstates ↗ | Maria Niedernhuber | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| DMT use in Cluster Headache: Interim Analysis of an International Survey (S23.003) ↗ | Emmanuelle Schindler, Kevin Lenaburg, Robert Wold | 2026 | Neurology | 0 |
| Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants ↗ | Erne L, Mueller L, Straumann I et al. | 2026 | Translational psychiatry | 0 |
| Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity ↗ | Emma Dobbin | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Efectos subjetivos vinculados al consumo de Dimetiltriptamina (DMT) y su potencial como auxiliar terapéutico en adultos jóvenes de Hidalgo ↗ | Abraham González Alvarado, Jorge G. Escobar-Torres | 2026 | Con-Ciencia Boletín Científico de la Escuela Preparatoria No 3 | 0 |
| Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review ↗ | de Paula CC, Vicentini AB, Guerra LTL et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity ↗ | Aneta Petrušková | 2026 | OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg | 0 |
| Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta-analysis ↗ | Wallace LM, Bujor A, Sudre G et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour ↗ | Scala M, Magrini E, Leccisotti I et al. | 2026 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 0 |
| Endogenous DMT Surge as a Candidate Mechanism for Terminal Lucidity in Dementia: A Hypothesis ↗ | James Tocher | 2026 | OSF Preprints (OSF Preprints) | 0 |
| Endogenous N,N-Dimethyltryptamine as a Rigid Mechanical Anchor and Thermodynamic Buffer During Apoptotic Transition ↗ | Enkhamgalan Nasanjargal | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Endogenous Tryptamines as Bioenergetic Regulators of the Binding Problem: The VESTA Framework ↗ | Artun Sina Bolukbasi | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation ↗ | Lin C, Wang X | 2026 | Molecular psychiatry | 0 |
| Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study ↗ | Poppe C, Lyck L, Bechtold L et al. | 2026 | Brain and behavior | 0 |
| Exploring Colombian medicinal flora used in indigenous and campesino health systems for neuropsychiatric disorders and neuropharmacological potential: an ethnopharmacological review ↗ | Brache K, Diazgranados M | 2026 | Frontiers in pharmacology | 0 |
| Exploring the Relationship Between Aphantasia and Dimethyltryptamine Levels in Cerebrospinal Fluid ↗ | J. Martin Strangeweather | 2026 | Figshare | 0 |
| Fabricated ancestrality: The Sonoran Desert toad, psychedelic globalization, and the ecological politics of 5-MeO-DMT ↗ | A.M Ortiz Bernal, C L Raison, A.M Vargas Prieto et al. | 2026 | Psychedelics | 0 |
| Falso positivo en el cribado de anfetaminas secundario a dimetiltriptamina ↗ | Bernardino Barceló Martín, José Manuel Arteaga Armas, Isabel Gomila Muñiz et al. | 2026 | Adicciones | 0 |
| From Acute Altered States to Durable Change: A Social-Psychological Framework for Contextual Framing, Integration, and Post-Acute Stabilization ↗ | Elias Rubenstein | 2026 | International Journal of Research and Innovation in Social Science | 0 |
| Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [ <sup>18</sup> F]FDG-PET study ↗ | Klemens Egger, Robert Bozsak, Helena D Aicher et al. | 2026 | Universität Zürich, ZORA | 0 |
| Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [¹⁸F]FDG-PET study ↗ | Klemens Egger, Robert Bozsak, Helena D. Aicher et al. | 2026 | Repository for Publications and Research Data (ETH Zurich) | 0 |
| Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [<sup>18</sup>F]FDG-PET study ↗ | Egger K, Bozsak R, Aicher HD et al. | 2026 | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism | 0 |
| Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes ↗ | Minauro-Sanmiguel F, Vargas-Perez H | 2026 | Neuroscience | 0 |
| Impact of CYP2D6 Polymorphisms on the Pharmacokinetics of N,N-Dimethyltryptamine and Harmine via PBPK Modeling and Simulation ↗ | Gabriella de Souza Gomes Ribeiro, Pieter Annaert, Frederico Severino Martins et al. | 2026 | Future Pharmacology | 0 |
| IMPLICACIONES PENALES DE LOS COMPORTAMIENTOS RELACIONADOS CON LA AYAHUASCA. ESTUDIO DEL OBJETO MATERIAL EN LOS “OTROS” DELITOS CONTRA LA SALUD PÚBLICA ↗ | Antonio Martín Pardo | 2026 | Revista de Derecho Penal y Criminología | 0 |
| In Silico Characterization of Desmodium gangeticum Compounds as Dual Modulators of MAO-B and 5- HT2A in Parkinson’s Disease: An Integrated Approach Combining Molecular Docking, ADMET Profiling, MM-GBSA, QSAR Modeling, and Molecular Dynamics Simulation ↗ | Akinma OE, Akinola OA, Ojo ID et al. | 2026 | Research Square | 0 |
| In silico insights into the adsorption and detection of dimethyltryptamine on metal doped C20 fullerene ↗ | Abdulrahman Sumayli, Saad M. Alshahrani, Jawaher Abdullah Alamoudi | 2026 | Scientific Reports | 0 |
| In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5'-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin ↗ | Jurowski K, Kobylarz D, Noga M | 2026 | Archives of toxicology | 0 |
| Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration ↗ | Magar V, Robbins M, Fernández Lobo Blanco ÓML et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial ↗ | Seynaeve M, Dunbar F, Hindocha C et al. | 2026 | CNS drugs | 0 |
| Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey ↗ | Arqueros M, Soler J, Cebolla A et al. | 2026 | Human psychopharmacology | 0 |
| Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review ↗ | Smith SA, Mohammad H, Lee LHN et al. | 2026 | Psychopharmacology | 0 |
| Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies ↗ | Dolenec P, Pelčić G, Pilipović K et al. | 2026 | Pharmaceuticals (Basel, Switzerland) | 0 |
| Isotopic DMT as a Probe of Spin-Dependent Psychedelic Pharmacology ↗ | Jean‐Patrick Pommier | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Isotopic DMT as a Probe of Spinorial Consciousness ↗ | POMMIER, Jean‐Patrick Pommier | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World ↗ | David J, Berkovich-Ohana A, Dor-Ziderman Y et al. | 2026 | PsyArXiv | 0 |
| LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study ↗ | Lowe MX, Darby QA, Kalcheff-Korn S et al. | 2026 | Journal of psychoactive drugs | 0 |
| Machine learning recovers folk classification of <i>Banisteriopsis caapi</i> from herbarium leaves an ayahuasca liana ↗ | Biazatti SC, Bambil D, Môra R et al. | 2026 | iScience | 0 |
| Metaphysics of The MindMetaphysics of the Mind: The Roots of Jungian Psychoanalysis & Spiritual Perception in Cognitive Neuroscience ↗ | Alan Peter Garfoot | 2026 | Global Journal of Arts Humanities and Social Sciences | 0 |
| Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat ↗ | Schlomberg JTT, Meling D, Grylka R et al. | 2026 | Scientific reports | 0 |
| Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons ↗ | Senānāyaka R | 2026 | PsyArXiv | 0 |
| Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT ↗ | D’Amelio TA, Garbagnoli TG, Cuello JR et al. | 2026 | bioRxiv | 0 |
| Multimodal brain, autonomic and phenomenological data for the acute effects of N,N-dimethyltryptamine (DMT) ↗ | Tomás Ariel D'Amelio, Tomás Gil Garbagnoli, Jerónimo Rodríguez Cuello et al. | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness—a psychometric analysis using the PES100 in controlled psychedelic studies ↗ | Kurt Stocker, Matthias Hartmann, Frederick S. Barrett et al. | 2026 | Religion Brain & Behavior | 0 |
| N,N-Dimethyltryptamine (DMT) Acutely Exposed to Mouse Ventral Tegmental Area I<sub>h</sub>-Negative Neurons Alters the Firing Rate and Conductance in a Sex-Dependent Manner ↗ | Eliasen JN, Rezagholizadeh A, Jacobsen HP et al. | 2026 | Journal of neurochemistry | 0 |
| N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain ↗ | Palner M, Kolesnik E, Baun C et al. | 2026 | Neuropharmacology | 0 |
| Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia ↗ | Armando Ordaz‐Hernández, M. Corona-Ramírez, Israel Jesús Orlando Guerrero | 2026 | Revista CienciaUANL | 0 |
| New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants ↗ | Silva MH | 2026 | Birth defects research | 0 |
| New psychoactive substances (designer drugs): an approach to classification ↗ | Azat R. Asadullin, Elvina A. Akhmetova, Ilia S. Efremov et al. | 2026 | Neurology Bulletin | 0 |
| New treatments for OCD? Evidence for cannabinoids and psychedelics ↗ | Van Ameringen M, Patel V, Patterson B et al. | 2026 | Journal of psychiatric research | 0 |
| nnDMT CH Abort Dose Estimator ↗ | [FIRST NAME] [LAST NAME] | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes ↗ | Jean‐Patrick Pommier, POMMIER | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| nwharbert8-ui/psychedelic-wj-architecture: Publication Release ↗ | nwharbert8-ui | 2026 | Open MIND | 0 |
| Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems ↗ | Zhang T, Lin C, Wang X | 2026 | ACS pharmacology & translational science | 0 |
| Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users ↗ | Bouso JC, Andión O, Estévez SF et al. | 2026 | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 0 |
| Pineal Gland and Hyperdimensional Wisdom: A Critical Desk-Based Review of Neuroendocrinology, Consciousness Studies, and Spiritual-Cultural Narratives ↗ | Hongyu Cao, Weixiang Gan | 2026 | Critical humanistic social theory. | 0 |
| Policy Considerations for Psychedelics in Research and Medicine – What’s Next on the Schedule? ↗ | Matthew A. Boehm, Oriana Mayorga | 2026 | Journal of Science Policy & Governance | 0 |
| POTENCIAL TERAPÊUTICO DA HOASCA NO TRATAMENTO DA DEPRESSÃO: REVISÃO DE ESCOPO ↗ | Adrian Santos de Souza, Endiamara Magda Segala Shigemori, Celso Ferraz Bett | 2026 | Revista Políticas Públicas & Cidades | 0 |
| Pre-analytical stability of tryptamine derivatives in blood and plasma: role of ascorbic acid and preservatives ↗ | Christopher McGrowder | 2026 | CUNY Academic Works (City University of New York) | 0 |
| Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates (Callithrix jacchus) subjected to chronic stress ↗ | Fernandes Pereira LR, Lira-Bandeira WG, Medeiros-Bandeira AS et al. | 2026 | Translational psychiatry | 0 |
| Preliminary effects of ayahuasca on mental and physical health: A systematic review of prospective studies ↗ | Haupt MJ, Carra S, Boehnke KF et al. | 2026 | Progress in neuro-psychopharmacology & biological psychiatry | 0 |
| Proliferative Effects of the Psychedelic <i>N,N</i>-Dimethyltryptamine (DMT) in Human Neural Stem Cells ↗ | Salerno JA, Dominguez ER, Karmirian K et al. | 2026 | ACS chemical neuroscience | 0 |
| ProliferativeEffects of the Psychedelic N,N-Dimethyltryptamine(DMT) in Human Neural Stem Cells ↗ | José Alexandre Salerno, Elizabeth R. Dominguez, Karina Karmirian et al. | 2026 | Figshare | 0 |
| Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults ↗ | Carter D, Reardon I, Swain J et al. | 2026 | Research Square | 0 |
| Protective Role of Dimethyltryptamine in Preserving Donor Cardiac Function in a Heterotopic Rat Transplantation Model ↗ | K. Benke, M. Csonka, R. Stengl et al. | 2026 | The Journal of Heart and Lung Transplantation | 0 |
| Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake ↗ | Bergh MS, Bogen IL, Vevelstad M et al. | 2026 | Journal of analytical toxicology | 0 |
| Psilocybin and the Evolutionary Significance of Altered Neural States: Interaction-Based Perspectives Beyond Deterrence Models ↗ | Rebensburg P | 2026 | EcoEvoRxiv | 0 |
| Psilocybin: Chemical Foundations and Emerging Therapeutic Potential ↗ | Patil SA, Hunsberger HC | 2026 | Mini reviews in medicinal chemistry | 0 |
| Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution ↗ | Matsukubo J, Friesen EL, MacDonald-Spracklin R et al. | 2026 | Canadian journal of public health = Revue canadienne de sante publique | 0 |
| Psychedelic-Assisted Psychosexual Therapy ↗ | Lohani Noor | 2026 | | 0 |
| Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling ↗ | Albert OM, Arthur A | 2026 | Therapeutic advances in drug safety | 0 |
| Psychedelic-induced hypomania and mania: a systematic review and meta-analysis ↗ | Eskinazi M, Nasserdine R, Cusin RM et al. | 2026 | Molecular psychiatry | 0 |
| Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT) ↗ | Lyons FE, Rockhill KM, Fox EJ et al. | 2026 | Journal of psychoactive drugs | 0 |
| Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action ↗ | Kazdan J, Ladha KS, Husain MI | 2026 | Pharmacology research & perspectives | 0 |
| Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil ↗ | Portes MAM, Bertoglio LJ | 2026 | Journal of psychoactive drugs | 0 |
| Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies ↗ | Zhang J, Lin C, Lv X et al. | 2026 | Biological psychiatry | 0 |
| Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology ↗ | Geraci J, Viirre E, Qorri B et al. | 2026 | Frontiers in pharmacology | 0 |
| Psychedelics: Future Therapeutics in Major Depression? ↗ | Olivier B, Olivier JDA | 2026 | Advances in experimental medicine and biology | 0 |
| Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers ↗ | Vipul Janardan, Amit Khanna, Om Prakash et al. | 2026 | Journal of Mental Health Disorders | 0 |
| Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations ↗ | Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB et al. | 2026 | Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater | 0 |
| Psychedelics produce enduring enhancement of reward responsiveness in male rats ↗ | Christopher W. Thomas, Kayleigh S. LaMalfa, Tobias P. Whelan et al. | 2026 | Neuropsychopharmacology | 0 |
| Rapid Isolation and High-Purity Characterization of N, N-Dimethyltryptamine from Mimosa tenuiflora for Analytical Standard Development and Regulatory Insight ↗ | Zhang Ming | 2026 | SSRN Electronic Journal | 0 |
| Reconstituting a two-step pathway for N,N-dimethyltryptamine (DMT) biosynthesis in bacteria ↗ | Lucas Henrique Junges, FLÁVIA LADA DEGAUT PONTES, Francisco J. Teles Mota et al. | 2026 | Metabolic Engineering Communications | 0 |
| Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review ↗ | Stojanović T, Nilsson KW, Fredriksson R et al. | 2026 | Clinical pharmacology and therapeutics | 0 |
| Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil ↗ | Nogueira M, García-Hernández S, Roberto GS et al. | 2026 | The International journal on drug policy | 0 |
| Reorganization of Human Brain Waves Across Diverse States of Consciousness. ↗ | Fotiadis, Panagiotis, Jang, Hyunwoo, Dai, Rui et al. | 2026 | bioRxiv : the preprint server for biology | 0 |
| Reported Safety Practices of Publicly Advertised Psychedelic Retreats ↗ | McGuire AL, Neitzke-Spruill L, Robinson JO et al. | 2026 | JAMA network open | 0 |
| Serotonergic Polypharmacology of 2-Halogenated Tryptamines. ↗ | Yacoub, Jeanine, Bray, Elena, Bayyat, Jude et al. | 2026 | bioRxiv : the preprint server for biology | 0 |
| Sex-dependent effects of psychedelics: review of evidence from rodent models ↗ | Rafał Marecki, Wiktoria Zaniewska, Adam Hamed et al. | 2026 | Frontiers in Psychiatry | 0 |
| Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience ↗ | Xin Y, Griffiths RR, Davis AK | 2026 | Journal of psychoactive drugs | 0 |
| Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics ↗ | Bhat A, Zolali E, Sakib MA et al. | 2026 | ACS chemical neuroscience | 0 |
| Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats ↗ | Lodetti G, de Bitencourt RM, Inserra A et al. | 2026 | Progress in neuro-psychopharmacology & biological psychiatry | 0 |
| Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish ↗ | Lodetti G, Inserra A, Redivo H et al. | 2026 | Psychopharmacology | 0 |
| Speech markers of psychological change following a psychedelic 5-MeO-DMT retreat ↗ | Kuc J, McAlpine RG, Sellers A et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment ↗ | Ishii M, Zervas M | 2026 | ScienceOpen Preprints | 0 |
| Supplemental Material for A Nondirective Physical and Psychological Support Protocol for Inhaled N,N-Dimethyltryptamine (DMT): A Qualitative Evaluation of Safety, Comfort, and Integration in a Clinical Setting ↗ | | 2026 | Psychology of Consciousness Theory Research and Practice | 0 |
| Synthesis and Biological Evaluation of 4‑Bromo-<i>N,N-</i>dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development ↗ | Bray E, Glatfelter GC, Maitland AD et al. | 2026 | ACS omega | 0 |
| Synthesis and BiologicalEvaluation of 4‑Bromo-N,N-dimethyltryptamine(4-Br-DMT): A Synthetic BuildingBlock for Future Analog Development ↗ | Elena Bray, Grant C. Glatfelter, Alexander D. Maitland et al. | 2026 | Figshare | 0 |
| The Architecture of Ego Dissolution: A Mechanical-First Evaluation of N,N-Dimethyltryptamine at the Sigma-1 and 5-HT2A Interfaces ↗ | Enkhamgalan Nasanjargal | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The Axis Mundi Hypothesis: Endogenous N,N-Dimethyltryptamine as a Neurobiological Bridge Between Conscious and Subconscious Processing - An Integrative Theoretical Framework ↗ | Mihai Alexandru | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder ↗ | Marini S, De Berardis D | 2026 | Preprints.org | 0 |
| The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review ↗ | Raikkerus H, Bujour A, Kennedy M et al. | 2026 | Acta neuropsychiatrica | 0 |
| The Endogenous Hallucination of Consensus Reality and the Inversion of the AI Alignment Calibration Problem ↗ | T. S. Eden | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The Last Dream: A Neurocognitive Model of Terminal Brain Activity and Subjective Time at Death ↗ | Sciacchitano Gianluca | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The Molecular Key to the Theta Field: A Zero-Parameter Formalization of Endogenous DMT and Consciousness State Transitions ↗ | Washburn, Jon | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review ↗ | Giaffone de Paiva Ferreira F, Fernandes JAB, Filev R et al. | 2026 | Journal of psychopharmacology (Oxford, England) | 0 |
| The role of Oceanic boundlessness in psilocybin-assisted therapy in patients with treatment-resistant depression: Exploring its relationship with connectedness to nature ↗ | Samuel Seymour | 2026 | OSF Preprints (OSF Preprints) | 0 |
| The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study ↗ | Camargos GS, de Faria Júnior GM, Lourenço M et al. | 2026 | Frontiers in psychiatry | 0 |
| The Use of Psychedelics in the Treatment of Adult ADHD: A Systematic and Mechanistic Review ↗ | Chmiel J, Malinowska A, Kurpas D | 2026 | International journal of molecular sciences | 0 |
| Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders ↗ | Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin | 2026 | Psychiatry and Clinical Psychopharmacology | 0 |
| Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease ↗ | Calleja-Conde J, Echeverry-Alzate V, Sanz-SanCristobal M et al. | 2026 | Experimental neurology | 0 |
| Toxicometabolomics Characterization of Two N1-Sulfonated Dimethyltryptamine Derivatives in Zebrafish Larvae and Human Liver S9 Fractions Using Liquid Chromatography-High-Resolution Mass Spectrometry ↗ | Punnamraju P, Manier SK, Hemmer S et al. | 2026 | Metabolites | 0 |
| Traces of the Other – Are DMT Entities Real? DMT Phenomenology in the Framework of Conscious Realism ↗ | Gallimore AR, Hermansson N, Hoffman DD | 2026 | PsyArXiv | 0 |
| Trifecta Study Post-registration - An Observational Study Evaluating the Impact of Ibogaine-Magnesium, 5-MeO-DMT, Magnetic e-Resonance Therapy, and Hormone Replacement Therapy in Special Operations Forces Combat Veterans ↗ | Brandon Weiss, Kathryn Pate | 2026 | Open Science Framework | 0 |
| Types of Hallucinogens as Drugs and Its Effects On the Human Body ↗ | Abul Kasem Rahman | 2026 | SHAREOK (University of Oklahoma) | 0 |
| Vaporizable Formulation of 5-MeO-DMT and THCV as Prophylactic or Therapeutic Agent for Treatment-Resistant Depression (TRD) and Anxiety Disorders ↗ | Henry P | 2026 | Preprints.org | 0 |
| Vaporized mebufotenin leads to improvement in treatment‐resistant depression ↗ | | 2026 | The Brown University Psychopharmacology Update | 0 |
| Visionary art and the limits of social constructivism ↗ | Orsolya Bajusz | 2026 | Visual Studies | 0 |
| We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine ↗ | Homon A, Laramie J, Hayward JJ et al. | 2026 | ChemMedChem | 0 |
| When I use a word . . . Terminology of hallucinogenic agents ↗ | J K Aronson | 2026 | BMJ | 0 |
| When Time Stops: Inside the Mind's Clock ↗ | EUGENE CATRAMBONE | 2026 | Zenodo (CERN European Organization for Nuclear Research) | 0 |
| Allelopathic effects of Psychotria viridis Ruiz & Pavon on the germination and initial growth of Lactuca sativa L ↗ | Amanda Andrade, Maria A. da Silva, Alison de Oliveira et al. | | RePEc: Research Papers in Economics | 0 |
| Encountering the Luminous Mother: Two Breakthrough DMT Narratives and the Six-Phase Architecture of Mystical Experience ↗ | Keppel Hesselink JM | | PhilPapers (PhilPapers Foundation) | 0 |
| From Silence to Song: Consciousness as a Recursive Inevitability of the Universe ↗ | Gleason, Cody | | | 0 |